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Abstract 
	  
Streptococcus pyogenes, also known as Group A Streptococci (GAS) causes many 
diseases, ranging from non-invasive (“Strep throat) to highly invasive (bacterial 
sepsis). GAS secretes various virulence factors implicated in pathogenesis and 
immune evasion, the best studied include superantigens. Regulatory T cells (Tregs) are 
a subset of CD4+ T cells, previously described in maintaining the fine balance of 
immune responses during infectious diseases; however, the precise role during 
streptococcal infection is unknown. The work in this thesis involves the 
characterisation of Tregs in the pathogenesis of GAS infection. Depletion of Tregs in 
inducible Foxp3.DTR knockout mice during GAS infection showed significant 
reduction in systemic bacterial spread and decreased serum levels of pro-
inflammatory cytokines (IL-6 and IFN-γ), suggesting Tregs are detrimental to the host 
response to this bacterium. Further examination of effector cells indicate a protective 
role for CD8+, γδ+ T cells and NK cells in this model of acute sepsis as depletion of 
either of these subsets exacerbated bacterial burden and altered cytokine production. 
Utilising a transgenic HLA-DQ8.Aβ0 murine model, previously demonstrated to be 
susceptible to streptococcal superantigens, up-regulation of Foxp3 gene and protein 
expression in secondary lymphoid tissues during early stages of infection was 
attributed to the presence of SMEZ superantigen, correlating with decreased bacterial 
load. SPEA superantigen was found to induce TH1 cells and enhanced IFN-γ 
production to lead to the so-called “cytokine storm” and increased bacterial burden. 
This suggests that GAS through the action of secreted superantigens, modulates the 
immune response to induce Tregs and establish a state of tolerance to hinder protective 
effector cells, such as CD8+, γδ+ T cells and NK cells and IL-17A production, while 
promoting pathogenic TH1 cells to drive potent immune pathology. 
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DNA    Deoxyribonucleic Acid 
dNTPs    Deoxynucleotide Triphosphates 
ds    double stranded 
DSS    Dextran Sulfate Sodium 
DT    Diphtheria Toxin 
DTH    Delayed-Type Hypersensitivity  
EAE    Experimental Autoimmune Encephalomyelitis 
EAU    Experimental Autoimmune Uveoretinitis 
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EDTA    Ethylenediaminetetraacetic Acid 
ELISA    Enzyme-Linked Immunosorbent Assay 
FCS    Fetal Calf Serum 
FMO    Fluorescence Minus One 
Foxp3    Forkhead box P3 
G-CSF    Granulocyte Colony-Stimulating Factor 
GALT    Gut-Associated Lymphoid Tissue 
GAS    Group A Streptococci 
GFP    Green Fluorescent Protein 
GITR    Glucocorticoid-Induced TNFR-Related protein 
HLA    Human Leukocyte Antigen 
HSPs    Heat Shock Proteins 
i.m    intra-muscular 
i.p    intra-peritoneal 
IBD    Inflammatory Bowel Disease 
IDO    Indoleamine 2,3-dioxygenase 
IFN    Interferon 
Ig    Immunoglobulin 
IHC    Immunohistochemistry 
iNKT cell   invariant Natural Killer T cell 
IL    Interleukin 
IRAK    Interleukin-1 Receptor-Associated Kinase 
IRF    Interferon Regulatory Factor 
IVIG    Intravenous Immunoglobulin 
Kb    Kilo-basepair 
KIRs    Killer-cell Immunoglobulin-like Receptors  
KO    Knockout 
L-Glut    L-Glutamine 
LAG-3    Lymphocyte-Activation Gene 3 
LAP    Latency-Associated Peptide 
LB    Luria Bertani 
LPS    Lipopolysaccharides 
LRR    Leucine Rich Region 
LTA    Lipoteichoic Acid 
	   21	  
M-CSF   Macrophage Colony-Stimulating Factor 
mAb    monoclonal Antibody 
MAPK    Mitogen-Activated Protein Kinase 
MDA-5   Melanoma Differentiation-Associated protein 5 
mDCs    Myeloid DCs 
MFI    Median Fluorescence Intensities 
MHC    Major Histocompatibility Complex 
MIC-A/B   MHC class I polypeptide-related sequence A/B 
MS    Multiple Sclerosis 
mTOR    Mammalian Target of Rapamycin 
MyD88   Myeloid Differentiation primary response gene 88 
NALT    Nasal-Associated Lymphoid Tissue 
NETs    Neutrophil Extracellular Traps 
NF-κB Nuclear Factor kappa-light-chain-enhancer of activated 
B cells 
NK    Natural Killer  
NLRs    NOD-Like Receptors 
NOD    Nucleotide-binding Oligomerisation Domain 
P/S    Penicillin/Streptomycin 
PAMPs   Pathogen Associated Molecular Patterns 
PBMCs   Peripheral Blood Mononuclear Cells 
PBS    Phosphate Buffered Saline 
PCR    Polymerase Chain Reaction 
pDCs    plasmacytoid Dendritic Cells 
PGN    Peptidoglycan 
PMA    Phorbol 12-myristate 13-acetate 
PRR    Pattern Recognition Receptor 
qRT-PCR   quantitative Real-Time Polymerase Chain Reaction 
RA    Retinoic Acid 
RAG    Recombination Activating Genes 
REST    Relative Expression Software Tool 
RHD    Rheumatic Heart Disease 
RIG    Retinoic acid Inducible Gene 
RLRs    RIG-I-Like Receptors 
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RNA    Ribonucleic Acid 
RORγt    RAR-related Orphan Receptor gamma t 
ROS    Reactive Oxygen Species 
RPMI     Roswell Park Memorial Institute 
RT    Room Temperature 
SDS    Sodium Dodecyl Sulfate 
SE-A/B/C   Staphylococcal Enterotoxins-A/B/C 
SEM    Standard Error of the Mean 
SLO    Streptolysin O 
SLS    Streptolysin S 
SMEZ    Streptococcal Mitogenic Exotoxin Z 
SNPs    Single Nucleotide Polymorphisms 
SOCS    Suppressor Of Cytokine Signaling 
SPE-A/B   Streptococcal Pyrogenic Exotoxin-A/B 
ss    single stranded 
STAT    Signal Transducer and Activator of Transcription 
STSS    Severe Toxic Shock Syndrome 
TCDD    2,3,7,8-Tetrachlorodibenzo-p-dioxin 
TCR    T Cell Receptor 
TDO    Tryptophan-2,3-dioxygenase 
Teff    T effector cells 
TGF-β    Transforming Growth Factor-β 
TH    T Helper 
THB    Todd Hewitt Broth 
THY    Todd Hewitt Yeast 
TIR    Toll/Interleukin-1 Receptor 
TLRs    Toll-Like Receptors 
TMB    3, 3′, 5, 5′-Tetramethylbenzidine 
TNBS    2,4,6-trinitrobenzenesulfonic acid 
TNF    Tumor Necrosis Factor 
TRAF    TNF Receptor Associated Factor 
Treg    Regulatory T cell 
WT    Wild Type 
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Chapter 1 
	  
1 Introduction  
 
1.1 The immune system  
 
The mammalian host has evolved many different elegant mechanisms to prevent 
colonisation and damage caused by pathogenic microorganisms. The primary 
functions of the immune system are to offer immunological recognition: 
discriminating between danger and non-danger, potent effector functions to eliminate 
pathogens and also immunological memory to provide lasting protection against re-
infection. The immune system can be sub-divided broadly into two groups: innate and 
adaptive immunity, each with unique but inter-connected qualities.  
 
 
1.1.1 An overview of the immune response 
 
When the human body first encounters an infectious agent, the primary line of host 
defence is the skin or mucosal surfaces forming physical barriers. If these barriers are 
breached, innate immunity is initiated, first to contain and eliminate the infection by 
various mechanisms such as phagocytosis and induced lysis of pathogens. 
Metchnikoff in 1905 originally proposed the hypothesis of phagocytic cells as a 
mechanism of protection against infection (Metchnikoff, 1905), and his theory was 
later supported by the work of Lurie and Suter (Lurie, 1938; Lurie, 1941; Suter, 
1953). Cells composing the innate immune system include: Dendritic Cells (DCs), 
macrophages, neutrophils, monocytes, Natural Killer (NK) cells, γδ T cells and the 
complement system, which will be discussed in more detail in Section 1.2.  
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Figure 1.1: Time course of immune responses during infection. 
After entry of the pathogens into the host, the microorganisms will activate the innate 
immune response. If innate immunity cannot eliminate the invading infectious agent, 
adaptive immunity is initiated to provide differentiated effector cells leading to enhanced 
pathogen clearance and creation of immunological memory, ready for quick re-activation 
upon secondary exposure to the same pathogen. 
 	  
 
Adaptive immunity, consisting of T and B lymphocytes is mounted after innate 
immunity. This slower response is due to antigen-mediated activation of naïve T and 
B cells followed by clonal expansion, providing differentiated effector cells to aid 
pathogen eradication (Kamat and Henney, 1976). This is achieved either through 
cytotoxic T cells (CTL) or T helper (TH) cells, which coordinate the immune response 
via cytokine production, while B cells are responsible for the production of antibodies 
to neutralise targets. Adaptive immune cells are key in the formation of 
immunological memory (Nossal and Mäkelä, 1962; Miller and Sprent, 1971; Vischer 
et al., 1967). After the primary infection has been eliminated in the resolution phase, 
secondary encounters with the same pathogen are eradicated more efficiently due to 
quick re-activation and proliferation of memory cells (Figure 1.1) (Nossal et al., 
1965). 
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1.1.2 An overview of microbial recognition 
 
 
Figure 1.2: Summary of signaling pathways utilised by the four different classes of 
PRRs. 
The four classes of PRRs (TLRs, NLRs, RLRs and CLRs) respond to the presence of 
microbial ligands or endogenous damaged tissue products to initiate signal transduction 
pathways. This induces gene expression of pro-inflammatory cytokines and type I interferons 
and aid pathogen clearance to subsequent activation of adaptive immunity or induce cell 
apoptosis (Chong and Sriskandan, 2011).  
 	  
 
The first step required for activation of the immune response is the recognition and 
discrimination of self and foreign particles. Innate immunity offers a broad specificity 
against pathogens using germline-encoded Pattern Recognition Receptors (PRRs) that 
can recognise common conserved pathogenic features or Pathogen-Associated 
Molecular Patterns (PAMPs). To date, four major families of PRRs have been 
characterised since their early identification: Toll-like receptors (Medzhitov et al., 
1997), Nod-like receptors (Steimie et al., 1993; Harton et al., 2002), C-type lectin 
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receptors (Santis et al., 1994) and Retinoic acid-induced gene (RIG)-1-like receptors 
(Rothenfusser et al., 2005) (Figure 1.2). Signaling through these receptors result in 
the production of pro-inflammatory cytokines, type I interferons, anti-microbial 
proteins and chemokines, all of which contribute to the host inflammatory response, 
as observed during bacterial infection and sepsis (Figure 1.2) (de Jong et al., 2010). 
 
The best studied examples of PRRs are Toll-like Receptors (TLRs), homologs of 
Toll, which was first discovered in Drosophilia in the 1980s (Andersen et al., 1985) 
and subsequently in mammals by Janeway and Medzhitov (Medzhitov et al., 1997). 
Found in both invertebrates and vertebrates, TLRs have evolved as pathogen sensors 
on innate cells but also connect with adaptive immunity via the activation of DCs, 
which subsequently stimulate adaptive immune cells (Kawai and Akira, 2010). TLRs 
also bridge the innate and adaptive immune system, expressed by a wide range of 
different subsets from lymphocytes to monocytes, macrophages, NK cells and DCs 
(Kadowaki et al., 2001; Muzio et al., 2000; Kabelitz, 2007; Hornung et al., 2002).  
 
TLRs can be broadly classified according to their location within the cell. TLR1, 2, 4, 
5, and 6 are found on the cell surface and bind extracellular ligands, typically derived 
from bacteria (Table 1.1). TLR3, 7, 8 and 9 are localised to endosomes and 
lysosomes within the cell, recognising nucleic acids from pathogens such as viruses 
that have been internalised (Table 1.1) (Barton and Kagan, 2009).	  Interestingly, TLRs 
can also sense host cell-derived ligands or Damage-Associated Molecular Patterns 
(DAMPs) as well as pathogen-associated ligands. DAMPs are produced during tissue 
damage, stress or trauma and tend to be either nuclear or cytoplasmic proteins 
released into the extracellular space during necrosis (Matzinger, 1994; Seong and 
Matzinger, 2004). Key examples of DAMPs include heat-shock proteins (HSPs), 
fibrogen and alarmins such as high mobility group box 1 (HMGB1) (Chang, 2010). 	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Table 1.1: Broad specificity of recognition by TLRs. 
A diverse range of known ligands, covering many different classes of microorganisms are 
recognised by TLRs (Chong and Sriskandan, 2011). 
 
TLR  Ligand Microbial source 
TLR1 Triacyl lipopeptides Bacteria 
TLR2 Peptidoglycans, lipopeptides, atypical LPS 
zymosan, phospholipomannan 
GPI anchors 
Heat Shock Proteins (e.g. HSP 70) 
Bacteria 
Fungi 
Protozoa 
Host cells 
TLR3 Poly I:C, dsRNA Virus 
TLR4 LPS 
Mannan, glucuronoxylomannan 
Glycoinositolphospholipids 
RSV fusion protein 
Heat Shock Proteins (e.g. HSP-60) 
Bacteria 
Fungi 
Protozoa 
Virus 
Host cells 
TLR5 Flagellin Bacteria 
TLR6 Diacyl lipopetides Bacteria 
TLR7 Synthethetic imiazoquinoline-like molecules, ssRNA Virus 
TLR8 ssRNA Virus 
TLR9 CpG DNA Bacteria, protozoa, virus 
TLR10  Function and ligand unknown - 
TLR11 (mouse only) Components of uropathogenic bacteria 
Profilin-like molecules 
Bacteria 
Protozoa 
TLR12-13 (mouse only) Function and ligand currently unknown - 
 
 	  
Upon ligand binding to TLRs, a conformational change in the receptor complex is 
induced, resulting in recruitment of adaptor signaling molecules, and signal 
transduction cascade within the cell. Two signaling pathways exist for TLRs; 
Myeloid Differentiation primary response gene 88 (MyD88)-dependent and MyD88-
independent pathways, both culminating in gene expression of key inflammatory 
products. All TLRs except for TLR3 utilise the MyD88-dependent signaling pathway, 
whereas TLR3 signals solely via the MyD88-independent route. TLR4 is unique as it 
can transmit signals from the extracellular surface via both pathways (Akira, 2003; 
Chang, 2010; Jin and Lee, 2008). 
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In the MyD88-dependent pathway, the cytoplasmic adaptor protein MyD88 binds 
with TLRs via its Toll/Interleukin-1 Receptor (TIR) domains, resulting in the 
recruitment of Interleukin-1 Receptor-Associated Kinase-4 (IRAK-4) to associate 
with the receptor complex via its death-domains (Medzhitov et al., 1998; Wesche et 
al., 1997). MyD88 facilitates IRAK-4 mediated phosphorylation of IRAK-1, a serine-
threonine kinase, which leads to activation and recruitment of BCL10 and subsequent 
dissociation from the receptor complex (Wesche et al., 1997).  BCL10, also known as 
CLAP is required for the optimal signaling of the transcription factor NF-κB 
(Srinivasula et al., 1999). Phosphorylated IRAK-1 associates with TRAF6, a 
polyubiquitin ligase to activate TAK1/TAB complexes and enhances the activity of 
IκB kinase complex (Figure 1.3) (Cao et al., 1996). AP1 transcription factor is also 
activated through this process through the MAPK signaling pathway (Medvedev et 
al., 2000).  The consequence of this signaling cascade is the nuclear translocation of 
NF-κB and thus, expression of pro-inflammatory cytokine genes, such as TNF-α and 
IL-6 (Figure 1.3) (Liebermann and Baltimore, 1990; Collart et al., 1990). Other 
adaptor proteins similar to MyD88 such as Mal and TIRAP are also recruited in this 
pathway but are limited to TLR1, 2 and 4 signaling only (Kenny et al., 2009). The 
presence of anti-inflammatory cytokines such as IL-10 may suppress the MyD88-
dependent pathway by degrading key signaling molecules such as IRAK4 and 
TRAF6 to prevent induction of pro-inflammatory cytokines (Chang et al., 2009). 
 
The MyD88-independent pathway triggers gene induction of type I interferons, such 
as IFN-β and occurs via ligand binding to TLR3 and TLR4 (Horng et al., 2001; 
Yamamoto et al., 2002).  The MyD88-independent pathway utilises unique adaptor 
proteins such as TRIF and TRAM, establishing a signal transduction cascade 
concluding with the activation of IRF-3 transcription factor to induce IFN-β and IFN-
inducible genes via STAT1, TKKε and TBK1/NF-κB activating kinases (Figure 1.3) 
(Kawai et al., 2001).  TRAM has evolved to be a TLR4-only adaptor protein 
(Yamamoto et al., 2003; Fitzgerald et al., 2003). It is now emerging that other TLRs, 
such as TLR2 are capable of inducing type I interferon responses, suggesting that 
other, unknown signaling pathways may also exist to bring about gene expression 
changes, depending on the required immune response upon infection (Barbalat et al., 
2009). 
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Figure 1.3: Overall signaling pathways utilised by TLRs. 
TLRs respond to various microbial ligands leading to signal transduction via the MyD88 
dependent and independent pathways. The MyD88 signaling pathway is depicted on the left 
hand side of the figure, while the MyD88 independent pathway signaling via TRAM is 
shown on the right hand side, culminating in transcription factor translocation into the 
nucleus to induce gene expression. Adapted from (Chong and Sriskandan, 2011).  
 
 
 
The net effect of TLR signaling via either MyD88-dependent or independent 
pathways is induced transcription of pro-inflammatory cytokines such as TNF-α and 
type I interferons to aid microbial clearance. However, another crucial role of TLR 
signaling is the activation of DCs and the subsequent initiation and polarisation of 
adaptive immunity. Combinations of TLR ligands (TLR3, TLR4 and TLR8) can 
work synergistically to trigger activation of DCs to produce cytokines, such as IL-12 
required for differentiation of TH1 cells, (Napolitani et al., 2005; Hou et al., 2008). 
TLR signaling can result in the up-regulation of MHC class II molecules on DCs to 
stimulate antigen presentation to cells of the adaptive immune system (Chandran et 
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al., 2009; Mitchell et al., 2010). TLR2 stimulation may also enhance proliferation of 
CD8+ memory T cells and enhance IFN-γ production (Mercier et al., 2009; Cottalorda 
et al., 2009) or induce TH17 cell differentiation via the production of polarising 
cytokine by Langerhans cells (Aliahmadi et al., 2009). TH1 cell activity can also be 
mediated via TLR2 signaling, suggesting that TLR2 may behave as a direct co-
stimulatory molecule on T cells, priming them for immediate activation (Imanishi et 
al., 2007; Komai-Koma et al., 2004). 
 
Nod-like receptors (NLRs) are a family of receptors with the predominant function to 
detect microbial components within the cytoplasm of the cell (Philpott and Girardin, 
2010). These receptors work in parallel with TLRs, such as TLR1, 2 and 7 to 
recognise infectious agents that have already entered the cell (van Heel et al., 2005). 
Class II, major histocompatibility complex, transactivator (CIITA) was first identified 
as a MHC Class II gene transactivator expressed by macrophages, B cells, T cells and 
DCs (Steimie et al., 1993).	  However, a splice variant of this protein was later found to 
share common features with other NLRs, establishing CIITA as the founding member 
of this class of PRRs (Nickerson et al., 2001).  
 
The human genome encodes 23 NLR family members, all of which exhibit similar 
structural features, such as an amino-terminal pyrin domain (PYD) or a caspase 
recruitment domain (CARD), a central nucleotide binding domain (NOD) and a 
carboxyl-terminal leucine rich repeats (LRRs), a feature shared with TLRs (Inohara et 
al., 1999). Well studied NLRs include NOD1 and NOD2, which are able to signal 
through NF-κB in a manner similar to TLRs (Inohara et al., 1999). 
 
NLRs have been highly researched in the past few years within the context of the 
inflammasome, a multi-protein complex with the main function of facilitating the 
maturation of some pro-inflammatory cytokines, such as IL-1β (Martinon et al., 
2002). NLRs are recruited to the inflammasome, however, the exact composition of 
this complex can vary, generally containing caspase-1, PYCARD, a NALP and 
sometimes caspase-5 or caspase-11 (Martinon et al., 2002). NLRs are key 
components in regulating the activation state of caspase-1, an enzyme, which cleaves 
the immature pro-form of IL-1β into active IL-1β in response to different 
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environmental signals. The release of pro-inflammatory cytokines in this manner, 
first studied during infectious diseases, such as Shigella flexneri infection is termed 
pyroptosis and is distinct from apoptosis (Hilbi et al., 1997). 
 
C-type lectin receptors (CLRs) are a family of transmembrane receptors, 
characterised by the presence of a conserved carbohydrate-binding domain (Figdor et 
al., 2002).  Carbohydrate ligands derived from a wide variety of pathogens, such as 
viruses, bacteria and fungi form the main core of ligands recognised by CLRs. There 
are four groups of CLRs based on key structural features: type I (mannose receptors), 
type II, type III (collectins) and type V (NK cell receptors). These receptors upon 
ligand stimulation induce pro-inflammatory cytokines via a separate signaling 
pathway from TLRs, but still result in NF-κB translocation into the nucleus (Zhang et 
al., 2009b). This signaling pathway can also modulate TLR-mediated immune 
responses via NF-κB, enhancing IL-10 gene and protein production via TLR3, 4 and 
5 (Gringhuis et al., 2007). Synergistic effects of combined signaling via TLR and 
CLR pathways have also been demonstrated in neutrophils and may possess a 
regulatory role during Mycobacterium tuberculosis BCG infection (Zhang et al., 
2009b). 
	  
CLRs are broadly expressed on most cell types, from macrophages to DCs. Dectin-1 
is one of the most commonly studied of the CLR family, recognising β-glucans found 
in fungi to promote the production of pro-inflammatory cytokines, such as TNF-α 
and also reactive oxygen species (ROS) via NF-κB signaling (Ariizumi et al., 2000; 
Willment et al., 2003; Brown et al., 2002; Underhill et al., 2005). Another well 
investigated CLR is DC-SIGN, found on DCs and may be involved in the recognition 
of sugars on specific viruses, such as influenza and Human Immunodeficiency Virus 
(HIV) (Carthagena et al., 2011; Itano et al., 2011). The recognition of these 
pathogens by macrophages and DCs play a key role in the subsequent activation of 
the adaptive immunity. 
 
RIG-1-like receptors (RLRs) are the last of the four major branches of PRRs. 
Characterised as RNA helicases, they are crucial for the recognition of viruses and 3 
family members have been identified; RIG-1 (Cheng and Lotan, 1998), melanoma 
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differentiation-associated gene 5 (MDA-5) (Kang et al., 2002) and LGP2 
(Rothenfusser et al., 2005). Localised within the cytoplasm of the host cell, RLRs 
bind genomic RNA of dsRNA viruses and dsRNA generated as part of the replicative 
cycle of ssRNA viruses. Upon activation of this class of PRR, anti-viral responses are 
mounted in the form of type I interferon production via NF-κB signaling (Yoneyama 
et al., 2005).  
 
RIG-1 has been demonstrated to recognise short dsRNA; up to 1Kb, favouring 
5’triphosphate ends enhancing type I interferon induction (Kato et al., 2008). It has 
also been suggested that in resting cells, RIG-1 may form an inhibitory complex with 
HSP-90α to regulate its function, suggesting that this RLR may have a role in 
regulating responses to DAMPs (Matsumiya et al., 2009). MDA-5 recognises longer 
dsRNA fragments; more than 2Kb in length, such as poly I:C, which is also 
recognised by TLR3 (Kato et al., 2008). LGP2 was first proposed as a negative 
regulator of RIG-1 and MDA-5. However, it has now emerged that mice lacking this 
RLR family member are unable to mount anti-viral responses, suggesting that LGP2 
may work synergistically with RIG-1 and MDA-5 (Satoh et al., 2010). There is 
conflicting data on whether RLRs can have an impact on inflammasome activity and 
is still under current investigation (Delaloye et al., 2009). 
 
Overall, different receptors have evolved to recognise conserved microbial and host 
cell derived ligands. Common PAMPs, such as poly I:C are recognised by different 
receptors (TLR3 and MDA-5) to maximise activation of both innate and adaptive 
immune cells and induce signal transduction and gene expression of key mediators of 
inflammation and pathogen clearance mechanisms. 	  	  	  
1.2 Innate Immunity  
 
Several cell types contribute to innate immunity due to their rapid activation in 
response to invading pathogens. These cell types initiate the first stages of immunity 
to limit spread of infection, actively destroy pathogenic microorganisms and secrete 
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cytokines and chemokines to recruit and prime adaptive immunity. Each of the key 
cellular components of innate immunity will be briefly described in the following 
section. 
 
 
1.2.1 Macrophages 
 
Macrophages were first identified as important cells involved in the phagocytosis of 
foreign particles and are derived from monocytes in the tissue upon the differentiation 
with M-CSF (Cohn and Benson, 1964; Stanley et al., 1976). Macrophages have been 
functionally sub-divided into two phenotypes; classically (M1) and alternatively 
activated (M2) macrophages. M1 macrophages are characterised by their induction 
with pro-inflammatory molecules, such as LPS and IFN-γ, producing an array of 
different pro-inflammatory cytokines like TNF-α, IL-1β, IL-6 and IL-12 also 
inducible Nitric oxide Synthase (iNOS) to produce Nitric oxide (NO) (Goldmann et 
al., 2010; Liu et al., 2011a; Trinchieri, 1997). M2 macrophages, in contrast, produce 
anti-inflammatory cytokines such as IL-4, IL-10, Transforming Growth Factor-β 
(TGF-β) and IL-1 decoy receptor and also exhibit arginase activity (Goldmann et al., 
2010; Liu et al., 2011a; Bastos et al., 2002).  
 
Apart from cytokine production, macrophages express CD80 and CD86 and MHC 
class II molecules, allowing antigen presentation to naïve T cells to activate adaptive 
immunity. Macrophages are also involved in direct killing of microbes by many 
different mechanisms. For example, this innate cell type can produce ROS and NO or 
anti-microbial peptides. Macrophages can produce elastase such as MMP12, which is 
stored in intracellular compartments and mobilised after phagocytosis to kill the 
microorganisms (Houghton et al., 2009). The role of macrophages during bacterial 
infection will be discussed further in Section 1.9.3. 
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1.2.2 Dendritic Cells (DCs) 
 
Dendritic Cells (DCs) are derived from monocytes through differentiation with GM-
CSF and IL-4. Very few terminally differentiated DCs are found in circulating blood, 
usually in the range of 0.5-2% of human Peripheral Blood Mononuclear Cells 
(PBMCs). Their primary function is antigen processing and presentation to naïve T 
cells and also cytokine production to create specific microenvironment to allow 
differentiation and polarisation of TH subsets (Tuettenberg et al., 2011).  
 
DCs can be divided into two groups; CD11c+CD123- myeloid DCs (mDCs) and 
CD11c-CD123+ plasmacytoid DCs (pDCs) with differing functions (Ito et al., 1999). 
Both these classes of cells are capable of producing pro-inflammatory cytokines, such 
as IFN-α in response to microbial stimuli, although mDCs can also secrete IL-10 and 
IL-12. TLR expression also differentiates these two subsets (Veckman and Julkunen, 
2008). mDCs have a broad range of TLR expression, except for TLR7 and 9, whereas 
pDCs express predominantly TLR7 and 9 and low levels of TLR1, 6 and 10 
(Veckman and Julkunen, 2008). DCs can also express the transcription factor 
Forkhead box P3 (Foxp3) to gain suppressive activity and can skew the T helper cell 
differentiation towards TH2 and Treg phenotype (Lipscomb et al., 2010). 
 
 
1.2.3 Neutrophils 
 
Neutrophils, also known as Polymorphonuclear Neutrophils (PMNs) are the most 
abundant cell type within the human white blood cell population. Essential for the 
initial defence against extracellular pathogens, neutrophils recognise microbes 
through the expression of many different PRRs such as NODs and TLRs. PMNs are 
produced and released from the bone marrow into the blood, offering rapid protection 
from invading pathogens. The levels of circulating neutrophils have been shown to be 
regulated by the expression of CXCR4; excessive signaling from this chemokine can 
lead to neutrophil containment within the bone marrow, whereas CXCR4 deficiency 
results in uncontrolled release of PMNs into the blood (Eash et al., 2010).  
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Neutrophils are often guided to the site of infection or inflammation via the release of 
endogenous pro-inflammatory DAMPs, produced by the process of necrosis and also 
by cytokines and chemokines such as IL-17A and IL-8 respectively (McDonald et al., 
2010). This subset of innate cells have three main mechanisms to attack 
microorganisms, phagocytosis, release of granules containing anti-microbial peptides 
and enzymes and ensnaring microbes through the release of a framework of DNA and 
proteases called Neutrophil Extracellular Traps (NETs). NET formation has been 
shown to be partly responsible for the neutralisation of Staphylococcus aureus 
(Pilsczek et al., 2010). Neutrophils have also been shown to be an important source of 
IL-17 during infection and will be discussed in more detail in Section 1.9.3 
(Matsuzaki and Umemura, 2007). 
 
PMNs can also exert regulation on T cell proliferation, effector function and survival 
during an immune response. This is achieved through the expression of OX40L on 
neutrophils and OX40 receptor on T cells. During poly-microbial sepsis, the 
expression of OX40L is significantly up-regulated on circulating neutrophils and 
macrophages. The importance of this ligand has been demonstrated through the use of 
OX40L-/- mice, which exhibit increased resistance to sepsis compared to wild-type 
mice (Karulf et al., 2010). This suggests that this interaction between T cells and 
neutrophils via OX40 may be detrimental to host survival during severe bacterial 
infection.  
 
 
1.2.4 Natural Killer (NK) cells  
 
Natural Killer (NK) cells are non-B, non-T lymphocytes, initially described in terms 
of their ability to lyse transformed or virally infected cells (Greenberg et al., 1975; 
Glimcher et al., 1977; Kiessling et al., 1975). While they are now appreciated to 
perform a far more complex role depending on both cytotoxicity and cytokine release 
in response to a range of environmental; changes including cellular stress, bacterial 
and fungal infection, the mechanisms of ligand recognition underpinning activation is 
often uncharted (Bauer et al., 1999; Vankayalapati et al., 2005; Hidore and Murphy, 
1986). NK cells are differentiated by interferons and other macrophage derived 
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cytokines, such as IL-2, IL-12, IL-18 and IL-15 (Mrózek et al., 1996; Riccardi et al., 
1983; Suzuki et al., 1997; Takeda et al., 1998). 
 
Two main subsets of NK cells were initially described in humans based on their 
expression of key markers; CD56 and CD16 (Nagler et al., 1989). CD56dimCD16+ 
NK cells represent the major population and are highly cytotoxic through their release 
of granules (Nagler et al., 1989; Mandelboim et al., 1996; Peritt et al., 1998). 
CD56brightCD16- NK cells are responsible for cytokine production, such as IFN-γ, 
TNF-α, IL-10 and GM-CSF (Cooper et al., 2001). Most NK cells located in the 
lymph nodes are of the CD56brightCD16- variety (Fehniger et al., 2003). The basic 
leucine zipper transcription factor E4bp4, also known as NFIL3 has been shown to be 
essential for the development of NK cells, indicating this may be an important genetic 
marker for NK cells (Gascoyne et al., 2009). It has been suggested that anti-
inflammatory cytokine; TGF-β may inhibit the development and maturation of NK 
cells through down-regulation of CD16 expression (Allan et al., 2010). 
 
In mice, four subsets of NK cells have been defined, based on CD11b and CD27 
expression, contrasting with the two main classes of NK cells in humans. 
CD11bdullCD27dull and CD11bdullCD27+ NK cells represent the most naïve 
populations; CD11b+CD27+ cells are an intermediate population and CD11b+CD27dull 
NK cells being defined as the most differentiated and mature subset (Choissone et al., 
2009). CD56bright human NK cells have been suggested to be similar to CD11dull 
mouse NK cell population (Vivier et al., 2008).  
 
NK cell development begins in the bone marrow like other hematopoietic cells, 
before migration to the periphery. The largest population of murine NK cells is found 
in the spleen (Grégoire et al., 2007). Murine NK cells express diverse chemokine 
receptors involved in NK cell trafficking from the bone marrow to the periphery. 
CCR2, CCR5, CXCR3 and CX3CR1 regulate NK cell recruitment in response to 
inflammatory signals. CD62L (L-selectin) is also required to allow murine NK cells 
to enter lymph nodes from the blood, with CCR7 required in human NK cells for the 
same role (Vivier et al., 2008).  
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The role of NK cells during infection has been well researched as key mediators of 
anti-viral effects, such as IFN-γ production, release of cytolytic granules for lysis of 
infected cells and induction of apoptosis via TRAIL (Scalzo et al., 2007). The 
expression of IFN-γ is mediated via T-bet transcription factor expression (Werneck et 
al., 2008). Cytotoxic granules are pre-formed within NK cells, ready for deployment 
upon activation from cytokine signals from other cells (Reefman et al., 2010). The 
role of NK cells is not restricted to the field of infectious diseases, but this cell 
population has also been implicated in autoimmune diseases such as Multiple 
Sclerosis (MS). For example, NK cells can suppress autoreactive T cell responses in 
the central nervous system in a murine model of MS (Hao et al., 2010).  
 
The activation of NK cells is dependent on a balance of activation and inhibitory 
signals through three classes of receptors; Killer-cell Immunoglobulin-like Receptors 
(KIRs) - the key molecules used by human NK cells and not found in mice, Ly49 
lectin-like receptors and NKG2 lectin-like receptors expressed on the cell-surface. 
KIRs can recognise polymorphic Human Leukocyte Antigen (HLA)-A, B and C 
allotypes, whereas CD94-NKG2A receptor complex can recognise HLA-E allotypes 
(Sivori et al., 2010).  
 
NK cell effector function is regulated by interactions between inhibitory receptors 
and self-MHC class I molecule expression by a process that has been termed 
‘licensing’ by Wayne Yokoyama and colleagues (Kim et al., 2005). This will be 
examined in more detail in Chapter 4. Cells expressing MHC class I molecules are 
more resistant to NK-mediated killing, this is due to inhibitory signals received via 
KIRs and NKG2 receptors (Yokoyama and Kim, 2006). NK cell killing of target cells 
is mediated by an overall activation signal received by receptors such as 2B4 in 
human NK cells (Betser-Cohen et al., 2010).  
 
A new subset of NK-like cells has been identified in human tonsils, Peyer’s patches 
and appendix. This unique population of cells expresses CD56 and NKp44 similarly 
to conventional human NK cells, but also secrete IL-22 in response to IL-23. These 
so-called “NK-22 cells” are similar to TH17 phenotype due to expression of CCR6, 
Acyl hydrocarbon receptor (AHR) and RAR-related Orphan Receptor γt (RORγt) 
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transcription factor (Cella et al., 2010). Further phenotypic analysis has also revealed 
NK-22 cells as functionally heterogeneous as some can produce IFN-γ, while others 
secrete IL-17 (Cella et al., 2010). Whether these cells are also present in mice is still 
the subject of on-going work. 
 	  
1.2.5 NKT cells. 
 
NKT cells, also known as invariant-(i)NKT cells, are found in the thymus, peripheral 
lymphoid organs and blood, and share some markers of both NK and T cells. Their 
ability to release a large, rapid burst of cytokine in response to innate activation 
marks this cell type an important bridge between adaptive and innate immunity. They 
express a largely invariant T Cell Receptor (TCR) α chain and one of three different 
β chains and it is hypothesised they can recognise antigens from glycolipids 
presented by MHC class I-like β2-microglobulin associated CD1d molecules (Behar 
et al., 1999; Brossay et al., 1998). CD1d is mainly expressed by DCs, macrophages, 
particular subsets of B and T cells (Arrenberg et al., 2008). Upon activation, iNKT 
cells can produce IL-4, IL-10 and IFN-γ, suggesting that they have both regulatory 
and effector phenotype. The expression of IL-4 and IL-10 may be controlled by the 
NK specific transcription factor E4bp4 (Motomura et al., 2011), while it has also 
been suggested that the transcription factor GATA-3 may be required for the 
maturation of iNKT cells (Kim et al., 2006), highlighting the share features of both 
NK and T cells. 
 
The regulatory function of NKT cells has been shown in several autoimmune models 
such as Experimental Autoimmune Uveitis (EAU), where TH17 and TH1 cell 
differentiation was diminished in vitro (Oh et al., 2011). Cell contact between NKT 
and TH17 cells was required to inhibit T cell development; whereas the release of IL-
4 from NKT was sufficient to suppress TH1 differentiation (Oh et al., 2011). NKT 
cells can also express Foxp3 with regulatory T cell-like phenotype such as CD25, 
CTLA-4 and GITR expression (Monterio et al., 2010). These cells can also suppress 
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the progression of disease in Experimental Allergic Encephalomyelitis (EAE) 
(Monterio et al., 2010). 
 
 
1.2.6 γδ T cells 
 
γδ T cells are a subset of T cells; characterised by their expression of γ and δ chains 
forming the TCR, although this may be a more limited repertoire compared to αβ 
TCR+ T cells due to less available gene segments (Elliott et al., 1988). Their 
development pathway is similar to αβ TCR T cells, beginning in the thymus before 
migration into the periphery (Born et al., 2010). Although less abundant than αβ TCR 
T cells, γδ T cells tend to accumulate in epithelial cell-rich tissue and lymphoid 
tissue. The ligands for γδ TCR activation are still largely unknown (Bonneville et al., 
2010). The function of these T cells has also shown to be fairly plastic, with both 
effector and regulatory roles implicated (Bonneville et al., 2010; Eberl and Moser, 
2009). 
 
Immune surveillance is an important process, protecting the host from any potential 
threats incurred during tissue damage, inflammation and infection. Stress-induced 
MHC class I-related molecules (MIC)-A/B molecules activate γδ T cells in the skin 
or intestines to detect damaged, infected or transformed cells (Groh et al., 1998; 
Sumaria et al., 2011).  
 
γδ T cells can express some receptors found on NK cells, such as NKG2D and 
NKG2A, indicating this cell subset may have overlapping function with NK cells. For 
example, increased expression of MICA/B on infected or transformed cells enhances 
interactions with the activating NKG2D receptor on γδ T cells to lead to target cell 
killing (Nedellec et al., 2010). A particular subset of human γδ T cells characterised 
as Vγ9Vδ2+ also exhibits antigen cross presenting abilities similar to Antigen 
Presenting Cells (APCs) through the expression of adhesion receptors, co-stimulatory 
molecules and MHC class I and II molecules, suggestive that this class of T cells can 
activate other T cells (Meuter et al., 2010). 
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The effector function of γδ T cells is mediated by cytokine production and release of 
cytotoxic granules containing perforin, granzymes and TRAIL (Eberl and Moser, 
2009). RORγt expression is also required for differentiation of γδ T cells and may 
also be linked to their ability to secrete IL-17 (O’Brien et al., 2009). Type I interferon 
signaling can negatively regulate IL-17A and IL-17F production by γδ T cells during 
bacterial infection (Henry et al., 2010). γδ T cells can also produce the pro-
inflammatory cytokine IFN-γ upon activation and CD27 co-stimulation has been 
suggested to expand this particular population of cells (Ribot et al., 2010). The 
expression of other markers such as CCR6 and NK1.1 can also distinguish γδ T cells 
that secrete IL-17 and IFN-γ respectively (Haas et al., 2009). 
 
This subset of T cells also demonstrates a regulatory role during infection or 
autoimmunity. γδ T cells can suppress Tregs via high expression of IL-23R, which 
correlates with cells that are potent producers of IL-17A. IL-23R+ γδ T cells can 
expand during the murine model of EAE and prevent the induction of Foxp3+ T cells 
via a IL-23 dependent mechanism (Petermann et al., 2010). γδ T cells can also 
provide co-stimulation to NK cells to aid tumour cytotoxicity, possibly via CD137L 
expression (Maniar et al., 2010), indicating this cell type as a potent source of 
effector and regulatory function. 
 
Overall, the different components of innate immunity offer rapid recognition of the 
invading pathogen to lead to effective killing and elimination of the ensuing infection. 
Consequences of innate immunity include neutrophil and phagocyte activation to kill 
microbes, with cytokine production leading to APC activation, antigen processing 
and presentation to activate the next branch of host defence; adaptive immunity. 
 
 
 
1.3 Adaptive immunity 
 
Adaptive immunity plays a critical role to enhance the clearance of pathogenic 
microorganisms if innate immunity is unable to effectively clear the infection. This 
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thesis is mainly concerned with CD4+ T cells, however the role of CD8+ T cells will 
be further discussed in Chapter 4. In the past few years, the field of CD4+ T cell 
immunity has diversified due to ongoing attempts to classify T helper cells into 
distinct subsets on the basis of cytokines and transcription factors required for 
differentiation, cell-surface phenotype, cytokine profile and effector functions.  
 
 
1.3.1 TH1 and TH2 cells 
 
It was originally proposed by Mossmann and Coffman in 1986 that naïve CD4+ T 
cells could differentiate into cells of different cytokine profile, either T helper (TH)-1 
or TH-2 cells, depending on the strength of the TCR activation signal and the cytokine 
microenvironment (Mosmann et al., 1986). TH1 cells were considered to be involved 
in the eradication of intracellular pathogens due to their ability to produce their 
hallmark cytokine, IFN-γ (Figure 1.4). TH2 cells secrete cytokines such as IL-4, IL-5 
and IL-13 in response to allergens and parasitic helminths infection (Figure 1.4). The 
end result is increased eosinophils, mast cell activation and Immunoglobulin (Ig)-E 
antibodies responses leading to chronic inflammation (Coffman, 2010). 
 
TH1 cells are defined by their expression of T-bet transcription factor (Szabo et al., 
2000), whereas TH2 cells are characterised in the master regulator; GATA-3 (Zheng 
and Flavell, 1997) (Figure 1.4). The presence of these respective transcription factors 
plays a determining role in dictating the cytokine profile associated with each 
particular T helper cell subset. For example, continuous T-bet expression may silence 
il-4 gene expression, therefore no IL-4 production is observed in TH1 cells (Zhuang et 
al., 2009). GATA-3 can also inhibit ifn-γ gene expression in TH2 cells (Yu et al., 
2009). 
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Figure 1.4: Naïve CD4+ T cell differentiation. 
Naïve CD4+ T cells differentiate into various T helper subsets in the presence of different 
cytokines and environmental signals. T helper subsets can be identified by expression of 
different transcription factors indicated inside the cell and are characterised by the secretion 
of hallmark cytokines, shown on the right hand-side of the figure. Key signaling pathways 
that lead to T cell differentiation are also indicated on the right side of the figure. 
 
 
 
The cytokine environment is central in providing the necessary signals for naïve 
CD4+ T cells to differentiate into T helper subsets. For example, IFN-γ and IL-12 
produced by DCs and macrophages are required for TH1 cell development (Hsieh et 
al., 1993) (Figure 1.4). In chronic inflammation, IFN-γ production by TH1 cells; as 
mediated by JAK3 and p38-MAPK and STAT1 and STAT4 dependent signaling 
pathways, may be triggered by the presence of IL-2, 7 and 15 from innate cell sources 
(Sattler et al., 2009).  
 
The main cytokine required for naïve T cell polarisation to TH2 cells is IL-4. IL-4 
binding to its cognate receptor, leads to recruitment and phosphorylation of STAT6 to 
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dimerise and translocate into the nucleus to induce the expression of TH2 cell specific 
genes such as GATA-3 (Kurata et al., 1999). Activation of STAT3 is also required 
for TH2 cell development, as knockout mice lacking STAT3 do not develop TH2 cells 
(Stritesky et al., 2011). This would suggest that STAT3 and STAT6 work 
synergistically to lead to the differentiation of TH2 cells (Figure 1.4).  
 
TH2 associated cytokines are not only produced by differentiated CD4+ T cells. IL-33, 
a new member of the IL-1 cytokine family, can induce the production of TH2 
associated cytokines and increase serum immunoglobulins, particularly in mast cells 
(Chen et al., 2009b). This novel cytokine can act through two receptors; ST2 and IL-
1RAcP to lead to classical signaling via NF-κB. It has also been hypothesised that IL-
33 may mediate allergic responses by mast cells (Pushparaj et al., 2009). IL-25, also 
known as IL-17E may also play a role in the development of lineage negative multi-
potent progenitor cells to produce TH2 related cytokines such as IL-4, IL-5 and IL-13 
(Saenz et al., 2010). 
 
The balance of TH1 and TH2 responses during infection is crucial to efficient 
clearance of pathogens. This has been demonstrated within the context of Respiratory 
Syncytial Virus (RSV) infection, whereby IFN-γ receptor knockout mice upon intra-
nasal infection exhibited enhanced TH2 responses. The resultant effect was increased 
eosinophil recruitment to the lung and elevated IL-4, IL-5 and IL-13 cytokine levels 
(Boelen et al., 2002). This imbalance in CD4+ T cells lead to worse lung pathology, 
despite no change in viral load compared to wild-type mice, highlighting the 
detrimental effect of TH2 cells during infection (Boelen et al., 2002). Parasitic 
infestations and subsequent TH2 responses can also augment disease outcome of other 
bacterial infections. For example, filarial parasites can induce strong TH2 responses 
and down-regulate protective TH1-mediated immunity during M. tuberculosis 
infection (Babu et al., 2009). This finding emphasises TH2 responses as detrimental to 
effective bacterial clearance.  
 
This view of pathogenic effects of TH2 cell during infectious diseases may be over-
simplistic, as other studies have offered complex contradicting observations. One 
such study investigating the role of IL-4 pre-treated macrophages on secondary 
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challenge with Neisseria meningitides showed decreased ability to phagocytose this 
Gram-negative bacterium and was accompanied with increase levels of pro-
inflammatory cytokines, such as IL-6 and TNF-α (Varin et al., 2010). These findings 
are contradicted by other work demonstrating vaccination of soluble FliC protein can 
enhance TH2 responses and lead to augmented TH1 immunity and hence better 
Salmonella typhimurium clearance (Bobat et al., 2011). These publications emphasise 
the fine balance between TH1 and TH2 mediated immunity during infection.  
 
 
1.3.2 TH17 cells 
 
The TH1/TH2 paradigm suggested by Mossmann and Coffman was revised when it 
was found that naïve CD4+ T cells could differentiate into other subsets with unique 
cytokine profiles and functions, such as TH17 and Tregs cells. Earlier studies of 
autoimmune diseases, such as EAE had postulated a pathogenic role for IFN-γ and 
TH1 cells. However, depletion studies of TH1 cells could not fully explain the disease 
pathology. It was only through the use of IL-12 (p35-/-) and IL-23 (p19-/-) transgenic 
animals that IL-23 and TH17 cells were initially linked to the development of 
autoimmune diseases like EAE in mice and also both intra- and extracellular 
pathogen infection (O' Connor Jr et al., 2010; Weaver, 2009; Cua et al., 2003). This 
class of T helper cells is marked by the key expression of the pro-inflammatory 
cytokine IL-17A, although other cytokines such as IL-17F, IL-21, IL-22 and IL-9 
have also been linked to the cytokine profile of TH17 cells (Nowak et al., 2009; 
Stephens et al., 2011). This T helper subset was initially acknowledged when human 
IL-17A was first identified in cDNA libraries of T cells and later confirmed to be 
secreted as a homodimer by activated memory T cells (Yao et al., 1995; Fossiez et 
al., 1996). This discovery has since paved the way for a rapid expansion in the study 
of TH17 responses in autoimmunity and infection.  
 
The key genetic marker for TH17 cells is the transcription factor RORγt and is 
essential for IL-17 production (Figure 1.4) (Ivanov et al., 2006; Crome et al., 2009). 
Other reliable markers for human TH17 cells are IL-23R and RORC. However, it has 
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been suggested that CD161, the human ortholog of murine NK1.1 may also be used a 
marker for T cells secreting IL-17 (Maggi et al., 2010). Human TH17 cells can also 
express CCR6 and CCR4 (Annunziato et al., 2009), indicating that this subset can 
express numerous markers. 
The cytokines required for TH17 cells differentiation from naïve CD4+ T cells has 
been contentiously debated for many years with differences observed between human 
and murine cells. TGF-β, IL-6 and IL-21 were initially considered to be responsible 
for the induction of TH17 cell development from naïve T cells in mice (Korn et al., 
2008; Yang et al., 2008; Volpe et al., 2008). The role of TGF-β during development 
of TH17 cells was debated (O’Garra et al., 2008) as some groups have shown the 
presence of this cytokine to have a redundant role (Das et al., 2009), although it may 
be required for IL-9 production (Beriou et al., 2010). IL-1β has also been implicated 
in TH17 cell differentiation in humans (Wilson et al., 2007; Acosta-Rodriguez et al., 
2007; Valmori et al., 2010). IL-23, a cytokine composed of p19 and p40 subunits acts 
during the later stages of TH17 cell differentiation to stabilise the phenotype, as 
oppose to differentiate and the expression of IL-23R is indeed induced by TGF-β 
(Figure 1.4) (Yang et al., 2008; Tato and O’Shea, 2006; McGeachy et al., 2009). IL-7 
is also required for TH17 cell survival, supporting the proposed general function of 
this cytokine to promote the survival of all T cells (Liu et al., 2010b). 
 
Interferon regulatory factor 4 (IRF4) is an important protein in TH2 and TH17 cell 
differentiation. Human naïve T cells require IL-1, IL-23 or IL-6 and TGF-β activated 
signaling for TH17 differentiation as it leads to downstream IRF4 and RORγt 
expression (Chung et al., 2009). The phosphorylation of STAT3 as a consequence of 
IL-6 mediated signaling is also critical for TH17 cell development (Figure 1.4) (Manel 
et al., 2008). Signaling via AHR may also lead to the production of IL-22 in response 
to environmental signals (Veldhoen et al., 2008). 
 
Other factors apart from the cytokine milieu may influence TH17 cell differentiation. 
For example, C5aR, a component of the complement cascade may trigger the 
induction of TH17 cells and this has been shown to be the case in an autoimmune 
model of arthritis (Hashimoto et al., 2010). This suggests the signals received during 
infection or inflammation may drive the differentiation of this subset of T cells.  
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IL-17A and IL-17F, the signature cytokines of TH17 cells can form a heterodimer to 
signal through the same receptor subunits; IL-17RA and IL-17RC (Gaffen, 2009; 
Onishi and Gaffen, 2010). The receptor for IL-17A consists of a single 
transmembrane protein and activation leads to induction of other pro-inflammatory 
cytokines such as IL-6 via NF-κB signaling (Shen and Gaffen, 2008; Moseley et al., 
2003). The observed effects of secreted IL-17 include recruitment of neutrophils via 
the induction of G-CSF and other chemokines such as CXCL8/IL-8 by various cells 
expressing IL-17R (Moseley et al., 2003). 
 	  
1.3.3 Regulatory T cells (Tregs) 
 
 
Figure 1.5: The role of Tregs to modulate immune responses. 
Tregs can suppress the immune response in various manners. Tregs can inhibit activation, 
proliferation, differentiation of naïve T cells and also terminal effector cell function (Sojka et 
al., 2008).  
 
 
 
The immune system must maintain a fine balance between defending the body from 
pathogens whilst minimising inflammatory damage to host cells. Integral components 
in coordinating this balance are regulatory T cells (Tregs), a subpopulation of T cells 
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involved with control of both adaptive and innate responses. Tregs have been a highly 
researched field in the past few years, as their function has been linked to 
autoimmunity, tumour immunity, control of infection and organ transplantation 
(Fehérvari and Sakaguchi, 2004; Sakaguchi, 2004). As the name suggests, Tregs 
regulate the function of T effector (Teff) cells and other cell types to dampen down the 
adaptive and innate response (Figure 1.5) (Fehérvari and Sakaguchi, 2004; 
Sakaguchi, 2004; Sakaguchi et al., 2007). 
 
Two subtypes of Treg cells are operationally defined, having different properties: 
naturally occurring Tregs (nTregs) and inducible Tregs (iTregs) (Figure 1.4). nTregs are 
characterised as CD4+CD25+Foxp3+ cells, which develop in the thymus and make up 
5-10% of all CD4+ T cells in humans or mice. Tregs can also be further defined based 
on integrin αEβ7 (CD103) expression; naïve Tregs are CD103-, while effector and 
memory Tregs express this integrin (Zhang et al., 2009a). 
 
It is believed that nTregs can recognise a wide array of self-antigens (Belkaid, 2007). 
Via TCR activation, they suppress the proliferation and cytokine release of 
CD4+CD25- cells in vitro co-cultures in an antigen non-specific manner (bystander 
suppression) (Belkaid, 2007; Tang and Bluestone, 2008; Zanin-Zhorov et al., 2006). 
The strength of the TCR signal leading to activation (for example, avidity of antigen) 
may also play a role in the rapid induction of Tregs during infection (Shevach et al., 
2008). It has been suggested that specialised DCs such as CD103+ DCs can promote 
Treg differentiation from naïve T cells, due to their capability to secrete the necessary 
cytokines for Treg induction (Yamazaki et al., 2008; Suffner et al., 2010).  
 
Although Tregs become anergic upon TCR stimulation, in the periphery IL-2 and IL-7 
is essential for their proliferation, whereas TGF-β is required for their differentiation 
and maintenance (Horwitz et al., 2008; Brandenburg et al., 2008; Korn et al., 2008; 
Shevach et al., 2008; Bayer et al., 2008). TGF-β binding to its cognate receptor 
activates Smad2 and Smad3, which may be required for foxp3 induction (Takimoto et 
al., 2010). CD28 co-stimulation with B7 ligands on DCs can lead to signaling to 
induce thymocytes to express Foxp3 (Guo et al., 2008; Scottà et al., 2008). Upon 
TCR activation and CD28 co-stimulation, transcription factors are induced to bind to 
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their respective promoter sequences and it has been suggested that the NF-κB 
signaling pathway may be vital in specific foxp3 induction (Soligo et al., 2011). This 
is further supported as c-Rel, a component of NF-κB as a requirement for the 
generation of nTregs and homeostatic proliferation of peripheral Tregs (Isomura et al., 
2009; Ruan et al., 2009; Deenick et al., 2010; Vang et al., 2010). 
 
iTregs are conventional CD4+CD25- cells that upon exposure to self or foreign 
antigens develop in the periphery in the presence of IL-10 and IL-27 to become Tr1 
cells, or in the presence of TGF-β and Runx1 and Runx3 signaling to induce foxp3 
expression to form TH3 cells (Klunker et al., 2009). Foxp3 expression is a loose 
requirement in these cell types (Hansen et al., 2007; Dardalhon et al., 2008; Nicolson 
et al., 2006; Vieira et al., 2004) and their suppressive potency is considerably lower 
than that of nTregs (Huter et al., 2008). IL-35 may be involved in the conversion of 
naïve T cells into iTregs (Collison et al., 2010) and indeed this cytokine is also 
produced by Foxp3+ Tregs as well (Collison et al., 2007). It has been suggested that 
iTregs are unstable as upon further re-stimulation in the absence of TGF-β, these cells 
lose Foxp3 expression. 
 
Tregs can suppress the proliferation and cytokine production of different innate and 
adaptive immune cells (Figure 1.5). CD4+CD25hiFoxp3+ T cells can suppress IFN-γ 
production from γδ T cells during M. tuberculosis infection (Mahan et al., 2009) and 
may be important in maintaining intestinal homeostasis by suppressing activated γδ T 
cells  (Park et al., 2010). The interaction between Tregs and neutrophils is unclear. 
Neutrophil infiltration to the site of inflammation may be limited by the presence of 
Tregs (Richards et al., 2010), although it has also been shown that human CD4+CD25hi 
cells can produce IL-8 to actively recruit neutrophils (Himmel et al., 2011). Tregs 
induced during acute Fried retrovirus infection can dampen down CD8+ T cell 
responses (Dietze et al., 2011). B cells and auto-reactive antibody production are 
implicated in the autoimmune disease Systemic Lupus Erythematosus (SLE) and 
activated Tregs may suppress these B cells via cell-contact dependent mechanisms to 
induce apoptosis to limit pathology (Iikuni et al., 2009). 
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Suppressive features are not just limited to CD4+ Tregs, but CD8+ Treg cells in humans 
particularly have also identified to share the phenotype. Foxp3 expression can also be 
induced in naïve CD8+ T cells (Tuovinen et al., 2008; Cosmi et al., 2003). In general, 
CD8+Foxp3+ T cells share the same features as their CD4+ counterparts but are less 
suppressive in comparison but still require TGF-β and TCR engagement for 
differentiation (Mahic et al., 2008; Mayer et al., 2011).  
 
 
1.3.4 Foxp3 and Treg development 
 
Foxp3 is a transcription factor that represses a variety of downstream effectors of the 
T cell activation pathway like il-2 transcription, while inducing expression of such 
genes as cd25 and ctla-4 (Li and Greene, 2008; Sadlon et al., 2010). The importance 
of Foxp3 is shown by the existence of scurfy mice, which have a frameshift mutation 
in foxp3 and so lack the forkhead domain of this transcription factor. These mice 
exhibit widespread autoimmunity due to dysfunctional Treg cells (Brunkow et al., 
2001). The autoimmune defect can be rescued by the adoptive transfer of wild-type 
Foxp3+ cells (Huter et al., 2008). Patients with IPEX syndrome also mirror this 
phenotype with the production of nTregs expressing mutated Foxp3 leading to severe 
impaired suppressive activity (Roncarolo and Gregori, 2008). 
 
The status of Foxp3 as the defining marker of Tregs is contentious, as it has been 
suggested it is not the main determinant factor in Treg cells development, rather it 
helps stabilise the phenotype (Hansen et al., 2007; Pacholczyk et al., 2007). This 
proposal has been contradicted by McFaddon and colleagues (McFadden et al., 2007) 
and Fontenot and colleagues (Fontenot et al., 2003), who suggest Foxp3 to be the 
master switch in Treg differentiation in terms of nTregs versus iTregs development. The 
forced over-expression of Foxp3 in CD4+CD25- T cells can down-regulate the 
secretion of TH1 and TH2 associated cytokines, supporting the theory that Foxp3 
expression represses other effector functions (Aarts-Riemens et al., 2008).  
 
Apart from Foxp3, many different proteins and signaling pathways have been 
implicated in Treg development. The DNA-binding inhibitor Id3 may be involved in 
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Treg development as TGF-β signaling pathways can lead to the production of this 
protein and can prevent GATA-3 from binding to the foxp3 promoter (Maruyama et 
al., 2011) Dec1 is a helix-loop-helix transcription factor and act to maintain the Treg 
phenotype by up-regulation of CD25 expression and prolong cell survival (Miyazaki 
et al., 2010). The transient inhibition of the mammalian target of rapamycin (mTOR)-
signaling enhances Treg cell proliferation, implicating this pathway as an important 
regulatory switch in Treg development (Delgoffe et al., 2009; Procaccini et al., 2011). 
 
 
1.3.5 Treg associated markers 
 
Early microarray data comparing gene expression patterns between CD4+CD25+ and 
CD4+CD25- T cells have suggested 77 out of 11,000 murine genes were significantly 
differentially expressed upon TCR stimulation (McHugh et al., 2002). From these 
genes, Foxp3 is the most reliable murine activation marker for Treg cells, although 
Lymphocyte Activation Gene-3 (LAG-3), Cytotoxic Lymphocyte Antigen-4 (CTLA-
4) and Glucocorticoid-Induced Tumor necrosis factor Receptor (GITR) are also used 
due to high constitutive expression along with CD25 in Tregs. Foxp3 expression in 
humans is not restricted purely to Tregs (Hori, 2008; Ziegler, 2006; Ziegler, 2007) as 
human CD4+ T cells can up-regulate Foxp3 following TCR stimulation unlike murine 
cells (Morgan et al., 2005; Walker et al., 2003). This high expression of Foxp3 in 
activated human CD4+ cells only appears to be a transient effect (Cosmi et al., 2003; 
Morgan et al., 2005).  
 
CTLA-4 is an important receptor expressed by activated T cells with most research 
connected with Tregs, due to their high expression profile. Foxp3 can induce the 
expression of ctla-4 via an interaction with the transcription factor NF-AT. It has 
been suggested that this receptor is key in the suppressive activity of Tregs as 
demonstrated by CTLA-4-/- mice exhibiting extreme autoimmune defects (Zheng et 
al., 2008b; Tang et al., 2008; Wing et al., 2008; Friedline et al., 2009).  	  
The importance of CTLA-4 during immune responses against pathogens has been 
highlighted by studies focused on bacterial infection with Listeria monocytogenes. 
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This intracellular Gram-positive bacterium is a predominant cause of acute 
gastrointestinal tract infection, with antigen specific CD4+ and CD8+ T responses 
induced. However, upon CTLA-4 blockade, these T cells responses are heightened 
and increased bacterial clearance is observed (Rowe et al., 2009), indicating CTLA-4 
may not be beneficial for an efficient immune response against L. monocytogenes.  
 
GITR is another proposed Treg associated marker, however, it is also expressed by 
other subsets of T cells such as CD8+ CTL cells. GITR is a co-stimulatory factor for 
T cells to induce T cell proliferation and IL-2 production (van Olffen et al., 2009). 
The role of GITR on CTLs has been demonstrated by the administration of agonistic 
anti-GITR antibody to enhance expansion of these cells during viral infection (Snell 
et al., 2010). GITR signaling leads to enhanced survival of CD8+ effector cells by 
increased anti-apoptotic Bcl-XL expression suppressing cell death pathways. 
 
LAG-3, also known as CD223 is found on activated NK and T cells and is closely 
related to the CD4 co-receptor. It can bind to MHC class II molecules with a higher 
affinity than CD4 and large amounts of this receptor have been found in intracellular 
compartments (Liang et al., 2008; Woo et al., 2010). The expression of this receptor 
is regulated by two transmembrane metalloproteinase called ADAM10 and 
ADAM17, which can cleave LAG-3 from the surface of other cells such as DCs to 
produce soluble LAG-3 (Workman et al., 2009). 
 
While Foxp3 is regarded a faithful marker for murine Tregs, human Tregs have been 
found to express other key markers. Latency-associated peptide (LAP) associates 
with dimeric mature TGF-β to prevent downstream signaling within the cell. Many 
different cells express the receptor for latent TGF-β or GARP, such as 
megakaryocytes and activated human Foxp3+ Tregs (Stockis et al., 2009; Tran et al., 
2009). It has been suggested that GARP, an orphan TLR composed of LRRs, may 
represent another marker for Tregs in humans as it allows for discrimination between 
suppressor and non-suppressor cells within the CD25+ population (Wang et al., 2009; 
Battaglia and Roncarolo, 2009). Another marker for Tregs in mice is CD49b (integrin 
α2), although this is also primarily been used as a marker for NK and NKT cells (Han 
et al., 2009b). In humans, CD127 (IL-7Rα) can also be used as a marker for Tregs 
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indicating the possible heterogeneous nature (Finney et al., 2010; Simonetta et al., 
2010).  
 
Since the discovery of Foxp3, many other transcription factors have now been 
implicated in Treg development. For example, Helios, a family member of the Ikaros 
transcription factor family has been correlated with Foxp3 induction and is expressed 
in 70% of Foxp3+ Treg cells in mice (Thornton et al., 2010). Ets-1 is the founding 
member of a family of winged helix-turn-helix transcription factors and is involved in 
many biological processes such as haematopoiesis, angiogenesis and tumour 
progression. Interestingly, when this transcription factor is knocked out in CD4+ T 
cells, Foxp3 expression is decreased correlating with diminished suppressive activity, 
suggesting that Ets-1 may play a role in foxp3 induction (Mouly et al., 2010). The 
discovery of a role for these transcription factors in Tregs development, suggest a 
possible fine-tuning approach to regulate Treg differentiation and suppressive activity. 
 
 
1.3.6 Treg suppressive function 
 
 
Figure 1.6: Proposed suppressive mechanisms exerted by Tregs on target cells. 
Four mechanisms by which Tregs exert their suppressive activities upon Teff cells have been 
proposed; [A] production of immunosuppressive cytokines, [B] direct induction of apoptosis 
of target cells, [C] disruption of metabolic processes in target cells and [D] targeting DCs 
directly to prevent further adaptive immune activation (Vignali, 2008). 
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The precise mechanism by which Tregs act upon T effector (Teff) cells is still not fully 
understood. The four proposed main mechanisms for Treg-mediated suppression are 
the release of immunosuppressive cytokines, induced apoptosis of target cells; 
disruption of metabolic processes in target cells or targeting DCs directly (Figure 1.6) 
(Vignali, 2008). 
 
Tregs can produce many immunomodulatory cytokines upon activation. The key 
cytokines are IL-10 and TGF-β (Figure 1.6A). IL-10 can inhibit MHC class II and co-
stimulatory CD80 and CD86 molecule expression on monocytes and macrophages 
(Couper et al., 2008). This anti-inflammatory cytokine can also limit the production 
of IFN-γ, IL-2, IL-4 and IL-5 production from CD4+ T cells (Couper et al., 2008). 
TGF-β is another immunosuppressive cytokine can inhibit the secretion of 
immunoglobulins (Corthay, 2009). A newly discovered suppressive cytokine, IL-35 
is also found to be secreted by Tregs. The role of this cytokine has been disputed as 
human Tregs have been not found constitutively express this cytokine like their murine 
counterparts (Bardel et al., 2008).  
 
The second mechanism of suppression is induced apoptosis of adaptive immune cells 
like follicular DCs, B cells and CD4+ T cells (Figure 1.6B) (Elpek et al., 2007; 
Hotchkiss and Karl, 2003). This is achieved through high expression of granzymes A 
and B and perforin on Tregs (Vignali et al., 2008; Shevach, 2009). Galectin-1 is also 
secreted by Tregs to bind glycoproteins such as CD45, CD43 and CD7 to induce 
apoptosis and inhibition of pro-inflammatory cytokines (Shevach, 2009). 
 
The third mode of suppression mediated by Tregs is metabolic disruption of the target 
cell via direct cell-to-cell contact between nTreg and Teff cells, possibly involving 
CTLA-4, membrane bound TGF-β and GITR interactions (Figure 1.6C) (McFadden 
et al., 2007; Savage et al., 2008). These interactions repress il-2 transcription in the 
target cell leading to apoptosis (Pandiyan et al., 2007; Scheffold et al., 2007). 
Apoptosis is also triggered through the production and release of cAMP, a potent 
secondary messenger that can inhibit T cell growth, differentiation and proliferation 
via gap junctions between Treg and Teff cells (Bopp et al., 2009). 
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Tregs can suppress the proliferation of target cells by blocking IL-2 as a means of 
cytokine deprivation to eliminate Teff cells by apoptosis, independent of APCs 
(Thornton and Shevach, 1998; Scheffold et al., 2007; Pandiyan et al., 2007). Fas-
FasL mediated pathways can also achieve induced cell death of target effector cells. 
High expression of an ectomenzyme, CD39 is also found on Tregs, hydrolysing 
extracellular ATP and ADP into AMP. It has been suggested the presence of ATP can 
promote TH17 differentiation and human CD39+Foxp3+ Tregs can suppress TH17 cells 
in EAE murine models of autoimmunity (Moncrieffe et al., 2010). Suppressive Tregs 
can also inhibit the effects of secreted TNF-α by releasing soluble TNFRII into the 
extracellular space to bind this cytokine and reverse the inflammatory response (van 
Mierlo et al., 2008). 	  
The last suppressive mechanism by which Tregs are suppressive is targeting DCs 
directly to prevent T cell activation (Figure 1.6D) (Belkaid and Rouse, 2005). Tregs 
can interact with DCs via LAG-3 and MHC class II molecules to block DC 
maturation and co-stimulatory signals to T cells (Liang et al., 2008). Tryptophane is 
an essential amino acid, required for the synthesis of essential cellular factors such as 
NAD+ and serotonin. This amino acid is degraded by two enzymes; tryptophan 2,3-
dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO), members of the 
kynurenine pathway (Curti et al., 2009). TDO is primarily expressed in the liver, 
whereas IDO is expressed by many different tissues and induced by inflammatory 
stimuli (Curti et al., 2009). IDO mediated suppression exerted by Tregs is achieved by 
inhibiting DC production of pro-inflammatory cytokines such as IL-6 and TNF-α 
before cell death is induced (Hill et al., 2007; Hotchkiss and Nicholson, 2006; 
Sakaguchi et al., 2009).  
 
Overall, various potent modes of suppression have been proposed for Tregs. It would 
appear that perhaps in vivo, a combination of these different mechanisms may be 
utilised by Tregs in order for this cell type to exert maximum effect on the immune 
response. 
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1.3.7 Other T helper subsets 
 
The repertoire of T helper subsets is continuously expanding over time. A new subset 
of CD4+ T helper cells, TH9 cells have been suggested to produce IL-9 and are a 
distinct population from TH2 cells. The cytokines required to differentiate naïve CD4+ 
T cells in to TH9 cells has been contested with the suggestion that TGF-β and IL-4 
may drive the development of this particular T cell subset (Veldhoen et al., 2008). 
Whereas, TGF-β and IL-1β has also been shown to differentiate naïve CD4+ T cells 
to produce IL-9, independent of IL-4 (Uyttenhove et al., 2010).  
 
IL-9 is been heavily implicated in allergic diseases, such as allergic asthma (Soroosh 
and Doherty, 2009). However, this cytokine may also have a role in autoimmunity as 
demonstrated by the co-transfer of TH9 and TH17 cells to induce EAE disease 
phenotype (Jäger et al., 2009). The role of TH9 cells during infectious disease is still 
largely unknown and warrants further investigation. Although the cytokine profile of 
TH9 cells may have been studied, the master regulator is still unknown and IRF4 
signaling has been suggested to be required as part of the induction process (Staudt et 
al., 2010). 
 
IL-22, a new member of the IL-10 related cytokine family is generally considered a 
signature TH1 cytokine. However, IL-22 is also linked due to its association with 
RORγt with the differentiation and expression of IL-17 in TH17 cells. In humans, a 
new subset of memory T helper cells defined by their expression of 
CCR6+CCR4+CCR10+ have been found to secrete IL-22 and IL-13 but not IFN-γ or 
IL-17 and have been tentatively named TH22 cells (Trifari et al., 2009). However, 
these cells may not represent a new T helper subset due to the presence of RORC, the 
human ortholog of RORγt. AHR expression may also regulate the expression of IL-
22 in these cells, leading to the suggestion that these are exactly TH17 cells (Trifari et 
al., 2009). To date, these cells have also not been identified in mice and are still under 
investigation. 
 
With the expansion of cytokines known to be produced by T cells, the categorisation 
of CD4+ T cells into discrete defined T helper subsets may prove to be a challenge in 
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the future. This may be due to changes in cytokine profiles according to the 
microenvironment and this will be discussed in the next section.  
 
 
1.3.8 T cell subset stability and plasticity 
 
Since the dissolution of the two T helper subset paradigm proposed by Mossmann 
and Coffman, the stability of T helper subsets has been much discussed in the past 
few years. The expression of specific transcription factors and cytokines were once 
regarded to repress the differentiation of other T helper subsets and maintain the 
stability of the final cell phenotype. This has been enforced through the use of certain 
signaling pathways, however, as these signaling pathways appear to be interlinked, 
this leaves the possibility of plasticity open for discussion. It is now emerging that T 
helper cell subsets are not rigid phenotypes resulting in final differentiation state but 
may be more be flexible than originally considered.  
 
It has been suggested an equilibrium between Foxp3 and RORγt exist in CD4+ T 
cells, indicative of plasticity between Tregs and TH17 cells. TGF-β can induce the 
expression of Foxp3 in naïve CD4+ T cells leading to Treg development, whereas IL-6 
has an inhibitory effect. However, TGF-β together with IL-6 and IL-21 in mice can 
induce RORγt activation and hence leading to TH17 differentiation (Bettelli et al., 
2008; Korn et al., 2008; Manel et al., 2008). It is interesting to note that transgenic 
mice over-expressing IL-6 to have increased nTreg levels with normal suppressive 
function, although iTregs development was impaired, suggesting that IL-6 has a more 
profound effect on the conversion of naïve CD4+ T cells into iTregs (Fujmoto et al., 
2011). IL-6 can induce Suppressor Of Cytokine Signaling (SOCS)-3 to inhibit TH17 
cell development, although TGF-β can reverse this suppression to promote TH17 cell 
differentiation (Qin et al., 2009).  
 
Curiously, human Foxp3+ T cells can still express IL-17 if they express CCR6 while 
retaining their suppressive quality, supporting the hypothesis of plasticity between 
Tregs and TH17 cells or a shared dual phenotype (Beriou et al., 2009). The presence of 
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IL-6 and IL-4 together can down-regulate the expression of Foxp3 in nTregs, resulting 
in a loss of suppressive function (Kastner et al., 2010). This suggests the cytokine 
environment is important for maintaining T cell phenotypes or inducing plasticity. 
 
The inverse relationship between IL-6 and TGF-β can be further manipulated by 
Retinoic Acid (RA), a vitamin A metabolite, which drives Treg generation by 
enhancing TGF-β signaling via Smad3 and NF-AT and preventing TH17 development 
in mice and humans (Bettelli et al., 2008; Lochner et al., 2008; Huehn et al., 2009; 
Wang et al., 2009a; Nolting et al., 2009). RA is produced by CD103+ DCs to induce 
iTregs in the gut to inhibit TH17 cells (Xiao et al., 2008). RA not only drives Treg 
development but can also promote the proliferation of activated human T cells via the 
production of IL-2 (Ertesvag et al., 2009).  	  
AHR has been implicated in regulating Treg and TH17 cell development by inhibiting 
TH17 differentiation by STAT1 activation (Kimura et al., 2008). These findings are 
further supported when a synthetic chemical, 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) is injected into mice, to bind AHR and induce immune suppression 
(Marshall et al., 2008). IL-27, another cytokine produced by innate cells can suppress 
TH17 responses and together with the action of TGF-β can induce the differentiation 
of IL-10 producing T cells with Tr1-like properties, influencing the balance between 
Tregs and TH17 cells (Bettelli et al., 2008). 
Despite the reported expression of RORγt in TH17 cells, it has been observed that less 
than half of these cells produce IL-17, its hallmark cytokine (Lochner et al., 2008). 
The ratio of Tregs and TH17 cells during murine models of infection and inflammation 
tend to be constant (Lochner et al., 2008) and it has been proposed that a possible 
source of TGF-β for TH17 differentiation may be the Tregs themselves (Zheng et al., 
2008). Only 25pg/ml TGF-β is required for TH17 conversion, whereas 2ng/ml is 
needed for Treg differentiation (O’Garra et al., 2008) indicating the immune system 
has evolved a subtle mechanism for fine-tuning the desired immune response, with a 
slight skewing towards TH17 differentiation.  
 
It is not only Tregs and TH17 cells that exhibit plasticity. GATA-3, the transcription 
factor for TH2 cells along with Foxp3 both have a competitive role in iTreg 
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development (Manel et al., 2008). GATA-3 can inhibit foxp3 induction by binding to 
its promoter and hence drive TH2 cell development over iTreg conversion. The reverse 
can also be said of Foxp3 binding to GATA-3 to block expression to promote Treg 
development (Dardalhon et al., 2008). Growth factor independent-1 (Gfi-1) is a 
transcriptional repressor and is transiently induced upon TCR stimulation. Gfi-1 can 
select GATA-3hi cells to allow for the differentiation of TH2 cells, while suppressing 
TH17 and Treg cell development (Zhu et al., 2009b).  
 
Epigenetic studies have revealed cis-regulatory elements within the ifn-γ, il-17a and 
il-17f loci, suggesting that these genes can also be remodeled in T cells and 
expression patterns are not fixed, confirming the theory of plasticity within T cells 
phenotype (Mukasa et al., 2010). T-bet and IFN-γ can directly inhibit TH17 cell 
development via Runx1 activity (Lazarevic et al., 2010; Villarino et al., 2010) and 
also Treg differentiation (Caretto et al., 2009). Runx3, another member of the Runx 
family can interact with T-bet to suppress il-4 expression and promote ifn-γ 
expression (Kohu et al., 2009; Yagi et al., 2010). Sphingosine 1-phosphate (S1P) is a 
lysophospholipid and signaling via its G protein-coupled receptor can block iTreg 
development, while promoting TH1 differentiation (Ohkura and Sakaguchi, 2009; Liu 
et al., 2010a). These results further emphasise the plastic nature of T cells and the 
interactions of transcription factors in T helper cell differentiation.  
 
The plasticity of T cells in humans and mice in vivo is now been demonstrated. CD4+ 
T cells extracted from human tumours have exhibit a TH17 phenotype, although can 
be differentiated into either IFN-γ producing cells or Foxp3+ cells in vitro upon TCR 
stimulation and expansion (Ye et al., 2011). The opposite can also be said to be true, 
as human memory Foxp3+ cells have been found to produce IL-17 ex vivo (Ayyoub et 
al., 2009). Foxp3+ cells infiltrating the central nervous system in the murine model of 
EAE express of IL-17 and IFN-γ (Espoito et al., 2010) and Foxp3+ cells can up-
regulate T-bet during inflammation via STAT1 signaling in this model (Koch et al., 
2009). TH1 cells in EAE can also co-produce IL-17 and IFN-γ or “ex-TH17” cells can 
shut down IL-17 production to become IFN-γ+ T cells (Kurschus et al., 2010; Hirota 
et al., 2011). Foxp3+ cells can also up-regulate GATA-3 to develop TH2 phenotype 
(Wang et al., 2010b). It would appear that Foxp3+ cells may represent the most 
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flexible of the T helper subsets and the concept of terminally differentiated T helper 
cells may no longer apply.  
 
Research is now emerging that Foxp3+ Tregs can also co-express other T helper cell 
associated transcription factors. For example, it has been demonstrated that some 
Foxp3+ cells can express T-bet and CXCR3 in the presence of IFN-γ during type 1 
inflammation (Koch et al., 2009). These Foxp3+T-bet+ cells do not produce IFN-γ but 
still retain their suppressive activity (Koch et al., 2009). GATA3 expression has also 
recently been shown to control foxp3 gene expression and consequently downstream 
effector function (Wang et al., 2011). This suggests that T-bet and GATA3 
expression may be required for Foxp3+ cells to respond to different environmental 
signals, such as inflammation. 
 
Overall, adaptive immunity has evolved many differentiated CD4+ T helper subsets, 
each equipped with unique functions, which are required to combat infection. 
 
 
 
1.4 Streptococcus pyogenes 
 
Bacteria can be broadly divided into two large groups according to a simple 
histological test known as Gram staining. Hans Christian Joachim Gram achieved this 
in 1884 through the discovery of different dyes to differentiate bacteria according to 
the physical properties of their outer cell wall structure (Gram, 1884).  
 
For Gram staining, bacterial samples are heat-fixed before staining with the primary 
stain, Crystal Violet (purple) before fixation with a mordant agent Gram’s iodine. The 
sample is then decolourised by acetone and counter-stained with safranin (pink) 
(Moyes et al., 2009). After this protocol, Gram-positive bacteria, such as 
Streptococci, Staphylococci and Clostridium species remain purple due to the 
presence of Crystal Violet-iodide complexes trapped within the thick cell wall 
composed of Peptidoglycan. Gram-negative bacteria, however do not have a cell wall 
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and hence lose their purple colour upon decolourisation and are counter-stained pink. 
Key examples of Gram-negative bacterium include Escherichia coli, Salmonella 
typhimurium, Vibrio cholerae and Bordetella pertussis. Gram staining remains an 
important microbiological test and offers an easy means to classify bacterial species.  
 
In 1933, Rebecca Lancefield developed a method to differentiate Streptococci strains 
according to expression of cellular carbohydrates into five distinct groups; A, B, C, D 
and E (Lancefield, 1933). To date, this classification has now been extended to reflect 
the emergence of new groups (G-H and K-V) across many different host species 
(Facklam et al., 2002).  
 
Streptococcus pyogenes is a Gram-positive bacterium and an example of a Group A 
Streptococci (GAS). It is defined by the Lancefield classification scheme by the 
surface expression of Group A carbohydrate, composed of Ν-acetylglucosamine 
linked to a rhamnose polymer backbone and also further characterised according to 
surface M protein serotype based on work carried out by Lancefield in 1928 
(Lancefield, 1928).  
 
To date, more than 100 M proteins encoded by emm genes have been identified with 
more serotypes added in the past decade to the Lancefield classification scheme 
(Facklam et al., 2002). In the past, identification of emm types was carried out by the 
Lancefield capillary precipitin technique or the slide agglutination procedure with the 
use of polyclonal anti-sera binding directly to M proteins. Nowadays, the standard 
method of emm typing involves Polymerase Chain Reaction (PCR)-based techniques 
amplifying the 5’ variable region of the emm gene, which defines the M serotype 
(Beall et al., 1996; Vitali et al., 2002). 
 
S. pyogenes (Figure 1.7) is typically cultured on blood agar and exhibits β-haemolytic 
activity, resulting in zones of red blood cell lysis around the bacterial colonies, an 
observation made by J. H. Brown in 1919 (Brown, 1919). This feature was later 
attributed to secreted virulence factors called Streptolysins, which will be later 
discussed in Section 1.6.2. 
 
	   62	  
 
Figure 1.7: Streptococcus pyogenes. 
Electron scanning micrograph of S. pyogenes (red) being engulfed by a neutrophil (white 
structure). Picture courtesy of Prof. J. Robinson. 
 
 
 
S. pyogenes is stereotypically classified as an extracellular pathogen as it replicates 
and mediates its pathogenesis from outside the cell via secreted virulence factors. 
This is in contrast to intracellular pathogens; such as Salmonella and Listeria species, 
which replicate inside host cells. S. pyogenes is a human obligate pathogen and 
naturally colonises the throat or skin to result in asymptomatic carriage or mild non-
invasive infections. However, severe invasive disease can be induced by this 
bacterium as well.  
 
Other examples of streptococcal species include Group B Streptococci (GBS) strains, 
such as Streptococcus agalactiae, the major cause of sepsis and meningitis in 
neonates, young infants and pregnant women (Lancefield and Hare, 1935). S. 
agalactiae has a complex etiology associated with the transmission of pathogenesis to 
neonates. This Gram-positive bacterium can be found naturally in mucosal surfaces, 
such as the vagina and can be pass on to newborns during birth. Similar to GAS, GBS 
exhibits β-haemolytic activity and also found naturally colonised asymptotically in 
healthy adults.  	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1.5 GAS infection  
 
1.5.1 GAS associated pathology 
 
S. pyogenes is the causative agent of numerous human diseases, ranging from mild 
non-invasive (impetigo and pharyngitis or “strep throat”) to severely invasive disease 
(bacterial sepsis and necrotising fasciitis) associated with high mortality of 
approximately 20-50% of affected patients (Cunningham, 2000).  
 
Epidemiologists have long studied bacterial sepsis due to the large burden it carries 
on the national health care service, estimated to be approximately $17 billon annually 
in the United States of America (Martin et al., 2003). From 1979 to 2000, the 
epidemiology of sepsis was studied in America, indicating that Gram-positive 
bacterial species were the most common cause of sepsis from the late 1980s onwards 
and was the overall 10th leading cause of death in the US (Martin et al., 2003).  
 
S. pyogenes has become an prevalent human pathogen due to the resurgence of 
invasive M1 and M3 serotype strains since the 1980s across many different 
developed countries, such as Norway (Martin and Høiby, 1990) and Australia 
(Carapetis et al., 1995). Some of these studies have correlated certain virulence 
factors, such as M proteins in contributing to the rise in particular strains to cause 
invasive human disease (Schwartz et al., 1990). Although a more recent study has 
shown that GAS strains with increased virulence are not the main contributing factor 
to the resurgence of invasive disease but rather the expression of such virulence 
factors enables the pathogen to spread throughout the population more effectively 
(Rogers et al., 2007). 
 
The increase number of invasive S. pyogenes infection was not just limited to 
America, but also true in Britain. An upsurge of M1 and M3 serotype S. pyogenes 
associated invasive infections was recorded between 1980-1990 (Colman et al., 
1993). An increase in the number of patients with invasive disease caused by S. 
pyogenes and Streptococcus pneumoniae has been more recently recorded above 
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seasonally expected levels in England (Zakikhany et al., 2011). This was observed 
throughout all age groups and concurrent with H1N1 viral infection, suggesting the 
rise in seasonal flu may contribute to the increased number of cases of invasive 
diseases caused by S. pyogenes (Zakikhany et al., 2011).  
 
 
1.5.2 Non-invasive GAS infection 
 
Most healthy adults are asymptotic carriers of S. pyogenes, naturally colonised on the 
skin and particularly in the throat with a high percentage of asymptotic carriers 
testing culture-positive after throat swabs. In some cases, S. pyogenes can cause mild 
infection of the skin or throat, presenting itself as impetigo, tonsillitis, pharyngitis or 
more commonly known as “Strep throat”. These types of infection can vary 
depending on the season. For example, pharyngitis tends to occur during autumn and 
winter, while impetigo appears more frequently during the summer (Cunningham, 
2000). 
 
A small percentage of young children present with recurrent tonsillitis, with the 
hypothesis formed that intracellular S. pyogenes can persist within tonsil tissue 
(Osterlund and Engstrand, 1997). Certain emm serotypes are associated with S. 
pyogenes induced throat infection, for example, emm1, 89, 2 and 12 (Blandino et al., 
2010). Mouse models of pharyngitis have demonstrated that both type I and 
interferon (IFN)-γ responses are important in controlling dissemination of S. 
pyogenes from nasal-associated lymphoid tissue (NALT), the murine equivalent of 
human tonsils to the draining lymph nodes (Hyland et al., 2009). This demonstrates 
that immune responses are very efficient at limiting non-invasive GAS diseases, such 
as pharyngitis.  
 
Scarlet fever is another example of a S. pyogenes associated infection in the throat. It 
is characterised by many symptoms such as skin rash (Figure 1.8), “strawberry 
tongue” and sore throat. Adults are less susceptible to scarlet fever infection, with 
young children being the largest affected age group. Many outbreaks correlating with 
different emm type isolates (e.g. emm75 and emm2) have been reported in the 21st 
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century, indicating this is still a prevalent disease (Dong, 2009). This infection is 
usually associated with the presence of secreted virulence factors called 
superantigens, which will be discussed later in Section 1.6.4.  
 
 
Figure 1.8: Characteristic skin rash induced by scarlet fever infection. 
Scarlet fever is caused by secreted exotoxins such as superantigens from S. pyogenes, 
resulting in presented symptoms of characteristic skin rash as shown above, sore throat, 
fever, bright red tongue with “strawberry” texture. 
 
 
 
Certain S. pyogenes serotypes (e.g. M49 and M55) can cause skin infection, such as 
impetigo or pyoderma and tend to be distinct from isolates that cause pharyngitis as 
discussed previously (Bisno and Stevens, 1996). These infections are limited to the 
face and extremities of the body and are highly contagious. S. aureus co-infection is 
commonly found during some clinical episodes of impetigo (Akiyama et al., 1999). 
The production of Exofoliative Toxin (ET) from S. aureus may be responsible for the 
blisters in bullous impetigo (Kato et al., 2011). However, this infection can be easily 
treated with antibiotics.  
 
 
1.5.3 Invasive GAS infection 
 
Severe invasive diseases have also been linked with S. pyogenes deep tissue infection, 
resulting in necrotising fasciitis, Streptococcal Toxic Shock Syndrome (STSS) and 
bacterial sepsis (Johansson et al., 2010), which is a leading cause of mortality in 
intensive care units in America (Martin et al., 2003). Bacterial sepsis primarily affects 
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older individuals; with more than 60% of septic patients aged 65 years or older and 
80% of deaths from this disease occur in aged patients. The term sepsis describes a 
systemic response to infection and clinical signs of severe sepsis include organ 
dysfunction and sepsis-induced hypoperfusion (Bone et al., 1992). 
 
M1 and M3 serotypes of S. pyogenes have gained notoriety in the press, commonly 
referred to as “flesh-eating” bacteria as the pathogen responsible for necrotising 
fasciitis (Figure 1.9). Progression of disease is mediated by the secretion of virulence 
factors, such as exotoxins, which lead to the destruction of the fascia, adipose tissue 
and muscle. Most cases of necrotising fasciitis caused by S. pyogenes show no point 
of entry by this bacterium and a previous episode of blunt trauma may contribute to 
the onset of disease (Nuwayhid et al., 2007).  
 
 
Figure 1.9: Necrotising fasciitis. 
Necrotising fasciitis or “flesh eating disease” usually occurs at a site of trauma, leading to the 
destruction of skin and deeper tissue commonly associated with S. pyogenes infection. 
Images courtesy of Prof. S. Sriskandan.  
 
 
 
Bacterial sepsis is a complex disease with various factors influencing the onset of 
pathology (Sriskandan and Altmann, 2008; Shimaoka and Park, 2008; Rittirsch et al., 
2008). The initial pro-inflammatory response is key in the development of sepsis as 
reviewed by Chong and Sriskandan (Chong and Sriskandan, 2011). Numerous 
pathways starting from early recognition of the pathogen lead to the downstream 
production of pro-inflammatory cytokines and chemokines such as IL-6, TNF-α and 
IL-8 (Damas et al., 1992; Miyoshi et al., 2010), NO and the activation of complement 
can contribute to the recruitment of immune cells, vasodilation and coagulation (Levi, 
2010), propagating the symptoms of bacterial sepsis (Figure 1.10). 
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Figure 1.10: Cascade of pro-inflammatory mechanisms leading to sepsis. 
Microbial products and endogenous damage tissue antigens are recognised by PRRs. This 
induces gene expression of various products to initiate the pro-inflammatory events and leads 
to the propagation of the symptoms of sepsis presented by patients (red boxes) (Chong and 
Sriskandan, 2011). 
 
 
 
The symptoms of severe sepsis have been attributed to the ill defined “cytokine 
storm”, whereby an excessive release of pro-inflammatory cytokines, such as TNF-α 
and IL-1β lead to large systemic inflammatory response observed in patients 
(Hotchkiss and Nicholson, 2006; Russell, 2006; Remick, 2007). However, this may 
be a simplistic view, as the administration of anti-cytokine antibodies either in the 
clinical setting or murine models does not offer protection from toxic shock (Reinhart 
and Karzai, 2001). Despite, high levels of TNF-α associated with severe sepsis, this 
cytokine may be beneficial. A clinical trial of a TNF-receptor: Fc fusion protein has 
been shown to bind and neutralise excessive TNF-α during sepsis and increased 
mortality (Fisher Jr et al., 1996).   
 
The initial hyper-inflammatory response is understood to aid the host in clearing the 
bacterial infection. However, regulatory mechanisms designed to control the immune 
response become dysfunctional, leading to immune suppression (Venet et al., 2008b; 
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Hotchkiss and Karl, 2003; Shimaoka and Park, 2008). At this stage, septic patients 
present increased IL-10 cytokine levels and tend to have a worse prognosis (Gogos et 
al., 2000). T cell anergy, a state of T cell unresponsiveness to antigen and enhanced 
TH2 responses mediated by p38 MAPK signaling are also observed during the later 
stages of STSS (Song et al., 2000). Sepsis also eventually leads to overall decreased 
ability to present antigens to T cells due to down-regulated expression of MHC class 
II molecules such as HLA-DR on monocytes (Le Tulzo et al., 2004; Fumeaux and 
Pugin, 2002). Large-scale apoptosis of immune cells also exacerbates the later stages 
of sepsis mediated immune suppression and will be discussed in more detail in 
Section 1.9.1. 
 
 
1.5.4 GAS infection associated sequelas 
 
Several autoimmune diseases are triggered as a consequence of S. pyogenes infection, 
emphasising the impact of different pathology induced by this Gram-positive 
bacterium. Many of these disorders are less prevalent in the West due to better health 
care regimens but remain a major health problem in developing countries, particularly 
affecting the young. Key examples of autoimmune GAS associated sequelas include 
acute rheumatic fever and acute glomerulonephritis.  
 
Acute Rheumatic Fever (ARF) is a delayed autoimmune sequela following GAS 
pharyngitis infection (Ellis et al., 2010). The disease exhibits many diverse 
symptoms, ranging from inflammation of the joints, heart, central nervous system and 
the skin (Guillherme and Kalil, 2010). Arthritis is the earliest feature of this 
autoimmune disease and ARF still remains the largest cause of acquired heart disease 
(rheumatic heart disease) in children, occurring within weeks post S. pyogenes 
infection (Stollerman, 1997).  
 
The progression of Rheumatic Heart Disease (RHD) is proposed to be mediated 
through the actions of auto-reactive antibodies and T cells, cross-reactive with both 
streptococcal components and host tissue such as cardiac myosin peptides (Kaplan, 
1963). This has been further confirmed through studies with T cell clones recognising 
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both streptococcal M5 peptides and myosin in a process known as molecular mimicry 
(Faé et al., 2006). 
 
The induction and progression of Acute Glomerulonephritis (AG), another example 
of an autoimmune GAS associated sequela is very similar to ARF. However, unlike 
ARF, AG is usually induced after streptococcal skin infection as well as after 
pharyngitis (Rodriguez-Iturbe and Musser, 2008). AG is an inflammatory condition 
of the glomerular capillaries in the kidneys, resulting in acute and chronic renal 
failure in children and young adults. It has been well recognised as a consequence of 
scarlet fever infection as described in 1812 (Wells, 1812). Clinical features of this 
disease include discoloured urine due to hematuria and edema of the face and 
extremities of the body (Couser, 1999).  
 
Progression of AG may be related to the deposition of immune complexes in the 
kidney such as C3 complement component and IgG (Couser, 1999). Many different 
streptococcal antigens have been suggested to bind in the glomerulus leading to 
pathogenesis. One such host antigen called Nephritis-associated Plasmin receptor 
(NAPlr), which is homologous to streptococcal GAPDH has been found deposited in 
the kidney, leading to disease (Oda et al., 2010). Other studies have focused on the 
role of antibodies against Streptococcal Pyrogenic Exotoxin B (SPEB), leading to the 
activation of complement and ensuing inflammation in the kidney (Cu et al., 1998). 	  
In conclusion, due to the many different associated consequences of GAS infection, 
S. pyogenes remains a prevalent human pathogen both in industrialised and 
developing countries. 	  	  
1.5.5 Treatment of S. pyogenes infection 
 
Given the range of different diseases caused by S. pyogenes, treatment is also varied 
to reflect this diversity of presented symptoms. S. pyogenes is sensitive to antibiotics 
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such as penicillin, which still remains the number one choice of treatment for non-
invasive infection such as impetigo and pharyngitis (Wessels, 2011).  
 
For invasive disease and bacterial sepsis, the administration of antibiotics, usually 
penicillin in combination with clindamycin given intravenously may slow the 
progression of disease. Intravenous fluids are also administrated to maintain blood 
pressure. Other therapies and interventions may be required for severe cases of 
invasive disease and necrotising fasciitis. For example, surgical debridement may be 
required to remove the infected necrotic tissue to limit further spread of infection and 
aid the recovery of the unaffected healthy tissue underneath (García-Casares et al., 
2010). 
 
The lack of protective antibodies against virulence factors formed during 
streptococcal infection is usually linked to worse prognosis during invasive disease. 
Intravenous polyspecific Immunoglobulin (IVIG) is a potential therapy against 
bacterial sepsis and necrotising fasciitis. This treatment offers high poly-specificity 
generated by antibodies pooled from several thousand donors against streptococcal 
virulence factors like superantigens and M proteins (Johansson et al., 2010). The 
effectiveness of IVIG treatment has been demonstrated in experimental animal 
models, whereby the effects of secreted superantigens were neutralised and enhanced 
bacterial killing and reduced systemic inflammation observed (Sriskandan et al., 
2006). The use of this therapeutic has also now been extended to the clinic 
successfully (García-Casares et al., 2010). 
 
The requirement for vaccination has been highlighted due to the resurgence of 
invasive GAS infection and the enormous burden it bears on the health care service in 
the past few decades. However, the choice of streptococcal target to induce antibody 
production has been faced with many difficulties to overcome the sheer diversity in 
M serotypes and also without inducing auto-reactive antibodies as highlighted in the 
development of ARF and AG autoimmune sequeals. Other GAS targets for vaccine 
suggested include fibronectin-biniding protein, streptococcal pyrogenic exotoxins and 
cell wall carbohydrates (Pandey et al., 2009). 
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1.6 Streptococcal virulence factors 
 
S. pyogenes produces different virulence factors to mediate disease pathology and 
prolong survival within the host. In this section, I will briefly describe the most 
commonly studied streptococcal virulence factors. 
 
 
1.6.1 CovRS regulatory system 
 
 
Figure 1.11: Gene expression induced by the CovRS two-component regulatory system. 
Environmental signals induce the phosphorylation of CovS (HPK), which in turns 
phosphorylates CovR (RR protein) to initiate expression of many different genes involved in 
the production of capsule, secreted proteins and regulation and adaption to the environment. 
 
 
 
Two-component regulatory systems are found ubiquitously and utilised by most 
prokaryotes, archea and a few eukaryotic organisms to sense and respond to changes 
within the environment. Two-component systems consist of a phosphotransfer 
scheme, involving two specific complexes; a membrane bound Histidine Protein 
Kinase (HPK) and a Response Regulator (RR) protein, usually found in the 
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cytoplasm of the cell. Upon extracellular signal transduction, the histidine kinase 
domain of the HPK, transfer a phosphate group to the RR protein (Stock et al., 2000).  
 
The expression of key virulence factors in S. pyogenes is mediated by a two-
component regulatory system called CovRS or CsrRS, with CovS representing the 
HPK and CovR, the RR protein (Graham et al., 2002). When this regulatory system is 
inactive, it leads to over-expression of the hyaluronic acid capsule resulting in a 
mucoid phenotype (Graham et al., 2002). CovR, exerting its regulatory role during 
late exponential or stationary phase, is a repressor of approximately 10-15% of the 
genome with many different genes linked to stress responses and virulence as 
highlighted by microarray studies (Figure 1.11) (Graham et al., 2002). 
 
Mutations in CovRS in M1 serotype S. pyogenes isolates can switch from a non-
invasive phenotype to hyper-virulence, characterised by increased resistance to 
neutrophil mediated killing and enhanced survival within the host. These mutants can 
arise spontaneously during invasive infection. Enhanced virulence may also be due to 
increased expression of SdaI DNase to degrade the DNA framework of NETs 
(Walker et al., 2007). It has also been found that M1 protein and hyraluronic acid 
capsule expression are indispensable and enhance survival of these hyper-virulent 
CovRS mutants (Cole et al., 2010).  
 
Subtleties in the regulation exerted by the CovRS system have been demonstrated 
through the use of single covR and covS knockout GAS mutants. For example, CovR 
retains some regulatory control in the absence of CovS but CovS cannot function 
without CovR (Treviño et al., 2009). covS knockout mutants were found to be 
severely out-competed by wild-type isolates in an ex vivo model of upper respiratory 
tract infection (Treviño et al., 2009). This indicates covS mutants may be positively 
selected for during invasive disease but not during upper respiratory non-invasive 
infections such as pharyngitis. 
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1.6.2 Exotoxins 
 
S. pyogenes can secrete different exotoxins to mediate its detrimental effects on the 
host. For example, GAS can produce a carboxylic esterase encoded by the sse gene, 
under the control of CovRS regulatory system. This esterase contributes to virulence, 
as mice immunised with a SSE knockout isolate are more resistant to lethal sub-
cutaneous GAS infection and exhibit diminished invasion of skin tissue (Zhu et al., 
2009a). If the sse gene is deleted, decreased severity of tissue destruction and limited 
dissemination of GAS from the skin is also observed (Zhu et al., 2009a). This 
highlights the importance of secreted exotoxins to enhance the survival of GAS 
within the host.  
 
Sepsis is characterised by devastating cell death during the later stages of disease. 
This is presented as apoptosis and necrosis of immune cells, such as macrophages. S. 
pyogenes can induce cell death via the production of pore-forming toxins, such as 
Streptolysin O (SLO) and Streptolysin S (SLS) (Gilbert, 2010).  
 
SLO is an oxygen-dependent secreted protein that binds cholesterol in eukaryotic 
membranes to form large holes and hence induces apoptosis. SLS is also another 
oxygen-dependent protein secreted by S. pyogenes with potent haemolysin activity to 
induce necrosis (Goldmann et al., 2009). This exotoxin is also responsible for the 
zones of red blood cell lysis when S. pyogenes is cultured on blood agar. SLS also 
inhibits neutrophil recruitment upon infection, enhancing the survival of the 
bacterium within the host by affecting the production of chemotactic gradients 
required to attract neutrophils to the site of infection (Lin et al., 2009).  
 
Another key exotoxin produced by S. pyogenes is Streptococcal Pyrogenic Exotoxin 
B (SPEB). SPEB is a cysteine protease with broad specificity, which can modulate 
host proteins like matrix proteins to mediate bacterial entry and virulence. It is 
produced as a precursor zymogen before autocatalytic processing and speb is also 
under the control of CovRS regulation. SPEB can cleave anti-bacterial chemokines 
such as IP10, and CXCL10 (Egesten et al., 2009). Interestingly, this exotoxin can 
also degrade streptococcal targets such as superantigens (Nooh et al., 2006). It has 
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been suggested that this virulence factor has also been an attractive target for 
streptococcal vaccine design in the past but process has been hindered as SPEB may 
be implicated in the induction of AG autoimmunity (Ulrich, 2008). 
 
IL-8 is an important chemokine, responsible for creating a chemotactic gradient to aid 
the migration of neutrophils to the site of infection and subsequent activation by 
induced CXCR1 or CXCR2 expression. S. pyogenes can produce a cell wall bound 
subtilisin-like serine protease, called SpyCEP to specifically cleave IL-8 and hence 
prolonging GAS survival (Edwards et al., 2005). SpyCEP is encoded by cepA gene 
under the control of CovRS regulation and can also be released as a soluble enzyme 
(Turner et al., 2009). Virulence of particular streptococcal isolates can be attributed to 
the high expression of SpyCEP (Zinkernagel et al., 2008). This protease can also 
cleave other chemokines such as Granulocyte Chemotactic protein-2 (GCP-2) and 
Growth-Related Onco-gene-α (GRO-α) to induce the same effect as IL-8 deactivation 
(Sumby et al., 2008). 
 
 
1.6.3 M proteins 
 
M proteins are virulence factors expressed on the bacterial cell wall and membrane, 
which act as surface antigens. They form fibrillar α-helical coiled-coil dimers, 
protruding from the bacterial surface. The C-terminal, located near the cell surface is 
conserved amongst M proteins, whereas the N-terminal is highly immunogenic 
(Robinson et al., 1993). As previously mentioned in Section 1.4, over 100 different M 
protein serotypes have been identified reflective of the sheer diversity in the C 
terminal of this group of virulence factor.  
 
This example of surface proteins can interact with fibrinogen, which in turn can bind 
via β-integrins expressed on neutrophils. This triggers the release of heparin-binding 
protein (HBP), which is a mediator of vasodilation, one of the clinical symptoms of 
sepsis (Macheboeuf et al., 2011). This effect has also been witnessed on human 
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peripheral blood monocytes in a TLR2 dependent manner (Påhlman et al., 2006), 
perpetuating the inflammatory response observed during septic shock. 
 
M proteins can also interact with other cells of adaptive immunity. M proteins 
secreted by S. pyogenes can interact with CD46 on CD4+ T cells to induce IL-10 
production and bystander suppression of T effector cells via granzyme B expression 
(Price et al., 2005). S. pyogenes may even directly bind to soluble CD46 to enhance 
survival (Lövkvist et al., 2008). It has also been shown soluble M1 protein, devoid of 
its membrane anchor can induce T cell proliferation and cytokine production, such as 
IFN-γ, acting in a manner very similar to superantigens (Påhlman et al., 2006). 
 
M proteins have been a suggested target for streptococcal vaccine design for many 
years as neutralising antibodies can be produced against these surface expressed 
proteins. It has been known that epitopes from M5 protein (M5308-319 and M517-31) can 
be presented by macrophages via MHC class II molecules and presented to CD4+ T 
cells (Degnan et al., 1997; Delvig and Robinson, 1998; von Delwig et al., 2002). A B 
cell epitope designated J8 has also been identified from the conserved region of M 
proteins (Pandey et al., 2009). Peptide synthesised from J8 was found to stimulate T 
and B cells to offer protection from GAS infection in mice (Pandey et al., 2009). 
However, research in this field of vaccine design has yet to yield any successful 
results in the clinic due to the sheer diversity in M protein serotypes (Smeesters et al., 
2008) and cross reactivity with human tissue exhibited by such neutralising 
antibodies.  
 
Other approaches have been developed in the hunt for non-M protein based vaccine 
targets. Genomic surface protein libraries were searched for potential candidates for 
vaccine design. One key finding was Spy 1536 proteins. If this gene is deleted in S. 
pyogenes, it leads to decreased bacterial binding to human plasma and extracellular 
matrix protein and it would appear that M protein expression is also dependent on the 
presence of this gene (Fritzer et al., 2010). Spy 1536 offers real potential as a vaccine 
target as protection against GAS infection has been shown upon deletion of protein in 
murine models of sepsis (Fritzer et al., 2010). 
 
 
	   76	  
1.6.4 Superantigens 
 
Table 1.2: Functional properties of superantigens secreted by S. pyogenes. 
The 11 different superantigens secreted by S. pyogenes, along with molecular weights, 
specificity with human TCR Vβ chains and potency of binding is shown as the concentration 
of superantigen required to stimulate half the number of PBMCs in vitro (P50) (Proft and 
Fraser, 2003). 
 
Superantigen Molecular weight 
(KDa) 
Human TCR Vβ  
specificity 
P50 (pg/ml) 
SPEA 26.0 2.1, 12.2, 14.1, 15.1 - 
SPEC 24.4 2.1, 3.2, 12.5, 15.1 0.1 
SPEG 24.6 2.1, 4.1, 6.9, 9.1, 12.3 2 
SPEH 23.6 2.1, 7.3, 9.1, 23.1 50 
SPEI 26.0 6.9, 9.1, 18.1, 22 0.1 
SPEJ 24.6 2.1 0.1 
SPEL/K 27.4 1.1, 5.1, 23.1 1 
SPEM 26.2 1.1, 5.1, 23.1 10 
SSA 26.9 1.1, 3, 15 - 
SMEZ-1 24.3 2.1, 4.1, 7.3, 8.1 0.08 
SMEZ-2 24.1 4.1, 8.1 0.02 
 
 
 
S. pyogenes is an example of a bacterium that expresses a wide range of 
superantigens. So far, 11 superantigens have been identified from GAS (Table 1.2) 
(Thulin et al., 2006). Unlike other streptococcal virulence factors such as SPEB, 
superantigens are encoded on temperate bacteriophages instead of chromosomal 
DNA (Ferretti et al., 2001; Proft et al., 2001; Proft and Fraser, 2003).  
 
The production of superantigens appears to be conserved within the Streptococci 
genus. For example, Streptococcus equi, a Group D Streptococci, associated with the 
infectious disease of strangles in horses, produces various superantigens such as 
SeeH, SeeI, SeeL and SeeM with similar immunogenic features to those secreted by 
GAS (Paillot et al., 2010). S. aureus is another common Gram-positive human 
pathogen that utilises superantigens, such as Staphylococcal Exotoxins (SE)-A, SEB 
and SEC to exert pathogenesis (Proft and Fraser, 2003). 
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The prevalence of invasive GAS isolates may be attributed to emm type and also by 
the expression of different superantigens. A study in Australia examined the genotype 
of 107 clinical GAS isolates and expression of the 11 different known superantigens. 
It was revealed that certain emm types were found to contain particular combinations 
of superantigens genes (Commons et al., 2008). For example, emm1 isolates were 
found to contain spea, speg, spej and smez but do not possess spec, ssa and speh 
(Commons et al., 2008). This may indicate that superantigens play a role in the 
prevalence of different emm types during infection. However, this can be argued from 
the other point of view, suggesting that the prevalent of certain superantigens are the 
main determinants in invasive disease (Lintges et al., 2010). 
 
While the presence of superantigens is not inextricably linked to the ability of GAS to 
cause sepsis, there is evidence linking specific clinical episodes to the presence of 
potent superantigens. A high proportion of all pathogenic GAS isolates encode one or 
more superantigens such as Streptococcal Pyrogenic Exotoxin A (SPEA). spea is 
present in 40-90% of S. pyogenes strains associated with invasive disease but only in 
15-20% of non-invasive strains (Sriskandan et al., 1999). In vivo experiments of mice 
given recombinant SPEA protein have been shown to develop pyrexia and 
hypotension (Lee and Schlievert, 1989).  
 
Superantigens are unlike conventional antigens as they bind to MHC Class II 
molecules in a region away from the peptide-binding groove and to the TCR variable-
β chain of the T cell, and do not require prior antigen processing (Dellabona et al., 
1990). Many different models have been proposed for how superantigens cross-link 
with MHC molecules and the TCR. Early crystal structures with SEC superantigen, 
suggested the protein displaces the TCR and MHC class II molecule like a wedge so 
there was no direct contact between TCR and antigenic peptide (Fields et al., 1996). 
Other models have suggested that some superantigens (e.g. SEH) have zinc-binding 
motifs to offer high affinity interactions with TCR and MHC class II molecule in a 
bridge-like structure (Figure 1.12) (Petersson et al., 2001). 
 
Streptococcal superantigens exhibit preferential binding to MHC class II molecules, 
with highest binding affinity to HLA-DQ, then -DR and weakest with –DP due to 
constriction in binding conformations (Sriskandan and Altmann, 2008; Rajagopalan 
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et al., 2007). This is highlighted in structural studies of SPEA, whereby a crucial 
disulphide bonds are required to induce superantigenic effects and strong affinity 
binding with HLA-DQ molecules (Kline and Collins, 1996).  
 
 
Figure 1.12: Schematic of superantigen binding to MHC class II molecule and TCR. 
Binding of superantigens to MHC class II molecule and TCR leads to T cell activation, 
proliferation and cytokine release (Llewelyn, 2005). 
 
 
 
Three groups of superantigens can be defined according to their specificity to TCR 
structures as reviewed by Bueno and colleagues (Bueno et al., 2007). The first group 
contains superantigens such as SEB will recognise any TCR β chain via their CDR2 
loops (Hayball et al., 1994). The second group (e.g. SPEA) requires more specific 
interactions and recognises TCR Vβ chain via CDR1 and CDR2 loops. The last group 
of superantigens (e.g. SPEC) is highly specific utilising all three CDR loops of the 
TCR (Kline and Collins, 1996; Sundberg et al., 2002).  Hence each superantigen 
binds to favoured Vβ families, resulting in TCR signaling and specific T cell 
expansion (Figure 1.12) (Llewelyn, 2005; Llewelyn et al., 2004; Llewelyn and 
Cohen, 2002). For example, Streptococcal Mitogenic Exotoxin-Z (SMEZ), the most 
potent superantigen, favours Vβ8+ T cells in mice (Unnikrishnan et al., 2002). 
 
Superantigen binding with T cells has been found to activate up to 20-30% of the host 
T cell population (Lappin and Ferguson, 2009), whereas conventional antigens only 
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activates approximately 1 in 104 to 1 in 106 T cells (Li et al., 1999). The resultant 
effect is T cell proliferation and cytokine production, such as IL-1, IL-6, IFN-γ and 
TNF-α (Figure 1.12) (Cunningham, 2000) as demonstrated when streptococcal 
supernatants are used to stimulate human PBMCs (Unnikrishnan et al., 2002). High 
levels of TNF-α are measured from murine spleens within 1 hour of exposure to 
purified superantigens (Sriskandan and Altmann, 2008).  
 
HLA-transgenic mice have been exploited in the study of superantigen driven 
immune responses. HLA-DR3 mice immunised with purified SEB via an intra-nasal 
route developed inflammation of the airways and lung (Rajagopalan et al., 2006). The 
immune response was further studied and typical effects of superantigen mediated T 
cell modulation were observed. For example, specific Vβ8+ expansion of CD4+ and 
CD8+ T cells were seen along with increased IFN-γ production (Rajagopalan et al., 
2006). A similar set of results was also attained after infection with SPEA in HLA-
DQ8 transgenic mice (Welcher et al., 2002). 	  
SMEZ induces a cytokine response approximately ten times higher than with SPEA 
(Yang et al., 2005). However, unlike other superantigens, SMEZ is the most 
polymorphic as demonstrated by the identification of 22 different smez alleles from 
21 different M serotype GAS isolates over a 15-year period in New Zealand (Proft et 
al., 2000). The creation of many different allelic variants of smez may be caused by 
the process of gene mosaisism, similar to homology gene recombination between two 
copies of the gene (Proft et al., 2000). Due to the highly polymorphic nature of 
SMEZ, very few neutralising antibodies have been detected in normal adult sera 
(Proft et al., 2000). This suggests that along with SMEZ representing the most potent 
superantigen to date, it is also the most prevalent and the most variable. 
 
Other superantigens such as SPEI and SPEJ have been less well researched. These 
two virulence factors are the second most potent superantigens after SMEZ (Proft et 
al., 2001). SPEI induced Vβ18+ T cell expansion, whereas SPEJ favoured Vβ2 and to 
a lesser degree Vβ8+ T cells (Proft et al., 2001). In vivo experiments have 
demonstrated that rabbits given 500µg of recombinant SPEJ all succumb to sepsis, 
indicative the potency of this superantigen (McCormick et al., 2001). 
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Superantigens have not only been exclusively found to interact with T cells but also B 
cells as well. Moraxella (Branhamella) catarrhalis is a Gram-negative bacterium 
associated with respiratory diseases, particularly in children. It is capable of secreting 
superantigens, such as Moraxella IgD-binding protein (MID), which targets human 
IgD. This virulence factor can cross-link with B Cell receptors (BCRs) to induce 
proliferation and cytokine production of B cells (Jendholm et al., 2009), reminiscent 
of streptococcal superantigens binding to TCR of T cells. However, MID also 
requires signaling via TLR9 to exert its effects (Jendholm et al., 2009). Superantigens 
secreted by viruses such as Lymphocytic Choriomeningitis Virus (LCMV) can also 
expand Vβ specific T cells (Punkosdy et al., 2011), emphasising the conservation of 
this class of virulence factor amongst various pathogenic microorganisms. 
 
 
1.6.5 Capsule 
 
 
Figure 1.13: Mucoid appearance of S. pyogenes. 
When heavily encapsulated S. pyogenes isolates are grown overnight on blood agar, they 
exhibit a mucoid phenotype, appearing like oil droplets on the agar (A), compared to smaller, 
more opaque wild-type isolates (B) (Stollerman and Dale, 2008). 
 
 
 
S. pyogenes is a typical Gram-positive bacterium as it expresses an outer capsule 
composed of hyaluronic acid (Kendall et al., 1937). This is not uncommon, as many 
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pathogenic bacteria such as S. aureus also express large polysaccharide capsules to 
avoid phagocytosis (Wilkinson et al., 1979). Protection from the innate immune 
system is achieved by blocking opsonins, such as C3 from coating the 
microorganisms and direct attachment to macrophages (Foley and Wood Jr, 1959; 
Dale et al., 1996; Whitnack et al., 1981). Host immunity can produce natural anti-
microbial peptides, such as the Hyaluronic Acid-Binding Peptide (HABP), PEP35 to 
trigger an immune response. This peptide has been shown to promote neutrophil 
recruitment during S. aureus infection to aid bacterial clearance (Lee et al., 2010a). 
 
Hyper-virulence of covS M1 serotype GAS mutants is accompanied by increased 
expression of capsule, leading to decreased adherence to epithelial cells and increased 
resistance to phagocytosis (Lyons and Ward, 1935; Hollands et al., 2010). 
Encapsulated GAS isolates are also able to manipulated host cells by binding to the 
hyaluronic acid binding protein, CD44 to allow entry into epithelium (Schrager et al., 
1998). The adaptive immune system can be impeded by the concealment of key 
surface antigens by capsule proteins shielding the pathogen from elimination. These 
features of capsule offer great protection from the host immune system. 
 
Overall, S. pyogenes has adapted to use many different pathogenic virulence factors 
to evade the immune system and hence prolonging survival within the host. 
 
 
1.7 Immunogenetics of sepsis susceptibility 
 
Individuals infected with the same strain of S. pyogenes can confer different 
outcomes in disease progression. This suggests that there may be genetic factors, 
unrelated to pathogens involved in the susceptibility of sepsis and severity of disease. 
Specific HLA class II haplotypes have been extensively studied due to the 
preferential binding of streptococcal superantigens to TCR and MHC class II 
molecules, which may influence the immunological response.  
 
	   82	  
From analysis of human PBMCs from healthy donors with known HLA genotypes 
stimulated with 2 clinical streptococcal isolates, it was found that HLA-DR15 and 
DQ6 alleles were associated with protection against STSS. Whereas, HLA-DR7 and 
DR5 alleles were indicators of high risk of developing invasive disease (Nooh et al., 
2011). More extensive analysis of HLA haplotypes and different clinical 
manifestations of S. pyogenes invasive disease have also indicated that patients with 
the DRB1*1501/DQB1*0602 haplotype were less likely to develop severe sepsis 
(Kotb et al., 2002). The DRB1*14/DQB1*0503 and DRB1*11/DQB1*0301 
haplotypes in this study were shown to be a high risk factor for severe sepsis and 
necrotising fasciitis (Kotb et al., 2002). This indicates that a genetic component does 
exist as a risk factor for developing severe invasive streptococcal disease. 
 
The allelic variation of MHC class II molecules in humans may influence different 
affinity to bacterial antigens and hence the varying susceptibility to invasive 
streptococcal disease. This is also reflected in mice. C3H/HeN and CBA/J mice are 
highly susceptible to GAS infection and sepsis, whereas DBA/2, C57BL/10 and 
BALB/c mice are resistant to disease and survive infection (Medina et al., 2001; 
Goldmann et al., 2005b). This has been linked to an association with H2 genotype. 
Transgenic BALB/c mice carrying the H2K region of C3H/HeN mice are equally 
susceptible as wild-type C3H/HeN strain to GAS infection with increased levels of 
IFN-γ, IL-12 and IL-6 in the blood (Goldmann et al., 2005b). This indicates that 
MHC class II or H2 genotype in either humans or mice have a major influence on the 
susceptibility and severity of streptococcal disease. 
 
Genetic risk factors are also associated with cytokine genes as well. As TNF-α, IL-6 
and IL-1β are considered hallmark cytokines during the initial pro-inflammatory 
stage of sepsis, genomic analysis of these genes has produced some interesting results 
regarding genetic susceptibility to S. pyogenes infection. Many Single Nucleotide 
Polymorphisms (SNPs) have been identified in the promoter region of tnf-α. One 
such SNP at position -308bp exhibited strong association with patients who 
developed severe septic shock (Mira et al., 1999). The same is true for il-6 and il-1β 
genes and also three SNPs in il-10 have been isolated, leading to decreased 
production and increased severity of sepsis (Sutherland et al., 2005; Lowe et al., 
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2003). However, correlating mutations in key cytokine genes with disease severity, 
susceptibility and prognosis across multiple genetic backgrounds has given 
inconsistent results. This suggests that larger sample sizes may be required or the 
genetic correlation is very weak (Papathanassoglou et al., 2006; Arcaroli et al., 2005).  
 
Point mutations in PRRs have also been investigated. This may be important as a 
decreased ability to detect and respond to microbial ligands may have a huge impact 
on the downstream responses to skew the onset of disease. Two specific SNPs 
(D229G and T399I) in humans tlr4 have been identified, with some correlation to 
increased risk to septic shock due to decreased cytokine production (Kumpf et al., 
2010). Interestingly, the D229G SNP in tlr4 has also been studied within the context 
of autoimmune diseases, such as MS with little impact on clinical disease found 
(Kroner et al., 2005). Another example of a polymorphism in a PRR gene is R753Q 
SNPs in human tlr2, initially identified within a cohort of white healthy donors and 
may results in a sequestered response to bacterial infection (Schröder et al., 2003; 
Lorenz et al., 2000).  
 
Overall, it would appear that certain MHC class II haplotypes are associated with 
susceptibility to GAS infection, presumably due to preferentially binding of 
superantigens to MHC class II molecules and TCR. However, mutations in key 
PRRs, such as tlr2 and tlr4 may also play a key initial role in determining the severity 
of disease. 
 
 
 
1.8 Mouse models of sepsis and inflammatory diseases 
 
Different animals models of sepsis and other inflammatory diseases have been 
developed in the past few decades to help researchers study the immune responses 
mounted during systemic infection. Each model has advantages and disadvantages 
associated and will be discussed in the following section. 
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1.8.1 Cecal Ligation and Puncture (CLP) model 
 
The Cecal Ligation and Puncture (CLP) model of sepsis is the most widely used 
model for experimental sepsis. It has been claimed to be the most realistic model for 
induction of poly-microbial sepsis.  
 
The cecum is an endogenous source of microorganisms and rupture of this tissue 
results in the release of this bacterial microenvironment into the peritoneal cavity, 
causing bacterial peritonitis and eventually sepsis and toxic shock when bacteria gain 
entry into the bloodstream (Rittirsch et al., 2009). The advantages of using the CLP 
model to study bacterial sepsis are that this technique can be adapted to induce sepsis 
with varying degrees of severity and may reflect a more realistic model of human 
disease but technically, it is hard to achieve consistency between experiments 
(Rittirsch et al., 2009).  
 
While most studies have focused on particular cell types of the innate and adaptive 
immune response, the complement system may play a significant role during sepsis. 
C5a has been proposed to have an inflammatory role in CLP-treated mice. This 
component of the complement cascade interacts with both DCs and γδ T cells to lead 
to the production of IL-17, which has been shown to be pathogenic in a CLP model of 
sepsis (Xu et al., 2010). C5a has also been found to alter the intracellular signaling in 
neutrophils in vitro and also during the onset of sepsis in vivo (Xu et al., 2010). Mice 
lacking either C1q and therefore lacking classical complement signaling activity or fd 
knockout mice, which lack alternative pathway have been shown to have increased 
mortality and bacterial burden in CLP models of sepsis (Dahlke et al., 2011). This 
highlights the importance of early innate immunity, such as complement in the 
activation of neutrophils and downstream effective bacterial clearance. 
 
HSP-70 has been implicated in the pathology of sepsis, particularly in aged patients. 
This chaperon protein has also studied in murine models of sepsis. For example, 
young HSP-70-/- mice do not display any difference in survival outcome compared to 
age-matched WT controls post CLP surgery (McConnell et al., 2011). There was 
however, a difference in older mice, where the presence of HSP-70 prevented 
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mortality by reducing sepsis-induced apoptosis and systemic inflammation 
(McConnell et al., 2011), indicating that DAMPs, such as HSPs are key in activating 
protective immune response. 
 
Many different disease models have emphasised the importance of cytokine 
production during infection. IL-33 can also influence the migration of neutrophils to 
the site of infection to aid bacterial clearance in CLP model (Alves-Filho et al., 
2010). Decreased serum levels of IL-6 and TNF-α, potent inducers of systemic 
inflammation were also observed upon IL-33 treatment (Alves-Filho et al., 2010). 
This suggests that IL-33 is protective and may represent a therapeutic agent against 
the onset of sepsis. Another possible therapeutic agent is recombinant IL-7, shown to 
induce proliferation of CD4+ and CD8+ T cells and suppress apoptosis mediated by 
CLP-induced sepsis (Unsinger et al., 2010). A similar role was also found for IL-15, 
which can protect CD4+, CD8+ T cells, NK cells and DCs from apoptosis during 
sepsis, improving overall survival during systemic disease (Inoue et al., 2010). 
However, whether this cytokine can be used as a therapeutic for treatment of sepsis 
remains unknown.  
 
The use of the CLP model has highlighted an interesting caveat in the study of Tregs 
during sepsis. CLP-treated mice exhibit an increase in the number of Tregs with 
suppressive activity. However, these mice are unable to contain the development of 
an implanted tumour due to enhanced immune suppression after the symptoms of 
sepsis has subsided (Cavassani et al., 2010). This is also mirrored in humans, where 
patients who have survived sepsis show evidence of a sustained immunosuppressive 
state. Mice subjected to poly-microbial sepsis are more susceptible to secondary 
bacterial infection, such as Pseudomonas aeruginosa, caused by decrease neutrophil 
recruitment as a consequence of immune suppression (Delano et al., 2010). 
 
Models of Acute poly-microbial Peritonitis (AP) are similar to CLP models of sepsis, 
as a surgical connection in the form of 18-gauge silicon tube is inserted in the cecum 
and out into the peritoneum, allowing microbiota to enter this cavity from the 
intestines. AP-operated mice exhibit elevated serum levels of IL-6 and IL-10 
compared to sham controls, accompanied with an influx of neutrophils (Barrera et al., 
2011). This mirrors immunological changes observed in CLP models of sepsis. These 
	   86	  
cytokine changes also correlate with increased bacterial burden in AP-treated mice, 
suggesting there is a dysfunction in the clearance of the resultant infection and also 
reflect a decreased proliferation of T cells (Barrera et al., 2011). This indicates 
appropriate adaptive immunity is not sufficiently mounted to offer protection from 
disease. 
 
 
1.8.2 Animal models of colitis 
 
Different murine models have also been developed to study other inflammatory 
diseases, such as colitis. Colitis usually refers to as the inflammation of the colon and 
it can be classified based on various disease phenotypes, such as autoimmune Crohn’s 
disease to infectious colitis, caused by the presence of Clostridium difficile and 
Shigella dysenteriae. The presence of gut microbiota is important in the induction of 
colitis, as mice housed in pathogen-free environments do not develop this disease 
(Feng et al., 2010). The study of colitis has offered interesting results regarding how 
the immune system can induce an inflammatory response and may be extrapolated to 
the study of sepsis. 
 
The most commonly used model of colitis involves the transfer of auto-reactive CD4+ 
T cells into RAG-deficient mice, resulting in inflammation of the large intestine. This 
highlights the potency of T cells in the induction of inflammation. This is emphasised 
by the requirement of IL-7 by memory colitogenic T cells to proliferate during the 
development of colitis in RAG-1-/- mice (Tomita et al., 2009). Co-stimulatory signals 
between CD27 expressed on T cells and CD70 on DCs may affect the development of 
colitis. This has been proposed in an animal model of colitis, whereby signaling via 
the CD27-CD70 co-stimulatory pathway was shown to be detrimental (Manocha et 
al., 2009; Cox et al., 2011). The blockade of CD70 or CD27 prevented the induction 
of colitis upon the transfer of autoreactive CD4+CD45RBhi T cells into RAG-deficient 
mice (Manocha et al., 2009).  
 
If T cells are important to drive inflammation, it is not inconceivable that IL-2 is also 
required to promote the proliferation of these antigenic T cells. This has been 
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demonstrated when CD4+CD45RBhi T cells from a IL-2-/- mouse cannot induce colitis 
when adoptively transferred into RAG-knockout mice (Kameyama et al., 2010). γδ+ 
TCR T cells may also be responsible for the onset of colitis through the production of 
IL-17 (Nanno et al., 2008; Do et al., 2011). A similar pathogenic role for T cells has 
been implicated in Inflammatory Bowel Disease (IBD). Neutralisation of IL-23 
ameliorates murine models of IBD, due to decreased T cell proliferation and TH17 
development in the intestines (Ahern et al., 2010), supporting the theory that T cells 
mediated immunity is not always advantageous to the host. 
 
As with sepsis, a possible detrimental role of TNF has been highlighted through the 
studies of colitis, where CD4+ T cells over-expressing the TNF receptor, TNFR2 
caused exacerbation of the disease (Dayer Schneider et al., 2009). Mice administrated 
with TNF have even been shown to develop toxic shock as a result. This effect may 
be mediated via TNF stimulating the production of type I interferons from 
macrophages and can be reversed by knocking out IFN-β in mice to protect them 
from induced shock (Huys et al., 2009). IL-17 from TH17 cells may also exacerbate 
TNF-induced shock (Takahashi et al., 2008). While TNF may be pathogenic during 
transfer models of colitis, the protective role of IL-10 from Tregs has been 
demonstrated to suppress the onset of colitis (Murai et al., 2009), emphasising the 
importance of immune regulation during inflammation. 
 
The administration of certain chemicals to animals can also artificially induce colitis. 
The intra-rectal administration of trinitrobenzene sulphonic acid (TNBS) in 
susceptible strains of mice has been shown to induce TH1 cells to cause colitis, while 
treatment with anti-CD70 antibody can inhibit disease (Manocha et al., 2009). 
Decreased foxp3 expression has also been found in a chemical induction model of 
transient colitis (Reardon et al., 2008). Activation of the AHR pathway through the 
administration of TCDD inhibited dextran sulphate sodium (DSS)-induced colitis, 
suggestive that this signaling pathway, generally associated with TH17 cell 
development may be protective in murine models of colitis (Takamura et al., 2010), 
which may explain the decrease in Tregs observed by Reardon and colleagues.  
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Overall, the use of animal models of sepsis and other associated inflammatory 
diseases has provided us with many key findings of how the immune system responds 
during infection and inflammation. They have also provided important tools to new 
therapeutics to better treat patients with sepsis. 
 
 
 
1.9 Immune responses during GAS bacterial infection and sepsis 
 
As the high mortality and morbidity associated with sepsis represent a huge 
economical burden on the health care service, much research has been conducted to 
better understand how the host immune system responds to systemic bacterial 
infection. I will present a brief summary of our current understanding of how 
apoptosis, autophagy, innate and adaptive immune response contribute to the onset 
and development of sepsis. 
 
 
1.9.1 Apoptosis during GAS infection and sepsis 
 
Large-scale apoptosis, particularly of lymphocytes is observed during the 
immunosuppressive phase of severe sepsis. This is attributed to apoptosis via both 
Fas and mitochondrial-mediated pathways. However, blocking either pathway only 
partially protects mice from CLP-induced sepsis (Chang et al., 2007), indicating that 
other pathways may operate to induce apoptosis and still remains a source of 
research. Successful capture of pathogens, such as S. pyogenes by phagocytosis can 
induce gene expression changes to up-regulate apoptotic pathways. For example, 
neutrophils that have engulfed S. pyogenes increase gene expression of components 
connected to TNF-signaling pathways (TNF-α, TRAIL) and also BAX and BCL2A1, 
important apoptotic mediators (Kobayashi et al., 2003).  
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A consequence of increased apoptosis of cells during sepsis is a defect in Delayed-
Type Hypersensitivity (DTH) responses as mediated by CD4+ T cells. CLP-operated 
mice have delayed DTH responses but return to basal levels by day 10 after surgery 
(Unsinger et al., 2010). These apoptotic cells can induce a state of tolerance, 
mediated by TRAIL-expressing CD8+ T cells to inhibit CD4+ T cells and hence the 
inhibition of delayed DTH responses (Unsinger et al., 2010). Human Tregs have also 
been shown to induce apoptosis via Fas-FasL mediated interactions of monocytes 
after stimulation with bacterial endotoxins (Venet et al., 2009). Septic patients can 
down-regulate their expression of HLA-DR on monocytes (Fumeaux and Pugin, 
2002). This results in an increase in Treg population and subsequent suppression of the 
immune response leading to anergy (Venet et al., 2009). 
 
 
1.9.2 Autophagy of GAS 
 
S. pyogenes is generally considered an extracellular pathogen, but can invade non-
phagocytic cells by endocytosis to persist within the host. This has been found to be 
the case for neutrophils (Staali et al., 2003), macrophages (Thulin et al., 2006) and 
lung epithelial cells (LaPenta et al., 1994). This Gram-positive bacterium can also be 
within minutes engulfed rapidly by human neutrophils, (Kobayashi et al., 2003). 
Although, GAS has been shown to be more resistant to phagocytosis compared to 
other bacteria, such as S. aureus and L. monocytogenes (Kobayashi et al., 2003).  
 
S. pyogenes can escape transportation to the lysosome via the secretion of SLO 
(previously discussed in Section 1.6.2), which has been demonstrated to inhibit GAS 
internalisation by keratinocytes and intracellular trafficking to lysosomes mediated by 
clathrin-dependent mechanisms (Håkansson et al., 2005; Logsdon et al., 2011). The 
host cell can still degrade internalised S. pyogenes once free in the cytoplasm. This is 
achieved through autophagy, the major pathway leading to the degradation of 
cytoplasmic components within eukaryotic cells. Autophagy is very efficient at 
eliminating GAS as shown in vitro. Internalised S. pyogenes within HeLa cells are 
held within intracellular membrane bound structures called GAS-containing 
Autophagosome-Like Vacuoles (GCAV) (Yamaguchi et al., 2010). Once the 
	   90	  
bacterium is captured within GCAVs, it can fuse with lysosomes, leading to 
degradation (Nakagawa et al., 2010). This remains a critical mechanism of bacterial 
clearance and will be discussed in more detail in Chapter 4. 
 
 
1.9.3 Innate immunity to S. pyogenes infection and sepsis 
 
Different aspects of immunity within the context of GAS infection or sepsis have 
previously been examined in murine and human studies. I will give a brief overview 
of our current understanding of the varying contribution from DCs, macrophages, 
neutrophils, NK, NKT and γδ T cells in the onset and development of sepsis. 
 
Only a few clinical GAS isolates are able to demonstrate DC maturation in vitro with 
human monocyte-derived DCs. Although, a ratio of 1:1 of live bacteria to DCs may 
mimic early infection (Cortes and Wessels, 2009). S. pyogenes has been suggested to 
induce maturation of DCs in vivo as characterised by the up-regulation of surface 
expression of MHC and co-stimulatory molecules. A M1 serotype S. pyogenes isolate 
was used to stimulate mDCs and pDC at a higher ratio of 5:1 live bacteria to DCs and 
showed increased expression of CD80 and CD40 on pDCs and also the production of 
cytokines associated with the disease phenotype from mDCs (IL-10, IL-12 and TNF-
α) (Veckman and Julkunen, 2008).  
 
Upon S. pyogenes activation, DCs were shown to be capable of stimulating naïve T 
cells to proliferate and differentiate into a TH1 phenotype (Veckman and Julkunen, 
2008). pDCs can undergo in vivo maturation upon SEA superantigen stimulation, 
although this was shown to require the presence of T cells and IFN-γ (Muralimohan 
and Vella, 2006). This emphasises how innate immune cells can respond to microbial 
infection to prime adaptive immunity. 
 
A protective role for DCs in sepsis has been postulated. If this cell type is depleted in 
CD11c-DT transgenic mice, significant increase in bacterial load was found in the 
draining lymph node and liver after sub-cutaneous infection with S. pyogenes (Loof et 
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al., 2007). This result is also mirrored by experiments demonstrating the lack of DCs 
contribute to increased mortality of mice in poly-microbial models of sepsis, TLR2 
and TLR4 may also be involved in the apoptosis of this valuable cell type (Pène et 
al., 2009). This highlights the importance of DCs in preventing the dissemination of 
bacteria into the lymph nodes and other systemic organs.  	  
Transcriptome analyses of murine macrophages infected with a M23 serotype S. 
pyogenes isolate revealed up-regulation of many key genes such as cytokines and 
chemokines (Goldmann et al., 2007). M1 and M2 macrophage associated markers, 
such as iNOS and arginase were also up-regulated upon infection, implicating this 
cell type is implicated in the elimination of S. pyogenes (Goldmann et al., 2010). 
Monocytes may also play a role during the onset of sepsis. For example, serum 
extracted from septic patients exhibited enhanced levels of IDO activity, correlating 
to increased severity of disease (Tattevin et al., 2010). 
 
While DCs and macrophages have been shown to be protective during some models 
of S. pyogenes infection, the role of neutrophils is still unclear with contradicting 
evidence found. Neutrophils may have a protective role during animal models of 
poly-microbial sepsis, as their failure to migrate to the site of infection correlates to 
worse disease prognosis (Freitas et al., 2009). In this model of CLP, IL-17 and 
subsequent signaling via IL-17 receptor was shown to recruit neutrophils and be 
beneficial to the host (Freitas et al., 2009). However, blockade of IL-17 and hence 
reduced neutrophil recruitment in CLP models of sepsis has also been shown to be 
protective, contradicting other groups’ data (Flierl et al., 2008).  
 
Another potential protective role of neutrophils has also further been highlighted 
through studies of TNF-α receptors; TNFR1 and TNFR2. If these receptors are 
knocked out in mice, it was deemed protective in a poly-microbial model of sepsis. 
Enhanced neutrophil recruitment was observed to aid bacterial clearance in the 
peritoneal cavity and overall enhanced survival (Secher et al., 2009). It was also 
shown in this model, TNF reduces the expression of CXCR2 on neutrophils to affect 
their ability to migrate to the site of infection and also induced apoptosis of infected 
	   92	  
target cells (Secher et al., 2009). This supports other observations of the detrimental 
effects of TNF as revealed in animal models of colitis. 
 
NKT cells during sepsis have also previously been examined in CLP models of poly-
microbial sepsis, showing a decrease of overall frequency after surgery (Hu et al., 
2009). However, this also correlated with an observed increase in the frequency of 
cytokine producing iNKT cells (Hu et al., 2009), suggesting that the remaining cells 
may have gained potent effector function. Despite these observed changes, NKT cells 
may be pathogenic, as inhibition of antigen presentation or activation by CD1d 
molecules blocks the release of pro-inflammatory cytokines and decreased mortality 
(Hu et al., 2009). NK cells may also be pathogenic during poly-microbial sepsis, as 
mice depleted of this cell type are less susceptible to mortality (Sherwood et al., 
2004). 
 
NKT cells may be sensitive towards superantigens stimulation due to their expression 
of TCR. For example, Vβ7+ and Vβ8+ NKT cells can proliferate upon stimulation 
with SEB and produce TNF-α in a similar fashion as T cells (Ragin et al., 2006). 
However, as NKT cells represent such a small percentage of the lymphocyte 
population, their contribution towards the pathogenesis of sepsis is minimal compared 
to T cells. NK cells may also indirectly respond to superantigens as well, although 
this is less well understood. Superantigens such as SEB and SPEA have been shown 
to activate Kupffer cells in the liver to produce pro-inflammatory cytokines like IL-12 
to activate NK and NKT cells (Dobashi et al., 1999).  
 
γδ T cells, another key cell type of the innate immunity branch have been implicated 
as pathogenic in adoptive cell transfer models of colitis. This particular cell 
population via the production of IL-17 may contribute to the differentiation of 
colitogenic TH17 cells, exacerbating the disease phenotype (Do et al., 2011). Mice 
subjected to CLP-surgery, followed by lung injury were found to have increased 
number of γδ T cells in the lung, despite low levels of cytokine production (Hirsh et 
al., 2004a). The authors suggested that γδ T cells might be beneficial to recovery post 
CLP surgery. This observation has been strengthened by experiments showing that 
IL-7 treated γδ T cells produced IL-17 to recruit neutrophils, aiding bacterial 
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clearance in a CLP model (Kasten et al., 2010).  However, in septic patients, 
decreased circulating γδ T cells have been noted, contradicting data from murine 
models (Venet et al., 2008a). Overall, from these finding, it would appear that γδ T 
cells are both pathogenic and protective in sepsis and their role requires further 
clarification.  
 
In conclusion, various cell components of the innate branch of immunity are 
implicated in the development of sepsis, either from human studies or animal models 
of disease. Data is still lacking for some of these cell types, particularly in the context 
of S. pyogenes infection and more research is required. 
   
 
1.9.4 Adaptive immunity to S. pyogenes infection and sepsis 
 
The presence and activity of T cells have been implicated in models of S. pyogenes 
infection and also sepsis. There is evidence to suggest that particular T helper cell 
subsets may be pathogenic or protective during bacterial infection, which I will 
discuss in the following section.    
 
IL-17A has been proposed to be a protective cytokine in mouse models of colitis, 
with TH17 cells representing the primary source. Colitis is believed to be a TH1 cell 
mediated disease and the effects of IL-17A can inhibit this specific cell population to 
suppress gut inflammation (Awasthi and Kuchroo, 2009). IL-23 secreted by APCs 
during inflammation such as IBD, can contribute to the disease phenotype by 
activating TH1 cells (O' Connor Jr et al., 2010), while IL-17 has been shown to 
modulate T cell driven colitis. Although the effects of this cytokine did not prevent 
the onset of the disease (O' Connor Jr et al., 2010), suggesting only a minor protective 
role. 
 
CD4+ T cells isolated from CLP-operated mice were found to proliferate poorly and 
produce less IFN-γ than sham treated mice (Scumpia et al., 2007). Upon treatment 
with anti-GITR agonistic antibody, this phenotype was reversed and increased T cell-
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dependent antibody class switching was observed along with increased production of 
TH1 and TH2 cytokines (Scumpia et al., 2007). This suggests that GITR induced 
signaling may be beneficial to restore T cell function during sepsis. However, the role 
overall of CD4+ T cells may be pathogenic in a mouse model of AP due to limited 
bacterial clearance (Busse et al., 2007). 
 
Co-stimulation is an important signal received by T cells from APCs to induce 
activation and differentiation. B7-H3 expression is induced by human monocytes, 
macrophages and DCs in the presence of inflammatory cytokines. This has been 
studied in septic patients, whereby increased levels of soluble B7-H3 in plasma were 
found and correlated with increased survival from sepsis (Zhang et al., 2010). A 
possible mode of action of B7 molecules in this setting is the augmentation of 
proliferation of antigen-specific T cells and enhance the induction of CTLs (Zhang et 
al., 2010).  
 
The induction of T helper subsets during S. pyogenes infection has not been well 
characterised to date. Most studies have concentrated on the effect of superantigens 
on T cell immunity. However, upon intra-nasal infection with S. pyogenes in mice, 
TH1 and TH17 cells producing IFN-γ or IL-17A respectively have been identified 
(Costalonga et al., 2008; Wang et al., 2010a). A TH2 phenotype as mediated by p38 
kinase signaling pathways has been implicated during the later stages of CLP-induced 
sepsis, as characterised by an induced state of immune suppression (Song et al., 
2000). This suggests that effector T cells may contribute to amelioration of infection 
 
The role of Tregs has also been investigated within the context of colitis. The presence 
of the cytokine IL-21 during an adoptive T cell transfer model of colitis decreased 
TGF-β mediated foxp3 induction, and together with IL-6 and TGF-β favoured TH17 
induction (Fantini et al., 2007). This emphasises the importance of the cytokine 
milieu during inflammation in establishing T helper cell differentiation. It has also 
been shown that CD4+CD45RBlo and CD8+CD122+ Tregs act synergistically to 
prevent the development of disease in a similar model of colitis, suggesting that in 
this experimental setting, Tregs may be protective (Endharti et al., 2011). 
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The role of Tregs during sepsis however is controversial. During the later stages of 
systemic infection, there is an increase in the number of circulating Tregs, as supported 
by elevated intracellular expression of Foxp3, TGF-β and IL-10 in septic patients 
(Kessel et al., 2009). Increased Treg number also correlated with heightened 
suppression of TH1 responses in septic patients (Monneret et al., 2003). This 
observation of increased frequency of CD4+CD25+ T cells has also been mirrored in 
CLP-operated mice (Wisnoski et al., 2007). Whether this correlates with worse 
prognosis is still unclear. Adoptive transfer of in vitro stimulated CD4+CD25+ T cells 
into CLP-operated mice showed decreased mortality and bacterial burden in a dose-
dependent manner and would suggest that Tregs may be beneficial in this model of 
poly-microbial sepsis (Heuer et al., 2005). 
 
iTregs can be induced in vivo in an experimental model of colitis, indicating that Foxp3 
expression is required for iTregs maintenance and suppressive function (Haribhai et 
al., 2009). During the later stages of immune suppression in sepsis, immature DCs 
can engulf apoptotic DCs to become tolergenic and promote the differentiation of 
naïve T cells into Tregs (Kushwah et al., 2010), further supporting previous evidence 
of increased levels of Tregs in septic patients. 
 
Pre-administration of superantigens, such as SEB can prime the immune response, 
resulting in effective eradication of pathogens. For example, mice pre-treated with 
SEB or SPEA before lethal infection with L. monocytogenes are protected from 
infection (Okamoto et al., 2001). This effect is mediated via enhanced cytotoxic 
activity of CD8+ T effector cells (Okamoto et al., 2001). Immunisation of 
superantigens into mice can induce deletion of superantigen-reactive CD4+ T cells by 
anergy, with nTregs and Tr1 cells remaining to dampen pathogenic immune responses 
(Eroukhmanoff et al., 2009). In an adoptive T cell transfer model of colitis, SCID 
mice given CD4+CD45RBhi cells together with SEB were shown to have impaired 
development of CD4+ T cells expressing Foxp3. This suggests superantigens may 
have an impact on Treg differentiation (Heriazon et al., 2009). Superantigens are not 
alone in their ability to induce cytokine responses in T cells. Cytolysins, such as alpha 
toxin produced by S. aureus can induce potent IL-17 responses from CD4+ T cells 
(Niebuhr et al., 2011). This emphasises how bacterial products can influence T cell 
mediated immunity. 
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While the role of Tregs during infection has been studied both in animal models and in 
man, phenotypic differences may arise between murine and human Tregs. For 
example, as previously discussed in Section 1.3.5, Foxp3 is not a reliable marker for 
Tregs in humans (Morgan et al., 2005). It should also be noted that humans can 
express two isoforms of Foxp3, one lacking exon 2 with diminished il-2 repression 
and suppressive activity compared to WT Foxp3 (Allan et al., 2005). Not all 
antibodies can distinguish the two isoforms of human Foxp3, which may offer one 
explanation why findings in animal models of infection may differ from actual human 
disease. 
 
In summary, there is evidence for particular T helper subsets and associated cytokines 
in the control or progression of poly-microbial models sepsis. These findings are 
mirrored in septic patients. Whether this is also true during acute S. pyogenes 
infection in murine and human studies is still largely unknown. 
 
 
1.9.5 The role of TLRs during sepsis 
 
It is essential for cells of the immune system to discriminate self from infectious 
agents to initiate the chain of events to contain and eliminate the potential threat. This 
is largely achieved through PRRs expressed on many different immune cells. A 
crucial role for TLRs has been implicated during S. pyogenes infection and sepsis as 
increased TLR2 and TLR4 expression are generally observed in septic patients 
(Tsujimoto et al., 2008; Knapp, 2010). 
 
TLR signaling culminates in the translocation of NF-κB into the nucleus to initiate 
expression of key genes associated with the inflammatory response. Without subunits 
forming this transcription factor, such as Rel family members, increased mortality 
was observed in sub-lethal poly-microbial models of sepsis, indicating that signaling 
via NF-κB is important to control the inflammatory response (Coutine et al., 2011). 
The importance of NF-κB signaling has also been highlighted in lymphocytes, as it 
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can also control apoptosis.  During sepsis, lymphocyte apoptosis correlates with 
decreased NF-κB activity. This suggests key anti-apoptotic genes regulated by NF-
κB are not expressed and may be a factor leading to increased T cell anergy observed 
during the later stages of sepsis (Groesdonk et al., 2007).  
 
TLR2 is not exclusively expressed on innate and adaptive immune cells. Non-
hematopoietic cells, such as endothelial cells also express TLR2 and may respond to 
Lipoteichoic Acid (LTA) to promote leukocyte migration (Gillrie et al., 2010). 
Endothelial cells may provide protective signals to the immune system. If NF-κB 
signaling is knocked out in endothelial cells, partial reversal of endotoxic driven 
hypotension is observed (Ding et al., 2009), emphasising the required role of NF-κB 
signaling by non-hematopoietic cells in the control of inflammatory responses 
(Pasparakis, 2009). 
 
There is an interesting link between TLR and MHC class II signaling pathways. It 
would appear that MHC class II knockout animals are protected from the stimulatory 
effects of LPS and bacterial infection due to impaired cytokine production, 
particularly by macrophages and DCs (Liu et al., 2011b). This suggests that MHC 
class II molecules promote TLR induced pro-inflammatory cytokines, possibly via 
the activation of Btk kinase (Liu et al., 2011b). 
 
The immune system has evolved an elegant system to prevent excessive triggering of 
TLR-mediated signaling. This is achieved through the expression of soluble 
extracellular TLR receptors that are capable of binding and sequestering microbial 
ligands. This reduces inflammation and implicates TLR signaling may not always be 
beneficial to the host during infection and sepsis (Raby et al., 2009). This concept is 
also highlighted in lethal infection with L. monocytogenes, leading to TLR2-mediated 
neutrophil apoptosis (Navarini et al., 2009). Contradictory, TLR signaling during 
CLP models of sepsis may be beneficial as MyD88-/- mice exhibit increased mortality 
compared to operated wild-type mice, due to decreased apoptosis of T and B cells 
(Peck-Palmer et al., 2008). This suggests that in some cases, TLR signaling may 
function to dampen the systemic response to infection. 
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Various ligands derived from S. aureus have been postulated to bind to TLR2. These 
include peptidoglycans (PGN), LTA and CpG unmethylated DNA. Mice lacking 
TLR2 have increased susceptibility to the effects of LTA, correlating with an 
impairment to produce TNF-α (Gillrie et al., 2010). However, during in vivo 
infection with S. aureus infection, TLR2 may negatively regulate the production of 
pro-inflammatory cytokines and promote bacterial survival within macrophages by 
induced phagocytosis (Gillrie et al., 2010; Watanabe et al., 2007; Shiratsuchi et al., 
2010). In a mouse model of otitis media, S. pneumoniae infection of TLR2-/- mice 
resulted in increased mortality due to decreased expression of TNF-α (Han et al., 
2009a). This suggests that TLR2 is not only required to sense microbial ligands 
derived from Gram-positive bacteria but it would appear to differentially regulate the 
production of protective cytokines depending on the nature of the infection. 	  
During live S. pyogenes infection, one of the key pro-inflammatory cytokines 
detected in septic patients is IL-1β. Streptolysin O (SLO) has been shown to activate 
the PRR, Nlrp3 and the inflammasome to produce this cytokine contributing to the 
so-called “cytokine storm” (Harder et al., 2009). S. pyogenes infection can also 
induce TLR2, 3, 7 and 8 expression after 24h stimulation with human macrophages, 
culminating in downstream expression of type I interferons (Miettinen et al., 2008). 
Models of poly-microbial sepsis have also demonstrated a pathogenic role for TLR9 
induced signaling, leading to excessive production of pro-inflammatory cytokines and 
cell death (Plitas et al., 2008).  
 
Other GAS associated virulence factors may also interact with TLRs. For example, in 
vitro SEA stimulation of splenocytes results in up-regulation of MyD88 and 
corresponding cytokine production (e.g. IL-1β and TNF-α) (Kisser et al., 2010). The 
same findings were attained when SEA was injected into C57BL/6 mice, indicating 
that this staphylococcal superantigen is activating the MyD88 signaling pathway to 
induce pro-inflammatory cytokine production (Kisser et al., 2010). However, the 
contrary is also true. Staphylococcal ligands binding to TLR2 expressed on 
monocytes may prevent T cell activation through the induced secretion of IL-10 
(Chau et al., 2009).  
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Overall, engagement of various TLRs during bacterial infection and sepsis has 
differing effects on the survival outcome. This suggests complexities in the control of 
the immune response by these receptors. However, very little work has focused on S. 
pyogenes and TLR stimulation in vivo and remains to be investigated. 
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1.10 Aims of this thesis 
 
There are many complexities to how the immune system responds to systemic S. 
pyogenes infection to lead to the development of sepsis. Different innate and adaptive 
immune cells have been implicated as either pathogenic or protective in different 
models of GAS infection or sepsis. There is evidence that septic patients exhibit 
elevated frequencies of Tregs with potent suppressive function but whether this is also 
true during acute S. pyogenes infection is unknown. Prof. Daniel Altmann’s 
laboratory, in collaboration with Prof. Shiranee Sriskandan has previously studied the 
effects of streptococcal superantigens on T cell immunity; however, the precise effect 
of superantigens on Tregs in vivo has not been properly addressed. Therefore, in this 
thesis I set out to address the following questions; 
 
• To investigate the function of T cells during acute S. pyogenes infection, in 
particular, the precise role of Tregs during GAS infection. 
 
• To characterise the phenotype of effector cell types important in limiting GAS 
pathology. 
 
• To create streptococcal superantigen knockout mutants to further investigate 
the role of this class of virulence factors on T cell immunity. 
 
• To characterise the kinetics of Tregs during acute S. pyogenes infection and 
determine whether streptococcal superantigens can influence the induction of 
this suppressive cell type. 
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Chapter 2 
	  
2 Materials and methods  
 
2.1 Non-commercial reagents 
 
2.1.1 Genotyping murine strains 
 
• Mammalian tissue lysis buffer  
Used for digestion of murine tail biopsies to extract genomic DNA for genotyping 
purposes as described in Section 2.4.2 
6.057g Tris 
0.9306g Ethylenediaminetetraacetic Acid (EDTA) 
5.844g NaCl 
1.0g Sodium Dodecyl Sulfate (SDS) 
Resuspend in 500ml ddH2O. 
 	  
2.1.2 Microbiological culture and streptococcal mutagenesis 
 
• Luria-Bertani (LB) broth  
Used for liquid culture of E. coli strains as described in Section 2.5.16 
10g Tryphtone (Merck, Germany) 
5g yeast extract (OXOID, UK) 
10g NaCl (Sigma-Adrich, UK) 
Resuspend in 1L H2O before autoclaving to sterilise. 
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• LB agar  
Used for plating out E. coli strains from glycerol stocks as described in Section 2.5.16 
200ml ddH20 
7.4g LB agar (Merck, Germany) 
The solution is autoclaved and cooled to 55°C before adding appropriate antibiotics 
(Table 2.4) and poured into sterile Petri dishes. 
 
• Todd-Hewitt Broth (THB)  
Used for liquid culture of S. pyogenes as described in Section 2.5.1 
36.4g Todd-Hewitt Broth (OXOID, UK) 
1L ddH20 
Autoclave solution to sterilise before use. 	  
• S. pyogenes electroporation media 
Use for resuspending S. pyogenes isolates prior to electroporation to generate 
superantigen knockout and complemented GAS strains as described in Section 2.5.18 
50ml ddH20 (pre-autoclaved) 
24.5g D-Glucose (Sigma-Aldrich, UK) 
Filter-sterilise glucose solution into autoclaved 500ml 1mM MgCl2 solution and 
stored at 4°C until use.  	  
• Todd-Hewitt-Yeast (THY) broth 
Use for the recovery of S. pyogenes isolates after electroporation as described in 
Section 2.5.18 
36.4g Todd-Hewitt Broth 
2g yeast extract  
1L ddH20 
Autoclave solution to sterilise before use. 	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• THY agar 
Used for plating out electroporated S. pyogenes isolates for antibiotic selection as 
described in Section 2.5.18 
7.28g Todd-Hewitt 
0.4g yeast extract 
4g bacterial agar (OXOID, UK) 
200ml ddH20 
The solution is autoclaved and cooled to 55°C before adding appropriate antibiotics 
(Table 2.5) and poured into sterile Petri dishes. 
 
 
2.1.3 Molecular biology 
 
• SET buffer  
Used for extraction of genomic streptococcal DNA for PCR analysis as described in 
Section 2.5.20 
750µl 5M NaCl (Sigma-Aldrich, UK) 
2.5ml 0.5M EDTA  
1ml 1M Tris, pH 7.5 (Sigma-Aldrich, UK) 
Resuspend in 50ml molecular biology water. 	  
• 50X TAE buffer  
Used for running nucleic acid agarose gels 
121.0g Tris 
28.6ml 16N acetic acid 
50ml 0.5M EDTA pH 8.0 
Resuspend in 500ml ddH2O. For pouring and running agarose gels, use 1X TAE. 
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2.1.4 Southern blot 
 
Reagents for used for determination of the orientation of inserted pGHostsmez 
plasmid into streptococcal genomic DNA as described in Section 2.5.22 	  
• Denaturation solution 
12.5ml 10M NaOH (BDH, UK) 
75ml 5M NaCl  
Resuspend in 250ml ddH2O. 
 
• Neutralisation solution 
125ml 1M TrisCl (Sigma-Aldrich, UK) 
75ml 5M NaCl 
Resuspend in 250ml ddH2O. 	  
• 20X SSC solution 
87.65g NaCl 
44.1g Sodium citrate (Sigma-Aldrich, UK) 
400ml molecular biology water 
The pH was adjusted to 7.0 with 14N HCl (BDH, USA) and total volume made up to 
500ml with molecular biology water and autoclaved. For subsequent wash steps, 2X 
and 0.5X SSC wash buffer are used. 
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2.1.5 Flow cytometry 
 
• Red blood cell lysis buffer 
Used to lyse red blood cells in whole blood and single cell splenocytes preparations 
prior to flow cytometric staining as described in Section 2.5.12 
4.14g NH4Cl (Sigma-Aldrich, UK) 
0.5g KHCO3 (Sigma-Aldrich, UK) 
0.018g EDTA 
Adjust pH to 7.35 with 0.1M NaOH and make up to 500ml with ddH20. Filter-
sterilise before use and store at room temperature until ready for use. 
 
 
 
2.2 Primers  
 
2.2.1 Primers for genotyping murine strains 
 
Table 2.1: List of primers for genotyping different strains of mice. 
All transgenic and knockout murine strains used in this study (Table 2.6) were maintained by 
PCR genotyping of tail biopsy DNA prepared as described in Section 2.4.2 with primers 
listed below. 
 
Target Strain of mice  Sense primer 
sequence (5’→3’) 
Anti-sense primer 
sequence (5’→3’) 
PCR product 
size (bp) 
Neomycin  All TCR KO CTTGGGTGGAGAGG
CTATTC 
AGGTGAGATGACAGG
AGATC 
280 
TCR β WT All TCR KO TGTCTGAAGGGCAA
TGACTG 
GCTGATCCGTGGCAT
CTATT 
544 
TCR δ WT All TCR KO CAAATGTTGCTTGT
CTGGTG 
GTCAGTCGAGTGCAC
AGTTT 
200 
Foxp3 WT Foxp3.DTR or HLA-
DQ8.Aβ0.DTR 
TGGACCGTAGATGA
ATTTGAGTT 
CCAGATGTTGTGGGT
GAGTG 
550 
DTR Foxp3.DTR or HLA-
DQ8.Aβ0.DTR 
GGGACCATGAAGCT
GCTGCCG 
TCAGTGGGAATTAGT
CATGCC 
65 
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Target Strain of mice  Sense primer 
sequence (5’→3’) 
Anti-sense primer 
sequence (5’→3’) 
PCR product 
size (bp) 
IL-17A WT IL-17A KO ACTCTTCATCCACC
TCACACGA 
GTACACCAGCTATCC
TCCAGATAG 
700 
IL-17A KO IL-17A KO ACTCTTCATCCACC
TCACACGA 
GCCATGATATAGACG
TTGTGG C 
500 
β2m WT β2m KO TATCAGTCTCAGTG
GGGGTG 
CTGAGCTCTGTTTTCG
TCTG 
230 
β2m KO β2m KO TATCAGTCTCAGTG
GGGGTG 
TCTGGACGAAGAGCA
TCAGGG 
410 
HLA-DQα HLA-DQ8.Aβ0 or 
HLA-DQ8.Aβ0.DTR 
TACCAGTTTTACGG
TCCCTC 
GGTAGCAGCGGTAGA
GTTG 
200 
HLA-DQβ HLA-DQ8.Aβ0 or 
HLA-DQ8.Aβ0.DTR 
GCATGTGCTACTTC
ACCAACG 
CACCGTGTCCACCGA
CGCCCG 
200 
H2 WT HLA-DQ8.Aβ0 or 
HLA-DQ8.Aβ0.DTR 
TCCGCAGGGCATTT
CGTGTA 
AGGGAGGTGTGGGTC
TCCGG 
500 
H2 KO HLA-DQ8.Aβ0 or 
HLA-DQ8.Aβ0.DTR 
TCCGCAGGGCATTT
CGTGTA 
GAGGATCTCGTCGTG
ACCCA 
300 
TLR2 WT TLR2 KO CTTCTTGAATTTGTC
CAGTACA 
ACGAGCAAGATCAAC
AGGAGA 
500 
TLR2 KO TLR2 KO CTTCTTGAATTTGTC
CAGTACA 
GGGCCAGCTCATTCC
TCCCAC 
300 
 
 
2.2.2 Primers for qRT-PCR 
 
Table 2.2: List of primers and hydrolysis probes used for qRT-PCR. 
To study the relative fold change in the expression of specific target genes during acute S. 
pyogenes infection, qRT-PCR was performed as described in Section 2.5.11 using primers 
and probes as listed below. 
 
Gene Sense primer Anti-sense 
primer 
Hydrolysis probe Product 
size 
NCBI 
sequence 
Reference 
genes 
     
b2m CTACTGGGATCA
GACATTGTGAT 
TGTGTACATTGC
TATTTCTTTCTGC 
TGCTCTGAAGAT
TCATTTGAACCT
GCT 
130 NM_0097
35.3 
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Gene Sense primer Anti-sense 
primer 
Hydrolysis probe Product 
size 
NCBI 
sequence 
GAGAAACCTGCC
AAGTGTGATGAC 
AGACAACCTGGT
CCTCAGTGTAG 
TCAAGAAGGTGG
TGAAGCAGGCAT 
100 NM_0080
84.2 
gapdh 
   0  
   C   
hprt1 AACCAGGTTATG
ACCTAGATTTGT
TT 
CAAGTCTTTCAG
TCCTGTCCATAA
T 
CCTAATCATTAT
GCCGAGGATTTG
GAA 
108 NM_0135
56.2 
rpl-13a CCTACCAGAAAG
TTTGCTTACCTG 
GATCTGCTTCTTC
TTCCGATAGTG 
TGACAGCCACTC
TGGGAGGAGAA
ACG 
132 NM_0094
38.4 
tbp CAGTGCCCAGCA
TCACTATTT 
GCATCCTCTGAA
TATCTCCTTAGA
A 
CATGGTGTGAAG
ATAACCCAGAAC
A 
83 NM_0136
84.3 
tfrc AATGGTAACTTA
GACCCAGTGGAG 
ATTAGCATGGAC
CAGTTTACCAGA 
TCCCGAGGGTTA
TGTGGCATTCAG
T 
90 NM_0116
38.3 
sdha CTGGTGTGGATG
TCACTAAGGAG 
CACCTGTCCCTT
GTAGTTAGTGG 
CACTGTGCATTA
CAACATGGGTGG
G 
92 NM_0232
81.1 
ywhaz AACTTAACATTG
TGGACATCGGAT
A 
TGGATGACAAAT
GGTCTACTGTGT
A 
TGAAGCAGAACA
GGAGAAGGAGG
G 
131 NM_0117
40.2 
      
Transcription 
factors & cell 
lineage 
markers 
     
foxp3 ATAGTTCCTTCC
CAGAGTTCTTCC 
ATGGTAGATTTC
ATTGAGTGTCCT
C 
CACCTATGCCAC
CCTTATCCGATG
G 
143 NM_0540
39.1 
gitr CAGACTTTGGAC
CAACTGTTCTC 
ACACAGCATTGT
GGGTCTTGT 
TTTGGATTTCTCA
CCATGTTCCCTG 
74 NM_1833
91.2 
ctla-4 TTAATGAAAGCA
GAGTGAACCTCA 
TCTGGATCAATG
ACATAAATCTGC 
CATACTTTGTGG
GCATGGGCAACG 
145 NM_0098
43.3 
lag-3 CTCAAGGTTCTG
GGTCTGGA 
ACTTGGCAATGA
GCAAAGAAG 
CCCTCTGACAGT
GTACGCTGCTGA
AG 
124 NM_0084
79.1 
t-bet ACTTTGAGTCCA
TGTACGCATCT 
AGGATACTGGTT
GGATAGAAGAG
GT 
CACCTGGACCCA
ACTGTCAACTGC
TT 
113 NM_0195
07.1 
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Gene Sense primer Anti-sense 
primer 
Hydrolysis probe Product 
size 
NCBI 
sequence 
gata-3 TACCACCTATCC
GCCCTATGT 
ACACACTCCCTG
CCTTCTGT 
ACAGCTCTGGAC
TCTTCCCACCAG 
138 NM_0080
91.3 
rorγt GTCTGCAAGTCC
TTCCGAGAG 
 
ATCTCCCACATT
GACTTCTG 
 
CTGCGACTGGAG
GACCTTCTACGG
C 
 
119 NM_0112
81.2 
Cytokines & 
enzymes 
     
tgf-β ATGTTCTTCAAT
ACGTCAGACATT
C 
TTGCTATATTTCT
GGTAGAGTTCCA 
TGCAGAGCTGCG
CTTGCAGAGATT
AA 
131 NM_0115
77.1 
il-6 GTTCCTCTCTGC
AAGAGACTTCC 
 
GTATCCTCTGTG
AAGTCTCCTCTC
C 
 
CTTGGGACTGAT
GCTGGTGACAAC
C 
 
111 NM_0311
68.1 
ifn-γ TCATTGAATCAC
ACCTGATTACTA
CC 
TTGACCTCAAAC
TTGGCAATAC 
CTTCTTCAGCAA
CAGCAAGGCGAA 
98 NM_0083
37.3 
tnf-α CTCACACTCAGA
TCATCTTCTCAA
A 
CTCCACTTGGTG
GTTTGCTA 
ACAAGCCTGTAG
CCCACGTCGTAG
C 
75 NM_0136
93.2 
il-10 TTAATGCAGGAC
TTTAAGGGTTAC
TT 
ATTCAAATGCTC
CTTGATTTCTG 
CCAAGCCTTATC
GGAAATGATCCA
GTT 
123 NM_0105
48.1 
il-17a CTGTGTGTGTGA
TGCTGTTGCT 
AAGGGAGTTAAA
GACTTTGAGGTT
G 
AGCTCAGCGTGT
CCAAACACTGAG
G 
149 NM_0105
52.3 
il-4 AACGAAGAACAC
CACAGAGAGTG 
AGTTCTTCTTCA
AGCATGGAGTTT 
TCGTCTGTAGGG
CTTCCAAGGTGC
T 
101 NM_0228
3.2 
il-9 GTCCCAACTGAT
GATTGTACCAC 
CGTGATGTTCTTT
AGGACTTCAACT
A 
TGATTTCTGTGT
GGCATTGGTCAG
C 
135 NM_0083
73.1 
mpo GGTCCAGATCAT
CACATACCG 
GAGGGTCTACTG
AGTCGTTGTAAG
A 
CCAACACCAAGG
GCAGGTAGTCC 
107 NM_0108
24.2 
      
TLRs      
tlr2 CAGACAAAGCGT
CAAATCTCAG 
CGTTTGCTGAAG
AGGACTGTTAT 
TTTGGCTCTTCTG
GATCTTGGTGGC 
87 NM_0119
05.3 
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2.2.3 Primers for S. pyogenes mutagenesis 
 
Table 2.3: List of primers used for streptococcal superantigen mutagenesis. 
To determine whether S. pyogenes isolates had been successfully mutated by the insertion of 
plasmids into host chromosome by electroporation, PCR analysis was performed using 
extracted streptococcal genomic DNA as described in Section 2.5.21 with primers below. 
 
Primer 
name 
Sequence (5’ →  3’) Tm (°C) Target 
aphI (F) ATAGGATGGCAAGATCCTGG 62.7 kanamycin 
cassette 
aphI (R) GCCATATTCAACGGGAAACG 66.1 kanamycin 
cassette 
rRNA (F) CGGTAACTAACCAGAAAGGG 60.0 rRNA 
rRNA (R) CGTTGTACCAACCATTGTAGC 61.8 rRNA 
smezP1 GTCAGCAAGTATATCTAC 42.9 smez promoter 
smezR600 TTCTATATCTAAATGCCC 48.8 smez (internal) 
S1 GCGGATCCGCGATAAACCCAGCGAACCAT 82.4 spea promoter 
A1 GCCTGCAGTAATGATGGAAAACAATAAAAAAGTATTG 72.4 spea (internal) smezF TCCCTTCTAAGGAATATCTATAGTACG 59.9 Internal smez 
probe smezR GTTCCAATCAAATGGGACGGAGA 69.8 Internal smez 
probe 
spea-EcoRI-
F 
GCGAATTCCAATCGCTTCTTTAAACTCATCTA 71.2 spea promoter 
spea-EcoRI-
R 
GCGAATTCGCAGTAGTAAGGTTGCCAA 70.6 end of coding spea 
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2.3 Bacterial strains 
 
2.3.1 E. coli bacterial strains 
 
Table 2.4: List of E. coli strains 
E. coli strains containing shuttle plasmids used for mutating superantigen genes in S. 
pyogenes isolates. 
 
Isolate Plasmid Antibiotic selection Reference 
H323 pDL278 Spectinomycin (50µg/ml) (Sigma-Aldrich, UK)  (LeBlanc et al., 1992) 
H376 pGHostsmez Kanamycin (40µg/ml) (Sigma-Aldrich, UK) (Unnikrishnan et al., 2002) 
H431 pDL278smez Spectinomycin (50µg/ml)  (Russell and Sriskandan, 
2008) 
H722 pDL278smezspea Spectinomycin (50µg/ml) - 
 
 
2.3.2 S. pyogenes bacterial strains 
 
Table 2.5: List of S. pyogenes strains 
S. pyogenes isolates generated and used for in vivo infection as described in Section 2.5.1  
 
Isolate M 
serotype 
Superantigen 
genotype 
Mutagenesis Antibiotic selection Reference 
H293 89 spea- smez+ - - (Unnikrishnan 
et al., 2002) 
H305 
(NCTC8198) 
1 spea+ smez+ - - (Sriskandan et 
al., 1999) 
H326 	   1 spea- smez+ Allelic replacement with pUCMUT 2.2 Kanamycin (400µl/ml) (Sriskandan et al., 1999) 
H361 1 spea-/+ smez+ Complemented 
with pDL278spea 
Spectinomycin 
(50µl/ml) 
(Unnikrishnan 
et al., 2001) 
H623 1 spea+ smez- Insertional 
duplication with 
pGhostsmez 
Erythromycin (1µl/ml) 
(Sigma-Aldrich, UK) 
- 
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Isolate M 
serotype 
Superantigen 
genotype 
Mutagenesis Antibiotic selection Reference 
H656 1 spea+ smez-/+ Complemented 
with pDL278smez 
Spectinomycin 
(50µl/ml) 
- 
H658 1 spea-/- smez-/- Insertional 
duplication with 
pGhostsmez 
Erythromycin (1µl/ml)  - 
H786 1 spea-/+ smez-/+ Complemented 
with 
pDL278smezspea 
Spectinomycin 
(50µl/ml) 
- 
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2.4 Strains of mice 
 
2.4.1 Animal Husbandry 
 
Table 2.6: List of murine strains used in this thesis 
 
Strain name Phenotype Background 
strain 
Supplier Reference 
C57BL/6 Wild-type (WT) - Charles River - 
TCR β KO TCR β-/- C57BL/6 Jackson Laboratory (Mombaerts et al., 
1991) 
TCR δ KO TCR δ-/- C57BL/6	   Jackson Laboratory (Itohara et al., 1993) 
TCR δβ KO TCR β-/- and TCR δ-/- C57BL/6	   Jackson Laboratory (Mombaerts et al., 
1992) 
Foxp3.DTR Inducible knockout of 
Foxp3-GFP+ cells 
C57BL/6	   Kind gift from A. 
Rudensky 
(Kim et al., 2007) 
IL-17A KO IL-17A-/- C57BL/6	   Kind gift from Y. 
Iwakura 
(Nakae et al., 2002) 
β2m KO β2m-/- C57BL/6	   Jackson Laboratory (Koller and Smithies, 
1985) 
HLA-DQ8.Aβ0 HLA-DQ8 transgenic, 
lacking endogenous 
mouse H2 
C57BL/6	   Made by D. Altmann (Boyton et al., 1998) 
HLA-DQ8.Aβ0.DTR HLA-DQ8 transgenic, 
lacking endogenous 
mouse H2, inducible 
knockout of Foxp3-GFP+ 
cells 
C57BL/6	   Crossed for project - 
TLR2 KO TLR2-/- C57BL/6	   Jackson Laboratory (Wooten et al., 2002) 
 
 
 
All strains of mice used in this thesis were either purchased from recognised 
commercial suppliers or given as kind gifts from the original producing labs (Table 
2.6). Mice were bred on site and maintained in accordance with UK government 
Home Office guidelines under closed IVC housing conditions. Prior pilot 
experiments showed the mice bred on site were not initially infected with S. 
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pyogenes, nor did health screens of the breeding rooms show any evidence of pre-
existing infection with any streptococcal strains. 
 
2.4.2 Genomic DNA extraction for genotyping 
 
For each strain of mice, the genotype was routinely determined by PCR technique 
using extracted genomic DNA from tail biopsies. Tissue was digested overnight at 
56°C in 400µl mammalian tissue lysis buffer (Section 2.1.1) and 10µl Proteinase K 
(100µg/ml; Sigma-Aldrich, UK). Next day, 200µl saturated NaCl solution was added 
and samples vigorously shaken for 30 sec before centrifugation for 15 min, 15,000g. 
The supernatant was transferred into a fresh eppendorf and 600µl iso-propanol added. 
The precipitated genomic DNA was pelleted by centrifugation at 9000g for 10 min. 
The pellet was washed in 750µl 70% ethanol by spinning again at 9000g for 10 min 
before air-drying. Genomic DNA was resuspended in 100µl molecular biology water. 
The concentration of genomic DNA was measured on a NanoDrop spectrophotometer 
(NanoDrop, USA) and ND1000 V3.1.2 software. Samples were diluted to 40ng/µl for 
amplification by PCR. 
 
 
2.4.3 Genotyping PCR 
 
The genotypes of the murine strains were determined from each litter by 
amplification of specific genes with appropriate primers (Table 2.1) using a BIOTAQ 
DNA polymerase (Table 2.7) with specific PCR thermal profiles (Table 2.8). PCR 
products were run on a 2% agarose gel made with 1X TAE buffer (Section 2.1.3) 
containing Sybr-Safe (Invitrogen, UK) at 120V for approximately 45 min and 
visualized under UV light. Expected pattern of PCR products for each strain of mice 
are indicated in Table 2.9. 	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Table 2.7: Master-mix for BIOTAQ based genotyping PCR (for 1 reaction) 
 
Component Volume (µ l) 
10X buffer (BIOLINE Ltd, UK) 2.5 
Magnesium (15mM) (BIOLINE Ltd, UK) 5 
dNTPs (1mM) (BIOLINE Ltd, UK) 5 
Molecular biology H2O  7.4 
BIOTAQ polymerase (5U/µl) (BIOLINE Ltd, UK) 0.1 
Sense primer (100µg/ml) 1.25 
Anti-sense primer (100µg/ml) 1.25 
Sample genomic DNA (40ng/µl) 2.5 
 
 
 
Table 2.8: Thermal profiles for genotyping PCRs. 
 
Target PCR Thermal profile 
Neomycin 94°C 3 min, 35 cycles of (94°C 30 sec, 64°C 1 min, 72°C 1 min), 72°C 2 min 
TCR β WT 94°C 3 min, 35 cycles of (94°C 30 sec, 64°C 1 min, 72°C 1 min), 72°C 2 min 
TCR δ WT 94°C 3 min, 37 cycles of (94°C 20 sec, 58°C 30 sec, 72°C 35 sec), 72°C 2 min 
Foxp3 WT 94°C 3 min, 35 cycles of (94°C 40 sec, 53°C 40 sec, 72°C 30 sec), 72°C 5 min 
DTR 94°C 5 min, 35 cycles of (94°C 15 sec, 59°C 15 sec, 72°C 45 sec), 72°C 2 min 
IL-17A WT 94°C 2 min, 40 cycles of (94°C 15 sec, 64°C 30 sec, 72°C 1 min), 72°C 10 min 
IL-17A KO 94°C 2 min, 40 cycles of (94°C 15 sec, 64°C 30 sec, 72°C 1 min), 72°C 10 min 
β2m WT 94°C 3 min, 35 cycles of (94°C 20 sec, 58°C 30 sec, 72°C 30 sec), 72°C 2 min 
β2m KO 94°C 3 min, 35 cycles of (94°C 20 sec, 58°C 30 sec, 72°C 30 sec), 72°C 2 min 
DQα 95°C 5 min, 32 cycles of (94°C 1 min, 55°C 1 min, 72°C 1 min), 72°C 8 min 
DQβ 95°C 5 min, 32 cycles of (94°C 1 min, 55°C 1 min, 72°C 1 min), 72°C 8 min 
H2 WT 95°C 5 min, 30 cycles of (94°C 45 sec, 60°C 45 sec, 72°C 1 min), 72°C 8 min 
H2 KO 95°C 5 min, 30 cycles of (94°C 45 sec, 60°C 45 sec, 72°C 1 min), 72°C 8 min 
TLR2 WT 94°C 3 min, 35 cycles of (94°C 30 sec, 65°C 45 sec, 72°C 45 sec), 72°C 2 min 
TLR2 KO 94°C 3 min, 35 cycles of (94°C 30 sec, 65°C 45 sec, 72°C 45 sec), 72°C 2 min 
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Table 2.9: Expected PCR products for genotyping transgenic mice. 
 
Strain Expected PCR product result 
TCR β KO Neomycin+, TCR β WT-, TCR δ WT+ 
TCR δ KO Neomycin+, TCR β WT+, TCR δ WT- 
TCR δβ KO Neomycin+, TCR β WT-, TCR δ WT- 
Foxp3.DTR Foxp3 WT-, DTR+ 
IL-17A KO IL-17A WT-, IL-17A KO+ 
β2m KO β2m WT-, β2m KO+ 
DQ8.Aβ0 DQα+, DQβ+, H2 WT-, H2 KO+ 
DQ8.Aβ0XFoxp3.DTR DQα+, DQβ+, H2 WT-, H2 KO+, Foxp3 WT-, DTR+ 
TLR2 KO TLR2 WT-. TLR2 KO+ 
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2.5 Methods 
 
2.5.1 Acute sepsis infection model 
 
S. pyogenes isolates (Table 2.5) were streaked from glycerol stocks stored at -80°C 
on to Columbia Blood Agar plates (Oxoid, UK) and gown overnight at 37°C, 5% 
CO2. Next day, four falcon tubes of 50ml Todd Hewitt Broth (Section 2.1.2) were 
each inoculated with a single streptococcal colony and cultured overnight at 37°C, 
5% CO2. The cultures were washed the next day three times in sterile Phosphate 
Buffered Saline (PBS) (Gibco; Invitrogen, UK) by centrifugation at 3000g, 15 min at 
4°C. The bacterial pellets were pooled together and resuspended in 2ml sterile PBS. 
To study immune responses during acute sepsis, 50µl of the bacterial suspension or 
sterile PBS for sham controls was given via the intramuscular (i.m) route into the 
right thigh of female mice at t=0h. Female mice were used in all experiments unless 
stated otherwise as previously found to be more susceptible to GAS infection 
compared to males (Faulkner et al., 2007). The bacterial inoculum was quantified by 
serial plating on to blood agar plates and was between 108-109 CFU per 50µl dose. 
Sterile PBS inoculum was also plated out and no bacterial contamination was 
detected.  
 
For all standard experiments described in Chapter 3 and 4, 8-12 female C57BL/6, 
TCR KOs, β2m KO, IL-17A KO and Foxp3.DTR mice were infected for 24h with 
H305 (NCTC8198), a M1T1 serotype WT clinical scarlet fever isolate (Sriskandan et 
al., 1999) and culled for microbial (Section 2.5.3), qRT-PCR (Section 2.5.7-11), flow 
cytometric (Section 2.5.12), serum cytokine (Section 2.5.4) and histological (Section 
2.5.13-15) analysis.  
 
For survival experiments, 6-8 female mice (C57BL/6, TCR KOs, β2m KO, IL-17A 
KO, Foxp3.DTR or TLR2 KO) were infected as described above and monitored for 
signs of systemic infection and culled when reached defined end-points (loss of more 
than 20% body weight, development of respiratory difficulties, loss of mobility and 
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motility, hunched posture and piloerrection). In some survival experiments, mice 
were tail-bled at 8-9h post infection to collect serum for cytokine analysis by ELISA. 
 
For longer time courses of H305 WT streptococcal infection as discussed in Chapter 
6, groups of 4 or 5 HLA-DQ8.Aβ0 female mice were infected as described above and 
culled at 24, 36 and 48h for serum, microbial and flow cytometric analysis. For the 
short time courses of H305 WT S. pyogenes infection, at defined time-points (t=4, 8, 
12 and 24h) post infection, groups of 10 infected mice or groups of 5 sham treated 
mice were culled for qRT-PCR analysis as part of 2 independent experiments. For 
flow cytometric analysis, groups of 7 infected HLA-DQ8.Aβ0 female mice were 
culled at 4, 8, 12 and 24h post infection along with groups of 6 sham-infected mice. 
For subsequent superantigen knockout isolate infections, groups of 8 female HLA-
DQ8.Aβ0 or HLA-DQ8.Aβ0.DTR female mice were infected with H305, H326, H623 
and H658 (Table 2.5) for 24h before harvesting for microbial, serum, qRT-PCR, flow 
cytometric analysis as part of two independent experiments. 
 
 
2.5.2 Antibody mediated and inducible depletion of target cells in vivo 
 
To study the role of specific cell types of interest such as CD25+, CD8+ and NK cells 
during acute S. pyogenes infection, antibody mediated depletion in vivo was carried 
out prior to intra-muscular streptococcal infection. The antibodies used for depletion 
were anti-CD25 (clone PC61; made by S. Steinbach), anti-CD8α (clone YTS 169; a 
kind gift from Prof. H. Waldmann, Dunn School of Pathology, Oxford), anti-NK1.1 
(clone PK136; eBioscience, UK). Pilot depletion experiments were carried out in 
C57BL/6 female mice to determine the dose of antibody required to successfully 
deplete the target cell and duration of depletion after a single administration. The 
presence of target cells after depletion was monitored by flow cytometry with 
antibodies directed against other epitopes of the target receptor or other key specific 
receptors for the target cell (Table 2.13). It was determined that 100µg PC61 (Figure 
3.8), 100µg YTS 169 (Figure 4.10) and 200µg PK136 (Figure 4.18) were adequate to 
deplete target cells for a minimum of 24h. Antibodies were administrated to mice via 
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an intra-peritoneal (i.p) route prior and also on the day of infection to maximise full 
knockdown of target cells.  
 
To deplete Foxp3+ cells in Foxp3.DTR or HLA-DQ8.Aβ0.DTR mice as described in 
Chapter 3 and 6, various dose of Diphtheria Toxin (DT; Sigma-Aldrich, UK) was 
given to mice i.p and the presence of CD4+CD25+Foxp3+ cells measured by flow 
cytometry from blood, spleen and inguinal draining lymph node. A single dose of 
1.25µg DT was sufficient to deplete CD4+CD25+Foxp3+ cells for approximately 48h 
as shown by flow cytometric analysis (Figure 3.13). For infection experiments, 
Foxp3.DTR or HLA-DQ8.Aβ0.DTR mice were depleted of Foxp3+ cells with 1.25µg 
DT every day two days prior and also on the day of infection in order to maintain full 
knockdown of target cells. 
 
 
2.5.3 Microbial analysis of infection 
 
To determine the bacterial burden incurred during streptococcal infection, tissue was 
harvested for bacterial counts. Mice were culled humanely in a CO2 chamber before 
cardiac puncture to obtain whole blood. 10µl whole blood was immediately added to 
10µl sodium heparin (Sigma-Aldrich, UK) and 35µl sterile PBS for bacterial counts. 
The rest of the blood was allowed to clot to collect serum for cytokine analysis by 
ELISA (Section 2.5.4). Half of the spleen was harvested and 10µl PBS per mg added 
for homogenisation. Thigh muscle and liver were dissected and 5µl sterile PBS per 
mg tissue was added and homogenised. 50µl of the sodium heparinised blood, spleen 
and liver were plated on to blood agar. 50µl of a 106 dilution of homogenised thigh 
tissue was plated on to blood agar. Plates were incubated overnight at 37°C, 5% CO2 
and β-haemolytic colonies counted the next day. Bacterial counts are expressed as 
Colony Forming Unit (CFU) per mg or ml of tissue or blood.  
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2.5.4 Serum cytokine analysis by Enzyme-linked Immunosorbent Assay (ELISA) 
 
Cytokine levels were determined post infection from serum by Enzyme-Linked 
Immunosorbent Assay (ELISA) using commercially available kits. Blood was 
collected from naïve, infected or sham-infected mice by cardiac puncture and allowed 
to clot before centrifugation at 1000g for 15 min. The serum was collected and stored 
at -20°C. Optimised sandwich ELISAs determined serum cytokines concentrations 
with IL-17A and IFN-γ antibody detection and capture pairs (MABTECH AB, 
Sweden) and IL-6 antibody pairs (Invitrogen, UK). In brief, capture antibody was 
diluted in the manufacturer’s recommended buffer (Table 2.10) and 100µl added to 
96-well immuno-plate (Greiner Bio-one, UK) overnight at 4°C. Next day, the plate 
was washed twice with 200µl PBS before blocking with 200µl 1% BSA/PBS for 1h 
at RT. The plates were washed twice with 200µl washing buffer (0.05% Tween/PBS) 
before 100µl of pre-diluted serum samples (1:50 in blocking buffer) added in 
duplicate. A 2-fold dilution series using recombinant cytokine was also added to the 
plate starting with the highest concentration as 1000pg/ml and lowest as 15.625pg/ml 
to form a standard curve to determine the concentration of the unknown samples. A 
negative control of 100µl blocking buffer was included to determine the background 
optical density. The plate was incubated overnight at 4°C. The following day, the 
ELISA plate was rinsed 5 times with washing buffer, before 100µl cytokine detection 
antibody diluted in blocking buffer (Table 2.10) added for 1h at RT. The plate was 
washed 5 times before 100µl Streptavidin-HRP (Invitrogen, UK) was added for 30 
min at RT. The plate was washed 6 times before 100µl 3,3', 5,5"-
tetramethylbenzidine (TMB) substrate (Sigma-Aldrich, UK) was added for detection 
and the colour change monitored. The enzymatic reaction was stopped by the addition 
of 100µl 1M H2SO4. Optical densities of samples against a recombinant protein 
standard curve were measured using an ELISA plate reader (µQuant BIO-Tek 
Instruments, Inc.) and KC Junior software was used to determine the concentration of 
the cytokines in samples, normalised against the background optical density of 
negative control.  
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Table 2.10: Concentration of reagents for ELISA. 
Final concentrations of antibodies and enzymes for serum cytokine ELISAs. 
 
Antibody or enzyme Concentration Dilution buffer  
IL-17A capture antibody 1µg/ml PBS, pH 7.4 
IL-6 capture antibody 1.25µg/ml 0.1M NaHCO3, pH 8.3 
IFN-γ capture antibody 1µg/ml 0.1M NaHCO3, pH 8.3 
IL-17A detection antibody 0.5µg/ml 1%	  BSA/PBS	  
IL-6 detection antibody 0.1µg/ml 1%	  BSA/PBS	  
IFN-γ detection antibody 0.5µg/ml 1%	  BSA/PBS	  
Streptavidin-HRP 1000X 1%	  BSA/PBS	  
 
 
2.5.5 Preparation of streptococcal stimulation factors 
 
For stimulation of either murine splenocytes or human PBMCs, different 
streptococcal preparations were used. In some instances, heat-killed S. pyogenes was 
used to stimulate murine splenocytes at a 1:1000 dilution (Section 2.5.6). Heat-killed 
GAS was prepared from the bacterial inoculum made as described in Section 2.5.1 
and boiled at 80°C for 1h.  	  
To investigate the role of secreted streptococcal superantigens, overnight cultures of 
S. pyogenes isolates (Table 2.5) were grown in 20ml RPMI 1640 (Gibco, Invitrogen, 
UK) containing 10% heat-inactivated Fetal Calf Serum (FCS) and 2mM L-Glutamine 
(L-Glut; all from Gibco, Invitrogen, USA) and bacterial counts were calculated to be 
similar (between 2-8 x107 CFU/ml) indicating similar growth rate. The cultures were 
filter-sterilised and stored at -20°C. The supernatants of these cultures contained the 
secreted superantigens from the given strain, which were used to stimulate human 
PBMCs and murine splenocytes (Section 2.5.6 and 2.5.25).  	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2.5.6 Cytometric Bead Assay (CBA)  
 
In order to characterise multiple cytokine responses during in vitro stimulation of 
murine splenocytes, Cytometric Bead Assay (CBA) was carried out. Foxp3.DTR 
female transgenic mice (n=5 per treatment group) were given two doses of DT or 
PBS for 2 days before spleens were harvested. Single cell suspensions were made in 
DMEM containing 10% FCS, Penicillin and Streptomycin (P/S; all from Gibco; 
Invitrogen, UK). 106 splenocytes were stimulated either with 100µl heat-killed H305 
S. pyogenes (Section 2.5.5) or cell-free streptococcal supernatants (Section 2.5.5) 
overnight at 37°C, 5% CO2. A positive control of splenocytes stimulated with 
Phorbol 12-myristate 13-acetate (PMA) and Ionomycin (10ng/ml & 500ng/ml 
respectively; Sigma-Aldrich, UK) was used, along with a negative control of 
splenocytes incubated in media only to determine the basal levels of cytokines. Next 
day, supernatants were collected and stored at -20°C until ready for CBA analysis of 
TNF, IFN-y, IL-17A, IL-9, IL-4 and IL-10 cytokine concentrations by mouse CBA 
Flex sets according to the manufacturer’s protocols (BD Biosciences, UK). 
Supernatants were diluted 1:5 in assay diluent and data acquired on a BD FACSArray 
(Becton Dickinson, UK). 
 
 
2.5.7 Total RNA extraction 
 
To assess the fold change in expression of specific target genes during acute 
infection, total RNA from tissue was extracted to make complementary DNA 
(cDNA) and quantitative Real-Time PCRR (qRT-PCR) analysis employed. Spleen 
and inguinal draining lymph nodes were harvested from naïve, sham-infected or 
infected mice and stored in 300µl RNALater RNA Stabilisation Reagent (Qiagen, 
UK) at -80°C until ready for use. Total RNA was extracted using acid phenol method 
with TRIzol (Invitrogen, UK). In brief, tissue was homogenised in 1ml TRIzol before 
200µl chloroform added and samples vigorously mixed. The samples were allowed to 
incubate at RT for 3 min before centrifugation at 12, 000g for 15 min at 4°C. The top 
colourless aqueous layer containing total RNA was transferred into 0.5ml iso-
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propanol and incubated for 10 min at RT. After another centrifugation step of 12, 
000g for 10 min at 4°C, the supernatant was discarded and 1ml 75% ethanol added 
and spun down at 7500g for 5 min at 4°C to wash the RNA pellet. The supernatant 
was discarded and the pellet allowed to air-dry before resuspension in 30µl RNase-
free water containing 1.5µl RNaseOUT Recombinant Ribonuclease Inhibitor 
(Invitrogen, UK) at 58°C for 10 min to prevent degradation of RNA. RNA 
concentration and nucleic acid/protein purity ratio were analysed using a NanoDrop 
spectrophotometer. Total RNA was diluted to 200ng/µl and stored at -80°C until 
ready for use. The integrity of total RNA was determined by running 1µg on a 2% 
agarose gel for 30 min at 100V before visualizing under UV light to identify 40S and 
60S mammalian ribosomal subunits (Figure 2.1). 	  
	  
Figure 2.1: Representative total RNA integrity agarose gel. 
Total RNA was extracted from spleens or inguinal draining lymph nodes harvested from 
either sham (n=5) or S. pyogenes infected (n=10) HLA-DQ8.Aβ0 mice (12h time point). 1µg 
total RNA was run on a 2% agarose gel. The two bright bands of the mammalian ribosomal 
subunits: 40S and 60S along with the smear of mRNA can be seen under UV light as shown 
above.  
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2.5.8 Reverse transcription 
 
1µg of total RNA was reversed transcribed into cDNA using Superscript III 
Reverse Transcriptase (Invitrogen, UK) in a two-step reaction. In brief, for one 
reaction mix, 1µl random primers (250ng/µl; Invitrogen, UK), 1µl dNTPs (10mM) 
and 6µl RNase-free water was added to 5µl total RNA (200ng/µl) and incubated at 
65°C for 5 min. The RNA mix was cooled on ice for 1 min before adding 1µl 0.1M 
DTT (Invitrogen, UK), 1µl Superscript III Reverse Transcriptase, 1µl RNase-out 
inhibitor and 4µl 5X first strand buffer (Invitrogen, UK). Reverse transcription was 
carried out at 50°C for 1h, followed by the final incubation at 70°C for 15 min to 
inactivate enzyme. cDNA was stored at -20°C until further analysis.  
 
 
2.5.9 Design of qRT-PCR primers and probes 
 
Primers and hydrolysis probes for qRT-PCR were designed using Primer3 software 
with the help from Daniel Lowther. Sequences for target genes of interest (Table 2.2) 
were obtained from NCBI and intron-exon boundaries identified. In order to ensure 
amplification of cDNA and not contaminating genomic DNA in the sample, the 
sense, anti-sense primers or the hydrolysis probe was designed over an exon-exon 
boundary. Sense and anti-sense primers were selected to be 20-27bp in length, 
between 30-70% GC content and have a melting temperature 60°C±3°C. The 
hydrolysis probe was chosen to be similar to the primers but with a higher melting 
temperature of 70°C±3°C and have dual fluorescence label attached (5’-FAM, 3’-
TAMRA). Secondary structures of primers and hydrolysis probes were checked with 
NetPrimer software to minimise the effect of primer dimers, cross dimers and hairpin 
loops secondary structures. Oligonucleotides were purchased from SigmaGenosys 
and resuspended in RNase-free water and stored at -20°C.  
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Table 2.11: Master-mix for BIOTAQ PCR for testing qRT-PCR primers (for 1 
reaction) 
 
Component Volume (µ l) 
10X buffer  2 
Magnesium chloride (50mM) 2 
dNTPs (1mM)  4 
Molecular biology H2O  9.3 
BIOTAQ polymerase (5U/µl)  0.2 
Sense primer (10µM) 1 
Anti-sense primer (10µM) 1 
Sample cDNA (50ng/µl) 0.5 
 
 
 
Primers were initially checked for specificity by conventional PCR analysis. Stock 
cDNA was prepared from naïve HLA-DQ8.Aβ0 female mice. Mice were humanely 
sacrificed and spleens harvested into RPMI tissue culture media containing 10% FCS, 
1% P/S and 1% L-Glut. A single cell suspension was prepared by passing the spleen 
through a 70µM cell sieve (Becton-Dickinson, UK). Cells were diluted to 3x106 
cells/ml and 1ml added to a 24-well flat bottom plate. Half of the wells were left un-
stimulated, while the other half were stimulated with concanavalin A (Sigma-Aldrich, 
UK) at a final concentration of 5µg/ml for 2 days at 37°C, 5% CO2. Afterwards, cells 
were harvested and total RNA and cDNA synthesis carried out as described in 
Section 2.5.7-8. The stock cDNA of either unstimulated or stimulated splenocytes 
was used to carry out conventional PCR, testing the qRT-PCR sense and anti-sense 
primers using BIOTAQ DNA polymerase (Table 2.11) using the following thermal 
PCR profile; 50°C 2 min, 95°C 10 min followed by 40 cycles of 95°C 30 sec, 60°C 
30 sec and 72°C 30 sec. PCR product was run on 2% agarose gel to determine the 
effectiveness and specificity of the designed primers.  
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2.5.10 Primer efficiency 
 
 	  
	  
Figure 2.2: Representative qRT-PCR primer/hydrolysis probe efficiency standard 
curve. 
A 5-fold serial dilution of stock cDNA was run by qRT-PCR for MPO primer and probe pairs 
and from the amplification plot (A), Ct values for each cDNA concentration were read at a 
threshold of 2000. A standard curve of log cDNA concentration versus Ct value (B) was used 
to calculate the primer pair/hydrolysis probe efficiency as calculated by MX3000Pro 
software. (Stratagene, USA)  
 
 
 
To calculate the fold change in gene expression, the efficiency of the qRT-PCR 
primer pairs and hydrolysis probes was determined using a standard curve of diluted 
A 
B 
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cDNA. A five-fold serial dilution of either un-stimulated or stimulated stock cDNA 
(Section 2.5.9) was run by qRT-PCR in triplicate for all reference and target genes. A 
linear standard curve was generated by plotting the log of the cDNA concentration 
against Ct (Cycle threshold) value read at a threshold of 2000 for each dilution. The 
efficiency of the primers and the R2 value (correlation coefficient) were acquired 
from the linear standard curve (Figure 2.2).  
 
 
2.5.11 Quantitative Real-Time PCR (qRT-PCR) 
 
qRT-PCR was run in triplicate on naïve, sham or S. pyogenes infected spleen and 
draining lymph node cDNA samples as prepared in Section 2.5.6, using in-house 
designed target gene specific primers and hydrolysis probes (Table 2.2) on a 
MX3000P real-time PCR thermocycler (Stratagene, USA). Target genes were run 
with two reference genes from a choice of eight (b2m, gapdh, hrpt1, rpl-13a, tbp, 
tfrc, sdha and ywhaz), validated by running qRT-PCR on cDNA from sham and 
infected HLA-DQ8.Aβ0 mice. The two reference genes that varied the least in terms 
of Ct value read at a threshold of 2000 for each different tissue were chosen as tissue 
specific reference genes. qRT-PCR reactions were performed in 20µl total volume as 
shown in Table 2.12 with a thermal profile of 50°C for 2 min, followed by 10 min at 
95°C and then 50 cycles of 15 sec at 95°C, 15 sec at 60°C and 15 sec at 72°C.  
 
Table 2.12: Master-mix for qRT-PCR (for 1 reaction) 
 
Component Volume (µ l) 
2X TaqMan Gene Expression Mastermix (Stratagene, USA)  10 
Molecular biology H2O  4 
Hydrolysis probe (1µM) 2 
Sense primer (10µM) 1 
Anti-sense primer (10µM) 1 
Sample cDNA (40ng/µl) 2 
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The fold change in gene expression, relative to time matched sham-infected samples 
were normalised to two tissue specific reference genes and calculated using the ΔΔCT 
method (Pfaffl, 2001; Pfaffl et al., 2002) by the Relative Expression Software Tool 
(REST), taking into account primer pair efficiency as calculated in Section 2.5.10 and 
randomisation statistical tests. 
 
 
2.5.12 Flow cytometry 
 
In order to quantify percentages of cells of interest during GAS infection, flow 
cytometry was used. Female mice inoculated with S. pyogenes, PBS or untreated 
were culled at defined time points and inguinal draining lymph nodes and spleens 
harvested and homogenised into a single cell suspension in PBS containing 10% FCS 
using 70µm cell sieves. Red blood cells were lysed in splenocyte preparations using 
0.5ml lysis buffer (Section 2.1.5) for 5 min. All cells were washed in ice-cold PBS 
(10% FCS) twice before blocking with Fc Block (1:1000 dilution; eBioscience, USA) 
for 10 min on ice. Surface staining was carried out with antibodies indicated in Table 
2.13 for 20 min at 4°C. Cells were washed and resuspended in 200µl 1X Fix/Perm 
solution (eBioscience, USA) for 30 min at 4°C. If intracellular staining was required, 
samples were washed twice in 1X permeabilisation buffer (eBioscience, USA) and 
intracellular antibodies (Table 2.13) are added for 30 min at 4°C before washing and 
fixation in 200µl 4% paraformaldehyde. Fluorescence Minus One (FMO) controls or 
isotope controls were used to determine positive stained populations and samples 
were run on a FACSAria II flow sorter and analysed using FlowJo software 
(Treestar, USA). Median fluorescence intensity (MFI) and percentages of 
lymphocytes or total cell populations were calculated using FlowJo software. 
Absolute numbers of stained cells was calculated by multiplying the percentage of 
total cells (calculated by FlowJo) by the total number cells from the tissue as obtained 
by cell counts with trypan blue staining.  
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Table 2.13: List of antibodies used for flow cytometry. 
 
Antibody Specificity Clone Flurochrome Company Type of 
staining 
γδ TCR γδ T cells GL4 PE BD Phamingen, UK Surface 
CD4 CD4+ cells GK1.5 APC-H7 BD Phamingen, UK Surface	  
CD4 CD4+ cells GK1.5 APC BD Phamingen, UK Surface	  
CD8a CD8+ cells 53-6.7 V450 BD Phamingen, UK Surface	  
CD8a CD8+ cells 53-6.7 FITC BD Phamingen, UK Surface	  
CD3e T and NKT cells 500A2 V500 BD Phamingen, UK Surface	  
NK1.1 NK cells PK136 PeCy7 BD Phamingen, UK Surface	  
CD282 TLR2+ cells 6C2 PE eBioscience, UK Surface 
CD335 NKp46 29A1.4 eFluor 450 BD Phamingen, UK Surface 
CD49b NK cells DX5 FITC eBioscience Surface 
Foxp3 Foxp3+ cells FJK-16S Alexa fluor 488 BD Phamingen, UK Intracellular 
IL-17A IL-17A+ cells TC11-18H10 Alexa fluor 647 BD Phamingen, UK Intracellular 
IFN-γ IFN-γ+ cells XMG1.2 Alexa fluor 700 BD Phamingen, UK Intracellular 
CD282 TLR2+ cells T2.5 Alexa fluor 647 eBioscience, UK Intracellular 
 
 
 
For ex vivo cytokine flow cytometry, mice were given Brefeldin A (BFA; Sigma-
Aldrich, UK) i.p to prevent the release of cytokines from cells during the infection 
(Liu and Whitton, 2005). The dose of BFA and length of incubation within the mouse 
was optimised for IL-17A cytokine release (Figure 2.3) and 50µg BFA given in the 
last 4h of the infection gave the maximal detection of cytokine by flow cytometry 
(Figure 2.3). 
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Figure 2.3: Ex vivo cytokine optimisation flow cytometry. 
C57BL/6 female mice (n=3 per group) were infected with 108 CFU H305 S. pyogenes for 
24h. In the last 4h of infection, mice were given various doses of BFA (25, 50 100, 150µg) 
i.p (A). Spleens were harvested and stained for IL-17A expression and representative 
histograms are shown above. The shaded histogram represents Fluorescence Minus One 
(FMO) control and the open histogram represents the IL-17A staining with the number in the 
top left corner indicating IL-17A MFI.  In an independent infection experiment, mice were 
given 50µg BFA for different lengths of time: 2, 4, 6 and 7h before harvesting spleens for IL-
17A staining and representative histograms are shown above (B). 
 
 
 
A 
B 
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To study the effects of S. pyogenes on TLR2 expression in whole blood, H305 and 
H293 exponential phase bacteria were obtained by adding 1ml overnight THB culture 
into 9ml fresh THB and grown until OD600=0.1. 5µl bacterial culture was added to 
50ml sterile PBS (~125 CFU/ml). Blood from HLA-DQ8.Aβ0 mice (n=16) was 
obtained by cardiac puncture and pooled. 1ml pooled blood was co-cultured with 
either 5µl diluted H305 or H293 cultures or 5µl PBS for 4h, 37°C, 5% CO2. Red 
blood cells were lysed in 5ml lysis buffer for 10 min at RT and cells centrifuged for 
10 min at 1200rpm. Supernatants were saved for viable bacterial counts (~250 
CFU/ml) and the pellets washed in 5ml PBS containing 1% P/S twice by 
centrifugation at 1200rpm, 10 min at RT and resuspended in PBS (10% FCS) before 
TLR2 surface and intracellular staining as described above. 
 
 
2.5.13 Haematoxylin & Eosin (H&E) staining 
 
H305 WT S. pyogenes or sham-infected thigh muscle was harvested from one female 
Foxp3.DTR mouse and snap-frozen in iso-pentene before storage at -80°C. Serial 
sections were cut at a thickness of 12µm using a cyrostat (Leica, UK) and sections 
collected on Superfrost plus microscope slides (VWR, UK) and stored at -80°C 
before subsequent staining to define histological changes in tissue during GAS 
infection.  	  
For Haematoxylin and Eosin (H&E) staining, sections were defrosted and incubated 
in ice-cold 1% hydrogen peroxide in methanol solution for 15 min before rinsing in 
tap water to wash off the alcohol. The slides were next immersed in 1% Mayer’s 
Haematoxylin solution (VWR, UK) for approximately 8 sec for nuclear staining 
before rinsing in running tap water for 5 min. The sections were fixed in 1% acetic 
acid in ethanol for 1 min before counter-staining with Eosin solution for 12 sec 
(VWR, UK). The slides were rinsed briefly in tap water and dehydrated in increasing 
concentrations of xylene (VWR, UK) before incubation in 100% xylene for 4 min. 
The section was mounted in DPX (VWR, UK) and a cover-slide added on top, 
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excluding air-bubbles. The sections were left to dry overnight before images taken on 
a light microscope (Leica, UK) at various objectives.  
 
 
2.5.14 Gram staining 
 
The presence of Gram-positive bacterium in Foxp3.DTR S. pyogenes or sham-
infected thigh tissue was detected by Gram staining. In brief, the snap frozen sections 
were stained in 1 min with Crystal violet (HARLECO, Fisher Scientific, UK) and 
rinsed in tap water. Gram iodine (HARLECO, Fisher Scientific, UK) was added fro 
30 sec as a mordant to fix the Crystal violet. The slide was flooded with 
ethanol/acetone decolouriser (HARLECO, Fisher Scientific, UK) before 
counterstaining with safranin (HARLECO, Fisher Scientific, UK) for 30 sec. The 
section was washed under a running tap. Gram-positive bacteria are stained purple, 
whereas Gram-negative bacteria are stained pink. Images of the section were 
immediately taken on a light microscope (Leica, UK) at various objectives.  
 
 
2.5.15 Immunohistochemistry (IHC)  
 
To visualise the presence of Group A carbohydrate, specific for Group A 
Streptococcus and myeloperoxidase (MPO), reflective of the presence of activated 
neutrophils in snap-frozen S. pyogenes or sham-infected Foxp3.DTR thigh muscle, 
Immunohistochemistry (IHC) was performed. In brief, tissue sections were incubated 
in ice-cold 1% hydrogen peroxide in methanol solution for 15 min before rinsing in 
PBS. Primary antibodies diluted in 1% serum/PBS (Table 2.14) were added to cover 
the entire section and incubated overnight at RT. The next day, the slide was rinsed in 
PBS twice and secondary biotinylated antibody (1:200 in 1% serum/PBS; Table 2.14) 
applied for 45 min at RT before washing in PBS. Avidin-Biotin Complex (ABC) 
solution was made up according to the manufacturer’s instruction (Vector 
Laboratories, UK) and incubated on the slide for 1h at RT. For visualising, 
chromagen (Vector Laboratories, UK) was applied for approximately 3 min and the 
	   133	  
reaction stopped by immersion in PBS. The nuclei were counterstained with 
Haematoxylin solution before dehydration in xylene and mounting in DPX was 
described in Section 2.5.13. 
 
Table 2.14: Antibodies used for IHC. 
 
Primary antibody Host Secondary 
antibody 
Specificity Dilution Dilution 
buffer 
Anti-Group A 
Carbohydrate 
Goat, 
polyclonal 
Anti-goat Group A Streptococcus 1:50 Donkey 
serum 
Anti-MPO Rabbit, 
polyclonal 
Anti-rabbit Myeloperoxidase 1:150 Goat 
serum 
 
 
 
2.5.16 Bacterial plasmid extraction and restriction digest 
 
In order to assess the relative contribution of streptococcal superantigens towards the 
disease associated pathology and interactions with T cells mediated immunity, it was 
necessary to create a panel of S. pyogenes knockout isolates from the M1T1 serotype 
H305 WT strain. Genetically knocking out superantigens in GAS isolates would 
allow the dissociation of immune responses mounted to the bacterial antigens from 
the more dominant and potent responses due to the presence of secreted 
superantigens.   
 
Sriskandan and colleagues have previously created superantigen knockout isolates 
from a M89 (H293) or M1 (H305) serotype WT S. pyogenes isolates using insertional 
duplication or allelic replacement mutagenesis (Unnikrishnan et al., 2002; Sriskandan 
et al., 1999). Similar experimental approaches were utilised to extend the panel of M1 
superantigen knockout strains for use in this study. E. coli hosts (H323, H376 or 
H431) (Table 2.4) containing the pre-constructed plasmids (pDL278, pGHostsmez 
and pDL278smez) used to knock out and complement smez in H293 (Unnikrishnan et 
al., 2002; Russell and Sriskandan, 2008) and H722 containing pDL278smezspea 
(Section 2.5.23) were plated out on LB agar plates (Section 2.1.2) containing 
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appropriate antibiotics (Table 2.4) and grown at 37°C, 5% CO2 overnight. Ten 50ml 
falcon tubes containing 10ml LB media (Section 2.1.2) with antibiotics were each 
inoculated with a single bacterial colony and grown overnight at 37°C with shaking 
(200rpm). Plasmids were extracted from bacterial host using a Midi-prep kit (Qiagen, 
USA) according to manufacturer’s protocol. In brief, overnight bacterial cultures 
were spun down and the pellet lysed to release plasmid DNA into supernatant, which 
was transferred and bound to spin-columns for washing steps. Plasmid was eluted 
from spin-columns and precipitated out of solution using 3.5ml iso-propanol and 
aliquoted into 1.5ml eppendorf tubes and spun down at 15,000g for 10 minutes to 
increase plasmid yield. The DNA pellets were washed with 300µl 70% ethanol and 
centrifuged at 15,000g for 10 minutes. The supernatant was discarded and the pellet 
air-dried for 20 minutes at RT before being resuspended in 25µl molecular grade 
water and pooled together. The concentrations of plasmid were determined using a 
Nanodrop spectrophotometer and found to be between 700-1000ng/µl. 
 
	  
Figure 2.4: Restriction digest of pGhostsmez plasmid. 
After plasmid extraction from E. coli with a midiprep extraction kit, pGhostsmez was 
digested with EcoRI for 2h at 37°C before running on a 1% agarose gel. Uncut plasmid was 
also run as a control. Restriction digest of plasmid produced two band; linearised plasmid: 
8Kb and 300bp smez’ triplet. 
 
 
 
The purity of the plasmids was verified by restriction digest. pGhostsmez was cut 
with EcoRI (New England Biolabs, USA) (Figure 2.4) to cut out the cloned in smez’ 
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triplet (Figure 5.1) (Unnikrishnan et al., 2002), while pDL278 and pDL278smez 
(Russell and Sriskandan, 2008) were digested with BamHI (GIBCO BRL, USA), 
either to linearised the plasmid or cut out cloned in smez coding region (Figure 2.5). 
4µl of digested product was analysed on a 1% agarose TAE gel and run for 1h at 
100V before visualization under UV light. 
 
 
Figure 2.5: Restriction digest of pDL278 and pDL278smez. 
After plasmid extraction from E. coli, pDL278 and pDL278smez were digested with BamHI 
enzyme for 2h at 37°C before running on a 1% agarose gel. Uncut plasmid was also run as a 
control. Restriction digest of pDL278 produced the linearised plasmid: 6Kb along with the 
900bp smez product in pDL278smez. 
 
 
 
2.5.17 Preparation of S. pyogenes electrocompetent cells 
 
S. pyogenes isolates for transformation to knockout or complement superantigens 
(H305, H326, H623 and H658) were plated on to blood agar and grown overnight at 
37°C, 5% CO2. 10ml THB was inoculated with a single colony and incubated 
overnight in the same conditions. Next day, the overnight culture was added to 90ml 
fresh THB and grown until OD600 was between 0.15 and 0.175. The bacterial cells 
were harvested by centrifugation at 3500g, 10 min at 4°C. The cells were washed 
twice in 10ml ice-cold electroporation media (Section 2.1.2) and resuspended in 
750µl ice-cold electroporation media. The cells were either used immediately for 
transformation or kept on ice until further use.  
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2.5.18 Bacterial electroporation  
 
75µl ice-cold electrocompetent bacterial cells were added to 5µl, 3µl or 1µl extracted 
plasmid (Section 2.5.16) in sterile eppendorf tubes before being transferred into ice-
cold 1mm E-shot™ standard electroporation cuvettes (Invitrogen, USA). The 
bacterial cells and DNA were electroporated at 1KV, 129ohms of resistance, 50µf 
capacitance using a Gene Pulser XCell™ electroporator (BIO-RAD, USA). A 
negative control of 5µl sterile water was also transformed into S. pyogenes isolates. 
1ml THY (Section 2.1.2) was added to the cuvette immediately after electroporation 
and transferred to 9ml fresh THY and incubated at 30°C for 3h. Cells were harvested 
at 2500g, 10 min at 4°C and resuspended in 500µl fresh THY and 100µl plated on to 
THY agar plates (Section 2.1.2) containing the appropriate antibiotics for positive 
clone selection (Table 2.5).  
 
H305/pGhostsmez and H326/pGhostsmez were plated on to THY plates containing 
erythromycin and incubated for 24-48 hours at 30°C, 5% CO2 to allow for plasmid 
replication. Bacterial cells transformed with either pDL278, pDL278smez or 
pDL278smezspea were plated on to THY plates containing spectinomycin and 
incubated at 37°C, 5% CO2 for 24 hours. The transformation efficiency was estimated 
to be 104 CFU/µg pDL278. Negative controls did not grow on antibiotic plates. 
 
 
2.5.19 pGhostsmez host chromosome integration 
 
Clones from H305/pGhostsmez or H326/pGhostsmez transformations were streaked 
on to blood agar plates to verify β-haemolytic activities, indicative of GAS isolates. 
5ml THY cultures containing erythromycin were made from the clones and incubated 
at 30°C, 5% CO2 overnight. 20% glycerol stocks were made from these cultures and 
stored at -80°C. 1ml of overnight culture was inoculated into 9ml fresh THY and 
incubated for 2h at 30°C and then moved to 37°C overnight for host chromosome 
integration. Next day, the cultures were spun down at 2500g, 10 min at 4°C and 
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resuspended in 500µl fresh THY. 100µl was plated out on to THY containing 
erythromycin plates and also blood agar plates to check for β-haemolytic activity and 
incubated overnight at 37°C. Clones from these plates were then used for glycerol 
stocks for permanent isolate storage.  
 
 
2.5.20 Streptococcal genomic DNA extraction 
 
Genomic DNA was extracted from transformed streptococcal cells for PCR 
verification of plasmid insertion. 50ml THB was inoculated with a single colony from 
a freshly plated out S. pyogenes isolate and incubated overnight at 37°C, 5% CO2. 
The cells were harvested by centrifugation at 2500g, 10 min at 4°C and resuspended 
in 1ml sterile PBS. 20µl mutanolysis (10,000U/ml; Sigma-Aldrich, UK) and 20µl 
lysozyme (100mg/ml; Sigma-Aldrich, UK) were added and incubated at 37°C for 10 
min. The samples were spun down at 200g for 10 min and resuspended in 500µl SET 
buffer (Section 2.1.3). 5µl 10% SDS solution (BDH, UK) and 0.5mg/ml Proteinase K 
(Sigma-Aldrich, UK) were added and incubated for 2h at 55°C with occasional 
mixing. 175µl 5M NaCl and 500µl chloroform were added and left to incubate at RT 
for 30 min. The samples were centrifuged at 4500g for 15 min and the aqueous layer 
transferred into clean eppendorf tubes and DNA precipitated with 500µl iso-propanol. 
DNA was pelleted at 16,000g for 5 min and washed with 1ml 70% ethanol at 16,000g 
for 3 min. The pellet was air-dried for 20 min and dissolved in 200µl molecular 
biology water. The concentration of genomic DNA was determined using a Nanodrop 
spectrophotometer.  
 
 
2.5.21 Streptococcal genomic DNA PCR 
 
The amplification of DNA sequences by PCRs was carried out to determine whether 
superantigen genes were knocked out in electroporated streptococcal isolates. 
Primers: aphI (F), aphI (R), rRNA (F), rRNA (R), S1 and A1 were used for smez KO 
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mutagenesis are shown in Table 2.3. Amplification were carried out using Mega-mix 
Blue (Microzone, UK) for products less than 1Kb in size and the master-mix for one 
reaction was made up as follows: 20.5µl Mega-mix Blue, 1.25µl sense primer 
(100µM), 1.25µl anti-sense primer (100µM) and 2µl genomic DNA (1:10 dilution 
∼100ng/µl DNA). The PCR samples were run on the following thermal profile:  	  
Temperature (°C) Time Number of cycles 
95 5 min 1X 
95 30 sec 
Annealing temperature 1 min 30 sec 
72 1 min 
 
30X 
72 4 min 1X 
4 HOLD 1X 
 
 
 
Annealing temperatures were calculated as 2°C below the lowest Tm of the primer 
pair being used. 10µl of PCR reaction was run on a 2% agarose gel and run for 1h at 
100V before visualization under UV light.  
 
 
Amplification of DNA products more than 1Kb were carried out with Bio-X-Act 
Short DNA polymerase (Bioline Ltd, UK). Primers (smezP1 and smezR600) were 
used for smez KO mutagenesis are shown in Table 2.3. Master-mix for 1 reaction 
were prepared as follows: 10µl 10X Optibuffer (Bioline Ltd, UK), 6µl 50mM MgCl2, 
10µl 10mM dNTPs, 1µl sense primer (100µM), 1µl anti-sense primer (100µM), 1µl 
Bio-X-Act Short DNA polymerase, 70µl molecular biology water, 2µl genomic DNA 
(1:10 dilution ~100ng/µl). Annealing temperatures were calculated as 2°C below the 
lowest Tm of the primer pair being used. The thermal profile below was used for 
product amplification before 4µl product was run on a 1% agarose gel for 1h at 100V.  	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Temperature (°C) Time    Number of cycles 
95 5 min 1X 
60 1 min 1X 
95 30 sec 
Annealing temperature 1 min 30 sec 
68 3 min 
 
30X 
68 10 min 1X 
4 HOLD 1X 
 
 	  
2.5.22 Southern blot 
 
Southern blotting was performed to confirm the orientation of pGhostsmez plasmid in 
the H305 host genome and hence disruption of functional smez transcription. An 
internal smez probe was constructed from a PCR product made from primers smezF 
and smezR (Table 2.3) at the start and end of smez from H305 genomic DNA. PCR 
was carried out using GoTaq DNA polymerase (Promega, USA) and the master-mix 
for one reaction was made up as follows: 0.5µl GoTaq DNA polymerase (5U/µl), 
20µl 5X Taq colourless buffer (Promega, USA), 10µl 1mM dNTPs, 1µl smezF 
primer (100µM), 1µl smezR primer (100µM), 65.5µl molecular biology water, 2µl 
H305 genomic DNA (1:10 dilution ∼100ng/µl DNA). The thermal profile below was 
used for product amplification. 
 
Temperature (°C) Time Number of cycles 
95 5 min 1X 
95 30 sec 
62 1 min 30 sec 
72 1 min 
 
30X 
72 4 min 1X 
4 HOLD 1X 
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The PCR product was purified using QIAquick PCR Purification Kit to remove 
contaminating PCR reagents (Qiagen Ltd, UK). 5µl purified PCR product was boiled 
with 11µl molecular grade water for 10 min before adding 4µl DIG high prime 
(Roche, Germany) and incubating for 3h at 37°C. The probe for Southern blotting 
was boiled again for 10 min before being added to 1ml DIG easy hyb (Roche, 
Germany). 
 
5µg genomic DNA from H305 (WT) and H305/pGhostsmez transformation clones 
were digested with XbaI enzyme (Promega, USA) in a total reaction volume of 20µl. 
5µl 1X loading buffer was added to all samples and then run on a 0.9% agarose gel 
without ethidium bromide for 2h at 120V along with 7µl DIG labeled DNA ladder III 
(Roche, Germany). The gel was covered in 1X TAE buffer containing 5µl ethidium 
bromide for 30 min and then visualised under UV light. The gel was washed in 
Denaturation solution (Section 2.1.4) twice for 15 minutes at RT with gentle shaking 
and rinsed in ddH20. The gel was washed twice in neutralisation solution (Section 
2.1.4) for 15 min at RT with gentle shaking before equilibrated in 20X SSC buffer 
(Section 2.1.4) for 10 min. The gel was set to blot on to nitrocellulose membrane 
overnight at RT. 
 
Next day, the membrane was UV crossed-linked at 1200J (UVC500 UV crosslinker, 
Hoefer) and allowed to air-dry. The membrane was blocked with 50ml DIG easy hyb 
at 42°C for 1h rotating. smez probe in DIG easy hyb was next added to the membrane 
and left rotating overnight at 42°C. 
 
The membrane was washed twice for 5 min in 2X wash buffer (Section 2.1.4) and 
then twice in 0.5X wash buffer (Section 2.1.4) (pre-heated to 68°C for 15 min with 
rotation). The blot was equilibrated in washing buffer (Roche, Germany) for 1 min 
before being submerged in blocking buffer (Roche, Germany) for 1h with gentle 
shaking. 1.5µl anti-DIG antibody (Roche, Germany) was diluted in 30ml blocking 
solution and added to the membrane once the blocking buffer had been discarded and 
incubated for 1h. The blot was washed three times in washing buffer for 15 min each 
and equilibrated in 20ml detection buffer (Roche, Germany) for 3 min. The blot was 
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developed by adding CSPD* substrate (Roche, Germany) and exposed to 
photographic film and developed using a Curix60 developer (AGFA). 
 
 
2.5.23 Cloning of pDL278smezspea plasmid 
 
In order to complement the double superantigen knockout phenotype in H658, it was 
necessary to construct a self-replicating plasmid containing both the coding regions of 
smez and spea. This was achieved by adding the spea coding sequence extracted from 
WT S. pyogenes genome into pDL278smez plasmid (Russell and Sriskandan, 2008) 
(Figure 2.6). 	  
	  
Figure 2.6: pDL278smezspea shuttle vector. 
pDL278smez plasmid was modified with the addition of spea gene into EcoRI restriction site 
to create a self-replicating shuttle vector expressing both smez and spea superantigen coding 
regions, retaining endogenous promoter sequences. 
 
 
 
In brief, spea gene including the promoter region was amplified from WT S. 
pyogenes genomic DNA (H305) by PCR with the addition of EcoRI restriction sites 
at the start and end of the product using primers spea-EcoRI-F and spea-EcoRI-R 
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(Table 2.3). Proof-reading BIO-X-Act-short DNA polymerase was used with the 
thermal profile as described in Section 2.5.20 with an annealing temperature of 70°C 
for 30 sec and extension at 68°C for 2 min. pDL278smez plasmid was extracted from 
H376 with a midiprep kit (Qiagen, UK) and the concentration and purity determined 
as described in Section 2.5.16. 16µl plasmid and PCR product were digested with 
EcoRI enzyme for 2h at 37°C in a total volume of 20µl in duplicate. The enzyme was 
heat-inactivated by heating at 65°C for 20 min. Arctic phosphatase (New England 
Biolabs, USA) was added to the cut plasmid and incubated for 1h at 37°C to prevent 
self-ligation of the plasmid before heat-inactivation of the enzyme at 65°C for 5 min. 
The plasmid and PCR product were run on a 0.9% agarose gel for 2h at 100V before 
linearised plasmid and cut spea product were cut out. The cut pDL278smez and spea 
were extracted from the agarose gel using a QIAquick gel extraction kit (Qiagen, UK) 
and each duplicate was pooled together before elution in 30µl molecular biology 
water to increase yield of DNA. 5µl of cut plasmid and PCR were run on 0.9% 
agarose gel to check purity before quick ligation 3:1 ratio of insert to vector using 
Quick T4 DNA ligase (New England Biolabs, USA) in a total volume of 20µl. 
Ligation reaction was incubated at 14°C overnight. Next day, 1µl ligation reaction 
was transformed into 100µl Max Efficiency DH5α chemical competent E. coli cells 
(Invitrogen, UK) by incubated of DNA and cells on ice for 30 min before heat-shock 
at 42°C for 45 sec. A positive control of 1µl of pDL278 and a negative control of 1µl 
water were also transformed into DH5α cells. The cells were placed on ice 
immediately after heat-shock for 2 min before 0.9ml RT SOC media (Invitrogen, UK) 
was added and incubated for 1h at 37°C with shaking (225rpm) to allow recovery 
after transformation. 200µl was plated on LB agar plates containing spectinomycin 
(50µg/ml) and incubated overnight at 37°C. Next day, colonies were picked and 
overnight cultures prepared for glycerol stocks and plasmid extraction using miniprep 
kit (Qiagen, UK). Extracted plasmids were digested with EcoRI and BamHI to verify 
the presence of the cloned spea and pre-existing smez fragments. Clone 18 and 20 
were found to contain both smez and spea coding regions and clone 20 was re-
designated as H772 (Figure 2.7). Sequencing of cloned spea product in H772 was 
performed with M13 primer pairs to confirm the absence of mutations creation by the 
cloning process before electroporation into H658 according to Section 2.5.16 to 
create H786. 
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Figure 2.7: Restriction digest of clone 18 and 20. 
Plasmids purified from clone 18 and 20 and pDL278smez were digested with BamHI (A) and 
EcoRI (B) for 2h at 37°C before run on a 0.9% agarose gel. Both clones 18 and 20 contained 
inserted 900bp smez product along with pDL278smez when cut with BamHI. Only clones 18 
and 20 contained 1.1Kb spea product upon digestion with EcoRI confirming the presence of 
the cloned in product. Uncut clones 18 and 20 (C) were found to be approximately 8Kb in 
size, confirming that only one copy of spea had inserted into the linearised pDL278smez 
vector.  
 
 
 
2.5.24 Preparation of human PBMCs and murine splenocytes 
 
Transgenic HLA-DQ8.Aβ0 (n=3-6) mice were humanely sacrificed and spleens were 
dissected out and passed through a 70µm cell sieve to obtain a single cell suspension. 
The splenocytes were resuspended in RPMI (10% FCS, L-Glut, P/S), ready for use in 
proliferation assays as described in the next section.  
 
In order to complement and confirm proliferation data obtained utilising murine 
splenocytes, 20ml of human blood was collected from a small cohort of healthy 
donors (n=2) and diluted 1:1 in PBS. Human PBMCs were separated out of whole 
blood by overlaying on top of an equal volume of Ficoll-Paque (Sigma-Aldrich, UK) 
and centrifuged at 800g for 25 min. The interface, rich in lymphocytes was washed in 
10ml RPMI 1640 (10% FCS, L-Glut, P/S) twice and resuspended in 5ml media mix. 
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2.5.25 Proliferation assays 
 
Proliferation assays were carried out on murine splenocytes or human PBMCs to 
assess the presence or absence of specific secreted streptococcal superantigens in the 
isolates prepared as described in Section 2.5.5. In brief, cell counts were carried out 
on both murine splenocytes and human PBMCs by diluting cells 1:10 in 0.4% Trypan 
Blue (Sigma-Aldrich, UK) and counting cells in a KOVA Glasstic® slide 10 with 
grids (Hycor, Biomedical Inc., USA). 100µl of prepared murine splenocytes 
(concentration of 3.5×105 cells/well) or human PBMCs (concentration 2×105 
cells/well) were seeded in triplicate into a flat bottomed 96-well plate and stimulated 
with 100µl of 10-fold dilutions of cell free bacterial supernatants or GAS infected 
HLA-DQ8.Aβ0 sera (1:20) at 37°C, 5% CO2. Negative control of 100µl media was 
also included. 1µ-Curie 3H-thymidine (Amersham, GE healthcare, USA) was added 
to each well after 88h for murine splenocytes and 64h for human PBMCs and cells 
were harvested after 8h of incubation onto filter mats (Wallac, Finland) in a 1295-004 
Betaplate 96-well cell harvester (Wallac and Berthold, UK). 
 
 
2.5.26 Streptococcal growth curves and opsonophagocytosis assay 
 
To determine the rate of growth of the various superantigen knockout mutants in 
liquid broth, overnight cultures of S. pyogenes isolates were diluted 1:10 with fresh 
THB and incubated at 37°C, 5% CO2. Every hour, the optical density of the cultures 
was sampled until stationary phase. This was repeated as part of three independent 
experiments.  
 
To determine the rate of growth of the superantigen knockout isolates in whole blood, 
an opsonophagocytosis assay was carried out. Overnight THB cultures were diluted 
1:10 with fresh broth and grown until the optical density was 0.17 at 600nm. 5µl of 
the exponential phase cultures was added to 50ml sterile PBS and 30µl was added to 
270µl human healthy donor blood (n=4) or female HLA-DQ8.Aβ0 murine blood 
(n=3) containing sodium heparin in triplicates. The infected blood cultures were 
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incubated for 3h at 37°C rotating before 10µl was plated out on to blood agar along 
with 10µl of the inoculum. The multiplication factor of CFU recovered from infected 
blood over CFU of the inoculum was calculated. 
 
 
2.5.27 Statistical analysis 
 
Appropriate statistical tests were carried out according to the nature of the data set 
using GraphPad Prism software (GraphPad Software Inc, USA) and data presented as 
mean ± SEM. Non-parametric Kruskal-Wallis statistical test was carried out on 
bacterial counts, proliferation assay, percentage weight loss during infection as data 
points did not follow normal Gaussian distribution and did not pass D’Agostino and 
Pearson normality testing. Significant differences in survival experiments were 
calculated using Log-Rank (Mantel-Cox) statistical test. Results for ELISA, CBA and 
opsonophagocytosis assays passed the D’Agostino and Pearson normality testing and 
parametric 1-Way ANOVA statistical testing was performed. For flow cytometry 
analysis, percentage of lymphocytes data sets were subjected to non-parametric 
Kruskal-Wallis statistical test due to the nature of ranked data points. For statistical 
analysis of absolute numbers and MFI of flow cytometric data, 1-Way ANOVA was 
carried out as results followed normal Gaussian distribution according to D’Agostino 
and Pearson normality testing. Bacterial growth curves were analysed using linear 
regression to determine any statistical differences. Significance differences in qRT-
PCR data was found using REST software based on a mathematical model of primer 
efficiencies and calculated Ct values before the expression ratio between sample and 
control groups are subjected to randomisation testing to determine significant 
differences. Significant differences between infected and sham controls for qRT-PCR 
are indicated as asterisks above the bars. 
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Chapter 3 
	  
3 The role of αβ and γδ T cells during acute Streptococcus pyogenes 
infection.  
 
3.1 Introduction 
 
It is important for the host immune system to mount appropriate responses in the face 
of invading pathogens. If pathogens do penetrate and invade the host tissue, innate 
immunity is initiated rapidly to neutralise microorganisms. Adaptive immunity in the 
form of T and B cells is lastly mounted after subsequent activation and clonal 
expansion to coordinate and enhance effector cell function. 
 
The role of T cells during infection has been demonstrated to be important in many 
different disease models. T cells can be divided into two populations based on their T 
Cell Receptor (TCR) expression; αβ and γδ T cells. αβ T cells are the predominant 
population, consisting of 95% of the total T cell population. They are capable of 
recognising a large array of antigens presented by MHC class II molecules on APCs, 
such as DCs, macrophages and B cells (Kupfer et al., 1987). γδ T cells on the other 
hand are fewer in number in circulating blood (5% of total T cell population) and tend 
to be more abundant in the gut mucosa (Born et al., 2010). The antigenic source of γδ 
T cell activation is still unknown, although a group of molecules collectively known 
as phosphoantigens have been proposed. It has also been suggested that this class of T 
cells are not restricted to activation by conventional antigen processing and 
presentation by APCs like their αβ T cell counterparts. Rather it has been stipulated 
they an be activated by direct γδ TCR binding to non-MHC molecules, such as viral 
glycoproteins (Sciammas et al., 1994).  
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A role of αβ and γδ T cells during sepsis has been highlighted by analysis of patients 
with Streptococcal Toxic Shock Syndrome (SSTS). One clinical study showed an 
expansion of γδ T cells in PBMCs taken from patients with SSTS (Arvand et al., 
1996). αβ T cells from the same cohort of GAS infected patients were also shown to 
proliferate upon stimulation in vitro with supernatants from the streptococcal isolates 
extracted from the same patients (Arvand et al., 1996). γδ T cells stimulated with 
heat-killed GAS produce IFN-γ (Follows et al., 1992), demonstrating that both αβ 
and γδ T cells activities are modulated either directly by the bacterium or via secreted 
virulence factors such as superantigens. 
 
The function of αβ and γδ T cells during sepsis has further been addressed 
experimentally using TCR knockout (KO) mice. TCR β knockout mice that have 
undergone Cecal Ligation Puncture (CLP) surgery, a poly-microbial model of sepsis, 
exhibited increased survival compared to operated wild-type (WT) control mice 
(Enoh et al., 2007). TCR δ KO mice however, exhibited no significant difference in 
survival relative to WT mice after CLP surgery (Enoh et al., 2007). This would 
suggest that in this experimental model of sepsis, αβ T cells are detrimental to the 
host during poly-microbial infection, whereas γδ T cells play no significant role in 
disease outcome. The use of these TCR knockout mice has not been previously used 
for studies of acute S. pyogenes infection to investigate the relative roles of αβ and γδ 
T cells. 
 
The pro-inflammatory cytokine, IL-17A, has been extensively linked to 
autoimmunity (Crome et al., 2010; Bettelli et al., 2008) and has also been examined 
in many different infectious disease models (Curtis and Way, 2009). Most research 
has focused on CD4+ T cells producing this cytokine, known as TH17 cells, with 
evidence demonstrating that IL-17A production by CD4+ T cells during S. 
pneumoniae or Klebsiella pneumoniae infection is beneficial due to increased 
neutrophil recruitment, aiding bacterial clearance in the lung (Zhang et al., 2009c; Ye 
et al., 2001b). These results were further confirmed through antibody-mediated 
depletion of IL-17A or CD4+ T cells shown to reverse the recruitment of neutrophils 
and monocytes to the site of infection and lead to increased bacterial colonisation and 
poor survival outcome (Zhang et al., 2009c). Over-expression of IL-17A in the 
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pulmonary compartments has similarly been shown to be beneficial, enhancing 
survival outcome during lethal K. pneumoniae infection (Ye et al., 2001a).  
 
Whether IL-17A has a role during S. pyogenes infection is not well understood with 
only a handful papers published to date. Tonsil cultures from patients with recurrent 
GAS-associated tonsillitis can be stimulated with heat-killed M1 serotype GAS to 
produce IL-17A together with TGF-β, suggestive of differentiation of TH17 cells 
during infection (Wang et al., 2010a). Purified superantigens from S. pyogenes and 
superantigen-contaminated preparations of Peptidoglycan are potent inducers of IL-
17A from T cells (Li et al., 2008). However, the direct contribution of IL-17A has not 
been examined during acute S. pyogenes infection either in mice or humans.  
 
In order to investigate the specific role of T cells during infectious diseases, various 
techniques have been employed. Early studies concentrated on the use of antibodies 
to specifically deplete a chosen cell population in vivo (Vignali et al., 1989; Müller et 
al., 1987). This has both advantages and disadvantages; for example, most antibodies 
used for depletion are specific and will only remove the chosen cell type in vivo. The 
use of antibodies to deplete specific targets has been so successful that it has been 
exploited in the field of translational medicine in the form of therapeutic treatments 
for certain human diseases.  For example, Infliximab, a monoclonal antibody targeted 
against TNF-α has been used to treat autoimmune and other inflammatory diseases, 
such as rheumatoid arthritis and Crohn’s disease (Silva et al., 2010). However, the 
efficiency of antibody-mediated depletion in vivo in experimental models can vary 
depending on antibody affinity with the target and the chosen dosing regimen to 
achieve a full knockdown can be time consuming and expensive. 
 
The use of antibodies to exclusively deplete cell types or cytokines during infection 
or autoimmunity has helped to enhance our understanding of the immune response. 
For example, BALB/c mice depleted of γδ T cells with a monoclonal anti-γδ TCR 
antibody (clone GL3) prior to coxsackievirus B3 infection showed delayed 
progression to mycocarditis due to decreased TH1 cells and increased Tregs numbers in 
the spleen (Huber, 2009). The pathogenic nature of IL-17A was also revealed in a 
murine model of Experimental Autoimmune Uveoretinitis (EAU) as shown by 
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amelioration of the disease upon antibody mediated IL-17A blockade (Amadi-Obi et 
al., 2007). These two examples demonstrate that antibody mediated depletion or 
neutralisation can be used effectively to show the pathogenic and protective nature of 
T cells and cytokines in different disease models.  
 
The use of antibodies has not always proved practical in studies focusing on one 
particular target cell or cytokine. Anti-asialo GM1 antibody has been extensively used 
to deplete NK cells in many different murine models. NK cell depletion with this 
antibody is usually achieved to a high specificity (Badgwell et al., 2002), however 
this antibody also exhibits cross reactivity towards monocytes and macrophages 
(Wiltrout et al., 1985). In this context, it would appear that the use of antibodies to 
mediate cell depletion is a useful technique to dissect out the role of a particular cell 
type or cytokine but caution must be taken in interpreting results if the antibody is 
non-specific. It should also be noted that the effects are transient and will only last as 
long as the antibody is given.  
 
Given the limitations of antibody mediated depletion, the popularity of transgenic 
murine models with subsets of T cells or cytokines genetically removed have risen 
over the past few years within the field of immunology (Moon and McSorley, 2009; 
Shultz et al., 2007). Their application ensures the knowledge and confidence that any 
results attained will be due to complete depletion, without the fear of partial and 
transient effects as observed through the use with neutralising antibodies. This field 
has also been expanded by the creation of conditional and inducible transgenic 
knockout models, allowing researchers to study cell types or transcription factors that 
have proved to be fatal or severely affect development if knocked out in conventional 
transgenic animals.  
 
Conventional transgenic models have been employed successfully to study the 
relative contribution of different T cell subsets and cytokines during bacterial 
infection. For example, the role of γδ T cells during L. monocytogenes infection was 
addressed in TCR δ-/- mice (Hamada et al., 2008). It was deduced that this particular 
subpopulation of T cells secreted IL-17A during the early stages of infection in the 
liver, which lead to the recruitment of neutrophils and hence decreased bacterial 
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burden (Hamada et al., 2008). The protective role of IL-17A was also further 
confirmed in L. monoyctogenes infected IL-17A-/- mice displaying exacerbation of 
the disease (Hamada et al., 2008). A similar pattern of immune responses was also 
observed during E. coli and Salmonella enterica serovar enteritidis infection (Shibata 
et al., 2007; Siegemund et al., 2009). These results would suggest that γδ T cells and 
through their subsequent IL-17A production correlated with a protective outcome 
during certain bacterial infection.  
 
The use of conventional knockout mice has not always been suitable for all 
experimental systems. Sometimes, the creation of knockout mice for target genes has 
shown these mutations are fatal to the survival and development of the animal. To 
overcome this problem, conditional knockout mice can be generated to allow the 
researcher to switch off the gene in a specific target organ or cell type in the adult 
animal using Cre-Lox recombination (Sauer, 1998), without the detrimental effects as 
exhibited by genetic knockout mice (Bockamp et al., 2008).  
 
Inducible knockout transgenic mice exploit the use of suicide reporters to selectively 
deplete a chosen population at any given time. One example of an inducible knockout 
model include the CD11c-DT transgenic mice, whereby CD11c+ cells are marked by 
Diphtheria Toxin Receptor expression and upon administration of Diphtheria Toxin 
(DT) into the mouse leads to selective apoptosis of CD11c+ cells (Loof et al., 2007). 
This has been used to study the effects of depletion of DCs during S. pyogenes 
infection, indicating that this cell type is key in IL-12 production during GAS 
infection (Loof et al., 2007). 
 
The aim of this chapter was to determine the relative contribution of αβ and γδ T 
cells during acute S. pyogenes infection using conventional TCR knockout transgenic 
models. I sought out to further dissect the role of the two different sub-populations of 
αβ T cells; regulatory and effector αβ T cells during systemic infection through the 
use of antibody mediated depletion and also inducible knockout mice. Given that a 
key issue in this example of bacterial sepsis is the relative contributions of direct 
bacterial pathology from immune/inflammatory collateral effects, I aimed to 
determine whether these cell types are protective or pathogenic during GAS infection. 
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Cytokine production from different cell types during acute S. pyogenes infection was 
also studied to evaluate whether IL-17A or IFN-γ responses are employed to bring 
about these immunological effects.  
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3.2 The contribution of αβ and γδ T cells during acute sepsis 
 
Immunity mounted by infectious pathogens such as E. coli (Shibata et al., 2007) and 
L. monocytogenes (Usami et al., 1995) revealed the complexity of T cell mediated 
responses. The relative contribution of αβ and γδ T cells during infectious diseases 
can vary, with both T cell population been implicated as either pathogenic or 
protective. The precise role of αβ and γδ T cells during S. pyogenes infection is still 
unclear with only a handful papers published regarding this matter in the CLP model 
of poly-microbial sepsis. I sought out in this chapter to investigate the relative 
contributions of αβ and γδ T cells during acute S. pyogenes infection with the use of 
TCR knockout transgenic mice.  
 
Various TCR knockout transgenic strains were employed to help study whether αβ or 
γδ T cells are required during acute sepsis as induced by S. pyogenes infection. The 
percentage survival of either TCR βδ or β knockout mice given a lethal dose of S. 
pyogenes via an intra-muscular route was compared to infected C57BL/6 controls 
(Figure 3.1). The lack of both αβ and γδ T cells in βδ knockout TCR mice proved to 
be protective as demonstrated by increased survival compared to WT controls post 
lethal infection with S. pyogenes (Figure 3.1A). The lack of αβ T cells in TCR β 
knockout mice also proved to be advantageous and increased the percentage survival 
compared to infected C57BL/6 mice (Figure 3.1A). These results were also in line 
with serum IL-6 and IL-17A concentrations taken 8h post infection. TCR βδ 
knockout mice had the lowest level of serum IL-6, a surrogate marker of systemic 
disease severity (Damas et al., 1992) (Figure 3.1B). Interestingly, TCR β knockout 
mice had elevated levels of IL-17A in the blood, presumably from the remaining γδ T 
cell population (Figure 3.1B). Overall, this set of data is suggestive that αβ T cells, 
and to a lesser extent γδ T cells contain a detrimental T cell population during lethal 
S. pyogenes infection.  	  
	   154	  
	   	  
Figure 3.1: Increased survival post lethal infection with S. pyogenes in the absence of αβ  
and γδ  T cells. 
A. Survival curve of infected C57BL/6, TCR β KO and TCR βδ KO mice (n=8 males and 
females). Mice were given 7x107 CFU H305 S. pyogenes (WT) via an intra-muscular route 
and monitored for defined end points and culled. The curves are significantly different 
(p=0.0139) as calculated by Log-Rank (Mantel-Cox) statistical test. 
B. Serum IL-6 and IL-17A analysis. Serum was collected 8h post infection and concentration 
of IL-6 and IL-17A determined by ELISA. Mean and SEM are represented and 1-way 
ANOVA statistical test was carried out, no significant differences were found.  
 
 
 
Sub-lethally infected TCR βδ or β knockout mice also showed a similar pattern of 
disease severity. 24h post infection, thigh, liver, spleen and blood were harvested to 
determine the bacterial burden. TCR βδ knockout mice had the lowest levels of 
recovered bacteria at the site of infection (thigh) and systemically (liver) compared to 
infected WT C57BL/6 controls (Figure 3.2A). TCR β knockout mice have 
intermediate levels of bacterial counts compared to WT and TCR βδ knockout mice 
(Figure 3.2A). There was however, no difference in the percentage weight loss 
between the three strains of infected mice (Figure 3.2B). The reduced bacterial counts 
in the TCR knockout mice also correlated with decreased serum IL-6 levels (Figure 
3.2C) and there appeared to be a marginal increase in serum IL-17A upon the 
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depletion of αβ T cells in TCR β knockout and depletion of both αβ and γδ T cells in 
TCR βδ knockout mice compared to infected WT controls (Figure 3.2C). 	  
 
Figure 3.2: The effect on bacterial burden upon removal of αβ  and γδ  T cells during 
acute S. pyogenes infection. 
A. Bacterial counts after 24h infection. C57BL/6, TCR β KO and TCR βδ KO mice (n=8 
females per strain) were infected with 2.1x108 CFU H305 S. pyogenes via intra-muscular 
route. Bacterial counts in the thigh, blood, spleen and liver was determined. Mean and SEM 
are represented and 1-way ANOVA statistical test was carried out and no significant 
differences was found. 
B. Percentage total weight loss after 24h infection. Start body weight and cull weight of each 
mouse was recorded and percentage total weight loss was calculated. 
C. Serum ELISA analysis of IL-6 and IL-17A. Serum was collected after 24h of infection and 
concentration of IL-6 and IL-17A measured by ELISA. 
 
 
 
From these sets of experiments, the presence of αβ T cells would appear to be most 
detrimental during systemic infection with S. pyogenes through the use of TCR β 
knockout mice (Figure 3.1). From the survival experiment, increased IL-17A in the 
blood of infected TCR β knockout transgenic mice was detected (Figure 3.1); 
suggestive that the remaining γδ T cells in this transgenic may be responsible for the 
production of this pro-inflammatory cytokine. The production of IL-17A may also be 
associated with the increased resistance to lethal infection with S. pyogenes. In order 
to determine whether γδ T cells are protective or pathogenic during GAS infection, 
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TCR δ knockout transgenic mice lacking γδ T cells were used for further 
experiments. 
 
 
Figure 3.3: Survival outcome post lethal infection with S. pyogenes upon removal of γδ  
T cells. 
A. Survival curve of infected C57BL/6 (n=7 females) and TCR δ KO mice (n=6 females). 
Mice were given 6x108 CFU H305 S. pyogenes (WT) i.m and monitored for defined end 
points and culled. 
B. Bacterial counts after 24h infection. C57BL/6 and TCR δ KO mice (n=8 females per 
strain) were infected with 1.4x109 CFU H305 S. pyogenes i.m. Bacterial counts in the thigh, 
blood, spleen and liver was determined. Mean and SEM are represented and 1-way ANOVA 
statistical test was carried out and no significant differences was found. 
C. Serum ELISA analysis of IL-6, IL-17A and IFN-γ. Serum was collected after 24h of 
infection and concentration of IL-6, IL-17A and IFN-γ measured by ELISA and no 
significant differences was found. 
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When TCR δ knockout transgenic mice were infected with a lethal dose of WT S. 
pyogenes, there was no significant difference between the survival rate between WT 
and TCR δ knockout animals (Figure 3.3A). However, during acute infection when 
tissue was harvested 24h post infection to determine bacterial burden in WT and TCR 
δ knockout transgenic mice, there was a general trend of increased numbers of 
recovered bacteria in infected TCR δ knockout transgenic mice (Figure 3.3B). It was 
curious to note, there was no statistical difference between levels of IL-6 and IL-17A 
in the blood of infected WT and TCR δ knockout mice (Figure 3.3C). However there 
was a modest increase of serum IFN-γ in infected TCR δ knockout mice (Figure 
3.3C).  
 
Overall, there may be a modest protective element associated with the presence of γδ 
T cells during acute S. pyogenes infection as demonstrated by a trend of increased 
bacterial burden in the early stages of infection in TCR δ knockout mice (Figure 
3.3B). This protective effect was however, not due to increased production of serum 
IL-17A as indicated in Figure 3.1. Increased serum IFN-γ as observed in infected 
TCR δ knockout mice (Figure 3.3C) and this cytokine may be detrimental towards 
bacterial clearance and contribute to the hyper-inflammatory response presented by 
septic patients. However, during lethal infection, it would appear that γδ T cells do 
not play a significant role in the survival outcome (Figure 3.3A). 
 	  	  
3.3 Gene expression changes upon S. pyogenes infection in TCR β and 
βδ knockout mice 
 
qRT-PCR analysis was carried out on draining inguinal lymph nodes and spleens 
harvested from S. pyogenes infected TCR βδ or β knockout mice to identify any 
changes in gene expression upon depletion of αβ and γδ T cells. foxp3 gene 
expression in the draining lymph node (DLN) was significantly down-regulated in 
both the TCR βδ and β knockout transgenic mice compared to infected C57BL/6 
	   158	  
mice, confirming these mice presumably lack Foxp3+ Tregs due to the loss of αβ T 
cells (Figure 3.4). Interestingly, there was also a significant difference in foxp3 
expression between infected TCR βδ and β knockout transgenic mice (Figure 3.4), 
suggestive that γδ T cells may also express foxp3. A similar pattern of down-
regulation gitr, ctla-4 and lag-3 expression (genes also associated with Tregs) was 
observed in infected TCR βδ and β knockout transgenic mice compared to infected 
controls (Figure 3.4). t-bet expression was decreased in TCR β knockout and even 
lower in TCR βδ knockout transgenic mice (Figure 3.4) upon infection with S. 
pyogenes, presumably due to the loss of αβ T cells. gata-3 and rorγt expression was 
significantly up-regulated in TCR β knockout mice compared to infected WT controls 
(Figure 3.4). This is surprising as these transcription factors are generally connected 
with TH2 and TH17 αβ T cells, which are absent in TCR β knockout mice. Perhaps, 
other immune cell types such as NK and iNKT cells are the source of these changes 
in transcription factor expression (Kim et al., 2006; Doisne et al., 2009).  
 
qRT-PCR analysis of cytokine gene expression in infected draining lymph nodes 
from TCR βδ and β knockout transgenic mice revealed only subtle changes in 
expression pattern compared to infected WT controls. il-10 and tnf-α gene expression 
was significantly down-regulated, whereas tgf-β was significantly up-regulated in 
TCR β knockout mice compared to infected WT controls (Figure 3.5). This is striking 
data as TGF-β and IL-10 are cytokine associated with Treg suppressive function and it 
would appear αβ T cells expressing IL-10 during GAS infection are depleted in TCR 
β knockout mice tgf-β expression in other cell types was increased. In TCR βδ 
knockout mice, ifn-γ and il-17a were significantly up-regulated relative to infected 
WT controls (Figure 3.5). Up-regulation of ifn-γ and il-17a upon the depletion of both 
T cell subsets could be attributed to other cell types, such as NK cells, that are known 
to secrete these pro-inflammatory cytokines and may have suppressive control 
liberated from them.   
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Figure 3.4: qRT-PCR analysis of transcription factor gene expression in DLNs from 
infected TCR β  and βδ  knockout mice. 
C57BL/6, TCR β KO and TCR βδ KO mice (n=8 females per strain) were infected with 
2.1x108 CFU H305 S. pyogenes i.m. DLNs were harvested for qRT-PCR analysis of 
transcription factor gene expression changes after 24h of infection. Infected samples were 
normalised to tissue specific reference genes and C57BL/6 sham treated samples. Fold 
change in expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
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Figure 3.5: qRT-PCR analysis of cytokine gene expression in DLNs from infected TCR 
β  and βδ  knockout mice. 
C57BL/6, TCR β KO and TCR βδ KO mice (n=8 females per strain) were infected with 
2.1x108 CFU H305 S. pyogenes i.m. DLNs were harvested for qRT-PCR analysis of cytokine 
gene expression changes after 24h of infection. Infected samples were normalised to tissue 
specific reference genes and C57BL/6 sham treated samples. Fold change in expression was 
determined by REST analysis and mean and SEM represented. Any significant differences 
are indicated: *p<0.05, **p<0.01, ***p<0.001. 
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In the spleen, changes in transcription factor gene expression were less impressive 
than in the draining inguinal lymph node. foxp3 expression was yet again 
significantly down-regulated in GAS infected TCR βδ and β knockout transgenic 
mice compared to infected WT controls (Figure 3.6A). No other differences were 
observed in transcription factor genes between infected WT and TCR knockout 
transgenic mice (data not shown). In order to study whether γδ+ TCR cells also 
express Foxp3; preliminary flow cytometric staining of splenocytes from infected 
C57BL/6 mice was carried out (Figure 3.6B). Indeed, only a very small percentage of 
γδ+ TCR cells were found to be Foxp3+ as well (approximately 1.62% of γδ+ cells) 
(Figure 3.6B). More samples will need to be tested in order to confirm this finding. 
 
 
Figure 3.6: Analysis of Foxp3 expression in spleens from infected TCR β  and βδ  
knockout mice. 
A. C57BL/6, TCR β KO and TCR βδ KO mice (n=8 females per strain) were infected with 
2.1x108 CFU H305 S. pyogenes i.m for 24h. Spleens were harvested for qRT-PCR analysis of 
foxp3 expression. Infected samples were normalised to tissue specific reference genes and 
C57BL/6 sham treated samples. Fold change in foxp3 expression was determined by REST 
analysis and mean and SEM represented. Any significant differences are indicated: **p<0.01, 
***p<0.001.  
B. Splenocytes from GAS infected C57BL/6 mice (n=1 female) were stained for Foxp3 and 
γδ TCR by flow cytometry. Gated γδ+ cells (PE stained) were preliminarily examined for 
Foxp3 (FITC stained) expression as shown above in the FACS plot. Percentage of Foxp3+γδ+ 
cells is shown in pink. 
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Figure 3.7: qRT-PCR analysis of cytokine expression in spleens from infected TCR β  
and βδ  knockout mice. 
C57BL/6, TCR β KO and TCR δβ KO mice (n=8 females per strain) were infected with 
2.1x108 CFU H305 S. pyogenes i.m. Spleens were harvested for qRT-PCR analysis of 
cytokine gene expression changes after 24h of infection. Infected samples were normalised to 
tissue specific reference genes and C57BL/6 sham treated samples. Fold change in expression 
was determined by REST analysis and mean and SEM represented. Any significant 
differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
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Cytokine gene expression in the spleen had switched from the profile observed in the 
draining lymph node with predominant differences in il-10 and ifn-γ expression 
between infected WT and TCR knockout mice detected (Figure 3.7).  il-10 was up-
regulated, with a significant difference between both TCR knockout transgenic 
compared to infected WT controls (Figure 3.7). il-6 and tnf-α were interestingly 
expressed at a much lower level than in the draining lymph node (Figure 3.7). ifn-γ 
was up-regulated with a significant difference between both TCR knockout 
transgenic compared to infected WT controls (Figure 3.7). There was no significant 
difference in il-17a gene expression in either of the infected TCR knockout 
transgenic strains (Figure 3.7). TH2 cytokine genes such as il-4 and il-9 were only 
marginally up-regulated compared to infected WT controls (data not shown), 
suggestive that these cytokines may not have a major role in the spleen during acute 
GAS infection.  
 
In summary, from the data extracted from infected TCR βδ and β knockout 
transgenic mice, it would appear that αβ T cells are on balance, detrimental during 
acute GAS infection as shown by increased survival towards lethal infection with S. 
pyogenes (Figure 3.1A) and decreased bacterial burden 24h post infection (Figure 
3.2A). qRT-PCR analysis confirmed the loss of αβ T cells in infected TCR βδ and β 
knockout transgenic mice correlated with decrease expression of transcription factors 
associated with Tregs, TH1 and TH17 cells in the draining lymph node (Figure 3.4). 
Perhaps these cell types are key in contributing to the increased bacterial burden 
observed in TCR knockout transgenic mice. Cytokine gene expression suggested high 
expression of il-10 and low expression of ifn-γ in the draining lymph node and spleen 
may play a role in the decreased bacterial burden in TCR βδ and β knockout 
transgenic mice compared to infected WT controls (Figure 3.2A). 
 
 	  
	   164	  
3.4 Regulatory and effector αβ T cells during S. pyogenes infection 
 
As experiments thus far have suggested that αβ T cells may be detrimental during 
GAS infection, two subsets of αβ T cells were further investigated to determine 
whether regulatory αβ T cells or effector αβ T cells were responsible for this 
phenotype. To achieve this, it was deemed necessary to utilise an experimental 
technique to specifically deplete regulatory αβ T cells, generally characterised by 
CD4+CD25+Foxp3+ cells to study if Tregs are the pathogenic cell population of αβ T 
cells during GAS infection. 	  
	  
Figure 3.8: PC61 antibody mediated depletion optimisation. 
Foxp3.DTR mice were given 100µl PBS (untreated, top panel) or 50, 100, 200µl PC61 
(1mg/ml, bottom panel) i.p for 24h. Spleens were harvest for flow cytometric analysis of 
CD4+CD25+Foxp3+ cells. Gated CD4+ cells (APC-H7 stained) were examined for CD25 (PE 
stained) and Foxp3 (GFP) expression as shown above. Experiment carried out with the help 
of Dr. R. Ingram. 
 
 
 
Antibody mediated depletion was chosen initially to deplete regulatory T cells during 
acute GAS infection. Tregs express CD25, also known as the alpha chain of the IL-2 
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receptor. An anti-CD25 monoclonal antibody (clone PC61) has been used 
successfully to deplete CD25+ cells by blocking IL-2 binding and has previously been 
used in studies of tumour rejection and autoimmunity (Onizuka et al., 1999; McHugh 
and Shevach, 2002). This depletion has been confirmed to have high specificity 
towards the knockdown of Tregs, corresponding to nearly 80% depletion of 
CD4+CD25+Foxp3+ through the administration of 200µg/ml PC61 antibody in my 
hands (Figure 3.8). 
 
Antibody clone PC61 was used to deplete CD25+ cells prior to infection with S. 
pyogenes for 24h to determine whether Treg cells were responsible for the pathogenic 
effects of αβ T cells. Upon removal of CD25+ cells, it was observed there was no 
difference in bacterial burden compared to infected mice given isotype matched 
control antibody (Figure 3.9A). This would suggest that, by this outcome measure, 
regulatory T cells play no role in S. pyogenes infection. There was however, a 
decrease in serum IL-6 and IL-17A in infected mice depleted of CD25+ cells (Figure 
3.9B), indicating decreased disease severity in the absence of Tregs.  
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Figure 3.9: The effect of PC61 antibody mediated depletion during acute S. pyogenes 
infection. 
A. Bacterial count upon PC61 antibody mediated depletion of CD25+ cells. C57BL/6 females 
(n=12 per treatment group) were given 100µl PBS (untreated) or 100µl PC61 (1mg/ml) i.p 
24h before and on the day of infection with 108 CFU H305 S. pyogenes i.m 24h post 
infection, thigh, blood, spleen and liver were harvested to determine bacterial burden. No 
bacterial growth as found in sham infected mice (data not shown). Experiment carried out 
with the help of Dr. R. Ingram. 
B. Serum IL-6 and IL-17A. Serum was collected from H305 infected PBS or PC61 treated 
mice (n=6 per treatment group) 24h post infection and serum IL-6 and IL-17A was measured 
by ELISA. Experiment carried out with the help of Dr. R. Ingram. 
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Figure 3.10: qRT-PCR analysis of transcription factor gene expression in spleen from 
infected PC61 treated mice. 
C57BL/6 females (n=12 per treatment group) were given 100µl PBS (untreated) or 100µl 
PC61 (1mg/ml) i.p 24h before and on the day of infection with 108 CFU H305 S. pyogenes 
i.m. Spleens were harvested for qRT-PCR analysis of transcription factor gene expression 
changes after 24h of infection. Infected samples were normalised to tissue specific reference 
genes and C57BL/6 sham treated samples. Fold change in expression was determined by 
REST analysis and mean and SEM represented. Any significant differences are indicated: 
*p<0.05, **p<0.01, ***p<0.001.  
 
 
 
qRT-PCR analysis was performed on draining lymph nodes and spleens from either 
isotype-matched controls or PC61 antibody treated infected mice. No difference in 
gene expression was observed in the draining lymph node in any transcripts analysed 
in infected PC61 and isotype control treated mice (data not shown). A decrease in 
foxp3 gene expression was observed in the infected spleens of PC61 treated mice 
compared to isotype-matched controls as expected due to CD25+ cell and hence Tregs 
depletion (Figure 3.10). This reduction in Treg associated transcriptional marker was 
also accompanied unexpectedly by significant down-regulation in transcription 
factors linked to other T cell subsets, such as t-bet, gata-3 and rorγt upon PC61 
treatment (Figure 3.10), indicating an effect on transcription in other T cell subsets 
also expressing CD25. 
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Figure 3.11: qRT-PCR analysis of cytokine gene expression in spleen from infected 
PC61 treated mice. 
C57BL/6 females (n=12 per treatment group) were given 100µl PBS (untreated) or 100µl 
PC61 (1mg/ml) i.p 24h before and on the day of infection with 108 CFU H305 S. pyogenes 
i.m. Spleens were harvested for qRT-PCR analysis of cytokine gene expression changes after 
24h of infection. Infected samples were normalised to tissue specific reference genes and 
C57BL/6 sham treated samples. Fold change in expression was determined by REST analysis 
and mean and SEM represented. Any significant differences are indicated: *p<0.05, 
**p<0.01, ***p<0.001. 
 
 
 
qRT-PCR analysis of cytokine gene expression in the spleen revealed upon treatment 
with PC61 before sub-lethal infection, there was a statistical difference between 
infected PC61 treated mice and isotype-matched control mice in all transcripts 
analysed (Figure 3.11). This was unexpected as the use of PC61 was originally 
thought only to deplete regulatory CD4+CD25+Foxp3+ cells, but it would appear that 
this antibody had a wider effect in the spleen.  
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Figure 3.12: Expression of CD25 on γδ  T cells. 
A. Preliminary flow cytometric staining of C57BL/6 splenocytes showing IL-17A expression 
of gated CD25+γδ TCR+ cell. Isotype control (Alexa fluor 647) is grey line, IL-17A stained 
(Alexa fluor 647) cells is black line. Experiment carried out with the help of Dr. R. Ingram. 
B. Preliminary analysis of percentage of IL-17A+CD25- and CD25+ γδ TCR+ cells (left panel) 
and IL-17A expression per cell (MFI) of CD25- and CD25+ γδ TCR+ cells (right panel) (n=3 
mice). 
 
 
 
The results produced through the use of PC61 antibody were unexpected, as infection 
experiments with TCR knockout transgenic mice suggested that αβ T cells were 
associated with more severe pathogenesis during S. pyogenes challenge, whereas no 
difference was found in bacterial burden upon CD25+ cell depletion. CD25 may be 
considered a reliable marker for Tregs but it is also an activation marker for T cells in 
general (Tenorio et al., 2011). Therefore, it was conceivable that PC61 was depleting 
regulatory CD4+CD25+Foxp3+ cells as well as activated T effector cells, which may 
be protective during GAS infection, including γδ T cells as suggested in Figure 3.3B. 
Preliminary flow cytometric analysis of splenocytes harvested from GAS infected 
C57BL/6 mice indicated that γδ T cells also express CD25 (Figure 3.12A). It was also 
noted that this CD25+ population of γδ T cells were also potent producers of IL-17A 
(Figure 3.12B-C), previously shown to be elevated in infected TCR β knockout 
transgenic mice (Figure 3.1B). 
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From these experiments, it was concluded that the use of antibody clone PC61 was 
not sufficiently specific to determine whether Tregs were beneficial or pathogenic 
subset of αβ T cells. PC61 administration to WT mice was found to deplete both 
regulatory and effector cell populations, for example γδ T cells, masking the true 
contribution of Tregs during acute sepsis.  
 	  
 
3.5 Specific depletion of Foxp3+ cells during acute sepsis 
 
Another method of depleting regulatory T cells was needed in replacement of PC61 
antibody mediated depletion. As Foxp3 is considered to the prototypic marker of 
Tregs, a Foxp3 knockout murine model would be ideal for studies into the role of Tregs 
during GAS infection. A strain of Foxp3 knockout mice called scurfy already exist 
but this strain of mice has been shown to have profound autoimmune defects and 
developmental problems due to the lack of functional Foxp3 and do not survive into 
adulthood (Brunkow et al., 2001). The use of scurfy mice therefore would not lend 
itself experimentally in this model of acute sepsis.  
 
Conditional inducible Foxp3 knockout mice (Foxp3.DTR) have previously been 
demonstrated to have specific depletion of Foxp3+ cells (Kim et al., 2007). A targeted 
construct containing cDNA encoding Diphtheria Toxin Receptor (DTR), followed by 
IRES and GFP sequences was inserted into the 3’ UTR of foxp3. Therefore, cells 
expressing Foxp3 would also express DTR and upon the administration of Diphtheria 
Toxin (DT) into the mouse would lead to specific depletion of Foxp3+ cells (Kim et 
al., 2007). The addition of a GFP tag also allowed the Foxp3+ cells to be tracked by 
flow cytometry.  
 
I decided to use Foxp3.DTR mice to investigate the role of Foxp3+ regulatory cells 
during acute sepsis. The dosing regimen of DT administration was first optimised to 
achieve full Foxp3+ knockdown in this strain of mice (Figure 3.13). Repeated daily 
doses of DT were given via an intra-peritoneal route into Foxp3.DTR mice for 3 
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consecutive days (Figure 3.13A) and percentage of Foxp3-GFP+ cells of the CD4+ 
population was analysed by flow cytometry from groups of mice culled either after 1, 
2 or 3 doses (Figure 3.13B). Foxp3+ cell depletion was achieved after 1 dose of DT 
and was maintained low by repeated doses, indicating efficient knockdown of target 
cells (Figure 3.13C). 
 
	  
Figure 3.13: Diphtheria Toxin mediated Foxp3+ cell depletion dose optimisation. 
A. Dose response of DT mediated Foxp3+ cell depletion. Foxp3.DTR (n=3 males per time 
point) were given 100µl DT (12.5µg/ml) i.p once a day for three consecutive days as shown 
in the schematic.  
B. Representative staining of Foxp3-GFP+ and CD4+ cells (APC-H7 stained) in the spleen of 
untreated (left) and day 1 DT treated mice (right). 
C. Percentage of CD25+Foxp3+ cells of gated CD4+ T cells upon Foxp3 depletion. Day 0 
were untreated mice, day 1-3 were Foxp3 depleted, representative of the number of DT doses 
received. Spleen, inguinal lymph node and blood were harvested and analysed by flow 
cytometry for the mean percentage of CD25+Foxp3+ cells of gated CD4+ T cells as 
represented. 
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Figure 3.14: Foxp3 recovery post Diphtheria Toxin mediated Foxp3+ cell depletion. 
A. Recovery of Foxp3+ cells post DT mediated depletion. Foxp3.DTR (n=4 males per time 
point) were given 100µl DT (12.5µg/ml) i.p once a day on day 0 and 1 as shown in the 
schematic.  
B. Percentage of CD25+Foxp3+ cells of gated CD4+ T cells post Foxp3 depletion. Foxp3.DTR 
(n=4 males per time point) were given 100µl DT (12.5µg/ml) i.p as shown in the schematic 
A. Day 0 were untreated mice, day 2-10 were groups of mice allowed to recover their Foxp3+ 
cells. Spleen, inguinal lymph node and blood were harvest and analysed by flow cytometry 
for the mean percentage of CD25+Foxp3+ cells of gated CD4+ cells represented. 
 
 
 
Having determined that DT mediated Foxp3+ depletion was achieved within 24h, it 
was next necessary to investigate how long this effect would last and how quickly the 
Foxp3+ cell population would recover post DT treatment. Foxp3.DTR mice were all 
given 2 daily doses of DT and then every two days thereafter, groups of mice were 
culled and percentage of Foxp3-GFP+ cells analysed by flow cytometry (Figure 
3.14A). Knockdown of Foxp3-GFP+ cells was achieved as expected two days after 
DT treatment (Figure 3.14B). However, the percentage of Foxp3-GFP+ cells of the 
CD4+ population rebounded quickly and was near WT levels by day 8 (Figure 
3.14B). This indicated that in order to maintain Foxp3+ cell depletion, DT would need 
to be given every other day to keep Foxp3+ cell levels low. 
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3.6 Pathogenic effects of Foxp3+ cells during acute S. pyogenes 
infection 
 
 
Figure 3.15: Effect of DT mediated Foxp3+ cell depletion during acute S. pyogenes 
infection.  
A. Bacterial counts after 24h infection. Foxp3.DTR mice were given 100µl PBS or DT i.p 
(n=9 females per treatment group) once every day for 2 days before and on the day of 
infection with 4.2x108 CFU H305 or PBS (sham infection) S. pyogenes i.m for 24h. Bacterial 
counts in the thigh, blood, spleen and liver was determined. No bacterial growth was detected 
in sham-infected mice (data not shown). Mean and SEM represented and 1-way ANOVA 
statistical test was carried out and any significant differences indicated: *p<0.05. 
B. Serum ELISA analysis of IL-6 and IL-17A. Serum was collected after 24h of infection and 
concentration of IL-6 and IL-17A measured by ELISA. 1-way ANOVA statistical analysis 
was carried out and any significant differences are indicated: *p<0.05, **p<0.01, 
***p<0.001.  
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Once the DT mediated depletion of Foxp3+ cells was optimised, Foxp3.DTR mice 
were given two daily doses of DT to deplete Foxp3+ cells prior and also one extra 
dose on the day of S. pyogenes infection to study whether Tregs are pathogenic during 
acute sepsis. Upon removal of Foxp3+ cells, there was decreased systemic bacterial 
burden in Foxp3.DTR mice after 24h of infection (Figure 3.15A). There was a slight 
decrease in numbers of recovered bacteria in the thigh; the site of infection in the DT 
treated mice (Figure 3.15A). This decrease in bacterial counts in DT treated mice was 
accompanied with a reduction of serum IL-6 compared to infected PBS treated mice 
(Figure 3.15B). The removal of Foxp3+ cells also resulted in increased serum IL-17A 
and decreased levels of IFN-γ (Figure 3.15B). This implies the decreased bacterial 
burden may be due to increased IL-17A production and this pro-inflammatory 
cytokine may be protective and IFN-γ may be pathogenic as suggested in experiments 
with infected TCR δ knockout transgenic mice (Figure 3.3C). 
 
 
Figure 3.16: Initial analysis of pathology of infected thigh muscle upon removal of 
Foxp3+ cells. 
Foxp3.DTR mice were given 100µl PBS or DT i.p (n=1 female per treatment group) once 
every day for 2 days before and on the day of infection with 4.2x108 CFU H305 S. pyogenes 
or PBS (sham) i.m for 24h. Thigh muscle was snap-frozen in is-pentane and stored at -20°C. 
5µm sections were cut using a cryostat for preliminary Gram staining (A) and staining with 
anti-Group A carbohydrate by Immunohistochemistry (B). Images were taken at 10X 
objective.  
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The slight decreased number of recovered bacteria at the site of infection in DT 
treated Foxp3.DTR mice was mirrored in a preliminary examination of snap frozen 
thigh tissue Gram-stained for the presence of Gram-positive bacterium (Figure 
3.16A). Gram-positive bacteria, stained purple were identified in PBS treated mice 
infected with S. pyogenes (Sham infected), whereas there was less staining in DT 
treated infected mice (Figure 3.16A). There was no staining in un-infected sham 
(sham sham) Foxp3.DTR mice (Figure 3.16A). This result was also mirrored by IHC 
staining for group A carbohydrate expressed on the surface of S. pyogenes (Figure 
3.16B). Sham infected thigh tissue contained the most GAS, stained brown compared 
to sham sham and DT infected treatment groups (Figure 3.16B). Due to the small 
number of samples, further work will need to be carried out to confirm these findings. 
 
 
Figure 3.17: Preliminary histology of infected thigh muscle upon removal of Foxp3+ 
cells. 
Foxp3.DTR mice were given 100µl PBS or DT i.p (n=1 female per treatment group) once 
every day for 2 days before and also on the day of infection with 4.2x108 CFU H305 S. 
pyogenes or PBS (sham) i.m for 24h. Thigh muscle was snap-frozen in iso-pentane and 
stored at -20°C. 5µm sections were cut using a cryostat before preliminary H&E staining (A) 
and anti-MPO by IHC (B). Images were taken at 10X objective.  
 
 
 
Preliminary H&E staining of thigh muscle harvested post S. pyogenes infection 
revealed intensive staining, indicative of increased inflammation in PBS treated 
Foxp3.DTR mice infected with S. pyogenes (Sham infected) (Figure 3.17A) 
compared to uninfected PBS treated (sham sham) and infected DT treated mice. Pilot 
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IHC analysis also showed increased MPO staining (brown) in sham infected thigh 
tissue (Figure 3.17B), reflective of increased neutrophil activation in PBS treated 
Foxp3.DTR mice infected with S. pyogenes. Infiltrating activated neutrophils may 
contribute to the increased inflammation in infected Foxp3.DTR with their Foxp3+ 
cells intact. Mice with Foxp3+ cells depleted showed signs of less inflammation and 
neutrophil activation (Figure 3.17A). 
 
 
Figure 3.18: Survival outcome post lethal dose of S. pyogenes upon removal of Foxp3+ 
cells. 
A. Survival curve of infected PBS (Foxp3+) or DT (Foxp3-) treated Foxp3.DTR mice (n=8 
females per group). Mice were given 100µl PBS or DT once a day for 2 days before and on 
the day of infection with 7x107 CFU H305 S. pyogenes (WT) and monitored for defined end 
points and culled. PBS and DT treatment was continued every day after infection. 
B. Serum was collected 8h post infection during the survival experiment. Concentration of 
serum IL-6 and IL-17A determined by ELISA. Mean and SEM are represented and 1-way 
ANOVA statistical test was carried out, no significant differences were found.  
 
 
 
As removal of Foxp3+ cells prior to sub-lethal infection with S. pyogenes resulted in 
decreased bacterial burden (Figure 3.15A), this was suggestive that Foxp3+ cells may 
be pathogenic during GAS infection. The survival outcome of Foxp3.DTR mice 
receiving a lethal dose of S. pyogenes treated with either PBS or DT was next 
determined (Figure 3.18A). Disappointingly, no significant difference in survival 
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outcome was noted in Foxp3.DTR mice with or without Foxp3+ cells (Figure 3.18A). 
Serum IL-6 and IL-17A levels 8h post infection were similar in infected PBS and DT 
treated mice (Figure 3.18B). This data implies that Foxp3+ cells may not have a 
significant role during long-term lethal bacterial challenge but may only be 
pathogenic during the early stages of infection.  
 
 
 
3.7 Gene expression changes in draining lymph node and spleen upon 
removal of Foxp3+ cells during acute GAS infection 
 
	  
Figure 3.19: qRT-PCR analysis of transcription factor gene expression in DLN from 
infected DT treated mice. 
Foxp3.DTR mice were either given 100µl PBS or DT i.p (n=8 females per treatment group) 
once every day for 2 days before and on the day of infection with 5x107 CFU H305 S. 
pyogenes or PBS (sham) i.m for 24h. DLN were harvested for qRT-PCR analysis of 
transcription factor gene expression changes after 24h of infection. Infected samples were 
normalised to tissue specific reference genes and C57BL/6 sham treated samples. Fold 
change in expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
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Draining lymph nodes and spleens were harvested for qRT-PCR analysis to identify 
any changes in gene expression in infected PBS and DT treated infected Foxp3.DTR 
mice. foxp3 gene expression was statistical decreased in draining lymph nodes from 
DT treated mice compared to PBS treated infected mice (Figure 3.19). Interestingly, 
gata-3 expression was also significantly down-regulated in the DT treatment group 
(Figure 3.19). Whether TH2 cells also express Foxp3 is debatable (Wang et al., 
2010b).  
 
Cytokine gene expression in the draining lymph node was also investigated by qRT-
PCR analysis. All transcripts studied were significantly up-regulated in general in 
response to infection with S. pyogenes compared to sham-treated mice (data not 
shown).  The only statistical difference between infected PBS and DT treated mice 
was il-9 expression (Figure 3.20). It is unclear whether IL-9, a known TH2 cytokine is 
important during GAS infection, despite gata-3, the transcriptional marker for TH2 
cells being down-regulated upon DT treatment during infection (Figure 3.19). 	  
	  
Figure 3.20: qRT-PCR analysis of il-9 gene expression in DLN from infected DT treated 
mice. 
Foxp3.DTR mice were either given 100µl PBS or DT i.p (n=8 females per treatment group) 
once every day for 2 days before infection with 5x107 CFU H305 S. pyogenes or PBS (sham) 
i.m for 24h. DLNs were harvested for qRT-PCR analysis of il-9 gene expression changes 
after 24h of infection. Infected samples were normalised to tissue specific reference genes 
and C57BL/6 sham treated samples. Fold change in il-9 expression was determined by REST 
analysis and mean and SEM represented. Any significant differences are indicated: *p<0.05, 
**p<0.01, ***p<0.001. 
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qRT-PCR analysis of transcription factor genes in the spleen mirrored similar 
expression pattern as in the draining lymph node for foxp3 and rorγt (Figure 3.21). 
However, there was no difference in gata-3 expression upon removal of Foxp3+ cells 
in the spleen, previously shown to be down-regulated in the draining inguinal lymph 
node (Figure 3.21). t-bet expression was significantly elevated in the spleen in DT 
treated mice relative to PBS treated controls (Figure 3.21). Depletion of Foxp3+ cells 
may have removed Treg mediated suppression over TH1 cells to allow this subset to 
proliferate. 
 
	  
Figure 3.21: qRT-PCR analysis of transcription factor gene expression in spleens from 
infected DT treated mice. 
Foxp3.DTR mice were either given 100µl PBS or DT i.p  (n=8 females per treatment group) 
once every day for 2 days before and on the day of infection with 5x107 CFU H305 S. 
pyogenes or PBS (sham) i.m for 24h. Spleens were harvested for qRT-PCR analysis of 
transcription factor gene expression changes after 24h of infection. Infected samples were 
normalised to tissue specific reference genes and C57BL/6 sham treated samples. Fold 
change in expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
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Figure 3.22: qRT-PCR analysis of cytokine expression in spleens from infected DT 
treated mice. 
Foxp3.DTR mice were either given 100µl PBS or DT i.p (n=8 females per treatment group) 
once every day for 2 days before infection with 5x107 CFU H305 or PBS (sham) i.m for 24h. 
Spleens were harvested for qRT-PCR analysis of cytokine gene expression changes. Infected 
samples were normalized to tissue specific reference genes and C57BL/6 sham treated 
samples. Fold change in expression was determined by REST analysis and mean and SEM 
represented. Any significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
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Gene expression of cytokines in the spleen of either sham or GAS infected 
Foxp3.DTR mice revealed that upon removal of Foxp3+ cells, there was a significant 
decrease in il-17a and il-4 transcription compared to PBS treated mice infected with 
S. pyogenes (Figure 3.22). This is in contrast to the belief that Tregs suppress TH17 and 
TH2 cytokine responses and may indicate depletion of Foxp3+ γδ cells as discussed 
above. Down-regulation of il-17a expression was in contrast to high levels of IL-17A 
protein in the serum of GAS infected DT treated mice (Figure 3.15B). On the other 
hand, il-9 expression was again elevated in the spleen of infected DT treated mice 
(Figure 3.22).  
 
Overall, from the qRT-PCR analysis of DT or PBS treated Foxp3.DTR mice infected 
with S. pyogenes, there was only a moderate change in gene expression in either the 
draining lymph node or spleen. Interestingly, increased il-9 expression was 
consistently observed in both the draining lymph node and spleen upon DT treatment. 
Whether this cytokine is responsible for the increased protection during acute S. 
pyogenes infection is unknown and will require further investigation. 
 
 
 
3.8 Cytokine responses mediated by Foxp3+ cells during GAS 
infection 
 
Depletion of Foxp3+ cells prior to acute S. pyogenes infection resulted in increased 
IL-17A and decreased IFN-γ serum levels (Figure 3.15B), indicating that the balance 
of Teff cytokine production may be controlled by Foxp3+ cells following S. pyogenes 
infection. In vitro and ex vivo cytokine responses were studied further in infected 
Foxp3.DTR mice to determine the extent of Treg mediated control over cytokine 
production. 
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Figure 3.23: Cytokine production post heat-killed S. pyogenes stimulation upon removal 
of Foxp3+ cells. 
Foxp3.DTR mice (n=5 mice per treatment group) were given 100µl PBS or DT (12.5µg/ml) 
for 2 days before spleens were harvested. 106 splenocytes were stimulated with heat-killed 
H305 WT S. pyogenes isolate, PMA/Ionomycin (positive control) and media only (negative 
control) for 24h. Supernatant was collected and CBA was carried out to measure the 
concentration of IFN-γ, TNF, IL-17A, IL-4, IL-9 and IL-10. Mean and SEM of 
concentrations minus background from media stimulated cells are represented and 1-way 
ANOVA statistical analysis was carried out and any significant differences indicated: 
***p<0.001. 
 
 
 
Multi-cytokine analysis was carried out on heat-killed S. pyogenes stimulated 
splenocytes harvested from Foxp3.DTR mice given PBS to maintain Foxp3+ cells or 
DT to deplete Foxp3+ cells. TNF, IL-4, IFN-γ, IL-9, IL-10 and IL-17A levels were 
measured in the culture supernatant by Cytometric Bead Assay (CBA) (Figure 3.23). 
Stimulation of splenocytes devoid of Foxp3+ cells in general resulted in increased 
production of all cytokines measured (Figure 3.23). IFN-γ production was 
significantly unleashed in the absence of Foxp3+ cells (Figure 3.23).  This is in line 
with evidence that Foxp3+ Treg cells can suppress proliferation and cytokine 
production from effector T cells (Thornton and Shevach, 1998).  
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Results from in vitro stimulation of splenocytes in the presence of heat-killed WT S. 
pyogenes were compared with ex vivo cytokine flow cytometric analysis of draining 
lymph nodes and spleens harvested from Foxp3.DTR mice either given PBS or DT 
before 24h infection with H305. Flow cytometric analysis of cell types in the draining 
inguinal lymph node revealed that only Foxp3+ cells were significantly reduced upon 
the administration of DT as expected (Figure 3.24) and there was no obvious changes 
in the percentage of IFN-γ+ or IL-17A+ cells of the lymphocyte population (Figure 
3.24). 
 
 
Figure 3.24: Cell types present in DLN upon removal Foxp3+ cells during S. pyogenes 
infection.  
Foxp3.DTR mice were either given 100µl PBS or DT i.p (n=8 females per treatment group) 
once every day for 2 days before infection with 4.2x108 CFU H305 S. pyogenes or PBS 
(sham0i.m for 24h. Draining inguinal lymph nodes were harvested for flow cytometric 
analysis of cell types and IL-17A and IFN-γ production. Mean and SEM of absolute numbers 
(top) of cell types and percentage of IFN-γ+ and IL-17A+ of lymphocytes are represented. 1-
way ANOVA statistical analysis was carried out on absolute numbers of cell types in the 
lymph node and any significant differences indicated: *p<0.05. Kruskal-Wallis statistical 
analysis was carried out on percentage of cytokine+ cells of lymphocytes data, no significant 
difference was found.  
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Figure 3.25: IL-17A and IFN-γ  production in DLN upon removal of Foxp3+ cells during 
acute sepsis. 
Foxp3.DTR mice were given 100µl PBS or DT i.p (n=8 females per treatment group) once 
every day for 2 days before and on the day of infection with 4.2x108 CFU H305 S. pyogenes 
or PBS i.m for 24h. DLN were harvested for flow cytometric analysis of IL-17A (A) and 
IFN-γ (B) production by various cell types. Mean and SEM of percentage of cytokine+ cells 
of lymphocytes (top) and absolute numbers of cytokine+ cells (bottom) are represented. 1-
way ANOVA statistical analysis was carried out on absolute numbers and any significant 
differences indicated: *p<0.05, **p<0.01, ***p<0.001. Kruskal-Wallis statistical analysis 
was carried out on percentage of cytokine+ cells of lymphocytes data and of total cell 
population and any significant differences indicated: *p<0.05, **p<0.01, ***p<0.001.  
 
 
 
Further analysis of IFN-γ+ or IL-17A+ producing cell types in the draining lymph 
node showed that upon S. pyogenes infection, IFN-γ responses were paradoxically 
more likely to be modulated in the absence of Foxp3+ cell mediated control (Figure 
3.25B) with CD8+ and CD4+ cells of the lymphocyte population producing less IFN-γ 
upon DT treatment during infection (Figure 3.25B). IL-17A responses were more 
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robust and upon Foxp3+ cell depletion with little difference between infected mice 
with or without Foxp3+ cells. It is interesting to see that a very small percentage of 
Foxp3+ cells were found to produce either IL-17A or IFN-γ, cytokines typical 
connected with TH17 and TH1 cells respectively (Figure 3.25).  
 
	  
Figure 3.26: Cell types present in spleen upon depletion of Foxp3+ cells during acute 
sepsis. 
Foxp3.DTR mice were either given 100µl PBS or DT i.p (n=8 females per treatment group) 
once every day for 2 days before infection with 4.2x108 CFU H305 or PBS (sham) i.m for 
24h. Spleens were harvested for flow cytometric analysis of cell types and IL-17A and IFN-γ 
production. Mean and SEM of absolute numbers (top) of cell types and percentage of IFN-γ+ 
and IL-17A+ of lymphocytes are represented. 1-way ANOVA statistical analysis was carried 
out on absolute numbers of cell types in the lymph node and any significant differences 
indicated: *p<0.05. Kruskal-Wallis statistical analysis was carried out on percentage of 
cytokine+ cells of lymphocytes data, no significant difference was found.  
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Figure 3.27: IL-17A and IFN-γ  production in spleen upon removal of Foxp3+ cells 
during acute sepsis. 
Foxp3.DTR mice were either given 100µl PBS or DT i.p (n=8 females per treatment group) 
once every day for 2 days before and on the day of infection with 4.2x108 CFU H305 S. 
pyogenes or PBS (sham) i.m for 24h. Spleens were harvested for flow cytometric analysis of 
IL-17A (A) and IFN-γ (B) production by various cell types. Mean and SEM of percentage of 
cytokine+ cells of lymphocytes (top) and absolute numbers of cytokine+ cells (bottom) are 
represented. 1-way ANOVA statistical analysis was carried out on absolute numbers and any 
significant differences indicated: *p<0.05, ***p<0.001. Kruskal-Wallis statistical analysis 
was carried out on percentage of cytokine+ cells of lymphocytes data and of total cell 
population and any significant differences indicated: *p<0.05, ***p<0.001.  
 
 
 
Cytokine production in the spleen of S. pyogenes infected Foxp3.DTR mice with or 
without Foxp3+ cells also exhibited a similar result to the draining lymph node. Only 
Foxp3+ cell were significantly reduced upon DT treatment (Figure 3.26). An 
expansion in the percentage of NK cells in the lymphocyte population during 
infection and DT treatment was also observed (Figure 3.26). There was no significant 
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change in the percentage of cell types in the spleen (Figure 3.26), or the percentage of 
IL-17A or IFN-γ producing lymphocytes (Figure 3.26). 
 
In contrast to the draining lymph node, where dominant changes in IFN-γ production 
were observed, significant differences in IL-17A production in γδ T and NK cells 
upon the removal of Foxp3+ cells during GAS infection were characterised (Figure 
3.27A). Yet again, decrease in the percentage of IFN-γ+ CD4+ T cells of the 
lymphocyte population was seen upon infection in Foxp3+ depleted mice compared to 
infected PBS treated controls (Figure 3.27B).  
 
In conclusion, from flow cytometric analysis of IL-17A and IFN-γ production during 
acute sepsis in mice with or without Foxp3+ cells, there was a differential role of each 
of these cytokines. Increased IL-17A response from γδ and NK cells in the spleen and 
reduced IFN-γ responses from CD8+ and CD4+ cells in the draining inguinal lymph 
node upon depletion of Foxp3+ cells during acute S. pyogenes may be responsible for 
the decreased bacterial burden in Foxp3.DTR mice with their Foxp3+ cells depleted. 
 
To further understand whether suppressed IL-17A responses in the spleen is involved 
in the pathogenic nature of Foxp3+ cells during acute sepsis, IL-17A knockout 
transgenic mice (Nakae et al., 2002) were utilised to determine if this pro-
inflammatory cytokine is protective during GAS infection.  
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Figure 3.28: Bacterial outcome post S. pyogenes infection upon depletion of IL-17A. 
A. Survival curve of infected C57BL/6 (n=7 females) and IL-17A-/- mice (n=6 females). Mice 
were given 6x108 CFU H305 i.m and monitored for defined end points and culled. 
B. Bacterial counts after 24h infection. C57BL/6 and IL-17A KO mice (n=8 females per 
strain) were infected with 1.4x109 CFU H305 S. pyogenes i.m. Bacterial counts in the thigh, 
blood, spleen and liver was determined. Mean and SEM are represented and 1-way ANOVA 
statistical test was carried out, no significant differences was found. 
C. Serum ELISA analysis of IL-6. Serum was collected after 24h of infection and 
concentration of IL-6 measured by ELISA. No significant difference was found.  
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There was no difference in survival of IL-17A knockout mice compared to infected 
WT controls after a lethal dose of WT S. pyogenes (Figure 3.28A). Bacterial counts 
from either WT or IL-17A knockout mice after 24h infection with H305 revealed a 
trend of increased bacterial burden, as shown by higher number of recovered bacteria 
in the blood, spleen and liver in IL-17A knockout mice relative to infected WT 
controls (Figure 3.28B). This was matched with a slight increase in serum IL-6 in 
infected IL-17A knockout mice (Figure 3.28C). However, no difference was found in 
serum IFN-γ in either strain of mice (data not shown). 
 
In summary, it would appear there is only weak evidence to confirm a protective role 
of IL-17A during acute S. pyogenes infection, as demonstrated here by increased 
systemic bacterial burden in IL-17A knockout mice compared to WT controls.  
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3.9 Discussion 
 
From the data presented in this chapter, it can be concluded that some T cell subsets 
are detrimental during acute S. pyogenes infection. This was found in particular for 
αβ T cells and γδ T cells, as shown by increased survival in TCR βδ knockout mice 
post lethal GAS infection (Figure 3.1). This was further confirmed by decreased 
bacterial counts in the thigh, spleen, liver and blood after 24h of infection with WT S. 
pyogenes (Figure 3.2B) and decreased levels of IL-6 in the serum (Figure 3.2C) in 
TCR βδ knockout mice.  
 
qRT-PCR analysis of draining lymph node and spleen harvested from infected TCR β 
and βδ knockout mice revealed some interesting changes in gene expression pattern. 
Removal of αβ T cell subset in TCR β knockout mice resulted in the down-regulation 
of foxp3 and t-bet gene expression (Figure 3.4). This was not surprising as these 
transcription factors are associated with αβ T cells. However, it was interesting to 
note that upon depletion of γδ T cells in TCR βδ knockout mice also further 
decreased foxp3 expression (Figure 3.4 & 3.6A). The nature of regulatory γδ T cells 
in human PBMCs has previously been published (Kühl et al., 2010), although this 
study stated this population was Foxp3-. This is in contrast to Cassetti and colleagues 
(Casetti et al., 2009), who found a particular subset of γδ T cells (Vδ2) expressing 
Foxp3 and fully capable of suppressing αβ T cells. Flow cytometry analysis of S. 
pyogenes infected C57BL/6 mice revealed a very small percentage of γδ T cells 
expressing Foxp3 (Figure 3.6B), whether these regulatory γδ T cells have a role 
during acute sepsis is still unclear.  
 
The lack of αβ and γδ T cells in infected TCR βδ knockout mice also demonstrated a 
down-regulation in some key cytokines associated with regulatory subsets. For 
example, il-10 was decreased in TCR βδ knockout mice compared to infected WT 
mice in the draining lymph node (Figure 3.5), whereas it was significantly up-
regulation in the spleen (Figure 3.7). The precise cellular source of il-10 transcription 
is unknown as only global expression in the target organ was examined and IL-10 can 
be made by several cell-types such as T cells, B cells and monocytes (Vieira et al., 
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2004; Mosmann et al., 1990; O'Garra et al., 1990; de Waal Malefyt et al., 1991). 
Therefore, this differential expression pattern may be due to the removal of αβ+ 
and/or γδ+ regulatory T cells in the draining lymph node, which are known to express 
IL-10 (Roncarolo et al., 2001; Kühl et al., 2010). The removal of suppressive control 
by αβ+ and/or γδ+ regulatory T cells in the spleen may explain the unleashed 
expression of il-10 by an unknown innate cell type, such as macrophages (Zhang et 
al., 2011). 
 
Overall, this set of data suggests that T cells may be contributing to the hyper-
inflammation presented in septic patients. This is in line with published data using the 
TCR β knockout mice in CLP models of poly-microbial sepsis exhibiting increased 
resistance to mortality (Enoh et al., 2007). In the same paper, the authors found no 
difference in mortality in TCR δ knockout transgenic mice compared to WT controls 
post CLP surgery (Enoh et al., 2007), which is in line to my finding using the same 
strain of mice infected with a lethal dose of S. pyogenes (Figure 3.3A). However, 
there was a general trend of increased recovered bacteria 24h post infection in TCR δ 
knockout mice compared to infected WT controls (Figure 3.3B), which does not 
agree with data from Enoh and colleagues. Decreased bacterial counts in CLP treated 
TCR δ knockout mice was detected in their model (Enoh et al., 2007). The different 
model of induced sepsis being utilised could explain this discrepancy.  
 
The precise subset of pathogenic αβ+ T cells was next examined through the 
depletion of regulatory T cells with anti-CD25 antibody (clone PC61). This antibody 
was used for most early studies investigating Tregs due to high specificity of depletion 
(Onizuka et al., 1999; McHugh and Shevach, 2002). This was also true in my hands 
as well (Figure 3.8). Disappointingly, the depletion of CD25+ cells prior to sub-lethal 
S. pyogenes infection did not yield any significant difference in bacterial counts 
between PC61 or isotype matched control antibody pre-treated mice (Figure 3.9A). 
There was a slight decrease in serum IL-6 and IL-17A in the PC61 treated mice in 
relation to isotype control treated mice (Figure 3.9B). qRT-PCR analysis confirmed 
that PC61 treatment decreased foxp3 gene expression as envisaged (Figure 3.10) and 
also all other transcripts examined (Figure 3.10-11). It was deduced the PC61 
antibody might also be depleting the effector T subsets, such as γδ T cells along with 
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the regulatory population. This was confirmed by flow cytometric analysis showing 
CD25+ γδ T cells were also high producers of IL-17A (Figure 3.12). CD25+ γδ T cells 
have previously been identified as potent IL-17 producers in mice (Shibata et al., 
2008). It was speculated that this population of cells might be responsible for serum 
IL-17A production observed in lethally infected TCR β knockout mice (Figure 3.1B). 
 
A more specific protocol to deplete regulatory cells was required to understand 
whether αβ+ Tregs are pathogenic in this model of acute sepsis. Inducible conditional 
Foxp3.DTR mice were used due to specific depletion of Foxp3+ cells upon the 
administration of Diphtheria Toxin (Kim et al., 2007). The depletion regimen in this 
transgenic model was optimised (Figure 3.13-14), before sub-lethal infection with S. 
pyogenes in mice with either their Foxp3+ cell population intact or depleted. Removal 
of Foxp3+ cells during sub-lethal GAS infection resulted in decreased systemic 
bacterial burden (Figure 3.15A). This correlated with a decrease in serum IL-6 and 
IFN-γ (Figure 3.15B), whereas serum IL-17A was elevated upon the depletion of 
Foxp3+ cells in infected mice (Figure 3.15B), suggestive that the presence of Foxp3+ 
cells might be detrimental during acute GAS infection. 
 
Removal of Foxp3+ cells appeared to limit the bacterial spread to the thigh, the site of 
infection (Figure 3.15A). Staining of snap-frozen thigh muscle revealed the presence 
of Gram-positive bacterium in infected mice with Foxp3+ cells with much less being 
detected in infected mice devoid of Foxp3+ cells (Figure 3.16A-B). Less 
inflammation was observed in infected DT treated mice (Figure 3.17A) due to 
perhaps enhanced bacterial containment and clearance, although not mediated by 
neutrophils as shown by decreased MPO IHC staining (Figure 3.17B). This is in 
contrast to published data now emerging relating to Treg suppression of innate 
immune populations such as neutrophils. Richards and colleagues (Richards et al., 
2010) have shown Tregs can limit neutrophils responses in the context of a murine 
tumour model. However, this mechanism could not be extrapolated to this model of 
acute sepsis and further quantification of MPO will need to be carried out to support 
my findings.  
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Despite a statistical difference in bacterial burden between mice containing Foxp3+ 
cells and these with this cell population depleted during a sub-lethal infection with S. 
pyogenes, lethal infection showed no difference in survival between the two treatment 
groups (Figure 3.18). Perhaps, the sheer long-term effects of GAS infection 
overwhelm the immune response and therefore make no difference if Foxp3+ cells are 
present or not during lethal infection. To date, the precise role of Tregs during invasive 
S. pyogenes infection has not been fully addressed although my data suggests that 
Tregs are detrimental. Tregs were found not to be induced during intra-nasal infection 
with S. pyogenes (Costalonga et al., 2008). However, this was based on a model of S. 
pyogenes colonisation in the Nasal Associated Lymphoid Tissue (NALT) and not 
associated with invasive disease. 
 
The role of Tregs during infection remains controversial and has been reviewed by 
Belkaid & Tarbell, (Belkaid and Tarbell, 2009). Tregs are pathogenic during the early 
stage of M. tuberculosis infection by limiting effector CD4+ and CD8+ T cells to 
prolong the bacterial expansion phase (Shafiani et al., 2010). On the other hand, Tregs 
may be beneficial during infection by limiting collateral damage caused by the 
ensuing immune response (Lund et al., 2008).  
 
From my finding presented in this chapter, the pathogenic role of Tregs during acute S. 
pyogenes may be due to limiting effector functions, reminiscent of the mechanism 
proposed in a tuberculosis model of infection (Shafiani et al., 2010). qRT-PCR 
analysis of draining lymph nodes and spleens from infected PBS or DT treated mice 
revealed very modest changes in cytokine gene expression changes, contrary to 
difference in pathogenesis being observed. il-9 expression was significantly up-
regulated in both the draining lymph node and spleen (Figure 3.20 & 3.22). IL-9 has 
been suggested to protect mice from Gram-negative bacterial infection (Grohmann et 
al., 2000). Whether IL-9 or perhaps even TH9 cells have a role during acute S. 
pyogenes infection has never previously been investigated and will be the target for 
future experiments.  
 
il-17a gene expression was up-regulated and ifn-γ expression was down-regulated in 
the spleen of infected mice devoid of Foxp3+ cells compared to their infected PBS 
treated counterparts (Figure 3.22). This was suggestive for protective and pathogenic 
	   194	  
roles for IL-17A and IFN-γ respectively during sepsis that may contribute to the 
observed decreased systemic bacterial burden in GAS infected DT Foxp3.DTR mice.  
 
In vitro stimulation of splenocytes from either PBS or DT pre-treated Foxp3.DTR 
mice with heat-killed WT S. pyogenes revealed that upon removal of Foxp3+ cells, 
there was increased production of TNF in the culture supernatant (Figure 3.23). IFN-
γ, IL-9, IL-10 and IL-4 were also increased in this splenocyte treatment group 
although not significant (Figure 3.23). IL-17A was only marginally lower than 
stimulated PBS pre-treated splenocytes (Figure 3.23). This would suggest that 
depletion of Foxp3+ cells has effects on in vitro cytokine production.  
 
Upon in vivo S. pyogenes infection of either PBS or DT pre-treated Foxp3.DTR 
transgenic mice, draining lymph nodes or spleens showed no difference in the 
percentage of either IL-17A or IFN-γ producing cells of the lymphocyte population 
(Figure 3.24 & 3.26), In the inguinal draining lymph node, IFN-γ responses were 
paradoxically suppressed in the absence of Foxp3+ cells during infection, particular in 
CD4+ and CD8+ T cell populations (Figure 3.25). The opposite was true in the spleen, 
where IL-17A responses were unleashed in γδ T and NK cells upon removal of 
Foxp3+ control during acute GAS infection (Figure 3.27). This set of data correlated 
with serum ELISA results (Figure 3.15B), where increased IL-17A levels and 
decreased IFN-γ levels in infected DT treated mice was measured. This is suggestive 
of differential expression of these two pro-inflammatory cytokines by either adaptive 
or innate cell types may be contributing to the decreased bacterial burden detected in 
the GAS infected Foxp3+ depleted mice. 
 
IFN-γ has previously been suggested to be limit dissemination of S. pyogenes from 
the NALT to the draining lymph node as shown through the use of IFN-γ-/- knockout 
mice (Hyland et al., 2009). Mice depleted of their NK cell population exhibit 
increased resistance to fatal infection with GAS and slower progression to severe 
disease (Goldmann et al., 2005a). This phenotype was also accompanied with 
decreased serum levels of IFN-γ, associated with the so-called cytokine storm 
induced during sepsis. This highlights that IFN-γ is both protective and pathogenic 
depending on the experimental model. Upon depletion of Foxp3+ cells in Foxp3.DTR 
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mice, there may be some unknown regulatory mechanism to suppress CD4+ and 
CD8+ T cells from producing IFN-γ to decrease bacterial burden in infected DT 
treated mice. In this model, it would appear that IFN-γ is pathogenic, consistent with 
evidence from Goldmann and colleagues (Goldmann et al., 2005a).  
 
The true effect of IL-17A during acute sepsis was further examined through the use 
of IL-17A knockout transgenic mice (Nakae et al., 2002). During lethal infection with 
WT S. pyogenes in WT or IL-17A knockout mice, no difference in the survival 
between these two strains of mice was found (Figure 3.28A). However, sub-lethal 
infection with GAS in WT or IL-17A knockout mice suggested a trend of increased 
bacterial burden in IL-17A knockout transgenic (Figure 3.28B). These findings are 
reminiscent of in vivo systemic versus local S. aureus infection in IL-17A-/- mice, 
whereby no difference in bacterial clearance was noted during systemic infection 
between knockout and WT strains (Henningsson et al., 2010). However, local 
infection of the knee-joint with S. aureus showed that IL-17A-/- mice exhibited severe 
arthritis and reduced bacterial clearance compared to infected WT mice (Henningsson 
et al., 2010). This shows, perhaps IL-17A may be redundant during the lethal S. 
pyogenes infection but may have a protective role during the early stages of local 
infection.  
 
The protective nature of IL-17A during other infectious disease models has been 
extensively demonstrated. For example, during S. pneumoniae or K. pneumoniae 
infection, TH17 cells are protective due to enhanced neutrophil recruitment aiding 
bacterial clearance (Zhang et al., 2009c; Ye et al., 2001a). IL-17A is produced by γδ 
T cells during E. coli infection and upon cytokine depletion, increased bacterial 
burden was observed (Shibata et al., 2007). These papers support my findings that 
this pro-inflammatory cytokine may be also protective during the early stages of 
acute S. pyogenes infection. 
 
Overall, through the extensive use of various transgenic models, there is some 
evidence that γδ T cells may be beneficial during the early stages of GAS infection. I 
have shown that αβ T cells are pathogenic during acute S. pyogenes infection. In 
particular, the Foxp3+ regulatory subset of αβ T cells are detrimental to the 
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pathogenic outcome during the early stages of infection. Removal of Foxp3+ cells 
increased IL-17A and decreased IFN-γ levels in the serum and changed the cytokine 
expression pattern of γδ, NK, CD8+ and CD4+ T cells, suggesting differential 
protective and pathogenic roles for these pro-inflammatory cytokines during sepsis.  
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Chapter 4 
	  
4 The role of MHC class I dependent mechanisms during acute S. 
pyogenes infection 
 
4.1 Introduction 
 
Adaptive immunity has evolved to efficiently clear and limit infection against diverse 
pathogenic microorganisms. As mediators of adaptive immunity, T cells can be 
defined based on their expression of their co-receptors, CD4 or CD8. CD4+ T cells 
are broadly associated with immune responses directed against extracellular bacterial 
infection due to their ability to facilitate other immune cell effector mechanisms, such 
as induce B cell isotype class switching and maturation and activation of cytotoxic T 
cells (CTLs) and macrophages (Berzins et al., 1988; Wagner and Röllinghoff, 1978; 
Cantor and Boyse, 1975). On the other hand, upon activation with antigen, CD8+ T 
cells can differentiate into CTLs with effector functions generally associated with 
responses against viral or intracellular pathogens that require the infected cell to be 
killed. During the early 1980s when the routes of antigen processing were being 
elucidated, it became clear that while the MHC class II/CD4 axis of immunity was 
primarily functioning to sample antigens phagocytosed from the external milieu, 
MHC class I/CD8 immunity was sampling endogenous peptides loaded in the 
endoplasmic reticulum, as would be the case in viral infection (Townsend et al., 
1986). 
 
Since the first reports during the early 1990s of mice deficient in either CD8 or β2-
microglobulin, it has been evident that this component of adaptive immunity is highly 
significant (though often not the sole mechanism) in adaptive immunity to 
intracellular pathogen infections (Bender et al., 1992; Harty et al., 1992; Fung-Leung 
et al., 1991). This is strong evidence that CD8+ T cells are key in mediating immunity 
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during viral infections. CD8+ T cells upon activation, differentiate into CTLs and 
exert anti-viral effects, such as the production of IFN-γ or TNF-α. This has been 
shown to control viral replication as demonstrated in a mouse model of Hepatitis B 
viral infection (Guidotti et al., 1996). A role for CD8+ T cells has also been 
implicated in other viral infection. For example, effector CTLs are activated infection 
with Herpes Simplex Virus (HSV)-2; however in this model, CD4+ T cells are also 
required for CD8+ T cell migration to the site of infection (Nakanishi et al., 2009). 
This highlights the importance of both types of T cells in mounting an effective 
immune response. While CTLs was implicated as protective in this study, other 
groups have found the CD8+ T cell mediated response to be part of the disease 
pathology. This has been demonstrated with Lymphocytic Choriomeningitis Virus 
(LCMV), whereby intra-cerebral infection of either WT mice showed neurological 
impairment and died of choriomeningtidis, while CD8 T cell depleted mice showed 
mild signs of illness but later recovered and survived infection (Fung-Leung et al., 
1991). 
 
CD8+ T cell immunity is also implicated in the response infection of cells by 
intracellular bacteria, such as L. monocytogenes. Antigens from this Gram-positive 
bacterium can be processed and presented by MHC class I molecules to CD8+ T cells 
(Grauling-Halama et al., 2009). The role of CD8+ T cells during intracellular bacterial 
infection has been exploited in vaccine candidates against M. tuberculosis and L. 
monocytogenes designed to induce protective CD8+ T cell mediated immunity 
(Nagata and Koide, 2010). 
 
The studies of MHC class I deficient mice also helped to define the role of class I in 
the function of other effector cell-types, NK cells and γδ cells (Liao et al., 1991; 
Pereira et al., 1992). NK cells were initially described in terms of the ‘missing self’ 
hypothesis, whereby tumorigenesis or viral infection subverts normal class I 
expression (Ljunggren and Kärre, 1990). This was demonstrated in vitro by NK cell 
killing of tumour cells lacking the expression of MHC class I molecules (Ljunggren 
and Kärre, 1990).  NK cells are now perceived to act through a complex balance of 
inhibitory and activating receptors, and seem able to detect a wide range of pathogens 
including bacteria and viruses (Bessoles et al., 2011; Jost et al., 2011). Since most of 
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these pathogens are not generally thought to cause class I down-regulation, other 
possibilities include recognition of class I-bound peptides or effects of induced stress 
proteins. 
 
NK cells can produce IL-17A and IFN-γ, important pro-inflammatory cytokines 
briefly discussed in Chapter 3. NK cells can be stimulated in the presence of IL-6 to 
produce IL-17A during Toxoplasma gondii infection (Passos et al., 2010). Host cells 
infected by viruses can also be killed by NK cells to limit further spread of disease 
(Lee et al., 2007). C57BL/6J mice with the beige mutation contain NK cells with 
decreased functions natural killing, and are more susceptible to Murine 
Cytomegalovirus (MCMV) infection, tending to have a poorer outcome (Bancroft et 
al., 1981). 
 
CD1d, a non-classical MHC class I-related molecule, can present antigens in the form 
of glycolipids to a specific class of restricted T cells called invariant NKT (iNKT) 
cells. These cells share characteristics of both NK and T cells, such as the expression 
of semi-invariant TCR and also markers associated with NK cells such as NK1.1 
(mouse only), bridging both innate and adaptive immunity (Van Kaer et al., 2011). 
Upon activation iNKT cells can produce a large array of different cytokines, rapidly 
and in large amounts, such as IL-4, IL-10, IL-17A, IFN-γ and TGF-β and are 
implicated in the response to infections (Leung and Harris, 2010). iNKT cells and 
CD1d molecules are important in pulmonary elimination of P. aeruginosa 
(Nieuwenhuis et al., 2002) and it has also been shown that iNKT can prevent the 
dissemination of Borrelia burgdorferi from the blood into host tissue (Lee et al., 
2010b). 
 
S. pyogenes is classically defined as an extracellular bacterium, exerting its 
pathogenic effects outside the cell. CD4+ T cell mediated immunity is key in 
eliminating this bacterium and S. pyogenes has seemingly evolved the secretion of 
virulence factors such as superantigens to modulate ensuing CD4+ T cell responses 
(Bueno et al., 2007). There is now emerging data to suggest this Gram-positive 
bacterium may be able to survive within cells such as neutrophils (Staali et al., 2003) 
and macrophages (Thulin et al., 2006), allowing further opportunity for infection. 
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Other virulence factors, such as Streptolysin O expressed by S. pyogenes can prevent 
the degradation of the bacterium inside the cell by the lysosome, prolonging survival 
within the host cell (Håkansson et al., 2005; Logsdon et al., 2011).  
 
If S. pyogenes can survive within host cells, it is conceivable that cytotoxic effector 
cells, such as CD8+ and NK cells may be required to elicit target cell killing. It has 
been shown that mice depleted of CD8+ T cells and NK cells are more resistant to 
CLP induced poly-microbial sepsis (Sherwood et al., 2004). However, the direct 
effect of CD8+ T cells and NK cells have not been properly addressed in acute S. 
pyogenes infection models.  
 
As shown by data and discussed in Chapter 3, there appeared to be a role for CD8+ T 
cells and NK cells during acute S. pyogenes infection. Infection experiments 
conducted using Foxp3.DTR transgenic mice would suggest that upon the removal of 
Foxp3+ Treg mediated suppression there was significantly decreased IFN-γ production 
by both CD8+ T cells and NK cells in the draining lymph node (Figure 3.25) and 
significant increased percentage of IL-17+ NK cells in the spleen (Figure 3.27). There 
was a very small increase in the absolute numbers of NKT cells both in the draining 
lymph node and spleen making IL-17A upon infection in the absence of Foxp3+ cells, 
although this was not significant. Whether these changes in cytokine production by 
CD8+ T cells, NK cells and to a lesser extent NKT cells upon the removal of Foxp3+ 
cells truly contribute to the decreased pathology still remains unknown. 
 
As CD8+ T cells and NK cells may be involved in my murine model of sepsis, the 
aim of this chapter was to further examine the role of these cell types during acute S. 
pyogenes infection. I will investigate whether CD8+ T cells and NK cells are 
pathogenic or protective during GAS infection. Both these two cell types share in 
common the requirement for MHC class I molecules, either through antigen 
presentation to CD8+ T cells or discrimination of self and non-self by NK cells, I will 
first examine whether MHC class I molecules is needed during acute sepsis induced 
by the classically regarded extracellular human pathogen S. pyogenes. 
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4.2 β2-mircrogloblin knockout mice exhibit increased bacterial burden 
during the early stages of S. pyogenes infection 
 
In order to determine whether MHC class I molecules are required during acute S. 
pyogenes infection, I decided to use a mouse model that lacked this molecule. β2-
microgloblin (β2m) is a component of the MHC class I molecule along with 
polymorphic α polypeptide chains. Transgenic mice created lacking β2m (Koller and 
Smithies, 1985; Koller et al., 1990) have been characterised to have no expression of 
MHC class I molecule due to the targeted loss of β2m (Koller et al., 1990). Another 
published phenotype of these knockout mice was the complete absence of CD4-CD8+ 
T cells, correlating with the loss of MHC class I molecules (Koller et al., 1990; 
Zijlstra et al., 2010).  
 
β2m knockout mice were infected with a lethal dose of S. pyogenes to investigate 
whether MHC class I molecule was required during infection with this Gram-positive 
bacterium. Survival was determined in C57BL/6 WT versus β2m knockout mice over 
the course of four days. There was no significant difference in survival post lethal 
infection with S. pyogenes in WT or knockout animals (Figure 4.1). This was 
suggestive that, MHC class I presentation is redundant during acute infection with 
GAS, at least as measured by survival. 
 
 
Figure 4.1: Percentage survival in β2m-/- mice post lethal S. pyogenes infection. 
Survival curve of infected C57BL/6 and β2m KO mice (n=7 females per strain). Mice were 
given 6x108 CFU H305 S. pyogenes (WT) i.m and monitored for defined end points and 
culled. 
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During a shorter course of infection of 24h, there was increased systemic bacterial 
burden in β2m knockout mice compared to WT controls, with more bacteria 
recovered in the thigh, blood, spleen and liver in the knockout mice (Figure 4.2). 
However, this increased bacterial spread in β2m knockout mice was accompanied 
curiously with a slight decrease in serum IL-6, a surrogate marker of disease severity 
compared to infected WT mice (Figure 4.3). Infected β2m knockout mice exhibited a 
trend of elevated serum IL-17A and decreased IFN-γ concentrations in the blood 
compared to infected WT controls (Figure 4.3). It should also be noted, there was no 
significant difference in the baseline levels of serum IL-6, IL-17A and IFN-γ in 
uninfected C57BL/6 or β2m knockout mice, confirming that the lack of class I 
expression did not alter the resting state of the production of these pro-inflammatory 
cytokines (Figure 4.3). 
 
 
Figure 4.2: Bacterial burden in β2m-/- mice. 
C57BL/6 and β2m-/- mice (n=6-7 females per strain) were infected with 6.5x108 CFU H305 or 
PBS (sham) i.m for 24h. Bacterial counts in the thigh, blood, spleen and liver was 
determined. Mean and SEM are represented and Mann-Whitney U statistical test was carried 
out and no significant differences were found. No bacterial growth was detected in sham 
infected C57BL/6 and β2m-/- mice (data not shown). 
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Figure 4.3: Cytokine production during acute S. pyogenes infection in β2m-/- mice. 
C57BL/6 and β2m KO mice (n=7 females per strain) were infected with 6.5x108 CFU H305 
or PBS (sham) i.m for 24h. Serum was collected and concentration of IL-6, IL-17A and IFN-
γ measured by ELISA. Mean and SEM are represented and 1-Way ANOVA statistical test 
was carried out and significant differences indicated: **p<0.01, ***p<0.001. 
 
 
 
These results from 24h infection experiments suggest there was a role of an MHC 
class I pathway during the early stages of acute S. pyogenes infection. However, it 
would appear that this role in antigen presentation may have been redundant during 
later stages of lethal S. pyogenes infection. 
 
 
 
4.3 Gene expression changes during early stages of S. pyogenes 
infection in β2m knockout mice 
 
qRT-PCR analysis was performed on cDNA from draining lymph nodes and spleens 
harvested from WT and β2m knockout mice after 24h infection with WT S. pyogenes 
to investigate if there were any changes in gene expression.  
 
No significant differences in gene expression were observed in the spleen of infected 
β2m knockout mice compared to infected WT controls (data not shown). However, 
there were changes detected in the inguinal draining lymph node (Figure 4.4). There 
was significant up-regulation of gitr, ctla-4 and lag-3 in infected β2m knockout mice 
compared to infected C57BL/6 controls (Figure 4.4). These are genes generally 
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associated with CD4+Foxp3+ Tregs but are also expressed by other activated cells such 
as CD8+ T cells, NK cells, B cells and macrophages (Nocentini and Riccardi, 2009; 
Workman et al., 2002). This was reflective of the presence of more activated cells 
during infection in β2m knockout mice. Interestingly, expression of master regulators 
of other CD4+ T helper subsets, such as t-bet, gata-3 and rorγt were also up-regulated 
in infected β2m knockout mice relative to infected controls (Figure 4.4), suggestive of 
increased differentiation of TH1, TH2 and TH17 cells respectively in the absence of 
MHC class I expression during the response to GAS infection.  
 
qRT-PCR analysis of cytokine gene expression in the draining lymph node revealed 
there was statistical increased expression of all transcripts analysed, including il-6 
and ifn-γ in infected β2m knockout mice compared to infected C57BL/6 controls 
(Figure 4.5). Infected β2m deficient mice showed an overall up-regulation of cytokine 
genes. However, there may exist a post-transcriptional mechanism regulating protein 
production to explain the slight decrease in serum IL-6 and IFN-γ levels in GAS 
infected β2m knockout mice relative to infected C57BL/6 controls (Figure 4.3). 
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Figure 4.4: Fold changes in transcription factor gene expression in β2m-/- mice during 
acute GAS infection. 
C57BL/6 and β2m-/- mice (n=6-8 females per strain) were infected with 2.1x108 CFU H305 or 
PBS (sham) i.m. DLN were harvested for qRT-PCR analysis of transcription factor gene 
expression changes after 24h of infection. Infected samples were normalised to tissue specific 
reference genes and C57BL/6 sham treated samples. Fold change in expression was 
determined by REST analysis and mean and SEM represented. Any significant differences 
are indicated: *p<0.05, **p<0.01, ***p<0.001. 
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Figure 4.5: Fold changes in cytokine gene expression in β2m-/- mice during acute GAS 
infection. 
C57BL/6 and β2m-/- mice (n=6-8 females per strain) were infected with 2.1x108 CFU H305 or 
PBS (sham) i.m. DLN were harvested for qRT-PCR analysis of cytokine gene expression 
changes after 24h of infection. Infected samples were normalised to tissue specific reference 
genes and C57BL/6 sham treated samples. Fold change in expression was determined by 
REST analysis and mean and SEM represented. Any significant differences are indicated: 
*p<0.05, **p<0.01, ***p<0.001. 
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4.4 Ex vivo cytokine production in infected β2m knockout mice 
 
 
Figure 4.6: Lack of CD8+ T cells and subsequent decreased IFN-γ  production in infected 
β2m-/- mice. 
C57BL/6 and β2m KO mice (n=2 females per strain) were infected with 2.1x108 CFU H305 
S. pyogenes i.m for 24h. Splenocytes were harvested and stained for IFN-γ+ (Alexa fluor 700 
stained) production in CD8+ (V450 stained; top panel), NK (Pe-Cy7 stained; middle panel) 
and NKT (gated on NK1.1+ cells expressing CD3-V500 stained; bottom panel) cells and 
analysed by flow cytometry. Representative staining is represented above. 
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As the qRT-PCR data revealed an overall up-regulation of all analysed cytokine 
transcripts, ex vivo flow cytometry was next performed to investigate whether there 
was a change in the cytokine profile of immune cells in infected β2m knockout mice. 
The phenotype of these mice was confirmed by flow cytometry to show β2m 
knockout mice had a severely decreased CD8+ T cell population and hence any 
cytokine production from this subset was also diminished particularly in the spleen 
(Figure 4.6). Interestingly, there was also impairment in IFN-γ production in NK and 
NKT cells in the spleen of β2m knockout mice as highlighted in Figure 4.6. This was 
not surprising, as these cells also require MHC class I expression for activation and 
function. β2m forms part of the CD1d complex, required for antigen presentation of 
glycolipids to iNKT cells (Arrenberg et al., 2008).  
 
Flow cytometric analysis of infected β2m knockout mice compared to infected WT 
controls revealed there was a significant decrease in the number of CD8+ T cells in 
β2m knockout mice in both the draining lymph node and spleen (Figure 4.7). This 
was in agreement with the expected phenotype of these mice (Koller et al., 1990). 
There was also a significant increased in the number of CD4+ T cells, particularly in 
the draining lymph node in the knockout animals (Figure 4.7), suggestive of a 
compensatory mechanism due to the decreased numbers of CD8+ T cells. Also there 
was an expansion of NK cell numbers present in β2m knockout mice (Figure 4.7).  
 
 
Figure 4.7: Cell types in β2m-/- mice during acute S. pyogenes infection. 
C57BL/6 and β2m KO mice (n=7 females per strain) were infected with 6.5x108 CFU H305 
S. pyogenes i.m for 24h. DLN and spleens were harvested for flow cytometric analysis of cell 
types present in these lymphoid tissues. Mean and SEM of absolute numbers of cell types in 
the DLN (left) and spleen (right) are represented. 1-way ANOVA statistical analysis was 
carried out and any significant differences indicated: *p<0.05, **p<0.01, ***p<0.001. 
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IL-17A and IFN-γ production, two examples of cytokines made by CD8+, NK and 
NKT cells were also measured by flow cytometry during early stages of S. pyogenes 
infection. In the draining lymph node, due to the general drop in CD8+ T cell 
numbers, decreased IL-17A and IFN-γ production by this cell type was also observed 
in infected β2m knockout mice compared to WT controls (Figure 4.8). Corresponding 
to the increased NK cell absolute numbers in the draining lymph node of knockout 
mice (Figure 4.7), there was also increased numbers of IL-17A+ and IFN-γ+ NK cells 
(Figure 4.8). No significant difference in the production of either cytokine by NKT 
cells was observed (Figure 4.7). 
 
 
Figure 4.8: IL-17A and IFN-γ  production in the DLN in infected β2m-/- mice. 
C57BL/6 and β2m KO mice (n=7 females per strain) were infected with 6.5x108 CFU H305 
S. pyogenes i.m for 24h. DLN were harvested for flow cytometric analysis of IL-17A (left 
panel) and IFN-γ (right panel) production by stained cell types. Mean and SEM of cytokine+ 
cells of lymphocytes (top panel) and absolute numbers (bottom panel) are represented. 
Kruskal-Wallis and 1-way ANOVA statistical analysis was carried out and any significant 
differences indicated: *p<0.05, ***p<0.001. 
 
 
 
In the spleen, a different cytokine profile for analysed cell types was observed. 
Decreased IL-17A or IFN-γ production was seen in CD8+ T cells of infected β2m 
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knockout mice as predicted (Figure 4.9). There was also increased numbers of IL-
17A+ Foxp3+, γδ+ and CD4+ cells in the spleen of infected β2m knockout mice (Figure 
4.9). In terms of IFN-γ production, there was increase percentage of IFN-γ+ Foxp3+ or 
γδ+ cells of the lymphocyte population (Figure 4.9). The reason for these changes in 
cytokine profile for Foxp3+ or γδ+ cells is unclear, however, it appeared to be linked 
to the lack of MHC class I expression.   	  
 
Figure 4.9: IL-17A and IFN-γ  production in the spleen in infected β2m-/- mice. 
C57BL/6 and β2m KO mice (n=7 females per strain) were infected with 6.5x108 CFU H305 
S. pyogenes i.m for 24h. Spleens were harvested for flow cytometric analysis of IL-17A (left 
panel) and IFN-γ (right panel) production by various cell types. Mean and SEM of cytokine+ 
cells of lymphocytes (top panel) and absolute numbers (bottom panel) are represented. 
Kruskal-Wallis and 1-way ANOVA statistical analysis was carried appropriately and any 
significant differences indicated: *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
Overall, through the use of β2m knockout mice there appeared to be some 
requirement for MHC class I molecules during the early stages of acute S. pyogenes 
infection. The deficiency of β2m resulted in increased bacterial burden and a shift in 
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cytokine production by Foxp3+, γδ+, CD4+ and NK cells, which may contribute to the 
increase pathology observed. 
 
 
 
4.5 Effects of CD8+ T cell depletion prior infection with S. pyogenes 
 
As a role for MHC class I was demonstrated during the early stages of GAS infection, 
with the greatest effect involving the loss of CD8+ T cells in this transgenic model, it 
was decided that the precise role of CD8+ T cells during S. pyogenes infection would 
be investigated through antibody-mediated depletion of this target cell. 
 
 
Figure 4.10: Optimisation of antibody-mediated depletion of CD8+ T cells. 
C57BL/6 mice (n=2 females) were treated with either 100µg YTS 169 or isotype matched 
control for 24 or 48h. Splenocytes were harvested and CD8+ T cells were stained and 
analyzed by flow cytometry. CD4+ T cells were also depleted using 100µg anti-CD4 
monoclonal antibody (clone YTS 191) as a positive control. Antibodies were a kind gift from 
Prof. H. Waldmann and Dr. S. Cobbold, Sir William Dunn School of Pathology, Oxford. 
Representative staining is shown above.  
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Antibody mediated neutralisation of CD8+ T cells was first optimised. One dose of 
anti-CD8α monoclonal antibody clone YTS 169 (Kish et al., 2005) was administrated 
to C57BL/6 mice and the presence of CD8+ T cells measured by flow cytometry with 
staining with clone 53-6.7 recognising another epitope of CD8 (Figure 4.10). CD8+ T 
cell mediated depletion was achieved to a high degree of specificity up to 24 and 48h 
post inoculation.  CD4+ T cells were also depleted with clone YTS 191 to ensure no 
cross reactivity between YTS 169 and other cell types (Figure 4.10). 
 
Having confirmed the CD8+ T cell population could be efficiently depleted and levels 
remained low up to 48h after one dose of antibody, it was decided that C57BL/6 mice 
would be given YTS 169 or isotype matched control antibody one day before and 
also on the day of infection with WT S. pyogenes for 24h to study the role of CD8+ T 
cells.  	  
24h post infection with S. pyogenes, increased bacterial counts were detected in the 
blood and liver in YTS 169 treated mice compared to infected control mice, 
indicating increased bacterial spread (Figure 4.11). There was a significant increase in 
numbers of recovered bacteria in the thigh; the site of infection in mice depleted of 
CD8+ T cells compared to isotype control treated mice  (Figure 4.11). The increased 
bacterial burden was also supported by amplified serum IL-6 levels in the anti-CD8 
antibody treatment group relative to sham infected and infected isotype control 
groups (Figure 4.12). 
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Figure 4.11: The effect on bacterial burden in CD8+ T cell depleted mice during acute S. 
pyogenes infection. 
C57BL/6 mice (n=6-8 females per treatment group) were pre-treated with 100µg YTS 169 
mAb or isotype matched controls one day before and on the day of infection with 6.7x108 
CFU H305 or PBS (sham) i.m for 24h. Bacterial counts in the thigh, blood, spleen and liver 
was determined. Mean and SEM are represented and Mann-Whitney U statistical test was 
carried out and any significant differences indicated: *p<0.05. No bacterial growth was 
detected in sham treated mice (data not shown). 
 
 
 
 
Figure 4.12: Serum cytokine levels in CD8+ T cell depleted mice during S. pyogenes 
infection. 
C57BL/6 mice (n=6-8 females per treatment group) were pre-treated with 100µg YTS 169 
mAb or isotype matched controls one day before and on the day of infection with 6.7x108 
CFU H305 pr PBS (sham) i.m for 24h. Serum was collected and concentrations of IL-6, IL-
17A and IFN-γ were measured by ELISA. Mean and SEM are represented and 1-Way 
ANOVA statistical test was carried out and significant differences indicated: **p<0.01, 
***p<0.001. 
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Figure 4.13: Fold changes in the DLN in CD8+ T cell depleted mice during infection.  
C57BL/6 mice (n=6-8 females per treatment group) were pre-treated with 100µg anti-CD8 
antibody (clone YTS 169) or isotype-matched controls one day before and on the day of 
infection with 2.3x108 CFU H305 S. pyogenes or PBS (sham) i.m. DLNs were harvested for 
qRT-PCR analysis of gene expression changes after 24h of infection. Infected samples were 
normalised to tissue specific reference genes and C57BL/6 sham treated samples. Fold 
change in expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
Draining lymph nodes and spleens were harvested from infected CD8+ T cell 
depleted and isotype control treated mice for qRT-PCR analysis to identify any 
differences in gene expression pattern. Disappointingly, little significant change was 
found between infected mice with their CD8+ T cell population intact or those with 
this subset depleted. In the draining lymph node, infected YTS 169 treated mice had 
significantly down-regulated their expression of t-bet compared to infected isotype 
control mice (Figure 4.13). il-4 gene expression was also significantly down-
regulated upon depletion of CD8+ T cell during infection (Figure 4.13).  
 
In the spleen, il-10, il-4 and il-9 expression was increased in infected CD8+ T cell 
depleted mice relative to infected controls (Figure 4.14). This suggested that despite 
the increased bacterial burden observed in CD8 T cell depleted mice; the pattern of 
gene expression induced by infection was relatively unaffected, with only moderate 
changes in t-bet and TH2 associated cytokine genes. CD8+ T cells can express the 
transcription factor T-bet (Intlekofer et al., 2008), but the relevance of  TH2 responses 
during S. pyogenes and associated superantigens remains unclear (Müller-Alouf et al., 
1996).  
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Figure 4.14: Fold changes in the spleen in CD8+ T cell depleted mice during infection. 
C57BL/6 mice (n=6-8 females per treatment group) were pre-treated with 100µg anti-CD8 
antibody (clone YTS 169) or isotype-matched controls one day before and on the day of 
infection with 2.3x108 CFU H305 S. pyogenes or PBS (sham) i.m. Spleens were harvested for 
qRT-PCR analysis of gene expression changes after 24h of infection. Infected samples were 
normalised to tissue specific reference genes and C57BL/6 sham treated samples. Fold 
change in expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01. 
 
 
 
4.6 Ex vivo cytokine production in infected CD8+ T cell depleted mice 
 
 
Figure 4.15: Cell types in CD8+ T cell depleted mice during S. pyogenes infection. 
C57BL/6 mice (n=8 females per treatment group) were pre-treated with 100µg anti-CD8 
antibody (clone YTS 169) or isotype matched controls one day before and on the day of 
infection with 6.7x108 CFU H305 S. pyogenes i.m for 24h. WT or CD8+ T cell depleted mice 
(n=2 females per strain) were inoculated with PBS i.m for 24h as sham controls.  DLNs and 
spleens were harvested for flow cytometric analysis of cell types present in these lymphoid 
tissues. Mean and SEM of absolute numbers of cell types in the DLN (left) and spleen (right) 
are represented. 1-way ANOVA statistical analysis was performed and any significant 
differences indicated: *p<0.05, **p<0.01. 
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As qRT-PCR revealed little difference in gene expression pattern upon the removal of 
CD8+ T cells during S. pyogenes infection, ex vivo cytokine flow cytometry was 
carried out to investigate if there was a switch in cytokine production in other cell 
types in the absence of CD8+ T cells during infection. Treatment of mice with YTS 
169 specifically depleted CD8+ T cells and the absolute numbers of other cell types, 
such as NK and CD4+ T cells were unchanged in the draining lymph node and spleen 
(Figure 4.15) as shown by flow cytometry. 
 
 
Figure 4.16: IL-17A and IFN-γ  production in the DLN in infected CD8+ T cell depleted 
mice. 
C57BL/6 mice (n=8 females per treatment group) were pre-treated with 100µg anti-CD8 
antibody (clone YTS 169) or isotype matched controls one day before and on the day of 
infection with 6.7x108 CFU H305 S. pyogenes i.m for 24h. WT or CD8+ T cell depleted mice 
(n=2 females per strain) were inoculated with PBS i.m for 24h as sham controls. DLNs were 
harvested for flow cytometric analysis of IL-17A (left panel) and IFN-γ (right panel) 
production by stained cell types. Mean and SEM of cytokine+ cells of lymphocytes are 
represented. Kruskal-Wallis or 1-way ANOVA statistical analysis were carried out 
appropriately and any significant differences indicated: *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
Due to the treatment of mice with YTS 169 antibody during GAS infection, there was 
an expected significant reduction in the percentage of IL-17+ and IFN-γ+ CD8+ T cells 
within the lymphocyte population in draining lymph nodes of mice (Figure 4.16). The 
percentage of IFN-γ+ CD4+ T cells of lymphocytes increased during infection perhaps 
due to a compensatory mechanism in the absence of CD8+ T cells (Figure 4.16). 
Surprisingly, there was also an elevation in the percentage of IFN-γ+ Foxp3+ cells in 
CD8+ T cell depleted mice upon infection (Figure 4.16), which will be discussed 
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further in Section 4.9. Whether there is an inhibitory CD8+ T cell population 
suppressing Foxp3+ cells from producing IFN-γ during infection remains unclear.  
 
 
Figure 4.17: IL-17A and IFN-γ  production in the spleen in infected CD8+ T cell depleted 
mice. 
C57BL/6 mice (n=8 females per treatment group) were pre-treated with 100µg anti-CD8 
antibody (clone YTS 169) or isotype matched controls one day before and on the day of 
infection with 6.7x108 CFU H305 S. pyogenes i.m for 24h. WT or CD8+ T cell depleted mice 
(n=2 females per strain) were inoculated with PBS i.m for 24h as sham controls. Spleens 
were harvested for flow cytometric analysis of IL-17A (left panel) and IFN-γ (right panel) 
production by stained cell types. Mean and SEM of cytokine+ cells of lymphocytes are 
represented. Kruskal-Wallis and 1-way ANOVA statistical analysis was carried out and any 
significant differences indicated: *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
In the spleen, IL-17A responses were more dominant than in the draining lymph 
node. Yet again, the absolute number of IFN-γ+ CD8+ T cells was reduced in the 
spleen of infected YTS 169 treated mice compared to infected isotype controls 
(Figure 4.17).  The percentage of IL-17 producing cells greatly shifted in infected 
CD8+ T cell depleted mice compared to infected isotype control mice. For example, 
there were significantly higher percentages of Foxp3+, CD4+, NK and NKT cells 
making IL-17A in the absence of CD8+ T cells during infection (Figure 4.17).  
 
Overall, the removal of CD8+ T cells was detrimental to the host during the early 
stages of S. pyogenes infection. Ex vivo cytokine flow cytometric analysis revealed 
increased production of IL-17A and IFN-γ by many different cell types in the 
draining lymph node. This suggested there might be a suppressive CD8+ T cell 
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population, which would normally dampen down these cytokine responses to prevent 
the increased bacterial burden observed in Figure 4.11. 
 
 
 
4.7 The role of NK cells during acute S. pyogenes infection  
 
As a potential role for NK cells was implicated from the studies utilising β2m 
knockout mice and also from CD8+ T cell depletions experiments, this cell type was 
depleted using antibodies to investigate whether NK cells have a protective or 
pathogenic role during S. pyogenes infection.  
 
 
Figure 4.18: Optimisation of antibody mediated depletion of NK cells. 
C57BL/6 mice (n=2 females) were treated with either 200µg PK136 (anti-NK1.1 antibody) or 
isotype matched control for 48h. Splenocytes were harvested and NK cells were stained for 
the expression of CD49b (FITC conjugated) and NKp46 (Pacific Blue conjugated) and lack 
of CD3 (V500 conjugated) and analyzed by flow cytometry. Representative staining is shown 
above with expression of CD3 and other NK-specific markers, CD49b or NKp46 of gated 
lymphocyte population shown in the left and middle panel (Walzer et al., 2007). The right 
panel shows expression of CD49b and NKp46 expression of gated CD3- lymphocytes. 
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Most studies have employed anti-NK1.1 antibody (clone PK136) to specifically 
deplete NK and NK1.1+ T cells in C57BL/6 mice (Setiady et al., 2010). After 
optimisation experiments increasing the amount of antibody and the number of doses 
administrated to the mice, full depletion of NK cells could not be achieved with this 
reagent (Figure 4.18). 200µg anti-NK1.1 antibody given two days before harvest for 
flow cytometric analysis produced the greatest percentage of NK cell depletion (84%) 
as shown by decreased percentage of CD3-CD49b+NKp46+ cells compared to isotype 
matched control mice (Figure 4.18). Increasing the amount of antibody or the number 
of doses given to mice did not increase the percentage of depletion.  
 
 
Figure 4.19: Weight loss in largely NK cell depleted mice during GAS infection. 
C57BL/6 mice (n=8 females per treatment group) were pre-treated with 200µg anti-NK1.1 
antibody (clone PK136) or isotype matched controls two days before and on the day of 
infection with 2.2x108 CFU H305 S. pyogenes i.m for 24h. Percentage weight loss of each 
infected treatment groups was determined. Mean and SEM are represented and Mann-
Whitney U statistical test was carried out and any significant differences indicated: *p<0.05. 
 
 
 
Having determined the protocol for NK cell depletion with clone PK136 in C57BL/6 
mice, animals were pre-treated with PK136 or isotype matched antibody two days 
before and also on the day of infection with S. pyogenes for 24h. Mice largely 
depleted of their NK cells lose more weight during infection compared to infected 
isotype controls (Figure 4.19). 
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Figure 4.20: Bacterial burden in largely NK depleted mice during GAS infection.  
C57BL/6 mice (n=8 females per treatment group) were pre-treated with 200µg anti-NK1.1 
antibody (clone PK136) or isotype matched controls two days before and on the day of 
infection with 2.2x108 CFU H305 S. pyogenes i.m for 24h. Bacterial counts in the thigh, 
blood, spleen and liver was determined. Mean and SEM are represented and Mann-Whitney 
U statistical test was carried out and any significant differences indicated: *p<0.05. 
 
 
 
	  
Figure 4.21: Cytokine levels in serum of largely NK cell depleted mice during infection. 
C57BL/6 mice (n=6-8 females per treatment group) were treated with 200µg PK136 or 
isotype matched controls two days before and on the day of infection with 2.2x108 CFU 
H305 S. pyogenes or PBS (sham) i.m for 24h. Serum was collected and concentrations of IL-
6, IL-17A and IFN-γ measured by ELISA. Mean and SEM are represented and 1-Way 
ANOVA statistical test was carried out and significant differences indicated: **p<0.01, 
***p<0.001. 
 
 
 
Similar to the experiments conducted with β2m knockouts and mice depleted of their 
CD8+ T cells, increased systemic bacterial burden was also observed in mice depleted 
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of NK cells during S. pyogenes infection. Increased numbers of recovered bacteria 
was found in the thigh, blood and liver of PK136 treated mice compared to isotype 
controls (Figure 4.20). Increased bacterial burden was accompanied with an increase 
in serum IL-6 in infected PK136 treated mice (Figure 4.21). Interestingly, the 
concentration of serum IL-17A and IFN-γ, cytokines known to be produced by NK 
cells was decreased in infected anti-NK1.1 treated mice compared to infected isotype 
controls (Figure 4.21). 
 
Overall, this set of data suggest that NK cells are protective during the early stages of 
S. pyogenes infection as partial depletion resulted in increased disease severity, 
perhaps due to the reduction of IL-17A and IFN-γ as detected in the serum of infected 
PK136 treated mice. 
 
 
 
4.8 Cytokine production by immune cells in the absence of NK cells 
during GAS infection 
 
As depletion of NK cells during acute S. pyogenes resulted in a decrease in serum IL-
17A and IFN-γ, ex vivo cytokine flow cytometry are carried out to see if this was 
fully attributed to the reduction in NK cell numbers. Treatment with PK136 antibody 
as shown in Figure 4.18 did not achieve full depletion but only a reduction in the 
absolute numbers of NK cells in either the draining lymph or spleen of infected mice 
(Figure 4.22). Absolute numbers of other cell types, including NKT cells (also 
expressing NK1.1) were unaffected by the treatment with this monoclonal antibody 
(Figure 4.22). 	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Figure 4.22: Cell types in PK136 treated mice during acute S. pyogenes infection. 
C57BL/6 mice (n=8 females per treatment group) were pre-treated with 200µg anti-NK1.1 
antibody (clone PK136) or isotype matched controls two days before and on the day of 
infection with 2.2x108 CFU H305 i.m for 24h. WT or NK cell depleted mice (n=2 females 
per strain) were inoculated with PBS i.m for 24h as sham controls. DLNs and spleens were 
harvested for flow cytometric analysis of cell types present. Mean and SEM of absolute 
numbers of cell types in the draining lymph node (left) and spleen (right) are represented. 1-
way ANOVA statistical analysis was carried out and no significant differences were found. 
 
 
 
 
 
Figure 4.23: IL-17A and IFN-γ  production in the DLN in infected PK136 treated mice. 
C57BL/6 mice (n=8 females per treatment group) were pre-treated with 200µg anti-NK1.1 
antibody (clone PK136) or isotype matched controls two days before and on the day of 
infection with 2.2x108 CFU H305 i.m for 24h. WT or NK cell depleted mice (n=2 females 
per strain) were inoculated with PBS i.m for 24h as sham controls. DLNs were harvested for 
flow cytometric analysis of IL-17A (left panel) and IFN-γ (right panel) production by various 
cell types. Mean and SEM of cytokine+ cells of lymphocytes are represented. Kruskal-Wallis 
and 1-way ANOVA statistical analysis was carried and any significant differences indicated: 
*p<0.05, **p<0.01, ***p<0.001. 
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In the draining lymph node, PK136 treatment resulted in decreased populations of IL-
17A+ producing Foxp3+, γδ+, CD4+, CD8+, NK and NKT cells (Figure 4.23). There 
was no change in the percentage of IFN-γ producing cells of the lymphocyte 
population in the draining lymph node upon treatment with anti-NK1.1 antibody prior 
to S. pyogenes infection (Figure 4.23). In the spleen, there was a general trend of 
fewer IL-17A or IFN-γ producing cells (Figure 4.24). The only significant difference 
in the percentage of IFN-γ producing cells of lymphocytes was from CD4+ T cells 
upon treatment with PK136 antibody (Figure 4.24). 	  
 
Figure 4.24: IL-17A and IFN-γ  production in the spleen in infected PK136 treated mice. 
C57BL/6 mice (n=8 females per treatment group) were pre-treated with 200µg anti-NK1.1 
antibody (clone PK136) or isotype matched controls two days before and on the day of 
infection with 2.2x108 CFU H305 S. pyogenes i.m for 24h. WT or NK cell depleted mice 
(n=2 females per strain) were inoculated with PBS i.m for 24h as sham controls. Spleens 
were harvested for flow cytometric analysis of IL-17A (left panel) and IFN-γ (right panel) 
production by various cell types. Mean and SEM of cytokine+ cells of lymphocytes are 
represented. Kruskal-Wallis and 1-way ANOVA statistical analysis was carried and any 
significant differences indicated: *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
In summary, NK cells were found to be protective during the early stages of acute S. 
pyogenes infection. As full depletion of NK cells could not be achieved through the 
use of PK136 clone antibody, interpretation of the data must be treated with caution. 
The greatest effect of PK136 treatment was the significant reduction in the percentage 
of IL-17A+ cells during infection, correlating with a drop in serum IL-17A levels. 
This suggests the presence of NK cells might be critical for the recruitment and 
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activation of other immune cells, such as T cells to produce IL-17A to aid bacterial 
clearance. 
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4.9 Discussion 
 
Pathogens have long evolved to infect and exploit host cells to replicate and evade the 
immune system. Many different bacterial species have been demonstrated to survive 
intracellularly within cells, eliciting either NK or CD8+ T cell-mediated immunity to 
contain and eliminate the infection. Commonly studied intracellular bacteria include 
the Gram-positive L. monocytogenes and Gram-negative S. typhimurium, whereby 
early electron microscope studies have demonstrated the presence of these bacterial 
species inside cells (Yokoyama et al., 1987; Armstrong and Sword, 1966).  
 
Many studies have implicated macrophages and neutrophils as immune cells 
important in the elimination of intracellular bacterium (Conlan and North, 1991). This 
is achieved through engulfment of pathogens and anti-microbial functions, such as 
the production of reactive oxygen species and enzymes and phagosome acidification 
(McRipley and SBarra, 1967; Rathman et al., 1996). NK cells also offer effective 
protection against intracellular bacterial infection, recognising infected cells due to 
down-regulation of MHC class I molecules as proposed by the “missing self” 
hypothesis (Ljunggren and Kärre, 1990; Kim et al., 2005). This leads to cytotoxic 
activity and cytokine production (e.g. IFN-γ) to kill infect cells containing 
intracellular bacteria (Nakae et al., 1990). It should also be pointed out that other 
receptors exist on the surface of NK cells such as CD137 to also respond pathogens to 
lead to effector functions (Lee et al., 2005). 
 
If cells of innate immunity are unable to clear infection, T cells are activated as part 
of adaptive immunity to boost effector function (Czuprynski et al., 1985). CD8+ T 
cells have similar effector phenotype as described for NK cells, such as cytolytic 
activity and cytokine production (Harty et al., 1992; Harty and Bevan, 1992; Roberts 
et al., 1993) and also require MHC class I molecules to present processed 
intracellular bacterial antigens for activation (Pamer, 1994; Darji et al., 1997; Szalay 
et al., 1994). 
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The role of MHC class I dependent pathways including CD8 activation in S. 
pyogenes infections has received little attention due to the classical view that this 
Gram-positive bacterium is an extracellular pathogen. This has implied that antigens 
might be presented through MHC class II presentation to CD4+ T cells. There is 
however, a body of experimental evidence that S. pyogenes can infect and survive 
within cells, such as neutrophils and macrophages (Staali et al., 2003; Thulin et al., 
2006). This suggests that processed streptococcal antigens may MHC class I 
biosynthetic pathway for presentation to CD8+ T cells. The aim of this chapter was to 
clarify whether MHC class I molecules (and hence CD8+ T and/or NK cells) are 
involved in host defense against S. pyogenes infection.  
 
β2m knockout mice, characterised by the lack of MHC class I molecule surface 
expression (Koller et al., 1990) were infected with a lethal dose of WT S. pyogenes 
and no difference in survival was found between infected WT and β2m knockout 
mice (Figure 4.1). However, bacterial counts taken after 24h infection in C57BL/6 
and β2m knockout mice indicated a trend of increased bacterial spread in knockout 
mice (Figure 4.2) and correlating with elevated serum IL-17A levels (Figure 4.3). 
However, serum IL-6, often used in protocols as a surrogate marker for 
severity/lethality, was reduced in β2m knockout animals (figure 4.3).  
 
qRT-PCR analysis of draining lymph nodes revealed overall increased gene 
expression of all immune transcripts studied (Figure 4.4-5), suggestive of a global 
change in gene expression in the absence of class I expression during S. pyogenes 
infection.  My data certainly indicate that MHC class I expression may play a role 
during the early stages of GAS infection.  This role could be for CD8+ T cell 
mediated killing of infected cells. In infected β2m knockout mice, severely decreased 
absolute numbers of CD8+ T cells were found in both the draining lymph node and 
the spleen (Figure 4.7).  
 
Twenty-four hours into an acute infection seems too early for a role of CTL killing of 
intracellularly infected host cells. A hypothesis that would link a set of changes, 
whereby immune transcripts associated with virtually all T cell subsets are enhanced 
would be decreased class I expression somehow enhanced the ability of the bacterial 
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superantigens to induce a cytokine storm. As I have discussed elsewhere in this 
thesis, this would also be compatible with the observed increase in bacterial spread.  
From the experiments I have reported here, it is impossible to be certain in what way 
an MHC class I-dependent responses might normally be curtailing this effect. An 
obvious candidate would be a CD8+ regulatory population that normally dampens the 
effect. In another example of bacterial infection (albeit using a capsular 
polysaccharide not expressed by GAS), a CD8+CD28- regulatory T lymphocyte 
population was induced by TCR cross-linking (Mertens et al., 2009). It should also be 
noted that there is some literature stating staphylococcal superantigens such as SEB 
(Häffner et al., 1996) and SEA (Baskar et al., 1996) may be able to interact with 
MHC class I molecules to lead to the activation of T cells, but whether is also true for 
streptococcal superantigens is unknown. 
 
The findings in CD8 depleted mice to some extent reiterated those in the β2m 
knockout mice, most clearly with respect to the increased bacterial spread. The fact 
that the phenotype in CD8-depleted mice was subtler than in the β2m knockouts may 
be compatible with a view that part of the knockout phenotype was attributable to 
altered function of another cell type, such as NK cells. Ex vivo cytokine flow 
cytometric analyses of lymphoid tissues from infected mice depleted of CD8+ T cells 
revealed a more dominant role for IFN-γ in the draining lymph node and IL-17A in 
the spleen (Figure 4.16-17). An increase percentage of Foxp3+ and CD4+ T cells 
within the lymphocyte population were making IFN-γ in the draining lymph node in 
the absence of CD8+ T cells upon infection with GAS (Figure 4.16). The same cell 
populations had switched to making IL-17A in the spleen (Figure 4.17). Whether 
these changes in cytokine profiles are due to compensatory mechanisms due to the 
loss of CD8+ T cells or whether these cell types are normally under the control of 
CD8+ Tregs is unknown. It has been suggested that during viral infection, CD8+ Tregs 
can be induced and can suppress the proliferation of viral-specific T cells (Nigam et 
al., 2010). More research is required whether this is also the case in my model of 
bacterial infection.  
 
From the findings stated above, it would suggest that CD8+ T cells are protective 
during acute S. pyogenes infection. The importance of CD8+ T cells during 
	   229	  
intracellular bacterial infection has been highlighted in many publications. L. 
monocytogenes is a typical intracellular bacterium and CD8+ T cells capable of 
secreting IFN-γ have been found to be induced as early as 16h post infection in mice 
(Bou Ghanem et al., 2011). Literature exists correlating GAS and autophagy, 
demonstrating that the immune system has evolved a system to eliminate intracellular 
S. pyogenes (Nakagawa et al., 2010; Yamaguchi et al., 2010; Yoshimori and Amano, 
2009). While the process of autophagy was not examined in my model of acute 
sepsis, this could lead itself to further work. Work has also been carried out on S. 
pneumoniae, another related Gram-positive bacterium has demonstrated that mice 
lacking CD8+ T cells also exhibit increased bacterial spread and decreased survival 
compared to WT controls (Weber et al., 2011). This is very similar to results obtained 
from my own studies. 
 
Figures 4.9 and 4.16 show, in the context of the β2m deficient mice and CD8 
depletion respectively, that an enhanced population of Foxp3+ IFN-γ+ cells in the 
spleen was detected (Figure 4.9). This convergence of data seems to argue that these 
cells are normally constrained by CD8 immunity. During the time that I was doing 
this work, reports began to appear about other settings in which these cells are found. 
It has now been shown for Foxp3+ cells to make pro-inflammatory cytokines such as 
IL-17A and IFN-γ during inflammatory conditions (Espoito et al., 2010). These 
findings are also mirrored in humans, whereby Foxp3+ Tregs can produce IFN-γ in the 
presence of IL-12 (Dominguez-Villar et al., 2011). 
 
CD8+ Tregs are less well defined compared to CD4+ Tregs (Joosten and Ottenhoff, 
2008). Mayer and colleagues (Mayer et al., 2011) have identified a population of 
CD8+ Tregs, similar to conventional CD4+ Tregs in terms of expression of key markers 
such as CD25, GITR and CTLA-4 but lacked suppressive capacity. Whether CD8+ 
regulatory T cells may normally suppress the production of IL-17A and IFN-γ from 
Foxp3+ or γδ+ cells during acute S. pyogenes as suggested in this model require 
further investigation.  
 
The role of MHC class I dependent antigen processing and presentation during sepsis 
has previously been explored. Sherwood and colleagues (Sherwood et al., 2003) used 
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a CLP model of poly-microbial sepsis in β2m knockout mice. They however, found 
this strain of mice were more resistant to mortality and attributed their increased 
survival to the loss of pathogenic CD8+ T cells and NK cells. This is the opposite of 
my findings in S. pyogenes induced sepsis, where β2m knockout mice have a worst 
outcome during the early stages of infection. This is reminiscent of data from another 
disease model of K. pneumoniae infection where the authors observed increased 
bacterial burden in infected β2m knockout mice (Cogen and Moore, 2009). However, 
this protection was not due to CD8+ T cells or NKT cells as shown by depletion 
studies (Cogen and Moore, 2009). In contrast to this paper, NK cells may be 
pathogenic in LPS-induced shock in β2m knockout mice (Emoto et al., 2001). With 
this in mind, it was necessary to investigate the individual roles of CD8+ T and NK 
cells during acute S. pyogenes infection.  
 
The role of NK cells was also studied in my model of acute sepsis. Given the lack of 
available tools to deplete NK cells, anti-NK1.1 antibody clone PK136 was chosen for 
my depletion studies (Figure 4.18). Other groups have use anti-asialo GM1 to deplete 
NK cells but it should be noted that a subset of monocytes and macrophages also 
express Asialo-GM1, therefore this antibody was deemed unsuitable for specific NK 
cell depletion. 
 
In vivo treatment with anti-NK1.1 antibody prior to infection with S. pyogenes 
resulted in increased weight loss (Figure 4.19), systemic bacterial burden as shown in 
the blood and liver (Figure 4.20) and increased serum IL-6 (Figure 4.21) compared to 
infected isotype treated control mice. Serum levels of IL-17A and IFN-γ were lower 
in infected PK136 treated mice compared to infected isotype treated controls (Figure 
4.21). This demonstrated that NK cells are protective during acute S. pyogenes 
infection.  I have subsequently been breeding mice lacking the E4bp4 transcription 
factor implicated as crucial for NK cell development as published by Brady and 
colleagues (Gascoyne et al., 2009) to determine in a knockout model whether I can 
confirm a clear role of NK cells. 
 
More in depth analysis of IL-17A and IFN-γ cytokine production by different cell 
types by flow cytometry showed IL-17A responses in the draining lymph node were 
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severely impaired upon PK136 treatment prior to infection with GAS (Figure 4.23). 
All studied cell types within the lymphocyte population exhibited an overall 
decreased in IL-17A production (Figure 4.23), suggestive that this cytokine may be 
protective during S. pyogenes infection, previously suggested and discussed in 
Chapter 3.  
 
From these depletion studies, I would summarise that diminished NK cell mediated 
responses appeared to be more detrimental to host immunity than the loss of CD8+ T 
cell mediated immunity. Without NK cells, it would appear that IL-17A responses by 
other cell types are not mounted and this was reflected by the decreased levels of IL-
17A in serum of infected PK136 treated mice (Figure 4.21) and also more significant 
bacterial burden across more sampled organs was detected in infected PK136 treated 
mice compared to infected CD8+ T cell depleted mice (Figure 4.20).  
 
As NK cells form part of innate immunity, perhaps this cell type is more crucial in 
mounting early responses against S. pyogenes infection. This would act to contain the 
infection and allow time for CD8+ T cells to be activated and expand before 
contributing to the immune response during the later stages of infection.  
 
Very little is known regarding the role of NK cells during S. pyogenes infection. It 
has been demonstrated that NK cells are pathogenic during an intravenous model of 
S. pyogenes infection with depletion mediated by anti-asialo GM1 treatment 
(Goldmann et al., 2005a) or in a CLP model of poly-microbial sepsis (Barkhausen et 
al., 2008). These findings are also very similar to an E. coli infection mouse model 
(Badgwell et al., 2002). This is in contrast to my findings, however, there is evidence 
in other infectious diseases models to suggest that NK cells may have a protective 
role. For example, NK cells are required for mounting an effective IFN-γ response 
against L. monocytogenes infection (Shegarfi et al., 2010). A mechanism whereby 
NK cells enhance bacterial clearance through interactions with macrophages in a CLP 
model of poly-microbial sepsis has also been proposed (Godshall et al., 2003) and 
NK cell dysfunction may be an indicator of poorer survival outcome (Hirsh et al., 
2004b). 
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In conclusion, my results would suggest that an MHC class I dependent effector 
mechanism (or regulatory effect) is required during the early stages of S. pyogenes 
infection and that CD8+ T cell and NK cells are protective during GAS infection. This 
offers an exciting caveat for studies of this oft-presumed extracellular pathogen.  
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Chapter 5 
	  
5 Creating superantigen knockout streptococcal isolates 
 
5.1 Introduction 
 
Pathogens have adapted to evade and subvert the resultant immune response. A 
number of microbial virulence factors fall into this category. S. pyogenes is an 
example of a bacterium, which expresses a wide variety of virulence factors to escape 
and modulate the host immune system post infection. These virulence factors include 
surface expressed M proteins and secreted superantigens. Superantigens are unlike 
conventional antigens as they bind to MHC class II molecules in a region away from 
the peptide-binding groove and to the TCR variable chain of the T cell, and do not 
require antigen processing (White et al., 1989; Dellabona et al., 1990). 
 
Most research has focused on the role of superantigens during invasive streptococcal 
disease as studies have demonstrated these virulence factors can induce pro-
inflammatory mechanisms and drive specific T cell expansion (Sriskandan and 
Altmann, 2008). While the presence of stimulation by superantigens is not 
inextricably linked to the ability of GAS to cause sepsis, there is supporting evidence 
connecting clinical cases of bacterial sepsis and toxic shock syndrome with the 
presence of secreted superantigens (Proft et al., 2003).  
 
Studies investigating the magnitude of cytokine responses upon stimulation of human 
PBMCs with streptococcal superantigens have revealed SMEZ as a potent inducer of 
both TH1 and TH2 cytokine production, whereas SPEA representing the least potent 
(Proft et al., 2007). From this study, great variation between healthy donors was 
found, with some individuals biased towards TH1 responses and others favouring TH2 
cytokine production (Proft et al., 2007). Despite evidence suggesting SPEA as a weak 
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stimulating superantigen, it is highly associated with invasive disease (Tyler et al., 
1992; Yu and Ferretti, 1989; Hauser et al., 1991). This would suggest different 
superantigens have diverse effects on the immune system; with some leading to 
potent effects, whereas some not. Further investigation is needed to dissect the 
precise relationship between immune responses and clinical relevant superantigens. 
 
Due to the lack of availability to date of streptococcal derived, immunodominant 
peptides or antigens, it is currently not possible to study the direct antigenic effects on 
the immune system; this is a source of ongoing research in the lab. The only tool at 
our disposal to study streptococcal antigenic immune responses is whole, heat-killed 
streptococcal preparations. However, co-culture with such a stimulus only offers a 
broad approach to investigating ensuing immune responses as this crude preparation 
contains numerous streptococcal membrane bound proteins and secreted virulence 
factors, such as superantigens. Thus, care is required to decipher results attained from 
stimulation experiments with heat-killed bacterial cultures. 
 
As it was not viable at present to study GAS associated antigenic-specific effects on 
the immune system, it was conceived that investigation of responses to infection in 
the presence or absence superantigenic effects on immunity might be possible. 
Sriskandan and colleagues (Sriskandan et al., 1999) have previously created two S. 
pyogenes isolates lacking either SPEA (M1 serotype mutant) or SMEZ (M89 serotype 
mutant) superantigens (Sriskandan et al., 2001). These knockout mutants were used 
for in vivo infection models and showed clear differences in terms of virulence and 
survival compared to WT isolates. This provides supporting evidence that 
superantigens are an important virulence factor secreted by S. pyogenes, although 
whether or to what extent this involved modulation of host immune responses is 
unknown. 
 
All previous data presented in Chapter 3 and 4 have utilised a M1T1 serotype WT S. 
pyogenes isolate called H305 (NCTC8198) (Sriskandan et al., 1999). This is a clinical 
isolate extracted from a patient with scarlet fever, which developed into necrotising 
fasciitis. It has been useful in murine models of acute sepsis due to its invasive nature 
and full complement of secreted superantigens, such as SPEA and SMEZ. The results 
attained from infection experiments in Chapter 3 and 4 have not addressed the 
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superantigenic nature of the isolate and that the observed immune responses, such as 
increased cytokine production, may be due to the presence of superantigen virulence 
factors.   
 
To investigate the effect of superantigens during acute GAS infection in my murine 
model of infection, it was deemed necessary to create additional M1 serotype 
streptococcal mutants with known superantigens genetically knocked out. These 
knockout isolates would be a useful tool to study the relative effects of the different 
superantigens upon infection in vivo, reflecting a more natural experimental model, 
contrasting to infection models whereby purified recombinant superantigens were 
administrated in vivo. 
 
 In this chapter, I have focused on the creation and characterisation of a panel of GAS 
superantigen knockout mutants. These streptococcal mutants would be used for later 
in vivo infection experiments in order to allow me to investigate whether there are 
any specific interaction between superantigens and immune cells, in particular Tregs.  
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5.2 Creation of streptococcal smez superantigen knockout isolate by 
insertional duplication mutagenesis  
 
To create a panel of superantigen knockout isolates to study superantigenic effects 
during infection, different mutagenic approaches were required. S. pyogenes WT 
strain, H305 secretes SMEZ and SPEA, two potent superantigens previously linked to 
the pathology of septic shock and potent inducers of host pro-inflammatory cytokines 
(Sriskandan et al., 2001; Unnikrishnan et al., 2002).  
 
 
Figure 5.1: Schematic of insertional duplication mutagenesis. 
Insertion of pGhostsmez plasmid into streptococcal WT genomic DNA would disrupt 
functional smez transcription to create a smez KO mutant. Primers used for verifying 
insertion and correct orientation of pGhostsmez plasmid are indicated. Positions of enzyme 
restriction sites for Southern blotting are also shown above. 
 
 
 
Mutagenesis to knock out superantigens in S. pyogenes had been previously been 
employed successfully. A self-replicating plasmid called pGhostsmez was made and 
used to genetically knock out smez in a M89 serotype S. pyogenes isolate (H293) 
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(Unnikrishnan et al., 2002). This plasmid was modified to contain three copies of the 
first 300bp of smez (smez’) to allow for homologous recombination with WT 
genomic DNA after bacterial transformation. At 30°C, after electroporation, 
pGhostsmez would self-replicate within S. pyogenes. However, temperature switching 
to 37°C would induce the plasmid to insert into the bacterial genome, recombining 
via smez’ and unroll into the middle of the WT gene to interrupt functional smez 
transcription and hence disrupt SMEZ expression in a process called insertional 
duplication mutagenesis (Figure 5.1).  
 
In order to create a smez-/- M1 serotype isolate for functional studies into the 
relationship between superantigens and Treg, the same mutagenesis strategy employed 
to knock out smez in H293 was used in H305 (M1 serotype WT isolate). pGhostsmez 
was extracted from E. coli (H376) and digested with EcoRI restriction enzyme to 
ensure it was the correct plasmid (see Methods 2.5.16). Restriction digest produced 
the expected 300bp fragment representing the three copies of smez’ cloned into the 
pGhost shuttle vector (8Kb) (see Methods 2.5.16). pGhostsmez was electroporated 
into H305 and four clones were produced after antibiotic selection with erythromycin 
as described in Chapter 2. 
 
 
Figure 5.2: Insertion of pGhostsmez into WT H305. 
PCR using genomic DNA extracted from H305 (WT) and smez KO clones (1-4) were 
amplified for the presence for ribosomal RNA (A): aphI kanamycin resistance cassette (B) 
and intact WT smez (C). Samples were run on a 2% agarose gel with Hyperladder II DNA 
markers (Bioline Ltd, UK). All samples were positive for rRNA (750bp). Only smez KO 
clones (1-4) contained aphI (700bp) and only H305 contained intact WT smez (800bp). 
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To confirm insertion of pGhostsmez into H305 after electroporation, PCR of 
extracted genomic DNA from the four potential smez KO clones was carried out. 
Amplification of ribosomal RNA DNA was performed by PCR with rRNA(F) and 
rRNA(R) primers to verify genomic DNA was extracted from the four smez KO 
clones as a positive control. All four KO clones and H305 produced the expected 
750bp fragment confirming there was genomic DNA (Figure 5.2A). Next, the 
kanamycin resistance cassette (aphI) located in pGhostsmez, permitting antibiotic 
selection was detected with primers AphI(F) and AphI(R) in the smez KO clones 
(700bp); however, this was absent in H305 WT genomic DNA (Figure 5.2B). Only 
WT genomic DNA from H305 contained the intact copy of smez (800bp) as shown 
by PCR with smezP1 and smezR600 primers, whereas the four KO clones did not as 
insertion of the plasmid into the middle of the smez gene produced a fragment too big 
to be amplified under standard PCR conditions (Figure 5.2C). Overall, it was 
concluded that the four smez KO clones produced after electroporation did contain 
pGhostsmez.  
 
It should be noted that homologous recombination can occur between WT smez and 
any one of the three copies of smez’ triplets in pGhostsmez containing clones with 
differing plasmid-derived fragments in the middle of WT smez. pGhostsmez can also 
unroll into WT smez in either direction, conferring two orientations of the plasmid in 
the bacterial genome. To determine the orientation of pGhostsmez in the bacterial 
genome of the four smez KO clones and whether homologous recombination had 
occurred in the predicted manner via the first smez’ triplet as shown in Figure 5.1, 
PCR analysis was carried out to amplify the DNA fragment from the smez promoter 
(smezP1 primer) to the kanamycin resistance cassette (AphI(R) primer), which was 
predicted to be only seen in smez KO clones. KO clones 2 and 3 produced the 
expected size band of 2.5Kb, indicative of recombination occurring via the first smez’ 
(Figure 5.3A). Interestingly, KO clones 1 and 4 did not produce the expected PCR 
band size, suggesting that mutagenesis had occurred in a manner not previously 
predicted to disrupt intact WT smez as shown in Figure 5.2C.  
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Figure 5.3: Orientation of pGhostsmez in smez KO clones. 
(A) Genomic DNA from H305 and smez KO clones (1-4) were amplified using smezP1 and 
aphI(R) primers. PCR products were run on a 1% agarose gel with Hyperladder I DNA 
markers (Bioline Ltd, UK). Smez KO clones 2 and 3 showed expected size bands (2.5Kb) 
corresponding to homologous recombination occurring with the first smez’ triplet leading to 
full length integration of pGhostsmez plasmid into host genome.  
(B) Southern blotting with smez probe was carried out using XbaI digested genomic DNA 
from H305 (WT) and smez KO clones (1-4). H305 contained WT 3.5Kb smez fragment, 
whereas this was replaced with two fragments (6 and 7Kb) in smez KO clone 2, indicating 
that pGhostsmez had inserted in the predicted manner as shown in Figure 5.1. 
 
 
 
The orientation of pGhostsmez was also determined by Southern blotting. Genomic 
DNA from the four smez KO clones was digested with XbaI restriction enzyme and 
fragments were probed for the presence of smez. Only KO clone 2 produced the 
expected cut fragments of 6Kb and 7Kb containing smez (Figure 5.3B) demonstrating 
insertional duplication mutagenesis had occurred in the predicted manner shown in 
Figure 5.1 to knock out smez. Overall, by PCR analysis and Southern blotting, smez 
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in KO clone 2 was knocked out and this clone was added to the S. pyogenes isolate 
collection and renamed as H623 (smez-/-). 
 
 
 
5.3 Complementing smez knockout phenotype in H623 
 
To confirm that smez had been knocked out in H623, the smez-/- genotype was 
complemented with a previously described pDL278smez plasmid encoding smez gene 
(Russell and Sriskandan, 2008) to determine if the WT SMEZ phenotype could be 
restored in the knockout mutant.  
 
pDL278 was modified to contain the WT smez gene along with its endogenous 
promoter region to create pDL278smez. Thus, bacterial transformation with this 
plasmid would lead to SMEZ expression.  pDL278smez was extracted from E. coli 
(H431) and digested with BamHI restriction enzyme to ensure correct plasmid 
extraction (See Methods 2.5.16). pDL278, the naked shuttle vector was also digested 
with BamHI (See Methods 2.5.16) as a control digest. Both plasmids produced 
linearised fragments upon digestion (6Kb) and pDL278smez also produced the 
expected smez fragments (900bp) (See Methods 2.5.16). pDL278smez was 
electroporated into H623 to produce the SMEZ complemented isolate, designated 
H626 (smez-/+).  
 
 
 
5.4 Phenotypic analysis of H623 and H626 
 
As the genotype of H623 had been demonstrated to be smez-/-, the phenotype of this 
mutant was next determined to ensure there was no SMEZ protein production. This 
was compared with the complemented mutant, H626 to confirm that the knocked 
down phenotype was attributed to the smez-/- genotype.  
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Figure 5.4: Comparison of mitogenic activities of H305, H623 and H626. 
10-fold dilutions of cell-free supernatants from H305 (WT), H326 (spea-/-), H361 (spea-/+), 
H623 (smez-/-) and H626 (smez-/+) were co-cultured with splenocytes from HLA-DQ8.Aβ0 
mice (n=6 females). 3H-thymidine incorporation into cells (in triplicates) in the last 8h of a 5 
day incubation was measured and ΔCPM calculated by subtracting background proliferation 
of un-stimulated cells from stimulated cells counts. Data represents mean values ± SEM. 
Kruskal-Wallis statistical was used and any significant difference are indicated: * p≤0.05, 
**p≤0.01, ***p≤0.0001. 
 
 
 
Cell-free supernatants were produced from H623 and H626 to determine their 
mitogenic activities, since secreted superantigens in supernatant can be used to induce 
T cell proliferation (Cunningham, 2000). A 10-fold dilution series of bacterial 
supernatants was co-cultured in a proliferation assay with murine HLA-DQ8.Aβ0 
splenocytes, established to be sensitive to the effects of streptococcal superantigens 
(Faulkner et al., 2007). Disrupting smez in H623 resulted in significantly less 
mitogenic stimulation of HLA-DQ8.Aβ0 splenocytes compared with H305 WT 
bacterial supernatant in a dose-dependent manner (Figure 5.4). This suggested that no 
SMEZ protein was present in the supernatant. Complementing H623 with 
pDL278smez in H626 restored the T cell proliferative response to near WT levels 
(Figure 5.4). These observations were also true when WT and smez-/- bacterial 
supernatant was co-cultured with human PBMCs but will need to be confirmed with 
more samples (Figure 5.5). 
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Figure 5.5: Mitogenic activity of H305 and H623 for human PBMCs. 
10-fold dilutions of cell-free supernatants from H305 (WT) and H623 (smez-/-) were co-
cultured with human PBMCs (n=2 healthy controls) in a preliminary study to confirm murine 
splenocyte proliferation assays. 3H-thymidine incorporation into cells (in triplicates) in the 
last 8h of a 3-day incubation was measured and ΔCPM calculated by subtracting background 
proliferation of un-stimulated cells from stimulated cells counts. Data represents mean values 
± SEM. Kruskal-Wallis statistical was used and any significant difference is indicated: * 
p≤0.05. 
 
 
 
M1 serotype S. pyogenes H326 (spea-/-) and H361 (spea-/+) isolates, previously made 
by Sriskandan and colleagues (Sriskandan et al., 1999; Unnikrishnan et al., 2001) 
were included in the proliferation assay to compare with the phenotype of H623. 
Depletion of SPEA protein production significantly reduced the mitogenic ability of 
H326 to induce splenocyte proliferation, correlating with published data 
(Unnikrishnan et al., 2001) and this knockout phenotype was restored in the 
complemented mutant, H361. Interestingly, knocking out SMEZ resulted in slightly 
less mitogenic effect compared to H326 (Figure 5.4) and could be accounted for by S. 
pyogenes secreting less SMEZ than SPEA.  
 
In summary, it was concluded that smez had been knocked out in H623 and 
complemented in H626 as shown by PCR and proliferation assay and these mutants 
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would be useful for later in vitro and in vivo infection experiments to study the effects 
of superantigens on Treg and Teff function. 
 
5.5 Creation of spea-/-smez-/- double knockout S. pyogenes mutant 
 
From further examination of the data from the proliferation assay of H623 (Figure 
5.4), it was observed that there was still some remaining mitogenic effect on 
splenocytes on addition of supernatant from this knockout mutant. This could be 
attributed to the presence of other, weaker, superantigens secreted by H623, such as 
SPEA, SPEF, SPEG and SPEJ (Sriskandan et al., 1999; Nooh et al., 2006). To 
expand the functional studies with the created knockout mutants, it was resolved that 
knocking out both smez and spea would be useful to study the contribution of both 
these superantigens towards the pathogenesis of sepsis.  
 
Using the same technique of insertional duplication mutagenesis with pGhostsmez, 
smez was knocked out in H326 (spea-/-) to create 6 potential double knockout (spea-/-
smez-/-) clones (DKO 1-6). PCR analysis for rRNA, aphI kanamycin resistance 
cassette and intact smez was carried out confirming the insertion and orientation of 
pGhostsmez in H326 as earlier described in Section 5.2 with the same predicted sized 
fragments (Figure 5.6A-C). DKO 2, 3 and 5 produced PCR products (2.5Kb) to 
indicate homologous recombination has occurred via the first smez’ triplet and 
genomic WT smez, whereas DKO 1, 4 and 6 produced fragments (300bp smaller) 
suggestive that recombination had occurred via the second smez’ triplet (Figure 
5.6D). The double knockout clones were also checked by PCR to ensure they were 
still spea-/- by using primers for the spea promoter (S1) and the aphIII kanamycin 
cassette from pUCMUT2.2 plasmid (A1) (Sriskandan et al., 1999). All the double 
knockout clones produced the same 1.8Kb sized fragment along with H326 (Figure 
5.6E). This PCR product was absent in H305 (WT) and H623 (smez-/-), verifying spea 
was still knocked out in the double knockout mutants and the insertional duplication 
mutagenesis had not affected the original spea-/- genotype. 
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Figure 5.6: Insertion and orientation of pGhostsmez into H326 (spea-/-) 
Genomic DNA from H305, H623, H326 and double knockout (DKO) clones (1-6) were 
amplified for the presence of rRNA; 750bp (A); aphI kanamycin resistance cassette; 700bp 
(B), intact smez; 800bp (C). The orientation of pGhostsmez was checked using smezP1 and 
aphI(R) primers: 2.5Kb product (D) as previously shown in Figure 5.3. The presence of 
pUCMUT2.2, the plasmid used to replace WT spea was amplified using S1 and A1 primers 
(1.8Kb product) to show spea was still knocked out in DKO clones (E). 
 
 
 
5.6 Phenotypic analysis of spea-/-smez-/- double knockout S. pyogenes 
mutant 
 
As PCR analysis confirmed that insertional duplication mutagenesis had occurred in 
all the double knockout mutants to disrupt smez and spea expression, double 
knockout clone 2 was picked for the isolate collection as homologous recombination 
via the first smez’ triplet had occurred in the same manner as in H623. This clone was 
renamed H658 (spea-/-smez-/-) and was complemented with pDL278smezspea (see 
Methods 2.5.23) to produce H786 (spea-/+smez-/+). The phenotype of these mutants 
was next examined.  
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Figure 5.7: Comparison of mitogenic activities of H305, H658 and H786. 
Cell-free supernatants (1:10 dilution) were co-cultured with splenocytes from HLA-DQ8.Aβ0 
mice (n=3 females) in a proliferation assay. 3H-thymidine incorporation into cells (in 
triplicates) in the last 8h of a 5-day incubation period was measured and ΔCPM calculated by 
subtracting background proliferation of un-stimulated cells from stimulated cells. Data 
represents mean values ± SEM. Kruskal-Wallis statistical was used and any significant 
difference are indicated: * p≤0.05, **p≤0.01, ***p≤0.0001. 
 
 
 
Cell-free supernatants from all the M1 superantigen mutants were prepared and the 
mitogenic effect of the secreted superantigens in the supernatant was tested in a 
proliferation assay as described in Section 5.4. Proliferation of splenocytes from 
HLA-DQ8.Aβ0 mice was greatly reduced when co-cultured with supernatants from 
H658 compared to H326 and was significantly decreased compared to wild-type 
H305. This knockout phenotype was restored in H786 to near WT levels (Figure 5.7).   
 
With the creation of numerous superantigen knockout and complemented 
streptococcal isolates by insertional duplication mutagenesis, the mutants for in vivo 
infection had to be chosen. As the complemented strains were produced by 
electroporation of modified pDL278 plasmid, requiring antibiotics to maintain the 
presence of the plasmid within the host bacterium, these isolates were not deemed 
suitable for in vivo infection. Antibiotics administration would be necessary alongside 
the bacterial inoculum to maintain the presence of the complementing plasmid within 
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the streptococcal isolate and this would skew the immune response observed in the 
host. With this decision, only four GAS isolates (Table 5.1) were chosen for later in 
vitro and ex vivo phenotypic analysis due to their stable genomic integrated 
superantigen knockout genotype. 
 
Table 5.1: Superantigen knockout isolates for in vivo infection 
The streptococcal isolates proposed for later in vivo murine infection experiments and their 
superantigen genotypes are shown, along with the form of mutagenesis used to generate the 
mutants. 
 
Isolate Superantigen genotype Mutagenesis 
H305 (WT) spea+ smez+ N/A 
H326 spea- smez+ Allelic replacement 
H623 spea+ smez- Insertional duplication 
H658 spea- smez- Insertional duplication 
 
 
 
5.7 Phenotypic characterisation of superantigen knockout isolates 
 
With the creation of the panel of streptococcal superantigen knockout isolates for 
later in vivo infection experiments (Table 5.1), further in vitro phenotypic analysis 
was performed to ensure mutagenesis had not affected other essential aspects of the 
mutants. The growth rate of each streptococcal isolate was measured in vitro in liquid 
culture (Figure 5.8). Overnight cultures of each of the isolates were inoculated into 
fresh broth and optical density at 600nm was followed every hour for 8h as an 
indirect method of assessing bacterial growth. There was no difference in the rate of 
growth of the four GAS isolates in broth (Figure 5.8), indicating the mutagenesis 
process had not affected the rate of proliferation and growth of these isolates in 
culture. 
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Figure 5.8: Growth rate of streptococcal superantigen knockout isolates. 
Growth rates of the streptococcal superantigen knockout mutants (H305, H326, H623 and 
H658) in Todd-Hewitt Broth were measured optically at 600nm in three independent 
experiments. Linear regression statistical testing was carried out and there was no significant 
difference between growth rates of each of the streptococcal superantigen knockout mutants. 
 
 
 
 
Figure 5.9: Opsonophagocytosis assay of superantigen knockout isolates. 
(A) Heparinised human blood (n=4 healthy control donors, in triplicate) or heparinised HLA-
DQ8.Aβ0 blood (n=3 females, in triplicate) (B) was cultured with exponential phase 
streptococcal superantigen KO mutants (H305, H326, H623 and H658) for 3h at 37°C. 
Bacterial counts (CFU) were determined and multiplication factor calculated by dividing 
infected blood CFU by inoculum CFU. 1-way ANOVA statistical test was carried out and no 
significant difference were found.  
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The rate of growth of GAS superantigen knockout isolates ex vivo was assessed by a 
pilot opsonophagocytosis assay (Figure 5.9). Exponential phase streptococcal mutants 
were cultured with human whole blood (Figure 5.9A) or HLA-DQ8.Aβ0 murine 
blood (Figure 5.9B) for 3h before the multiplication factor from the original 
inoculation dose was calculated. Initial analysis showed no significant difference in 
the rate of growth of the four GAS isolates in either human or mouse blood (Figure 
5.9), confirming the mutagenesis had not affected the rate of growth of the isolates in 
whole blood. Interestingly, it would appear that the multiplication effect of H326 and 
H623 in heparinised human blood could be divided into two groups of donors, those 
who phagocytose S. pyogenes well and those who did not. As the HLA-class II 
genotype of the healthy donors used for this experiment was not known, the pattern of 
opsonophagocytosis cannot be correlated to immune responses based on HLA-class II 
preferential binding of superantigens expressed by the four streptococcal isolates. 
 
 
Figure 5.10: Initial analysis of ex vivo mitogenic activities of superantigen knockout 
isolates. 
Sera (1:20) from streptococcal infected (H305, H326, H623 & H658) or PBS immunised 
(PBS) mice (n=2) were co-cultured with human PBMCs (n=5 healthy control donors) in a 
pilot proliferation assay. 3H-thymidine incorporation into cells (in triplicates) in the last 8h of 
a 3-day incubation period was measured and ΔCPM calculated by subtracting background 
proliferation of un-stimulated cells from stimulated cells. ConA was used a positive control 
for proliferative responses and serum from PBS immunised mice determined the background 
signal. Data represents mean values ± SEM. Kruskal-Wallis statistical test was used and no 
significant difference were found. 
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The ex vivo mitogenic phenotype of the streptococcal isolate was studied to verify the 
superantigen knockout phenotype was retained during infection in a mouse model. 
HLA-DQ8.Aβ0 mice were infected with the panel of superantigen knockout isolates 
for 24h and serum collected to stimulate human PBMCs in a proliferation assay 
(Figure 5.10). The murine serum would contain the secreted superantigens from the 
streptococcal mutants. There was no significant difference between the different 
superantigen knockout infected murine sera used to stimulate human PBMCs.  This 
could have been due to the extremely low dilution and number of samples of serum 
used. However, the pattern of mitogenic stimulation was similar to that observed in 
vitro with HLA-DQ8. Aβ0 splenocytes (Figure 5.7) and human PBMCs (Figure 5.5). 
The serum from H305 infected mice induced the most proliferation of PBMCs and 
then followed by H326, H623 and H658 infected serum induced the least amount of 
proliferation.  
 
Overall, it was concluded that process of mutagenesis to create the panel of four 
streptococcal superantigen knockout isolates had not affected the growth rate of the 
mutants, either in broth or whole blood and they retained their superantigenic 
identities during infection in a mouse model. 
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5.8 Discussion 
 
Overall, due to the lack of availability of bacterial reagents to study streptococcal 
antigenic responses, I sought out in this chapter to create a new panel of genetically 
stable streptococcal superantigen knockout isolates to dissect out the different 
superantigenic responses during acute GAS infection.  
 
As discussed in Chapter 1, superantigens are an important class of virulence factors 
secreted by both streptococcal and staphylococcal clinical isolates and are tentatively 
linked to the pathogenesis of bacterial sepsis. In STSS, there is an approximate 
correlation with number and or potency of superantigens (Proft et al., 2003), and this 
in turn has been supposed to facilitate pathogenesis through an ill-described process 
utilising the so-called “cytokine storm”.  
 
I have created a number of streptococcal superantigen knockout isolates based on a 
M1 serotype WT S. pyogenes clinical isolate, formerly cultured from a patient with 
scarlet fever. By using insertional duplication mutagenesis, smez was knocked out of 
H305 to create H623, a new M1 serotype isolate. This had previously never been 
done before as published work was based on an M89 S. pyogenes isolate (Sriskandan 
et al., 1999).   
 
By PCR analysis, it was confirmed this knockout mutant did not contain intact smez 
gene (Figure 5.2) and proliferation assay performed with supernatant from this 
mutant co-cultured with HLA-DQ8.Aβ0 splenocytes showed a significantly decreased 
mitogenic effect on target cells (Figure 5.4). This knockout phenotype was reinforced 
by complementation studies with H626 to show that upon addition of pDL278smez, a 
plasmid carrying the smez gene and endogenous promoter, the knockout phenotype 
could be restored back to near WT levels in a proliferation assay (Figure 5.4).  
 
These results were reminiscent of the smez-/- phenotype shown in H377, the M89 
serotype knockout isolate mutated with pGhostsmez (Unnikrishnan et al., 2002), 
whereby this isolate was shown to have reduced mitogenic activity in human PBMCs 
and HLA-DQ8 splenocytes. In this paper from our lab, the authors studied the 
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cytokine profile of PBMCs co-cultured with H377 cell-free supernatant by ELISA 
and found the presence of SMEZ could account for a time-dependent release of pro-
inflammatory cytokines, such as IFN-γ, TNF-α, IL-1β and IL-8 (Unnikrishnan et al., 
2002). They also confirmed there was a specific Vβ11+ T cell expansion post WT S. 
pyogenes (H293) stimulation of murine splenocytes and this was absence upon smez 
knockout mutant (H377) co-culture (Unnikrishnan et al., 2002). These phenotypic 
traits were not addressed in my characterisation experiments and could be future 
work to truly validate the smez knockout phenotype of H623.  
 
A spea-/-smez-/- double superantigen knockout mutant (H658) was created based on an 
existing spea-/- M1 S. pyogenes isolate (H326). Knocking out both smez and spea in 
the mutant appeared to greatly reduce its ability to induce proliferative responses on 
HLA-DQ8.Aβ0 splenocytes compared to both H305 (WT) and even H326 (spea-/-) 
(Figure 5.7). This knockout phenotype was returned to WT levels by the additional 
electroporation with pDL278smezspea plasmid to create H786 (Figure 5.7). This 
work thus, documents the first double superantigen knockout mutant made based on 
H305 WT S. pyogenes isolate.  
 
With the deliberate exclusion of complemented isolates for future in vivo infection 
experiments due to their unstable superantigen expression profile, the four remaining 
S. pyogenes isolates were further characterised to determine whether other aspects of 
their phenotype were affected. The growth rate of H305, H326, H623 and H658 were 
found to be no different if grown in liquid broth or whole blood, suggesting that the 
lack of superantigens does not affect their growth (Figure 5.8 and Figure 5.9). 
Characterisation of H623 and H658 had never been conducted until now, although 
H326 had previously been found to have no difference in growth rate in broth or 
murine whole blood compared to H305 (Unnikrishnan et al., 2001). H377, the M89 
smez knockout mutant was also shown to have no difference in growth rate in broth 
or murine whole blood compared to H293 WT isolate, indicative that the insertion of 
pGhostsmez was unlikely to affect the growth of the bacterium (Unnikrishnan et al., 
2002).  
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The superantigenic phenotype of the four selected S. pyogenes mutants was retained 
in vivo in the serum of infected mice, conferring a stable expression pattern of 
superantigens (Figure 5.10). This reassures that, during in vivo infection experiments, 
the subsequent immune response would be due to the presence or absence of the 
given superantigens secreted by the various knockout mutants.  
 
Few papers have been published regarding genetic superantigen knockout 
streptococcal mutants. The field has been dominated by experiments concentrating on 
the use of purified recombinant superantigens administrated in vitro or in vivo. 
Superantigens from S. equi, a Group C Streptococci and causative agent of strangles 
in horses were co-cultured in vitro with equine PBMCs to induce T cell proliferation 
and IFN-γ production (Paillot et al., 2010). Recombinant SPEA has also been 
inoculated into HLA transgenic mice to study the resultant immune response 
(Welcher et al., 2002; Rajagopalan et al., 2006). Some papers have published work 
pertaining to isolates with certain point mutations within a particular superantigen, 
but these experiments have been limited to structural analysis of interactions between 
superantigens and TCR or MHC class II molecules (Kline and Collins, 1996).  
 
In summary, the use of these four S. pyogenes superantigen knockout mutants 
described in this chapter would be hugely beneficial in understanding the relative 
contributions of different superantigens during acute sepsis within the context of an in 
vivo infection model. This will be discussed in Chapter 6. 
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Chapter 6 
	  
6 Characterisation of regulatory T cells during acute Streptococcus 
pyogenes infection  
 
6.1 Introduction 
 
The conventional view of the immune response considers innate immunity to be 
recruited and activated first during infection, acting fast within minutes to hours to 
eliminate and prevent the spread of pathogens. This is generally followed by the 
functionally linked but slower adaptive immunity, providing support to the innate 
response with terminally differentiated effector cells and offering long-lasting 
protection in the form of memory cells and, in the case of B cells, affinity maturation 
(Kamat and Henney, 1976; Nossal et al., 1965; Nossal and Mäkelä, 1962; Vischer et 
al., 1967).  
 
Innate immunity offers a broad specificity against pathogens using germline-encoded 
Pattern Recognition Receptors (PRRs) that recognise common conserved pathogenic 
features or Pathogen-Associated Molecular Patterns (PAMPs) (Uematsu and Akira, 
2006; Beutler, 2009; Kawai and Akira, 2010). With this in mind, innate immunity 
acts in a non-specific manner, which is in contrast to adaptive immunity, which 
utilises antigen specific receptors generated by V(D)J recombinase (Yancopoulos et 
al., 1986).  
 
PRRs expressed on innate cell types, such as scavenger receptors on macrophages are 
key in pathogen recognition and mediate up-take and killing microorganisms as part 
of the normal immune response. To date, there are several families of PRRs, the most 
commonly studied being Toll-Like Receptors (TLRs), expressed on most innate 
immune cells, such as DCs and macrophages (Takeuchi and Akira, 2010). 
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Recognition of microbial ligands by innate cell types initiates a chain of events, 
culminating in the activation of adaptive immunity in the form of B or T cells (Hou et 
al., 2008).    
 
Adaptive immunity is slower acting than innate immunity, as it requires activation 
and priming, usually by innate components such as DCs before lymphocyte clonal 
expansion, which can take days before being able to efficiently aid the host response 
(Kamat and Henney, 1976). It should also be noted that members of adaptive 
immunity express PRRs (Hornung et al., 2002). Both T and B cells themselves have 
been shown to express a wide array of TLRs, both on their surface and also in 
intracellular compartments, suggestive that microbial products can directly activate 
these subsets of cells, without the need of innate cell mediated signals (Zarember and 
Godowski, 2002).  
 
A particular subset of CD4+ T cells have been highly researched in the past few years 
due to their immuno-suppressive function, termed regulatory T cells (Tregs). A role for 
Tregs has been implicated during several different infectious models with differing 
outcomes (Mittrücker and Kaufmann, 2004; Belkaid, 2007) and previously discussed 
in Chapter 3.  
 
The induction of Tregs during the later stages of infection has been deemed as 
beneficial to the host in order to limit tissue damage caused by the activated immune 
system. Depletion of Tregs during murine malaria infection with Plasmodium yoelii 
protected mice from death, suggesting that suppression of effector cells was 
protective in this system (Hisaeda et al., 2004). However, there is evidence that Tregs 
may also contribute to delaying the initial immune response to control the spread of 
pathogens during infection. Pathogen-specific Tregs have also been identified during 
M. tuberculosis infection and have been shown to limit the appearance of IFN-γ 
producing effector T cell subsets associated with protective immunity (Shafiani et al., 
2010). 
 
To date, very little research has been carried out on the function or kinetics of Tregs 
induction during S. pyogenes infection. Costalonga and colleagues (Costalonga et al., 
2008) had reported that S. pyogenes in nasal-associated lymphoid tissue (NALT) 
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induced TH1 subsets, although Treg induction was not found in this experimental 
model. Previous work has predominantly focused on streptococcal superantigens and 
Treg induced tolerance (Papiernik, 2001). However, these studies were mainly based 
on staphylococcal superantigens. 
 
Repeated exposure of superantigens, such as SEA and SEB from S. aureus can induce 
Tregs characterised by expression of CTLA-4 and IL-10 production with suppressive 
capacity (Noël et al., 2001). Similar experiments have demonstrated that superantigen 
induced Tregs, dissimilar from nTreg commonly described in humans and mice, as they 
do not express CD25 (Feunou et al., 2003). CD4+CD25- T cells can be stimulated to 
gain suppressive function post repeated exposure to SEA in models of tolerance 
(Grundström et al., 2003). It should also be pointed out that bacteria are not the only 
source of this virulence factor as virus can also produce superantigens (Punkosdy et 
al., 2011).  
 
The precise kinetics of induced Tregs during infection has been investigated in many 
different models. During the early stages of mucosal infection with HSV, both 
activated effector and regulatory T cells are recruited to the site of infection (Lund et 
al., 2008). Tregs with suppressive function are seen to proliferate in draining lymph 
nodes and at the site of infection in the first four days post inoculation (Lund et al., 
2008). Depletion of Tregs in Foxp3.DTR transgenic mice infected with HSV increases 
viral load in the mucosa and central nervous system and mice rapidly succumb to 
infection (Lund et al., 2008), indicating that Tregs are beneficial in this model.  
 
Tregs subset of cells express TLRs, either on their surface or in internal compartments. 
For example, CD4+CD25+ cells have been shown to express TLR4 and can be 
activated via LPS stimulation (Caramalho et al., 2003) and enhance their proliferation 
and survival (Gelman et al., 2004; Liu and Zhao, 2007). Tregs also express TLR2 
although their function is still debated (Sutmuller et al., 2006). 
 
The natural ligands for TLR2 are Lipoteichoic Acid (LTA) or bacterial lipoproteins. 
tlr2-/- mice exhibit decreased peripheral CD4+CD25+ Treg cells compared to WT 
littermates as shown by flow cytometry, leading to the conclusion that this particular 
TLR is involved in Treg cell population expansion (Crellin et al., 2005; Netea et al., 
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2004; Zanin-Zhorov et al., 2006). This has been reinforced by work in which purified 
CD4+CD25+ Tregs co-cultured with PAM3Cys, a TLR2 agonist were found to have 
enhanced proliferative abilities and hence increased Treg numbers (Tang et al., 2008). 
The addition of PAM3Cys also increased CD25 expression (Tang et al., 2008) and the 
MyD88 dependent pathway was also required as myd88-/- mice exhibited decreased 
CD4+CD25+ Tregs similar to the tlr2-/- mice (Sutmuller et al., 2006). The precise 
mechanism by which TLR2 activates Tregs is still unclear. Whether TLR2-mediated 
activation of Tregs plays a role during S. pyogenes infection warrants further 
investigation.  
 
In this chapter, I will characterise the kinetics of Tregs during acute S. pyogenes 
infection and investigate whether secreted streptococcal superantigens have any 
influence on Treg induction. This will be achieved through in vivo infection in our 
HLA-DQ transgenic mouse model with streptococcal superantigen knockout isolates 
created and described in Chapter 5. I will also briefly examine whether TLR2 has a 
part to play in the induction of Tregs during GAS infection and correlate this to the 
presence or absence of streptococcal superantigens. 
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6.2 Kinetics of Tregs during chronic S. pyogenes infection 
 
 
Figure 6.1: Representative staining of CD4+CD25+Foxp3+ T cells.  
HLA-DQ8.Aβ0 females were infected with 9x106 CFU H305 WT S. pyogenes i.m at t=0h. At 
defined time points, groups of mice (n=4 at t=0h and 48h, n=5 at t=24h and 36h) were culled 
and DLNs (A) and spleens (B) were harvested for flow cytometry analysis of 
CD4+CD25+Foxp3+ cells. Representative dot-plots gated on CD4+ cells show Foxp3 
expression (y-axis) and CD25 expression (x-axis). Percentages in quadrants are based on 
gated CD4+ cells. 	  	  
 
To characterise the kinetics of Tregs during acute S. pyogenes infection, HLA-DQ 
transgenic mice were utilised in this study, having formerly been demonstrated to be 
sensitive to GAS infection, in particular to the presence of secreted streptococcal 
superantigens (Faulkner et al., 2007). Before carrying out a time course of infection, 
draining inguinal lymph nodes and spleens were harvested 24h post infection for flow 
cytometric analysis of CD4+CD25+Foxp3+ cells (Figure 6.1). From this infection 
protocol, I established that it was possible to detect the presence of 
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CD4+CD25+Foxp3+ Treg cells in this model by flow cytometry (Figure 6.1). HLA-
DQ8.Aβ0 mice were next infected with 9x106 CFU H305, a scarlet fever clinical S. 
pyogenes isolate via intra-muscular route in a longer chronic infection protocol 
(Figure 6.2). 	  
 
Figure 6.2: Detection of Foxp3+ cells during chronic S. pyogenes infection.  
HLA-DQ8.Aβ0 females were infected with 9x106 CFU H305 i.m at t=0h. At defined time 
points, groups of mice (n=4 at t=0h and 48h, n=5 at t=24h and 36h) were culled and DLNs 
(A) and spleens (B) were harvested for flow cytometry analysis of CD4+CD25+Foxp3+ cells. 
Representative histograms show Foxp3 expression (black line) of CD4+CD25+ T cells 
compared to Fluorescence Minus-One (FMO) controls (shaded histogram). Percentages of 
Foxp3+ cells shown by the bracket are of gated CD4+CD25+ cells. 
 
 
 
Having validating the choice of readout for the detection of Tregs during GAS 
infection, draining inguinal lymph nodes and spleens were harvested at various time 
points post infection with 9x106 CFU H305 S. pyogenes before CD4+CD25+Foxp3+ 
Treg cells were stained and measured by flow cytometry (Figure 6.2).  
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Figure 6.3: Kinetics of Tregs during chronic S. pyogenes infection.  
HLA-DQ8.Aβ0 females were infected with 9x106 CFU H305 WT S. pyogenes i.m at t=0h. At 
defined time points, groups of mice (n=4 at t=0h and 48h, n=5 at t=24h and 36h) were culled 
and DLNs (A) and spleens (B) harvested for flow cytometry analysis of CD4+CD25+Foxp3+ 
cells. Mean and SEM of percentage of CD25+Foxp3+ of CD4+ T cells (top), percentage of 
CD4+CD25+Foxp3+ of total cells (middle) and Foxp3 expression per cell (bottom) are shown. 
Kruskal-Wallis statistical test was carried out and any significant differences are indicated: 
*p<0.05. 
 
 
 
In the draining lymph node, the expression of Foxp3 remained constant within the 
CD4+CD25+ T cell population during the time course of S. pyogenes infection. In the 
spleen, there was a decrease in expression of Foxp3 per cell (MFI) from CD4+CD25+ 
population, with a significant drop at 36h post infection in relation to uninfected t=0h 
controls (Figure 6.3). The percentage of CD25+Foxp3+ cells within the CD4+ T cell 
population appeared to increase in the draining lymph node, whereas this population 
was marginally contracted in the spleen compared to un-infected controls (Figure 
6.3).   
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It was interesting to observe changes in the kinetics of Tregs within a relative short 
amount of time (24-36h) post GAS infection, as adaptive immune responses are 
generally characterised in textbook terms as appearing several days post the initial 
infection (Murphy et al., 2007). With this in mind, it was decided the disease 
phenotype would be examined within a shorter time course of an acute S. pyogenes 
infection to try to correlate this with early changes in the kinetics of Tregs. 
 
 
 
6.3 Increase bacterial burden during acute S. pyogenes model of 
infection 
 
As relative quick changes in the kinetics of Foxp3+ Tregs were observed during S. 
pyogenes infection, a shorter time course of GAS infection was established with a 
higher dose of H305 WT S. pyogenes to induce acute disease and sepsis in the HLA 
transgenic mouse model. Disease pathology along with changes in Tregs were 
investigated at 4, 8, 12 and 24h post infection. H305 bacterial overnight cultures for 
in vivo infection were resuspended in PBS to give a dose of approximately 108 CFU 
per 50µl. However, due to experimental constraints, it was not viable to achieve the 
same dose for each experiment, as it was not possible to quantify the precise CFU of 
the inoculum before infection. Serial dilution of the inoculum was the only method in 
order to quantify the dose, however, this would only give the CFU dose the next day 
after infection.   
 
As the infection progressed, the mice had increased percentage weight loss (Figure 
6.4A), indicative that systemic infection was induced within 24h post infection. In 
contrast, mice injected with PBS appeared to recover and put on weight from 12 to 
24h post inoculation. There was increased bacterial burden in the sampled thigh, 
blood, spleen and liver tissue over time (Figure 6.4B), correlating with the increased 
percentage body weight loss. No S. pyogenes was detected in sham treated mice (data 
not shown). 
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Figure 6.4: Pathogenic responses during acute S. pyogenes infection in HLA-DQ8.Aβ0 
transgenic model. 
A. Percentage total weight loss during acute WT S. pyogenes infection. HLA-DQ8.Aβ0 
females were infected with 4x108 CFU H305 WT S. pyogenes or PBS (sham) i.m at t=0h. 
The start weight of each mouse was recorded. At defined time points, groups of mice (n=7 
per infected time point and n=4 per sham time point) were culled and the end weight 
recorded. The percentage total weight loss was calculated and the mean and SEM are 
represented.  
B. Bacterial counts during acute WT S. pyogenes infection. HLA-DQ8.Aβ0 females were 
infected with 1x108 – 109 CFU H305 WT S. pyogenes or PBS (sham) i.m at t=0h as part of 
three independent experiments. At defined time points, groups of mice were culled and 
bacterial counts were determined (n=17 per infected time point for blood, spleen and liver 
and n=14 per infected time point for thigh tissue). No bacterial growth was detected from any 
sampled organs of sham-infected mouse (data not shown).  
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Figure 6.5: Cytokine responses during acute GAS infection in HLA-DQ8.Aβ0 transgenic 
model. 
HLA-DQ8.Aβ0 females were infected with 4x108 CFU H305 WT S. pyogenes or PBS (sham) 
i.m at t=0h. At various time points, groups of mice were culled (n=6 per infected time point 
and n=4 per sham infected time point) and serum collected for cytokine analysis. Serum IL-6 
and IL-17A concentrations were measured by ELISA, mean and SEM represented. No 
significant differences were found using 1-way ANOVA statistical analysis. Experiment was 
carried out with Dr. R. Ingram. 
 
 
 
Cytokine analysis of IL-6 and IL-17A by ELISA was performed on serum collected 
from the short time course of infection. IL-6 levels were below levels of detection in 
sham-treated mice, correlating with lack of induced disease (Figure 6.5). However, in 
S. pyogenes infected mice, there was a steady increase in IL-6 in the serum, peaking 
at 8h post infection before declining (Figure 6.5). IL-17A levels in the serum 
displayed a different pattern of production. Interestingly, IL-17A was detected in 
sham-treated mice, despite the absence of microbial infection (Figure 6.5). This is 
reminiscent of immune-surveillance mechanisms mediated by innate cell types such 
as γδ T cells (Hayday, 2009). S. pyogenes infected mice had slightly higher levels of 
serum IL-17A at 4, 8 and 24h post infection (Figure 6.5).  
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6.4 Changes in gene expression during acute WT S. pyogenes infection 
 
 	  
 
Figure 6.6: qRT-PCR analysis of transcription factors expression during acute S. 
pyogenes infection. 
HLA-DQ8.Aβ0 females were infected with 1x108 - 109 CFU H305 WT S. pyogenes infected 
at t=0h as part of 2 independent experiments or PBS (sham). At various time points, groups 
of mice were culled (n=10 per infected time point and n=5 per sham time point) and DLN (A) 
and spleens (B) harvested for qRT-PCR analysis of transcription factor gene expression. 
Infected samples were normalised to tissue specific reference genes and sham treated 
samples. Fold change in expression was determined by REST analysis and mean and SEM 
represented. Any significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001.  
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qRT-PCR analysis was carried out on draining lymph nodes and spleen from S. 
pyogenes infected mice from the short time course of acute infection. Fold changes in 
gene expression were calculated relative to time matched sham controls. Changes in 
the expression of transcription factors genes as markers for defined T helper cell 
subsets were investigated to see if infection induced augmentation of gene 
expression.  
 
In the draining lymph node, foxp3 gene expression was significantly increased above 
time-matched sham controls, indicative of elevated Tregs appearing within 4h of 
infection (Figure 6.6A).  This also correlated with increased with gitr expression, 
another possible marker for Tregs (McHugh et al., 2002) (Figure 6.6A).  t-bet, gata-3 
and rorγt gene expressions were also studied as master regulators for TH1, TH2 and 
TH17 cells subsets respectively. During acute GAS infection, t-bet, gata-3 and rorγt 
gene expression was increased over time in the draining lymph nodes (Figure 6.6A), 
suggestive of TH1, TH2 and TH17 differentiation.  
 
In the spleen, foxp3 gene expression was decreased below time-matched sham 
controls, indicative of perhaps declining Treg levels (or at least, Foxp3 transcription) 
in this organ (Figure 6.6B). This however, did not match with gitr expression (Figure 
6.6B). It should be noted that GITR is not a Treg specific marker and is also expressed 
on activated T cells (Nocentini and Riccardi, 2009). t-bet and gata-3 gene expression 
was up-regulated (Figure 6.6B), suggestive that TH1 and TH2 T cell subsets may be 
differentiating in the spleen. There was however, no difference in rorγt gene 
expression compared to sham-treated controls (Figure 6.6B). This suggested that 
there were no changes in TH17 polarisation or activation in the spleen.  
 
qRT-PCR analysis of fold changes in cytokine gene expression during the short time 
course of GAS infection was next studied. Draining lymph nodes and spleens were 
harvested from sham and S. pyogenes infected mice at various time point post 
infection with 108 CFU H305.  
 
tgf-β gene expression was up-regulated in S. pyogenes infected draining lymph nodes, 
whereas, there was no significant difference in il-10 gene expression in the lymph 
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node in S. pyogenes infected mice compared to PBS treated mice. Acute phase 
cytokines genes such as il-6 and tnf-α expression were up-regulated in infected mice, 
correlating with serum IL-6 levels (Figure 6.5) and reflective of systemic disease 
onset. Despite the increase in expression of t-bet and rorγt in the draining lymph node 
(Figure 6.6A), the gene expression of the hallmark cytokines of TH1 and TH17 cells; 
IFN-γ and IL-17A respectively did not reflect this. The level of transcription of these 
cytokines was significantly down-regulated compared to sham-treated controls 
(Figure 6.7). There was no change in gene expression pattern of il-4 transcription. il-9 
expression was significantly down-regulated over the time course of acute infection 
(Figure 6.7), despite evidence of a trend of up-regulation of gata-3, particularly at 
12h post infection (Figure 6.6A). Although il-9 was significantly up-regulated upon 
infection compared to sham controls at 4 and 8h, the increased expression of the 
master regulator of TH2 cells does not correlate with increased expression of the 
respective hallmark cytokines, il-4 and il-9 as shown by qRT-PCR analysis. 
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Figure 6.7: qRT-PCR analysis of cytokine expression in the lymph node during acute S. 
pyogenes infection. 
HLA-DQ8.Aβ0 females infected with 1x108 - 109 CFU H305 WT S. pyogenes infected at t=0h 
as part of 2 independent experiments or PBS (sham). At various time points, groups of mice 
were culled (n=10 per infected time point and n=5 per sham infected time point) and DLN 
harvested for qRT-PCR analysis of cytokine gene expression. Infected samples were 
normalised to tissue specific reference genes and sham treated samples. Fold change in 
expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
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Figure 6.8: qRT-PCR analysis of cytokine expression in the spleen during acute S. 
pyogenes infection. 
HLA-DQ8.Aβ0 females infected with 1x108 - 109 CFU H305 WT S. pyogenes infected at t=0h 
as part of 2 independent experiments or PBS (sham). At various time points, groups of mice 
were culled (n=10 per infected time point and n=5 per sham infected time point) and spleens 
harvested for qRT-PCR analysis of cytokine gene expression. Infected samples were 
normalised to tissue specific reference genes and sham treated samples. Fold change in 
expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001.  
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Although the gene expression of tgf-β in the draining lymph node was significantly 
up-regulated, the expression of this cytokine in the spleen was significantly down-
regulated (Figure 6.8). il-10 was significantly up-regulated in the spleen (Figure 6.8), 
suggestive this anti-inflammatory cytokine, associated with Treg function may be 
playing a dominant role in the spleen. il-6 was up-regulated in the spleen at all time 
points similar to the draining lymph node. tnf-α was only significantly up-regulated at 
later time points of the infection course (Figure 6.8). In contrast to the draining lymph 
node, ifn-γ and il-17a gene expression was elevated compared to sham-treated 
controls (Figure 6.8). Increased ifn-γ correlated with increased t-bet expression in the 
spleen, however, the pattern of il-17a expression did not match decreased rorγt 
transcription. This suggested that other cell types, apart from TH17 cells may be 
contributing to the increased expression of il-17a, such as NK cells. il-4 and il-9 
expression in the spleen did not differ from sham-treated controls and during the later 
stages of GAS infection decreased (Figure 6.8). This suggests TH2 cytokines may not 
play a significant part in the spleen during acute S. pyogenes infection, although il-9 
gene expression was significantly increased 4 and 8h post infection in the draining 
lymph node.   
 
 
Figure 6.9: qRT-PCR analysis of mpo expression during acute S. pyogenes infection. 
HLA-DQ8.Aβ0 females infected with 1x108 - 109 CFU H305 WT S. pyogenes infected at t=0h 
as part of 2 independent experiments or PBS (sham). At various time points, groups of mice 
were culled (n=10 per infected time point and n=5 per sham infected time point) and DLN 
(A) spleens (B) harvested for qRT-PCR analysis of mpo expression. Infected samples were 
normalised to tissue specific reference genes and sham treated samples. Fold change in 
expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
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qRT-PCR analysis was performed for changes in innate immune markers. mpo was 
studied as a marker for neutrophil activation (Schmekel et al., 1990). Gene expression 
of this gene was found to be down-regulated both in the draining lymph node and 
spleen (Figure 6.9), suggesting that neutrophils are not activated during acute S. 
pyogenes infection. 
 
In summary, qRT-PCR analysis revealed induction of foxp3 expression in the 
draining lymph node, possibly due to up-regulation of tgf-β. This was contrasted in 
the spleen, where foxp3 transcription was down-regulated. Gene markers for pro-
inflammatory cytokines, such as il-6, tnf-α, ifn-γ and il-17a were significantly 
elevated in the spleen over time, reflective of the response to developing systemic 
infection. 
 
 
 
6.5 Kinetics of Tregs during acute WT S. pyogenes infection 
 
 
Figure 6.10: Representative staining of Tregs during acute S. pyogenes infection. 
HLA-DQ8.Aβ0 females were infected with 4x108 CFU H305 WT S. pyogenes infected at 
t=0h. 24h post infection DLN were harvested for flow cytometric analysis of 
CD4+CD25+Foxp3+ cells. Representative staining based on gated CD4+ T cells expressing 
CD25 and Foxp3: isotype control (left) and Foxp3 stained (right) from DLN. Percentage of 
Foxp3+ of CD4+CD25+ T cells is shown in the gate. Experiment carried out with Dr. R. 
Ingram. 
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As qRT-PCR analysis for the acute time course of infection experiment suggested a 
maintained elevation in foxp3 expression in the draining inguinal lymph node and a 
progressive fall in the spleen, the kinetics of Tregs were followed directly by flow 
cytometry. A short time course of infection with H305 S. pyogenes was carried out in 
the HLA-DQ8.Aβ0 murine model. Draining lymph nodes and spleen were harvested 
for flow cytometric analysis for CD4+CD25+Foxp3+ cells (Figure 6.10). 
 
 
Figure 6.11: Flow cytometric analysis of Tregs during acute WT S. pyogenes infection.  
HLA-DQ8.Aβ0 females were infected with 4x108 CFU H305 WT S. pyogenes infected at 
t=0h or PBS (sham). At various time points, groups of mice were culled (n=7 per infected 
time point and n=6 per sham infected time point) and DLN (A) and spleens (B) harvested for 
flow cytometric analysis of CD4+CD25+Foxp3+ cells. Mean and SEM of absolute numbers 
(left), percentage of total cells (middle) and Foxp3 MFI (right) of CD4+CD25+Foxp3+ cells 
are represented. Data is normalised to time-matched sham controls. 1-way ANOVA statistical 
test was carried out on absolute numbers and Foxp3 MFI data and Kruskal-Wallis statistical 
test was carried out on percentage of total cells data. Any significance differences are 
indicated: *p<0.05, ***p<0.001. Experiment carried out with Dr. R. Ingram. 
 
 
 
From flow cytometric analysis of Tregs during a short time course of acute GAS 
infection, increased expression of Foxp3 per cell in terms of MFI (Figure 6.11A) was 
observed in the draining lymph node. However, there were only moderate changes in 
the absolute numbers of CD4+CD25+Foxp3+ cells (Figure 6.11A) and percentage of 
CD25+Foxp3+ of CD4+ T cells (Figure 6.11A) over time. The increase in Foxp3 MFI 
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in Tregs over the time course of GAS infection, mirrors previous qRT-PCR data of 
increased foxp3 gene expression in the draining lymph node with significant up-
regulation observed from 8 to 24h (Figure 6.6A). 
 
In the spleen, there was a decrease in the absolute number of CD4+CD25+Foxp3+ 
cells from 4 to 24h (Figure 6.11B). This was reflected in the gradual fall in the 
percentage of CD25+Foxp3+ of CD4+ T cells (Figure 6.11B). Interestingly, there was 
a slight increase in Foxp3 MFI over time in the spleen (Figure 6.11B), indicating that 
although there are less Tregs in the spleen, they are expressing more Foxp3 per cell. 
The Foxp3 MFI flow cytometric data does not agree with qRT-PCR analysis of 
infected spleen samples, whereby gene expression of foxp3 was significantly 
increased from 4 to 8h post infection and then decreased (Figure 6.6B), but would 
generally correlate with overall decrease in the absolute numbers of Tregs in the spleen 
over the 24h of GAS infection.  
 
Overall, changes in Tregs induction and absolute numbers were detected during acute 
S. pyogenes infection by qRT-PCR and flow cytometric analysis. Systemic bacterial 
burden increased with time post infection, matched with amplified IL-6 levels in 
serum. foxp3 gene expression increased in the draining inguinal lymph node, whereas 
fell in the spleen and correlated with changes in elevated Foxp3 MFI in the draining 
lymph node and decrease in absolute numbers of Tregs in the spleen.  
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6.6 Streptococcal superantigens contributes to disease pathology  
 
 
Figure 6.12: Pathogenic responses during superantigen knockout S. pyogenes mutant 
infection.  
HLA-DQ8.Aβ0 females (n=8 per isolate and n=3 per sham group) were infected with PBS 
(sham) or 2-4x108 CFU H305, 3-7x108 CFU H326, 3-7x108 CFU H623, 2-6x108 CFU H658 
at t=0h as part of 2 independent experiments for 24h. (A) Percentage total weight loss was 
calculated and mean and SEM represented. Kruskal-Wallis statistical test was carried out and 
any significance differences are indicated: *p<0.05, **p<0.01. (B) Bacterial counts for thigh, 
blood, spleen and liver were calculated and mean and SEM represented. Kruskal-Wallis 
statistical test was carried out and any significant differences are indicated: *p<0.05, 
**p<0.01. Sham infected mice did not show any bacterial growth from sampled organs (data 
not shown). 
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S. pyogenes secretes superantigens as virulence factors; this has been presumed to 
operate through subversion of appropriate immunity, though there is a paucity of 
described mechanism (Proft and Fraser, 2003). It has been documented that 
streptococcal superantigens are in most cases correlated with invasive diseases, such 
as bacterial sepsis and necrotising fasciitis (Sriskandan and Altmann, 2008). In order 
to link changes in disease pathology to Treg kinetics to the presence or absence of 
streptococcal superantigens, bacterial mutants were created with known (and 
phenotypically strongest) superantigens knocked out as described in Chapter 5.  
 
HLA-DQ8.Aβ0 mice exhibiting heightened sensitivity to streptococcal superantigens 
[due to the high affinity binding between HLA-DQ and the streptococcal 
superantigens (Llewelyn et al., 2004)] were utilised in acute infection with a panel of 
superantigen knockout isolates (Table 5.1). Previous experiments had suggested 
significant decrease in the absolute numbers of Tregs in the spleen and increase in 
Foxp3 expression in the draining lymph nodes 24h post infection with WT H305 
infection. HLA-DQ8.Aβ0 transgenic mice were infected via intra-muscular route with 
the superantigen knockout isolates for 24h before bacterial counts, serum cytokine 
ELISA, qRT-PCR and flow cytometric analysis were carried out.  
 
Knocking out spea superantigen gene in either WT (H326) or a smez-/- mutant (H658) 
S. pyogenes resulted in significantly increase percentage weight loss compared to 
sham-treated mice (Figure 6.12A). The lack of smez superantigen gene in WT S. 
pyogenes (H623) lead to a significant reduction in percentage weight loss upon 
infection compared to H326 (spea-/-) (Figure 6.12A), indicative of less severe 
systemic infection.  
 
Bacterial counts were carried out to assess the spread of infection with the various 
superantigen knockout isolates. Sham-treated mice did not exhibit any growth of β-
haemolytic bacteria (data not shown). H658 infection lead to significantly decreased 
bacterial counts in the thigh compared to WT S. pyogenes (Figure 6.12B), suggesting 
the lack of SMEZ and SPEA may contribute to this reduction in CFU. In the blood, it 
was observed H623 infected mice had the highest amount of recovered bacteria, even 
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higher than H326 (Figure 6.12B). This was also true in the spleen and liver (Figure 
6.12B).  
 
The removal of SMEZ in the WT strain (H623) resulted in increased bacterial burden 
compared to WT infection. My data would also suggest that the lack of SPEA in 
H326 and H658 would lead to less severe systemic infection, particularly in the 
blood. However, it was interesting to note, H326 had been shown to induce 
bacteraemia compared to H305 WT infection but this was carried out in CD1 outbred 
mice (Sriskandan et al., 1999). The use of HLA transgenic mice (thus conferring 
superantigen sensitivity in contrast to mouse H-2A, which bind poorly) may explain 
the difference in pathology induced by H326 infection. 
 
 
Figure 6.13: Cytokine responses during superantigen knockout S. pyogenes mutant 
infection. 
HLA-DQ8.Aβ0 females (n=8 per isolate and n=3 per sham group) were infected with PBS 
(sham) or superantigen knockout S. pyogenes isolate (2-4x108 CFU H305, 3-7x108 CFU 
H326, 3-7x108 CFU H623, 2-6x108 CFU H658) at t=0h as part of 2 independent experiments 
for 24h. Serum was collected and concentrations of IL-6, IL-17A and IFN-γ were determined 
by ELISA and mean and SEM represented. 1-way ANOVA statistical test was carried out 
and any significant differences indicated: *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
Infection with the superantigen knockout mutants resulted in elevated levels of IL-6, 
with no observed significant difference between the various isolates. The increase in 
recovered bacteria systemically post H623 infection correlated with a significant 
increase of IL-17A in the serum compared to sham-treated mice (Figure 6.13). WT S. 
pyogenes (H305) and H623 infected mice appeared to have increased concentration 
of IFN-γ in the blood (Figure 6.13). It would appear that the lack of SPEA in H325 
lead to decreased levels of serum IL-17A and IFN-γ (Figure 6.13), suggestive that 
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this streptococcal superantigen may be a potent mediator of the observed “cytokine 
storm” in septic patients. The reverse can be said for H623, whereby upon removal of 
this superantigen lead to increased production of pro-inflammatory cytokines (Figure 
6.13). 
 
In conclusion, the presence of streptococcal superantigens such as SMEZ and SPEA 
modulate the disease pathology, particularly at the site of infection. This is 
demonstrated by the reduction in recovered bacteria in the thigh. However, the lack of 
SMEZ in H623 resulted in increased bacteraemia and systemic release of IL-17A, 
indicating different superantigens may have different effects on the immune response. 
 
 
 
6.7 Streptococcal superantigens play a role in specific gene expression 
during in vivo infection 
 
As differences in disease pathology were observed upon infection with the 
superantigen knockout mutants, the gene expression pattern during in vivo infection 
was next examined to see if the presence or absence of superantigens influenced the 
transcriptional profile. HLA-DQ8.Aβ0 mice were infected with 108 CFU of each of 
the various streptococcal superantigen knockout isolates and draining lymph nodes 
and spleens were harvested for qRT-PCR analysis.  
 
qRT-PCR analysis of draining inguinal lymph node cDNA showed a reduction in 
foxp3 expression in the absence of smez transcription during H623 and H658 
infection and this was not significantly different from sham-treated mice (Figure 
6.14A). However, gitr and ctla4 expression did not match the reduction seen for 
foxp3 transcription, reflective that these two markers are not restricted to Tregs (Figure 
6.14A). t-bet and rorγt expression was up-regulated during infection with no 
differences between all the different GAS knockout isolates (Figure 6.14A). There 
was no change in gata3 gene expression upon infection with the S. pyogenes 
superantigen knockout mutants (Figure 6.14A). This suggests that in the draining 
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lymph node, only foxp3 gene expression was primarily affected by the absence of 
SMEZ superantigen.  
 
 
 
Figure 6.14: qRT-PCR analysis of transcription factors expression during acute 
superantigen knockout S. pyogenes infection.  
HLA-DQ8.Aβ0 females (n=8 per isolate and n=3 per sham group) were infected with PBS 
(sham) or 2-4x108 CFU H305, 3-7x108 CFU H326, 3-7x108 CFU H623, 2-6x108 CFU H658 
at t=0h as part of 2 independent experiments for 24h. DLN (A) and spleen (B) were harvested 
for qRT-PCR analysis of transcription factor gene expression. Infected samples were 
normalised to tissue specific reference genes and sham treated samples. Fold change in 
expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001.  
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In the spleen, foxp3 expression was unchanged during in vivo infection with the 
different superantigen knockout isolates (Figure 6.14B), which contradicts the 
transcriptional profile observed in the draining lymph node (Figure 6.14A). gitr 
expression followed a similar pattern of expression to foxp3 and was significantly 
down-regulated in spea knockout mutants compared to WT H305 (Figure 6.14B). 
ctla4 expression was significantly up-regulated in all strains of S. pyogenes compared 
to sham-treated mice with no difference between the different isolates (Figure 6.14B). 
t-bet and rorγt expression was down-regulated in H658 compared to WT H305 in the 
spleen, indicating that SPEA may be required to induce transcriptional changes in 
these genes (Figure 6.14B). gata3 expression was unchanged in the spleen, similarly 
to the draining lymph node (Figure 6.14B).  
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Figure 6.15: qRT-PCR analysis of cytokine expression in the DLN during acute 
superantigen knockout S. pyogenes infection. 
HLA-DQ8.Aβ0 females (n=8 per isolate and n=3 per sham group) were infected with PBS 
(sham) or superantigen knockout S. pyogenes isolate (2-4x108 CFU H305, 3-7x108 CFU 
H326, 3-7x108 CFU H623, 2-6x108 CFU H658) at t=0h as part of 2 independent experiments 
for 24h. DLN were harvested for qRT-PCR analysis of cytokine gene expression. Infected 
samples were normalised to tissue specific reference genes and sham treated samples. Fold 
change in expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
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In the inguinal draining lymph nodes, most of the transcripts measured were up-
regulated apart from il-17a and il-9 (Figure 6.15). il-4 transcription was unchanged 
upon infection with all streptococcal isolates in the draining lymph node (Figure 
6.15). There was no significance between found between H305 WT isolates and the 
streptococcal knockout isolates (Figure 6.15). Increased transcription of pro-
inflammatory cytokines such as il-6 and tnf-α were reflective of systemic infection 
(Figure 6.15) and correlated with high IL-6 production in the serum of S. pyogenes 
infected mice (Figure 6.13). ifn-γ was only significantly up-regulated in H623 
compared to sham infected mice, suggestive that the removal of SMEZ may 
contribute to this effect (Figure 6.15) and matched the production of serum IFN-γ 
(Figure 6.13).  
 
In the spleen, all transcripts apart from tgf-β and tnf-α were up-regulated upon 
infection with the GAS isolates (Figure 6.16). The only significant difference 
between H305 WT infection and the superantigen knockout mutants was found with 
H326 infection. The lack of SPEA in this isolates resulted in decreased il-10 and il-6 
gene expression (Figure 6.16), correlating with a modest decrease in serum IL-6 
(Figure 6.13) and reduced bacterial burden (Figure 6.12B). 
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Figure 6.16: qRT-PCR analysis of cytokine expression in the spleen during acute 
superantigen knockout S. pyogenes infection. 
HLA-DQ8.Aβ0 females (n=8 per isolate and n=3 per sham group) were infected with PBS 
(sham) or superantigen knockout S. pyogenes isolate (2-4x108 CFU H305, 3-7x108 CFU 
H326, 3-7x108 CFU H623, 2-6x108 CFU H658) at t=0h as part of 2 independent experiments 
for 24h. Spleens were harvested for qRT-PCR analysis of cytokine gene expression. Infected 
samples were normalised to tissue specific reference genes and sham treated samples. Fold 
change in expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
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Figure 6.17: qRT-PCR analysis of mpo expression during acute superantigen knockout 
S. pyogenes infection. 
HLA-DQ8.Aβ0 females (n=8 per isolate and n=3 per sham group) were infected with PBS 
(sham) or superantigen knockout S. pyogenes isolate (2-4x108 CFU H305, 3-7x108 CFU 
H326, 3-7x108 CFU H623, 2-6x108 CFU H658) at t=0h as part of 2 independent experiments 
for 24h. DLN and spleen were harvested for qRT-PCR analysis of mpo expression. Infected 
samples were normalised to tissue specific reference genes and sham treated samples. Fold 
change in expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
qRT-PCR analysis of innate markers such as MPO was determined to examine 
whether the presence or absence of superantigens had an impact on neutrophil 
activation. In the lymph node, mpo expression was found to be down-regulated upon 
infection with S. pyogenes compared to sham-treated controls, with a significantly 
increase in H623 compared to H305 (Figure 6.17). In the periphery, there was an 
increase in mpo expression in the spleen during H326 infection, inducing high level 
of expression compared to PBS-treated mice (Figure 6.17). 
 
Overall, it was deduced that the lack of SMEZ [often considered the most potent of 
the superantigens (Unnikrishnan et al., 2002)] in H623 and H658 was associated with 
reduced expression of foxp3 in the draining lymph node, possibly via tgf-β induction 
and that SPEA may be responsible for systemic induction of t-bet. This suggests that 
particular superantigens may contribute to the differentiation of different T cell 
subsets, influencing cytokine production. For example, ifn-γ expression was up-
regulated in H623 infected lymph nodes, perhaps due to the lack of Treg 
differentiation induced by SMEZ. 
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6.8 Kinetics of Tregs during streptococcal superantigen knockout 
isolates infection 
 
To confirm whether SMEZ superantigen was responsible for Foxp3 induction as 
suggested by qRT-PCR analysis, direct detection of Tregs was performed in HLA-
DQ8.Aβ0 mice infected with 108 CFU of each of the various streptococcal knockout 
isolates. Draining lymph nodes and spleens were harvested to assay the kinetics of 
Tregs during in vivo infection by flow cytometry.  
 
In the draining lymph nodes, it was interesting to note that infection with H623 (smez-
/-) resulted in a significantly decreased expression of Foxp3 per cell (MFI) compared 
to sham controls (Figure 6.18A). This mirrored the down-regulation of foxp3 
expression in the lymph node of H623 infected mice (Figure 6.14A). Despite a fall in 
Foxp3 expression per cell, there was a significantly increase in the percentage of 
CD4+CD25+Foxp3+ cells of the total cell population upon infection with H623 
(Figure 6.18A). In the spleen, there was a consistent reduction in Foxp3 MFI 
expression upon WT S. pyogenes infection (Figure 6.18B). H326 infection resulted in 
a slight increase in Foxp3 MFI (Figure 6.18B). Overall, in the spleen, there was no 
change in the percentage of CD4+CD25+Foxp3+ cells of the total cell population 
(Figure 6.18B). 
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Figure 6.18: Flow cytometric analysis of Tregs during acute superantigen knockout S. 
pyogenes infection. 
HLA-DQ8.Aβ0 females (n=8 per isolate and n=3 per sham group) were infected with PBS 
(sham) or 5x108 CFU H305, 7x108 CFU H326, 8x108 CFU H623, 6x108 CFU H658 at t=0h 
for 24h. DLN (A) and spleens (B) were harvested for flow cytometric analysis of 
CD4+CD25+Foxp3+ cells. Mean and SEM of Foxp3 MFI (left) and percentage of total cells 
(right) of CD4+CD25+Foxp3+ cells are represented. 1-way ANOVA statistical test was carried 
out on absolute numbers and Foxp3 MFI data and Kruskal-Wallis statistical test was carried 
out on percentage of total cells and percentage of lymphocytes data. Any significance 
differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
In summary, analysis of Treg kinetics during superantigen-dependent infection by 
flow cytometry suggests the presence of SMEZ was responsible for Foxp3 MFI 
expression in Tregs in the draining lymph node, however it did not affect the expansion 
in absolute numbers or percentages of this subset during infection. Very little effect 
of the presence or absence of streptococcal superantigens was seen in the spleen.  
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6.9 Bacterial profile upon depletion of Tregs in the absence of 
streptococcal superantigens 
 
From the experiments so far, it would appear the absence of certain superantigens 
such as SMEZ resulted in down-regulation of foxp3 gene expression (Figure 6.14A) 
and decrease in Foxp3 expression in CD4+CD25+Foxp3+ cells in the draining lymph 
nodes (Figure 6.18A). This was accompanied by high levels of recovered bacteria in 
the blood (Figure 6.12B). This was suggestive that this streptococcal superantigen 
may have a role in Treg induction, correlating with systemic disease upon H623 
infection. I decided to investigate the disease profile upon specific depletion of Tregs 
in superantigen-mediated infection. This was achieved by crossing HLA-DQ8.Aβ0 
mice with Foxp3.DTR mice to create a new transgenic model (HLA.DQ8.Aβ0.DTR) 
to study the role of Tregs during GAS infection.   
 
HLA.DQ8.Aβ0.DTR mice were divided into 2 main treatment groups, those receiving 
doses of PBS to maintain their population of Foxp3+ cells and those receiving doses 
of Diphtheria Toxin (DT) to deplete this population. Each of these treatment groups 
was infected with the panel of four superantigen knockout isolates (n=8 for DT 
treated mice and n=2 for PBS treated group). Sham infected mice (n=2) were also 
included in this study for comparison to infected mice. 
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Figure 6.19: Bacterial counts from superantigen knockout S. pyogenes infection in 
HLA-DQ8.Aβ0.DTR transgenic model. 
HLA-DQ8.Aβ0.DTR females were treated with DT or PBS i.p (n=8 per DT per isolate group 
and n=2 per PBS per isolate group) every day for 2 days prior to infection with PBS (sham, 
n=2) or superantigen knockout S. pyogenes isolate (2x109 CFU H305, 2x109 CFU H326, 
9x108 CFU H623, 4x108 CFU H658) for 24h. Bacterial counts for thigh, blood, spleen and 
liver were calculated and mean and SEM represented. Kruskal-Wallis statistical test was 
carried out and any significant differences are indicated: *p<0.05. Sham infected mice did not 
show any bacterial growth from sampled organs (data not shown). 
 
 
 
Specific depletion of Foxp3+ cells by the administration of DT resulted in increased 
levels of recovered superantigen knockout mutant bacteria in the thigh compared to 
infected mice containing Foxp3+ cells (Figure 6.19). The only exception to this was 
during H658 infection, where no difference was found between mice with or without 
Tregs (Figure 6.19). In the blood, spleen and liver, there were only subtle differences in 
the bacterial counts between the different superantigen knockout isolates either in DT 
or PBS treated groups (Figure 6.19). No bacterium was recovered from any tissues 
from sham-infected mice (data not shown). 
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Figure 6.20: Cytokine responses from superantigen knockout S. pyogenes infection in 
HLA-DQ8.Aβ0.DTR transgenic model. 
HLA-DQ8.Aβ0.DTR females were treated with DT or PBS i.p (n=8 per DT per isolate group 
and n=2 per PBS per isolate group) for 2 days prior to infection with PBS (sham, n=2) or 
superantigen knockout isolate (2x109 CFU H305, 2x109 CFU H326, 9x108 CFU H623, 4x108 
CFU H658) for 24h. Serum was collected and concentrations of IL-6, IL-17A and IFN-γ 
determined by ELISA and mean and SEM represented. 1-way ANOVA statistical test was 
carried out and no significant differences were found. 
 
 
 
Cytokine ELISA analysis of serum harvested from S. pyogenes superantigen 
knockout isolates infected DT or PBS treatment groups revealed that IL-6 was 
marginally elevated in the knockout mutant infected mice compared to H305 treated 
groups (Figure 6.20). There was no difference between DT and PBS treated groups. 
There appeared to have slightly higher levels of IL-17A and IFN-γ in the blood of the 
infected DT groups compared to PBS treated groups (Figure 6.20). This was in line 
with the concept of depleting Tregs removes control over effector cell populations and 
hence cytokine production. 
 
It would appear that depletion of Foxp3+ cell during infection had the greatest effect 
at the site of local infection, with more bacteria detected in the thigh. This effect was 
dependent on the presence of superantigens such as SPEA and SMEZ. Systemically, 
no significant differences were observed upon the removal of Foxp3+ cells or 
superantigens. Thus the presence of Foxp3+ cells was associated with worse bacterial 
clearance at the site of acute infection and survival of GAS was enhanced by the 
presence of SMEZ and SPEA. 
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6.10 Flow cytometric analysis of cytokine producing cells upon 
removal of Tregs 
 
Analysis of IFN-γ and IL-17A producing cell types during superantigen knockout 
infection was carried out to better define the source of the modest elevation seen in 
serum cytokines. Groups of HLA.DQ8.Aβ0.DTR mice were treated with DT or PBS 
to remove or maintain Foxp3+ cells before infection with the four streptococcal 
superantigen knockout isolates or PBS (sham) for 24h. Inguinal lymph nodes and 
spleens were harvested for flow cytometric analysis of IFN-γ and IL-17A producing 
cell populations. 	  
 
Figure 6.21: Cell types in DLN from superantigen knockout S. pyogenes infection in 
HLA-DQ8.Aβ0.DTR transgenic model. 
HLA-DQ8.Aβ0.DTR females were treated with DT or PBS i.p (n=8 per DT per isolate group 
and n=2 per sham per isolate group) every day for 2 days prior to infection with either PBS 
(sham, n=2) or 2x109 CFU H305, 2x109 CFU H326, 9x108 CFU H623, 4x108 CFU H658 for 
24h. In the last 4h of infection, BFA was administrated i.p. DLN were harvested for ex vivo 
cytokine flow cytometry analysis. Absolute number of cell types (top) and percentage of 
cytokine producing cells (bottom) from lymphocyte gate in the draining lymph node were 
calculated and mean and SEM represented. Kruskal-Wallis statistical test was carried out and 
no significant difference was found.  
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In the inguinal draining lymph nodes, there was generally increased absolute numbers 
in all cell populations upon GAS infection compared to sham-infected controls. 
Depletion of Foxp3+ cells was not associated with significant differences in the 
absolute numbers of any cell populations, nor in the percentage of IFN-γ+ and IL-
17A+ cells in the lymphocyte gate (Figure 6.21).  
 
 
Figure 6.22: IL-17A and IFN-γ  production in DLN from superantigen knockout S. 
pyogenes infection in HLA-DQ8.Aβ0.DTR transgenic model. 
HLA-DQ8.Aβ0.DTR females were treated with DT or PBS i.p (n=8 per DT per isolate group 
and n=2 per sham per isolate group) for 2 days prior to infection with PBS (sham, n=2) or 
superantigen knockout isolate (2x109 CFU H305, 2x109 CFU H326, 9x108 CFU H623, 4x108 
CFU H658) at t= for 24h. In the last 4h of infection, BFA was administrated i.p. DLNs were 
harvested for ex vivo cytokine flow cytometry analysis. Percentage of lymphocytes (top) and 
absolute number (bottom) of IL-17A (A) and IFN-γ (B) producing cells in the draining lymph 
node calculated and mean and SEM represented. Kruskal-Wallis statistical test was carried 
out and no significant difference was found.  
 	  
 
The main source of IL-17A during S. pyogenes infection in this transgenic model 
surprisingly appeared to be CD8+ T cells (Figure 6.22A), reminiscent of the findings 
on GAS infection discussed in Chapter 4. Upon depletion of Foxp3+ cells, there were 
higher absolute numbers of CD8+ T cells and NK cells compared to sham-infected 
controls. IFN-γ responses seemed to be more dominant than IL-17A responses with 
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more cells producing this cytokine. CD8+, CD4+ T cells and NK cells were the main 
source of IFN-γ (Figure 6.22B) with CD8+ T cells dominating. Upon the depletion of 
Foxp3+ cells in the DT treated group, there were higher absolute numbers of CD8+ T 
cells and NK cells producing IFN-γ compared to sham-infected controls, little 
difference being seen when mice were infected with the various superantigen 
knockout isolates (Figure 6.22B). 
 
 
Figure 6.23: Cell types in the spleen from superantigen knockout S. pyogenes infection 
in HLA-DQ8.Aβ0.DTR transgenic model. 
HLA-DQ8.Aβ0.DTR females were treated with DT or PBS i.p (n=8 per DT per isolate group 
and n=2 per sham per isolate group) for 2 days prior to infection with PBS (sham, n=2) or 
2x109 CFU H305, 2x109 CFU H326, 9x108 CFU H623, 4x108 CFU H658 for 24h. In the last 
4h of infection, BFA was administrated i.p. Spleens were harvested for ex vivo cytokine flow 
cytometry analysis. Absolute number of cell types (top) and percentage of cytokine 
producing cells from lymphocyte gate (bottom) in the spleen were calculated and mean and 
SEM represented. Kruskal-Wallis statistical test was carried out and no significant difference 
was found.  
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In the spleen, there was a general reduction in the absolute number of all cell 
populations in infected mice upon the administration of DT compared to sham 
controls (Figure 6.23). There was however, an increase in the percentage of IL-17A 
and IFN-γ producing cells within the total population upon infection compared to 
sham controls with little difference between mice containing or depleted of Foxp3+ 
cells (Figure 6.23).  
 
 
Figure 6.24: IL-17A and IFN-γ  production in the spleen from superantigen knockout S. 
pyogenes infection in HLA-DQ8.Aβ0.DTR transgenic model. 
HLA-DQ8.Aβ0.DTR females were treated with DT or PBS i.p (n=8 per DT per isolate group 
and n=2 per sham per isolate group) for 2 days prior to infection with PBS (sham, n=2) or 
superantigen knockout isolate (2x109 CFU H305, 2x109 CFU H326, 9x108 CFU H623, 4x108 
CFU H658) for 24h. In the last 4h of infection, BFA was administrated i.p. Spleens were 
harvested for ex vivo cytokine flow cytometry analysis. Percentage of lymphocytes (top) and 
absolute number (bottom) of IL-17A (A) and IFN-γ (B) producing cells in the spleen were 
calculated and mean and SEM represented. Kruskal-Wallis statistical test was carried out and 
no significant difference was found.  
 
 
 
NK cells were found to be main source of IL-17A in the spleen with a trend to 
increased absolute numbers or responding cells upon the removal of Foxp3+ cells 
(Figure 6.24A). This was also true for CD8+ T cells producing IL-17A (Figure 
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6.24A). There were equal number of CD4+, γδ+ and NKT cells upon Foxp3+ removal 
compared to mice treated with PBS (Figure 6.24A). As with the inguinal lymph node, 
the IFN-γ responses in the spleen were greater than IL-17A responses. CD4+, CD8+ 
cells and NK cells were all found to produce this cytokine (Figure 6.24B). 
Interestingly, H658 infected mice with their Foxp3+ population intact appeared to 
contain large absolute numbers of NK producing IFN-γ, although this does not reach 
significance (Figure 6.24B).  
 
As little difference was found in the production of IL-17A and IFN-γ upon the 
removal of Foxp3+ cells during in vivo infection in the absence of superantigens, 
multi-cytokine analysis was performed to determine whether any other cytokines 
were affected by the removal of Foxp3+ cells. Splenocytes from Foxp3.DTR mice, 
treated with PBS or DT were stimulated with cell-free supernatant from the four 
superantigen knockout isolates for 24h before supernatant collected for CBA analysis.  
 
 
Figure 6.25: Differential cytokine production upon removal of Foxp3+ cells. 
Foxp3.DTR mice (n=5 mice per treatment group) were given 100µl PBS or DT (12.5µg/ml) 
for 2 days before spleens were harvested. 106 splenocytes were stimulated with cell-free 
supernatants from superantigen knockout isolate (H305, H326, H623 and H658), 
PMA/Ionomycin (positive control) and media only (negative control) for 24h. Supernatant 
was collected and CBA was carried out to measure the concentration of IFN-γ, TNF, IL-17A, 
IL-4, IL-9 and IL-10. Mean and SEM of concentrations minus background from media 
stimulated cells are represented and 1-way ANOVA statistical analysis was carried out and 
any significant differences indicated: *p<0.05. 
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PMA/Ionomycin stimulation of the splenocytes was carried out to serve as a positive 
control for cytokine production. Upon Foxp3+ cell removal, IFN-γ production was 
generally elevated compared to PBS treated splenocytes, in particular upon 
stimulation with cell-free supernatant from H623 (Figure 6.25). There was no 
difference in the production of TNF, IL-17A and IL-4 between PBS and DT-treated 
splenocytes (Figure 6.25). However, stimulation of DT-treated splenocytes with 
supernatant from H658 resulted in decreased production of IL-17A and IL-4, 
although not significant (Figure 6.25). IL-9 production was not stimulated by any of 
the S. pyogenes supernatants, with the exception of H326 in PBS-treated splenocytes 
(Figure 6.25). IL-10 production was not detected upon H305 supernatant stimulation 
in PBS-treated splenocytes (Figure 6.25).  
 
Overall, the removal of Foxp3+ cell mediated control during infection with the panel 
of four streptococcal superantigen knockout isolates resulted in only a modest 
changes in systemic disease pathology. Although Foxp3+ cells may somehow aid 
bacterial clearance at the site of infection as shown by increased bacterial counts in 
infected DT-treated mice (Figure 6.19), this appears to be only partially dependent on 
superantigens (Figure 6.19). There was only a marginal increase in the production of 
IL-17A and IFN-γ in the serum of infected mice (Figure 6.20), mirrored by the subtle 
changes in the cytokine production as shown ex vivo (Figure 6.21-24) and in vitro 
(Figure 6.25). This collection of data would suggest that Tregs do not play a significant 
role during systemic infection but may be beneficial at the site of the infection via 
cytokine-independent mechanisms. 
 
 
 
6.11 TLR2 expression on Tregs during acute S. pyogenes infection 
 
There is evidence for a possible role for TLR2 in the activation of Tregs during 
microbial infection (Sutmuller et al., 2006).  Whether this class of innate receptors is 
also involved in my model of S. pyogenes infection is unclear but it may explain how 
the rapid adaptive immune response observed during acute GAS infection. Flow 
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cytometry was performed to confirm that Tregs expressed TLR2 and whether GAS 
influenced protein expression. 
 
HLA-DQ8.Aβ0 blood was collected and cultured in vitro with exponential phase 
H305 and H293 S. pyogenes isolates for 4h before flow cytometric analysis of TLR2 
expression on Foxp3+ cells was carried out in a pilot study.  H305 stimulation 
increased expression of intracellular TLR2 in Foxp3+ cells compared to un-stimulated 
and H293 (M89 serotype GAS, lacking SMEZ) stimulated blood (Figure 6.26). This 
suggested there might be a specific interaction between S. pyogenes and TLR2, in 
particular in Tregs.  
 
 
Figure 6.26: Representative TLR2 expression of Foxp3+ cells in un-stimulated and GAS 
infected blood. 
Pooled HLA-DQ8.Aβ0 whole blood was preliminarily infected with H305 or H293 in vitro 
for 4h and intracellular TLR2 stained in gated Foxp3+ cells. (Red line: isotype matched 
control; green line: TLR2 expressed in un-stimulated blood; blue line: H305 infected blood; 
brown line: H293 infected blood). 
 
 
 
qRT-PCR analysis of HLA-DQ8.Aβ0 draining inguinal lymph nodes and spleens 
during acute WT S. pyogenes infection revealed significantly elevated expression of 
tlr2 in the lymph node (Figure 6.27). The increase of tlr2 gene expression was also 
matched by the up-regulation of foxp3 expression over the same time course of 
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infection (Figure 6.6A), suggesting that tlr2 expression may be linked to WT S. 
pyogenes infection, perhaps in Tregs.  
 
 
Figure 6.27: qRT-PCR analysis of tlr2 expression during acute S. pyogenes infection. 
HLA-DQ8.Aβ0 females were infected with 1x108 - 109 CFU H305 S. pyogenes at t=0h as part 
of 2 independent experiments or PBS (sham). At various time points, mice were culled (n=10 
per infected time point and n=5 per sham infected time point) and DLN or spleens harvested 
for qRT-PCR analysis of tlr2 expression. Infected samples were normalised to tissue specific 
reference genes and sham treated samples. Fold change in expression was determined by 
REST analysis and mean and SEM represented. Any significant differences are indicated: 
*p<0.05, **p<0.01, ***p<0.001. 
 
 
 
 
Figure 6.28: qRT-PCR analysis of tlr2 expression during acute superantigen knockout 
infection.  
HLA-DQ8.Aβ0 females (n=8 per isolate and n=3 per sham group) were infected with PBS 
(sham) or superantigen knockout isolate (2-4x108 CFU H305, 3-7x108 CFU H326, 3-7x108 
CFU H623, 2-6x108 CFU H658) as part of 2 independent experiments for 24h. DLNs and 
spleen were harvested for qRT-PCR analysis of tlr2 gene expression. Infected samples were 
normalised to tissue specific reference genes and sham treated samples. Fold change in 
expression was determined by REST analysis and mean and SEM represented. Any 
significant differences are indicated: *p<0.05, **p<0.01, ***p<0.001. 
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Previous evidence has suggested that streptococcal superantigens may contribute to 
increased expression of TLR2 on monocytes (Hopkins et al., 2008). Whether this 
interaction can also be extrapolated to Tregs in my model of acute sepsis was next 
examined. HLA-DQ8.Aβ0 mice were infected with 108 CFU of the streptococcal 
superantigen knockout isolates and the expression of tlr2 was studied by qRT-PCR. 
No differences were found in the expression of tlr2 in either the draining lymph node 
or spleen 24h post infection between the four various superantigen knockout isolates 
(Figure 6.28). However, the loss of SPEA in H326 and H658 up-regulated tlr2 
expression in the spleen above sham-treated levels. This suggests SPEA may inhibit 
tlr2 gene expression in the spleen. 
 
 
Figure 6.29: Flow cytometric analysis of surface TLR2 expression during acute 
superantigen knockout S. pyogenes infection.  
HLA-DQ8.Aβ0 females (n=8 per isolate and n=3 per sham group) were infected with PBS 
(sham) or superantigen knockout S. pyogenes isolate (5x108 CFU H305, 7x108 CFU H326, 
8x108 CFU H623, 6x108 CFU H658) for 24h. DLN (A) and spleens (B) were harvested for 
flow cytometric analysis of TLR2 expression on CD4+CD25+Foxp3+ cells. Mean and SEM of 
surface TLR2 MFI (left) and percentage of lymphocytes (right) of CD4+CD25+Foxp3+TLR2+ 
cells are represented. 1-way ANOVA statistical test was carried out on absolute numbers and 
Foxp3 MFI data and Kruskal-Wallis statistical test was carried out on percentage of total 
cells and percentage of lymphocytes data. Any significant differences are indicated: 
**p<0.01. 
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Flow cytometric analysis of surface TLR2 expressed on Tregs was performed on the 
draining lymph node and spleen in the various superantigen knockout isolate infected 
mice. There was a significantly increased percentage of TLR2+CD4+CD25+Foxp3+ 
cells in the lymphocyte population upon infection in the absence of SMEZ (H623) 
compared to sham-treated controls in the draining lymph node (Figure 6.29A). The 
expression of surface TLR2 on Tregs in the spleen revealed a different picture 
compared to the draining lymph node. H658 infected mice showed elevated surface 
TLR2 MFI expression on CD4+CD25+Foxp3+ cells relative to H305 infected mice 
(Figure 6.29B). This is indicative that the absence of superantigens, in particular 
SPEA and SMEZ, contributed to the increased expression of surface protein TLR2 on 
Tregs.  
 
 
Figure 6.30: Flow cytometric analysis of intracellular TLR2 expression during acute 
superantigen knockout S. pyogenes infection.  
HLA-DQ8.Aβ0 females (n=8 per isolate and n=3 per sham group) were infected with PBS 
(sham) or 5x108 CFU H305, 7x108 CFU H326, 8x108 CFU H623, 6x108 CFU H658 for 24h. 
DLN (A) and spleens (B) were harvested for flow cytometric analysis of TLR2 expression on 
CD4+CD25+Foxp3+ cells. Mean and SEM of surface TLR2 MFI (left), percentage of 
lymphocytes (right) of CD4+CD25+Foxp3+TLR2+ cells are represented. 1-way ANOVA 
statistical test was carried out on absolute numbers and Foxp3 MFI data and Kruskal-Wallis 
statistical test was carried out on percentage of total cells and percentage of lymphocytes 
data. Any significant differences are indicated: *p<0.05, **p<0.01. 
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The expression of intracellular TLR2 on Tregs was also assayed by flow cytometry. 
The percentage of TLR2+CD4+CD25+Foxp3+ cells of lymphocytes was increased in 
H623 infected draining lymph node compared to sham-infected controls (Figure 
30.B), similar to the surface expression of TLR2 (Figure 6.29A). This was indicative 
that the presence of SMEZ may inhibit the intracellular expression of TLR2 on Tregs 
in the lymph node and spleen. In the spleen, there was a decrease in intracellular 
TLR2 MFI on CD4+CD25+Foxp3+ upon GAS infection, except for H326, which has 
the opposite effect of increased intracellular TLR2 expression in Tregs (Figure 6.30B). 
This suggests that SPEA inhibits intracellular TLR2 expression in Tregs. There was 
also increased percentage of TLR2+CD4+CD25+Foxp3+ cells of the lymphocyte gate 
in the absence of SPEA and SMEZ (H658 infection) (Figure 6.30B). 
 
Overall, there appeared to be some evidence that streptococcal superantigens may be 
linked to TLR2 transcription and protein expression. The absence of SMEZ 
streptococcal superantigen in H623 during in vivo infection resulted in an increase in 
the percentage of surface and intracellular TLR2+CD4+CD25+Foxp3+ cells of 
lymphocytes.  This was evidence that this particular superantigen may negatively 
influence TLR2 expression of Tregs, but whether this is directly connected to foxp3 
expression observed in Figure 6.14A and hence Treg induction, is unknown. 
 
 
 
6.12 The role of TLR2 during acute WT S. pyogenes infection 
 
As TLR2 may have a role during Treg function and development as shown by other 
infectious disease models, this was also explored in my acute S. pyogenes infection 
model. To achieve this, TLR2-/- mice were utilise to determine the precise role of this 
innate receptor during GAS infection.  
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Figure 6.31: Percentage survival of S. pyogenes infected TLR2-/- mice. 
C57BL/6 (n=8) and TLR2-/- (n=8) females were infected with 6x108 CFU H305 WT S. 
pyogenes i.m at t=0h. Mice were monitored for percentage total weight loss or signs of septic 
shock and culled at defined end-points.  
 
 
 
WT C57BL/6 and TLR2-/- mice were infected with a lethal dose of H305 WT S. 
pyogenes. There appeared to be no difference in terms of survival between the two 
strains of mice infected (Figure 6.31). This implies that TLR2 has little role during 
lethal systemic infection.  
 
This was also mirrored by little difference in bacterial counts recovered from WT and 
TLR2-/- mice infected with 109 CFU H305 for 24h (Figure 6.32). There was a trend of 
lower bacterial counts in the blood of TLR2-/- infected mice, indicative of perhaps 
decreased systemic bacterial burden. Serum IL-6 and IL-17A levels were also 
measured with no significant difference found, although serum IFN-γ was statistical 
higher in infected TLR2-/- mice compared to WT mice (Figure 6.33). 
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Figure 6.32: Bacterial counts from S. pyogenes infected TLR2-/- transgenic mice. 
C57BL/6 (n=8) and TLR2-/- (n=7) females were infected with 1x109 CFU H305 WT S. 
pyogenes i.m at t=0h for 24h. Bacterial counts were calculated for thigh, blood, spleen and 
liver and mean and SEM represented. Kruskal-Wallis statistical test was carried out and no 
significant differences found.  
 
 	  
	  
Figure 6.33: Cytokine responses from S. pyogenes infected TLR2-/- transgenic mice. 
C57BL/6 (n=8) and TLR2-/- (n=7) females were infected with 1x109 CFU H305 WT S. 
pyogenes via i.m for 24h. Serum was collected and concentrations of IL-6, IL-17A and IFN-γ 
measured by ELISA. Mean and SEM are represented and 1-way ANOVA statistical test was 
carried out and any significant differences indicated: *p<0.05. 
 
 
 
In summary, it appears that TLR2 signaling plays little role during acute S. pyogenes 
infection as demonstrated by the lack of significant difference in survival or bacterial 
counts recovered in WT and TLR2-/- transgenic mice. 
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6.13 Discussion 
 
The role of Tregs during acute S. pyogenes infection has not previously been 
characterised in detail. Furthermore, the precise role of immune responses induced by 
superantigens has not been fully characterised, though it is always assumed to be an 
immune subversion strategy. From the experiments performed and described in this 
chapter, it was clear that the adaptive immune response was initiated quicker than 
originally perceived, within hours of WT GAS infection. Increased bacterial burden 
over time (Figure 6.4B) correlated with high levels of serum IL-6 (Figure 6.5). foxp3 
gene expression was increased in the draining lymph node and down-regulated in the 
spleen (Figure 6.6). This pattern of gene expression was also matched in the protein 
production as measured by flow cytometry in the draining lymph node and spleen 
(Figure 6.11).  
 
The change in numbers of Foxp3+ Tregs in the draining lymph node and spleen could 
be explained by the migration of Tregs from the periphery to the lymph node at the site 
of infection. Tissue-specific migration can be achieved through the expression of 
particular receptors. For example, the integrin α4β7 and the chemokine receptor 
CCR9 are expressed by Tregs to allow homing to the intestines and associated 
lymphoid tissues in response to inflammation (Menning et al., 2010). Other 
chemokines such as CCR2, 5 and 7 allow Tregs to migrate to draining lymph nodes 
(Zhang et al., 2009a). Chemokine receptor and integrin expression on Foxp3+ Tregs 
during acute GAS infection could be further investigated as another parameter to 
determine if this subset of cells is being recruited to the site of infection to dampen 
down immune responses. 
 
Elevation of Treg absolute numbers and increased bacterial burden over time 
suggested that Tregs may be contributing to pathogenesis in this in vivo infection 
model. This is in line with data reported in Chapter 3, whereby S. pyogenes infected 
Foxp3.DTR transgenic mice depleted of Foxp3+ cells have decreased bacterial 
burden, particularly in the blood (Figure 3.15). This observation however, can only be 
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confirmed if the suppressive phenotype of the increased number of Tregs detected is 
fully characterised.   
 
The observed change in Treg kinetics can be related to the presence of streptococcal 
superantigens. Models correlating Tregs with superantigens produced as part of 
bacterial infection have not been previously described. The HLA-transgenic model 
utilised in this chapter provided me with a useful tool to study the effects on Tregs 
induction by superantigens, normally secreted in vivo by S. pyogenes.  
 
SPEA enhanced TH1 associated transcription factor as demonstrated by the down-
regulation of t-bet during H326 (spea-/-) infection (Figure 6.14B). SMEZ induced 
both Foxp3 gene (Figure 6.14A) and protein expression (Figure 6.18A). Knocking 
out these superantigens correlated with increased bacterial counts, particular in the 
blood in H623 infected mice (Figure 6.12B) and decreased bacterial burden in H326 
infected mice (Figure 6.12B). This was paradoxical data, as it would suggest that the 
induction of Foxp3+ Treg cells, not observed during smez-/- infection, may be 
beneficial during infection. The working hypothesis thus suggests that potent 
superantigen activation of Treg, is beneficial to bacterial pathogenesis and spread. This 
may be either because of some beneficial effect of the T cell cytokine storm, or more 
contentiously, because S. pyogenes may sometimes be able to spread as an 
intracellular pathogen (LaPenta et al., 1994; Osterlund and Engstrand, 1997; Thulin 
et al., 2006; Staali et al., 2003). Removing the Tregs from the activated mix thus 
simply allows the phenotype to be enhanced. 
 
Results also suggested that TH1 cells induced by SPEA are pathogenic as spea-/- mice 
had lower levels of t-bet expression and bacterial burden (Figure 6.12B). This was in 
contrast to data presented in Chapter 3 proposing Tregs as pathogenic during acute S. 
pyogenes infection. The different murine models used could explain this difference. 
Foxp3.DTR mice are not sensitive to superantigens and the heightened responses 
observed in HLA transgenic mice might be more prone to Foxp3+ mediated control 
induced by superantigens.  
 
Depletion of Foxp3+ Tregs during superantigen-mediated infection of HLA-
DQ8.Aβ0.DTR mice reduced any specific effects of superantigens on Tregs as no 
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significant differences was found in the systemic bacterial counts after infection with 
the superantigen knockout isolates (Figure 6.19). A difference in recovered bacterial 
numbers, dependent on superantigens was observed in the thigh upon depletion of 
Foxp3+ cells (Figure 6.19), suggesting that superantigens interacting on Tregs at the 
site of infection are beneficial. This supports the general conclusion that there was a 
previously unknown interaction between streptococcal superantigens and Tregs in this 
model. 
 
Ex vivo intracellular staining of various cell populations during infection with the 
superantigen knockout S. pyogenes isolates upon Foxp3+ cell depletion did not reveal 
any strong changes in cytokine production (Figure 6.22 & 6.24). Only modest 
elevations in IFN-γ production in CD8+ and NK cells were observed upon the 
removal of Treg (Figure 6.22). The importance of these cell types during acute 
streptococcal infection has already been highlighted in Chapter 4. This suggests that 
if superantigens such as SMEZ are inducing Tregs to alter the pathogenesis, it is not via 
release of Treg mediated control over effector cell production of cytokines. 
 
Previous work from other groups has demonstrated an interaction between 
superantigens and Treg induction (Papiernik, 2001; Taylor and Llewelyn, 2010), 
reinforcing results  in this chapter showing superantigens, such as SMEZ can induce 
Tregs. Most work has concentrated on purified superantigen commonly secreted by S. 
aureus, such as SEA and SEB. Repeated exposure of superantigens induce a state of 
tolerance with modulated TH1 cytokines release (e.g. IFN-γ and IL-2) and was 
associated with induction of regulatory CD4+CD25+ T cells secreting IL-10 (Noël et 
al., 2001; Pontoux et al., 2002; Feunou et al., 2003; Grundström et al., 2003). This 
regulatory T cell was confirmed to be Foxp3+ Tregs due to induced Foxp3 expression 
(Schartner et al., 2008). The addition of TGF-β before re-stimulation of CD4+ T cells 
with SEB enhanced this cell population’s capacity to produce this cytokine and was 
correlated with suppressive activity over B cell mediated antibody production (Zheng 
et al., 2002).   
 
Not all superantigens have been associated with Treg induction. SEB has been shown 
to inhibit Tregs isolated from human PBMCs in an APC-dependent manner (Cardona 
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et al., 2006). This was achieved through GITR-L expression on monocytes induced 
by SEB exposure and was followed by Treg proliferation and loss of suppressive 
function (Cardona et al., 2006). This could be extrapolated to explain why SPEA 
secreted by S. pyogenes showed a slight trend of inhibiting foxp3 gene expression and 
stimulated induction of TH1 cells, as characterised by increased t-bet gene expression 
(Figure 6.14). 
 
Superantigens driven responses are not just limited to Tregs and other cells of adaptive 
immunity. Innate immunity is also influenced by the presence of superantigens during 
infection. Tanriver and colleagues (Tanriver et al., 2009) showed that endogenous 
superantigens encoded in the Mouse Mammary Tumour Virus (MMTV) genome, 
randomly integrated into the mouse genome prevented the migration of NK cells and 
matured DCs. This was reminiscent of qRT-PCR analysis showing that upon the 
absence of SMEZ compared to WT infection, there was significant up-regulation of 
mpo, an activation marker of neutrophils (Figure 6.17). Perhaps, this particular 
superantigen linked to foxp3 expression could be also be preventing the recruitment 
and activation of innate cell population, such as neutrophils. 
 
Microbial products are key in initiating the immune response during infection with 
most research focused on TLRs. Tregs have been shown to express TLRs, for example 
TLR2 (Figure 6.26). It has also been suggested that TLR2 signaling can also 
stimulate Treg proliferation (Chen et al., 2009a). Much interest has been generated in 
this specific PRR, generally associated with increased signal transduction during 
Gram-positive infection with some groups concentrating on TLR2 expression of Tregs 
during fungal infection (Sutmuller et al., 2006). Superantigens can induce TLR2 
expression on monocytes (Hopkins et al., 2008), however whether TLR2 expression 
on Tregs is involved during GAS infection was partially addressed in this chapter and 
requires further work. 
 
TLR2 gene expression was induced during a short time course of S. pyogenes 
infection and matched with the pattern of up-regulation in foxp3 expression (Figure 
6:27). This increase in tlr2 expression weakly correlated with the presence or absence 
of streptococcal superantigens as in vivo infection with superantigen knockout 
isolates did not change tlr2 expression in the draining lymph node (Figure 6.28). 
	   306	  
However, upon infection in the spleen with smez-/- (H623) a slight down-regulation in 
tlr2 expression was detected and was compared with sham controls (Figure 6.28).  
This weakly suggested that SMEZ superantigen might be involved in the induction of 
tlr2 gene expression in the spleen. 
 
Superantigens also affected TLR2 expression on the surface and in intracellular 
compartments of Tregs during in vivo infection (Figure 6.29 & 6.30). The percentage 
of CD4+CD25+Foxp3+ cells of lymphocytes expressing surface TLR2 was 
significantly elevated during H623 infection in the draining lymph node (Figure 
6.29A) and the expression of surface TLR2 per CD4+CD25+Foxp3+ cells in the 
spleen was increased in H658 infected mice compared to WT H305 controls (Figure 
6.29B). However, absolute numbers of Tregs expressing intracellular TLR2 was 
reduced during H623 infection, correlating with qRT-PCR data (Figure 6.30B). Flow 
cytometric analysis of Tregs in the draining lymph node showed that SMEZ might in 
fact be inhibitive resulting in decreased surface TLR2 protein expression and 
percentage of Treg of lymphocytes to express surface TLR2.  
 
Correlating increased bacterial burden seen in H623 infected mice with decreased 
foxp3 expression and increased percentage of CD4+CD25+Foxp3+ cells expressing 
surface TLR2 would suggest a possible switch in Treg phenotype in the absence of 
SMEZ. Previous work has documented that TLR2 controls the expansion and 
function of Tregs (Sutmuller et al., 2006). As the phenotype of the Tregs during this 
model of acute sepsis is unknown, we cannot state whether TLR2 is suppressing the 
function of Tregs as proposed by Oberg and colleagues (Oberg et al., 2010) or 
stimulating TH1 responses (Patel et al., 2005).  
 
Whether there is an interaction between superantigens and TLR2 expression still 
remains inconclusive and more research required. Other streptococcal virulence 
factors may be driving TLR2 signaling upon GAS infection. For example, the role of 
M proteins has previously been identified to act via TLR2 on human monocytes to 
drive an inflammatory response (Påhlman et al., 2006). This particular virulence 
factor has not been addressed in this study.  
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The precise role of TLR2 during S. pyogenes infection was further investigated 
through the use of TLR2-/- knockout mice. However, upon either lethal or sub-lethal 
infection with WT S. pyogenes, there was no significant difference in survival or 
bacterial burden (Figure 6.31 & 6.32). This was indicative that TLR2 and subsequent 
downstream signaling were dispensable during GAS infection. There was a slight 
drop in the number of recovered bacteria from the blood of infected TLR2-/- mice, 
suggesting these mice were less bacteraemic than WT mice (Figure 6.32). An 
increase in serum IFN-γ was also detected in TLR2-/- mice (Figure 3.33). Perhaps, 
pro-inflammatory responses from innate immune cell types may be activated 
independent of TLR2 signaling, similar to work published by Gratz and colleagues 
(Gratz et al., 2008). 
 
Overall, the kinetics of Tregs during acute S. pyogenes infection was revealed and 
correlated to the presence of key streptococcal superantigens for the first time. SMEZ 
was found to be responsible for enhanced Foxp3 gene and protein expression, 
inducing Tregs, which limited bacterial burden. This suggests that in this model of 
acute sepsis, Tregs are beneficial. The precise mechanism of signal transduction 
leading to foxp3 up-regulation is unknown. SMEZ was yet again found to induce tlr2 
gene expression in the spleen and correlated with low absolute numbers of Tregs 
expressing this intracellular receptor in the absence of this superantigen. However, 
these effects were small as TLR2 overall was found to be redundant in the survival 
post lethal S. pyogenes infection.  
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Chapter 7 
7 Conclusions and general discussion  
 
 
In this thesis, I initially characterised the relative contribution of adaptive and innate 
immune responses during acute S. pyogenes infection. I present evidence indicative of 
a potential role for Tregs in exacerbation of pathology during acute bacterial sepsis and 
interactions with specific streptococcal virulence factors. In the following section, I 
will summarise my results and the implications of these findings within the context of 
previous published data regarding immunity mounted during Gram-positive infection. 
 
 
7.1 Summary of the role of Tregs during acute streptococcal infection 
 
S. pyogenes is the causative agent of divergent diseases, from non-invasive (impetigo 
and “strep throat”) to severely invasive (necrotising fasciitis and bacterial sepsis) 
(Cunningham, 2000). High mortality is associated with bacterial sepsis and remains a 
large burden on the nation health service. This Gram-positive human pathogen has a 
large array of virulence factors to evade and modulate the immune response 
(Cunningham, 2000). Most studies conducted on T cell mediated immunity during 
bacterial systemic infection have utilised the poly-microbial CLP animal model of 
experimental sepsis (Sherwood et al., 2004; Chung et al., 2006; Enoh et al., 2008; 
Enoh et al., 2007). However, very little work has been performed regarding the direct 
intimate interaction of this bacterium with T cells during in vivo acute infection.  
 
From the initial studies of αβ and γδ T cells during acute S. pyogenes infection as 
discussed in Chapter 3, it appears that T cell-mediated immunity is detrimental to 
survival outcome after GAS infection via an intra-muscular route of challenge. On 
further dissection of this observation, regulatory αβ+ T cells, classically defined as 
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Tregs were found to be pathogenic, as induced depletion of this subset in Foxp3.DTR 
mice limited dissemination of systemic infection. Unleashing of Treg-mediated control 
of γδ+ T cells lead to increased IL-17A production in the spleen and was supported by 
a trend to increased, systemic bacterial burden in IL-17A-/- and TCR δ-/- mice; 
however this observation will need to be further confirmed.  
 
Upon more detailed investigation of the kinetics of Tregs during S. pyogenes in 
Chapter 6, increased Foxp3 gene and protein expression in peripheral lymphoid organ 
correlated with increased bacterial burden over a short time course of GAS infection 
in HLA-DQ8.Aβ0 transgenic mice. This further supports the conclusion that the 
presence of Tregs is detrimental during S. pyogenes infection. Exploiting the sensitivity 
of this HLA transgenic model to streptococcal superantigens, it was determined that 
SMEZ superantigen expression was necessary to induce foxp3 gene expression. 
Depletion of Foxp3+ cells in HLA-DQ8.Aβ0.DTR mice resulted in the loss of 
superantigen driven systemic pathology. Thus, this is evidence that specific 
streptococcal virulence factors can modulate Treg-mediated immune responses.  
 
Overall, fast kinetics of Tregs in terms of foxp3 gene expression was observed within 
hours of acute bacterial infection, indicative that this branch of adaptive immunity 
initiates immune regulation faster than might have been thought. This induction was 
partially attributed to secreted potent streptococcal superantigens rapidly promoting a 
state of immune suppression.  
 
 
 
7.2 The hypothesised role of Tregs during acute GAS infection 
 
Much scientific progress has been made since the original proposal of “suppressor T 
cells” in the 1970s (Gershon, 1975). Tregs have been characterised as suppressors of 
both adaptive and innate immune responses (Sakaguchi, 2004) and research has been 
conducted regarding this cell type within the context of various infectious pathogens 
with differing survival outcomes shown (Belkaid, 2007). From the published work to 
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date, it is becoming more and more clear, a fine balance between Treg-mediated 
suppression and enhanced effector function exists in order to protect the body from 
collateral damage caused by potent anti-microbial responses without impeding 
efficient eradication of harmful pathogens from the host (Belkaid and Rouse, 2005; 
Suvas and Rouse, 2006).  
 
During infection, it may be beneficial for pathogens to induce, recruit and maintain 
the survival of Tregs, so as to promote their own persistence within the body. Treg 
induction can be achieved by influencing the cytokine milieu to favour conversion of 
naïve CD4+ T cells into Tregs through the production of IL-10 or TGF-β from other 
cell types, such as monocytes (Walther et al., 2005; Suvas et al., 2003). The resultant 
effect of Treg induction during infectious diseases has been extensively studied, 
however, different pathogens can invoke different immunological responses, which 
will be discussed in the following section.  
 
A protective effect of Tregs during infection has been demonstrated in murine models 
with various pathogenic microorganisms. For example, Tregs delay the recruitment of 
DCs, NK and T cells into draining lymph nodes of mice upon infection with Herpes 
Simplex virus (HSV) to limit immunopathology (Lund et al., 2008). Parasitic 
infection with African trypansomes can lead to potent TH1 immune responses, 
however, nTregs producing IL-10 can expand in the spleen and liver of infected 
C57BL/6 mice to constrain immune pathology exacerbated by CD4+ IFN-γ+ T cells 
(Guilliams et al., 2007). Tregs were also found to suppress inflammation during 
Pneumocystis carinii infection (McKinley et al., 2006), suggestive that this cell type 
may ameliorate disease. It has also been proposed that Tregs can activate immune cells 
as well as suppress to indirectly counter infection. This has been demonstrated during 
Candida albicans infection in mice, whereby Tregs can up-regulate the expression of 
TH17-associated cytokine genes such as il-17a, il-17f and il-22 in CD4+ T cells to aid 
fungal clearance (Pandiyan et al., 2011).  
 
The profound importance of Tregs in suppressing over-activated immune responses 
and inflammation during infection is also seen in the context of the gastro-intestinal 
tract and autoimmunity. The link between Tregs and a pathological intestinal immune 
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responses was initially demonstrated in human patients with IPEX syndrome: 
autoimmunity arises from the lack of Foxp3+ cells often encompassing severe 
intestinal inflammation (Gambineri et al., 2003). As the gut is home to many different 
commensal bacteria and a major source of exogenous antigens, it is easy to appreciate 
the beneficial role of Tregs in dampening down immune response and preventing 
inflammation under normal conditions as an example of oral tolerance (Barnes and 
Powrie, 2009). Effector cells such as γδ T cells, normally under the control of Tregs 
have been implicated as pathogenic with the ability to induce inflammation in the 
intestines to lead to colitis (Park et al., 2010). The number of Tregs can be regulated 
within the gut to also maintain tolerance. The administration of anti-RANK-L 
monoclonal antibody in vivo augmented Treg-mediated suppression of colitogenic 
CD4+ T cells to suggest that the RANK/RANK-L signaling pathway between 
dendritic and Treg cells may be an important suppressive mechanism by which Tregs 
can prevent DCs from presenting antigen to naïve CD4+ T cells (Tomita et al., 2009). 
This overall highlights the importance of Treg-mediated suppression of activated 
effector cells to control intestinal inflammation. 
 
The beneficial effects of Tregs-mediated suppression have not been found across all 
types of infections. Detrimental effects of the presence and function of Tregs have 
been proposed for plasmodium infection in mice, whereby depletion of CD4+CD25+ 
cells protected mice against lethal infection with Plasmodium yoelii (Hisaeda et al., 
2004). Delayed immune responses were also observed in mice infected with M. 
tuberculosis due to suppression by Tregs, allowing expansion of mycobacterium in the 
lung (Shafiani et al., 2010). A similar observation was also made during Friend viral 
infection, whereby, Treg-mediated suppression of CD8+ T cells lead to inefficient viral 
clearance (Myers et al., 2009). nTregs are also induced during Helicobacter pylori 
infection in the gut to allow bacterial colonisation and persistence by the induction of 
tolerance and TH17 cell suppression (Kao et al., 2010). Fungi, such as Aspergillus 
fumigatus can successful evade the immune response through the differentiation of 
Tregs to allow for establishment of chronic lung infection (Montagnoli et al., 2006), 
demonstrating that many pathogens exploit immune regulation to their own survival 
advantage.  
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Our original premise on initiating this study perhaps veered to the likelihood that, 
since streptococcal sepsis is often characterised in terms of the key role of an 
excessive cytokine response in disease outcome, this might be a setting in which Tregs 
would have a protective role to dampen down heightened effector function. Since 
infection by GAS is generally regarded as a case of superantigen shock from an 
overactive immune response, along with genetic risk factors (Kotb et al., 2002; 
Welcher et al., 2002; Llewelyn et al., 2004), this might have been predicted to be a 
case where Tregs are protective. Here in Chapter 3, we found the opposite, that is, Tregs 
appear to be constraining protective immunity as specific removal of Foxp3+ cells 
during the early stages of infection was actually protective in a murine model of acute 
sepsis, possibly due to the unleashing of suppression over γδ+, CD8+ T and NK cells.  
 
Experiments conducted in our HLA transgenic murine model showed that amplified 
Treg frequency correlated with increased bacterial burden in Chapter 6. Data from this 
model is in line with studies documenting increased frequencies of circulating Tregs in 
the blood of septic patients (Venet et al., 2004) and also mirrored other animal studies 
utilising the murine model of poly-microbial sepsis (Wisnoski et al., 2007). Overall, 
these findings validate the use of our HLA transgenic mice in this study. 
 
As the majority of the experiments conducted in this study were focused on the early 
stages of infection, the relative contribution of Tregs during the later phases of the 
immune response are still unclear. Ongoing work in the group includes attempting to 
optimise a long-term infection model, but it has not been trivial to find a point 
between doses so high that they are lethal before 72h, and lower so that they are 
cleared by local, innate mechanisms without clear evidence of any adaptive response 
or pathology. It is not unconceivable that there may be a differential role of Tregs as 
the loss of Foxp3+ cells did not affect the overall survival post lethal GAS challenge. 
This would suggest that either, Tregs play little role in the late stages of bacterial sepsis 
or the host is too overwhelmed by the immune driven damage caused to host tissue in 
order for Tregs to exert any protective immune suppression. This concept has been 
previously addressed in Foxp3.DTR mice during chronic Salmonella infection, with 
enhanced Treg activity found during the later stages of infection (Johanns et al., 2010) 
Depletion of Foxp3+ cells at different stages of S. pyogenes infection in our 
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humanised animal model may provide valuable information in order to clarify this 
hypothesis. 
 
My findings in the HLA transgenic mouse model, clearly indicate that SMEZ 
streptococcal superantigen, probably the most potent virulence factor of this 
bacterium, may act partly through the immune subversion of inducing an 
inappropriate, acute Treg responses. The evolution of these streptococcal virulence 
factors can greatly enhanced survival within the host. However, it should not be 
forgotten that virulence factors are non-essential genes compared to the vital genes 
required for replication and metabolism (Ulrich, 1999). Tight regulation is in place to 
control the expression of virulence factors to conserve energy utilized by the 
pathogen (Ulrich, 1999). However, dysregulation of regulatory elements, such as 
CovRS in S. pyogenes can lead to hyper-virulence and associated increase severity of 
invasive disease (Turner et al., 2009). Mutations in regulatory genes may occur due 
to immunological pressure presented to the bacterium by the host and may explain the 
up-surge of invasive M1 serotype strains and the rise in the number of antibiotic 
resistant strains admitted to intensive care units (Willems et al., 2011).  
 
Bacteriophages are the source of many different DNA elements, such as the genes 
encoding streptococcal superantigens (Beres et al., 2002). These phages also appear 
to be present in other bacterial species as well, for example the dairy bacterium 
Lactococcus lactis (Desiere et al., 2011), highlighting the widespread nature of 
horizontal genetic transfer between bacterial species. The presence of these phages 
increases the fitness of the bacterium to survive and in some cases act as virulence 
factors (Desiere et al., 2011). Therefore, S. pyogenes isolates have evolved to retain 
these beneficial phages encoding superantigens to evade and exploit host immune 
response, such as Treg and TH1-mediated immunity as discussed in Chapter 6 and 
ultimately prolong their lifespan within the host.  
 
As S. pyogenes is a human pathogen, it is not surprising that streptococcal 
superantigens have greatest affinity in the context of human TCR Vβ/HLA 
interactions, with approximately 100-1000 times less sensitivity to mouse T cells 
(Fleisher et al., 1991). T cells from non-human primates (e.g. rhesus monkeys) also 
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exhibit superantigen driven responses such as specific TCR Vβ expansion and pro-
inflammatory cytokine production upon stimulation with staphylococcal 
superantigens: SEA, SEB and SEC (Bawari and Ulrich, 1995). Increased sensitivity 
of non-primate T cells to superantigens may be due to strong affinity to specific TCR 
Vβ sequences (Bawari and Ulrich, 1995). This highlights that these pathogens have 
adapted to subvert specific host species immune cells and emphasises the importance 
of studying GAS-mediated responses in humanised transgenic models, primates, or 
human cells directly. 
 
Upon further investigation as discussed in Chapter 6, streptococcal SMEZ 
superantigen was found to induce Foxp3+ cells in my model of acute sepsis and upon 
removal of this superantigen, there was decrease in expression of Foxp3 gene and 
protein and increased bacteraemia (Figure 7.1). One possible mechanism that SMEZ 
could induce Tregs would be that this superantigen is favouring specific Vβ11+ T cell 
expansion (Unnikrishnan et al., 2002), particularly amongst Tregs expressing this Vβ 
allele. As SMEZ is a potent superantigen, it is not unfeasible that other T cell subsets 
will also be activated, however, qRT-PCR analysis of draining lymph node and 
spleens from HLA-DQ8.Aβ0 infected with H623 (smez-/-) did not show any 
significant changes in gene expression of t-bet, gata-3 or rorγt transcription factors 
for TH1, TH2 and TH17 cells respectively. 
 
While no effect of SMEZ on T cell associated transcription factors apart from foxp3 
was observed in my model of acute sepsis, interestingly, SPEA superantigen 
promoted TH1 induction via T-bet and lead to increased IFN-γ secretion, which may 
contribute to the well-documented downstream immunological effects observed 
during sepsis, known as the “cytokine storm” (Sriskandan and Altmann, 2008) 
(Figure 7.1). Perhaps, SPEA is inducing specific expansion of Vβ4, 5.1, 2 or 6+ T 
cells (Sriskandan et al., 2001), leading to activation and differentiation into IFN-γ 
producing TH1 cells. 
 
The expansion of Tregs would benefit GAS, due to enhanced suppression of key 
effector cells, which would normally hinder S. pyogenes colonisation and persistence 
within the host. From work presented in Chapter 3 and 4, it appears that effector cells 
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such as NK, CD8+ and γδ+ T cells may prove beneficial to the host in order to slow 
disease progression. The production of IL-17A from these cells may be the protective 
factor. It has been well documented that IL-17A can recruit neutrophils to the site of 
infection to lead to effective elimination of pathogens (Ye et al., 2001a; Cho et al., 
2010). Whether this is also the case in my model of sepsis is unknown, as the precise 
frequency of neutrophils was not directly assessed. However, preliminary IHC 
analysis of infected thigh tissue depleted of Foxp3+ cells in Chapter 3 showed 
decreased levels of MPO staining, a marker for neutrophil activation (Schmekel et al., 
1990). This suggests the removal of Foxp3+ cells, paradoxically correlated to 
decreased neutrophil activation, indicating that neutrophils play a very minor or 
indeed pathogenic role at the site of infection during acute infection. This requires 
further investigation. 
 
Other studies have indicated that innate signaling receptors such as TLRs can also 
influence intestinal homeostasis by activating components of adaptive immunity, in 
the form of Tregs. For example, TLR9 is able to recognise un-methylated CpG 
dinucleotides derived from gut flora commensals to negatively regulate the frequency 
of Tregs in the intestines, suppressing TH1 and TH17 effector function (Hall et al., 
2008). However, a study by Boulard and colleagues have shown that the loss of 
TLR2 does not affect intestinal inflammation and TLR2-/- mice have normal levels of 
functional Foxp3+ Tregs to suppress effector T cell mediated responses (Boulard et al., 
2010). This finding is reminiscent of my results showing the loss of TLR2 during 
acute S. pyogenes infection had little impact on bacterial burden and resistance to 
survive lethal challenge, however, the frequency of Tregs or transcriptional changes in 
foxp3 in this model was not assessed, requiring further investigation.  
 
In order for Treg induction to be initiated, S. pyogenes must be directly sensed by 
immune cells. Investigating the expression of the innate receptor TLR2 on Tregs 
during infection with smez-/- GAS isolate revealed a global decrease in tlr2 gene 
expression in the spleen and a reduction in the absolute numbers of Tregs expressing 
intracellular TLR2. This would suggest that S. pyogenes and SMEZ could modulate 
Treg-mediated immunity via interactions with TLR2 in this cell population (Figure 
7.1). The precise mechanism of signal transduction between TLR2 and Foxp3 is 
unknown. However, it has previously been shown by Hopkins and colleagues, that 
	   317	  
SMEZ can increase the surface expression of TLR2 on monocytes in a MHC class II 
dependent manner (Hopkins et al., 2008). The requirement of MHC class II for TLR2 
signaling and subsequent pro-inflammatory cytokine induction has also been 
demonstrated by Liu and colleagues (Liu et al., 2011b). Whether these proposed 
signaling pathways are also true in Tregs is unclear and more work is required to 
determine if TLR signaling pathways lead to the observed expansion or 
differentiation of Foxp3+ cells. 
 
Overall, the depletion of Foxp3+ mediated suppression does appear to contribute to 
the unleashing of control over innate and adaptive immune cell types as demonstrated 
by changes in cytokine production from innate and adaptive cells. However, taken 
together, during acute GAS infection there is an intimate interaction between host and 
invading pathogen. S. pyogenes has exquisitely evolved to retain bacteriophage-
derived superantigens to manipulate immune regulation mechanisms to promote its 
own endurance within the body at the expense of the ensuing immune response. 
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Figure 7.1: Schematic representation of the interaction between streptococcal 
superantigens and Tregs. 
A. Onset and progression of invasive streptococcal disease. During the initial infection with 
S. pyogenes, expression of superantigens is induced by the bacterium to evade and modulate 
the immune response. Secreted SPEA superantigen leads to TH1 differentiation and 
subsequent IFN-γ production, a hallmark cytokine of the so-called “cytokine storm” observed 
during sepsis. S. pyogenes produces SMEZ superantigen to induce Foxp3+ Tregs via TLR2 to 
suppress effector cells (NK, CD8+ and γδ+ T cells) to prevent bacterial clearance. The net 
effect is the propagation of pathogenic TH1 cells and ensuing disease pathology associated 
with un-controlled production of pro-inflammatory cytokines and suppression of protective 
immune cell types to allow S. pyogenes to replicate. 
B. Bacterial clearance and resolution of infection. If effective host immunity is mounted or 
the presence of secreted streptococcal superantigens neutralized by antibody responses, TH1 
cells will diminish in the absence of SPEA and protective effector cells such as NK, CD8+ 
and γδ+ T cells will be unleashed from Foxp3+ mediated control to lead to direct bacterial 
elimination by induced apoptosis or phagocytosis or production of cytokines such as IL-17A 
to enhance resolution of disease.  
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7.3  Future work 
 
This thesis has offered a number of new insights into effector and regulatory cell 
function during the initial stages of infection, with many intriguing questions raised 
from the work carried out. From the data presented, streptococcal superantigens 
appear to play a key role during infection through possible stimulation of Tregs. To 
further complement my findings, investigating the unknown phenotype of the Tregs 
during the time course of S. pyogenes infection would be crucial to determine 
whether these cells are exerting enhanced suppressive activity or whether they are 
dysfunctional. Since completing the studies for this thesis, work of others and myself 
in the lab has encompassed DNA microarray comparison of effector population from 
Treg depleted or wild-type infected mice. A number of different cell types have been 
shown here as potentially protective during GAS infection, including NK cells. This 
work is being further explored through the use of E4bp4 NK cell knockout mice.  
This approach could be extended to investigate other effector cells types as well. As 
S. pyogenes is a human pathogen, it would be essential to extend this work to human 
studies to see if there is a correlation between my finding utilising murine models 
with data looking directly at human responses.  
 
In summary, future work following this study continuing the characterisation of Tregs 
during S. pyogenes infection would include: 
 
• Detailed phenotypic analysis of Tregs such as cytokine profile (e.g. IL-10, TGF-β 
and IL-35), expression of markers associated with induction of apoptosis in target 
cells (e.g. granzyme A and B). Chemokine expression could be studied to 
understand the functional role of increased Tregs in the draining lymph node post 
GAS infection. The TCR Vβ repertoire of Tregs could also be determined to better 
comprehend superantigen-driven expansion during infection.  
 
• Investigate further the protective role of NK cells during GAS infection with the 
use of E4bp4-/- mice, which lack NK cells (Gascoyne et al., 2009). The role of 
other cell types such as neutrophils, known to produce IL-17A could also be 
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studied. From my findings, IL-9 appears to be important during S. pyogenes 
infection; it would be interesting to find out whether this cytokine is protective 
during GAS infection? 
 
• Addressing the nature of antigen-specific Tregs with a panel of streptococcal 
surface proteins (available in our lab through a collaboration with Dr G Grandi, 
Novartis, Siena) would offer insight into the contribution of specific immune 
targets in stimulating T cells during infection. This could lead to epitope mapping, 
followed by vaccine design.  
 
• Ultimately, the role of Tregs during S. pyogenes infection would be extended to 
look at human responses utilising PBMCs or in vitro cell cultures derived from 
tonsil samples taken from patients with recurrent GAS-associated tonsillitis. 
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